
<html lang="en"     class="pb-page"  data-request-id="0bd976b5-8653-4714-9d56-fe7005c7a530"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b01765;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-4;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action" /></meta><meta name="dc.Creator" content="Benoît  Bestgen" /></meta><meta name="dc.Creator" content="Irina  Kufareva" /></meta><meta name="dc.Creator" content="Weiguang  Seetoh" /></meta><meta name="dc.Creator" content="Chris  Abell" /></meta><meta name="dc.Creator" content="Rolf W.  Hartmann" /></meta><meta name="dc.Creator" content="Ruben  Abagyan" /></meta><meta name="dc.Creator" content="Marc  Le Borgne" /></meta><meta name="dc.Creator" content="Odile  Filhol" /></meta><meta name="dc.Creator" content="Claude  Cochet" /></meta><meta name="dc.Creator" content="Thierry  Lomberget" /></meta><meta name="dc.Creator" content="Matthias  Engel" /></meta><meta name="dc.Description" content="Protein CK2 has gained much interest as an anticancer drug target in the past decade. We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with ..." /></meta><meta name="Description" content="Protein CK2 has gained much interest as an anticancer drug target in the past decade. We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 28, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01765" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01765" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01765" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01765" /></link>
        
    
    

<title>2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01765" /></meta><meta property="og:title" content="2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0016.jpeg" /></meta><meta property="og:description" content="Protein CK2 has gained much interest as an anticancer drug target in the past decade. We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with first small molecule ligands based on the 4-(4-phenylthiazol-2-ylamino)benzoic acid scaffold. In the present work, structure optimizations guided by a binding model led to the identification of the lead compound 2-hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (27), showing a submicromolar potency against purified CK2α (IC50 = 0.6 μM). Furthermore, 27 induced apoptosis and cell death in 786-O renal cell carcinoma cells (EC50 = 5 μM) and inhibited STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945 (EC50 of 1.6 μM vs 5.3 μM). Notably, the potencies of our allosteric ligands to inhibit CK2 varied depending on the individual substrate. Altogether, the novel allosteric pocket was proved a druggable site, offering an excellent perspective to develop efficient and selective allosteric CK2 inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01765"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01765">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01765&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01765&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01765&amp;href=/doi/10.1021/acs.jmedchem.8b01765" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1817-1836</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01766" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01296" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Benoît Bestgen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benoît Bestgen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, 69373 Lyon Cedex 8, France</div><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany</div><div class="loa-info-affiliations-info">Institut National de la Santé et de la Recherche Médicale, U1036, 38000 Grenoble, France</div><div class="loa-info-affiliations-info">Commissariat à l’Energie Atomique, Institute of Life Sciences Research and Technologies, Biology of Cancer and Infection, 38000 Grenoble, France</div><div class="loa-info-affiliations-info">Unité Mixte de Recherche-S1036, University of Grenoble Alpes, 38000 Grenoble, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Beno%C3%AEt++Bestgen">Benoît Bestgen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2019-2113" title="Orcid link">http://orcid.org/0000-0002-2019-2113</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Irina Kufareva</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Irina Kufareva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Irina++Kufareva">Irina Kufareva</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9083-7039" title="Orcid link">http://orcid.org/0000-0001-9083-7039</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weiguang Seetoh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weiguang Seetoh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weiguang++Seetoh">Weiguang Seetoh</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1138-6581" title="Orcid link">http://orcid.org/0000-0002-1138-6581</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chris Abell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chris Abell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chris++Abell">Chris Abell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9174-1987" title="Orcid link">http://orcid.org/0000-0001-9174-1987</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rolf W. Hartmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rolf W. Hartmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus C2.3, 66123 Saarbrücken, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rolf+W.++Hartmann">Rolf W. Hartmann</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5871-5231" title="Orcid link">http://orcid.org/0000-0002-5871-5231</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruben Abagyan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruben Abagyan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruben++Abagyan">Ruben Abagyan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9309-2976" title="Orcid link">http://orcid.org/0000-0001-9309-2976</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc Le Borgne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc Le Borgne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, 69373 Lyon Cedex 8, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Le+Borgne">Marc Le Borgne</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1398-075X" title="Orcid link">http://orcid.org/0000-0003-1398-075X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Odile Filhol</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Odile Filhol</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut National de la Santé et de la Recherche Médicale, U1036, 38000 Grenoble, France</div><div class="loa-info-affiliations-info">Commissariat à l’Energie Atomique, Institute of Life Sciences Research and Technologies, Biology of Cancer and Infection, 38000 Grenoble, France</div><div class="loa-info-affiliations-info">Unité Mixte de Recherche-S1036, University of Grenoble Alpes, 38000 Grenoble, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Odile++Filhol">Odile Filhol</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1964-7958" title="Orcid link">http://orcid.org/0000-0003-1964-7958</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claude Cochet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claude Cochet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut National de la Santé et de la Recherche Médicale, U1036, 38000 Grenoble, France</div><div class="loa-info-affiliations-info">Commissariat à l’Energie Atomique, Institute of Life Sciences Research and Technologies, Biology of Cancer and Infection, 38000 Grenoble, France</div><div class="loa-info-affiliations-info">Unité Mixte de Recherche-S1036, University of Grenoble Alpes, 38000 Grenoble, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claude++Cochet">Claude Cochet</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1772-4270" title="Orcid link">http://orcid.org/0000-0002-1772-4270</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thierry Lomberget</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thierry Lomberget</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, 69373 Lyon Cedex 8, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Lomberget">Thierry Lomberget</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4071-0002" title="Orcid link">http://orcid.org/0000-0002-4071-0002</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Matthias Engel</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Engel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#325f531c575c55575e725f4a1c475c5b1f415353405e535c561c5657"><span class="__cf_email__" data-cfemail="1f727e317a71787a735f7267316a7176326c7e7e6d737e717b317b7a">[email protected]</span></a>. Phone: +49-681-302-70312.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Engel">Matthias Engel</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5065-8634" title="Orcid link">http://orcid.org/0000-0001-5065-8634</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01765&amp;href=/doi/10.1021%2Facs.jmedchem.8b01765" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1817–1836</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 28, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 November 2018</li><li><span class="item_label"><b>Published</b> online</span>28 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01765" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01765</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1817%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBeno%25C3%25AEt%2BBestgen%252C%2BIrina%2BKufareva%252C%2BWeiguang%2BSeetoh%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D4%26contentID%3Dacs.jmedchem.8b01765%26title%3D2-Aminothiazole%2BDerivatives%2Bas%2BSelective%2BAllosteric%2BModulators%2Bof%2Bthe%2BProtein%2BKinase%2BCK2.%2B2.%2BStructure-Based%2BOptimization%2Band%2BInvestigation%2Bof%2BEffects%2BSpecific%2Bto%2Bthe%2BAllosteric%2BMode%2Bof%2BAction%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1836%26publicationDate%3DFebruary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01765"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1664</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01765" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Benoît&quot;,&quot;last_name&quot;:&quot;Bestgen&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;Kufareva&quot;},{&quot;first_name&quot;:&quot;Weiguang&quot;,&quot;last_name&quot;:&quot;Seetoh&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;Abell&quot;},{&quot;first_name&quot;:&quot;Rolf&quot;,&quot;last_name&quot;:&quot;W. Hartmann&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;Abagyan&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Le Borgne&quot;},{&quot;first_name&quot;:&quot;Odile&quot;,&quot;last_name&quot;:&quot;Filhol&quot;},{&quot;first_name&quot;:&quot;Claude&quot;,&quot;last_name&quot;:&quot;Cochet&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Lomberget&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Engel&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1817-1836&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01765&quot;},&quot;abstract&quot;:&quot;Protein CK2 has gained much interest as an anticancer drug target in the past decade. We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with first small molecule ligands based on the 4-(4-phenylthiazol-2-ylamino)benzoic acid scaffold. In the present work, structure optimizations guided by a binding model led to the identification of the lead compound 2-hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (27), showing a submicromolar potency against purified CK2α (IC50 = 0.6 μM). Furthermore, 27 induced apoptosis and cell death in 786-O renal cell carcinoma cells (EC50 = 5 μM) and inhibited STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945 (EC50 of 1.6 μM vs 5.3 μM). Notably, the potencies of our allosteric ligands to inhibit CK2 varied depending on the individual substrate. Altogether, the novel allosteric pocket was proved a druggable site, offering an excellent perspective to develop efficient and selective &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01765&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01765" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01765&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01765" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01765&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01765" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01765&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01765&amp;href=/doi/10.1021/acs.jmedchem.8b01765" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01765" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01765" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01765%26sid%3Dliteratum%253Aachs%26pmid%3D30689946%26genre%3Darticle%26aulast%3DBestgen%26date%3D2019%26atitle%3D2-Aminothiazole%2BDerivatives%2Bas%2BSelective%2BAllosteric%2BModulators%2Bof%2Bthe%2BProtein%2BKinase%2BCK2.%2B2.%2BStructure-Based%2BOptimization%2Band%2BInvestigation%2Bof%2BEffects%2BSpecific%2Bto%2Bthe%2BAllosteric%2BMode%2Bof%2BAction%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D4%26spage%3D1817%26epage%3D1836%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/jmcmar.2019.62.issue-4/20190228/jmcmar.2019.62.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Protein CK2 has gained much interest as an anticancer drug target in the past decade. We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with first small molecule ligands based on the 4-(4-phenylthiazol-2-ylamino)benzoic acid scaffold. In the present work, structure optimizations guided by a binding model led to the identification of the lead compound 2-hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (<b>27</b>), showing a submicromolar potency against purified CK2α (IC<sub>50</sub> = 0.6 μM). Furthermore, <b>27</b> induced apoptosis and cell death in 786-O renal cell carcinoma cells (EC<sub>50</sub> = 5 μM) and inhibited STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945 (EC<sub>50</sub> of 1.6 μM vs 5.3 μM). Notably, the potencies of our allosteric ligands to inhibit CK2 varied depending on the individual substrate. Altogether, the novel allosteric pocket was proved a druggable site, offering an excellent perspective to develop efficient and selective allosteric CK2 inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The protein kinase CK2 has an exceptional position within the human kinome due to the significant proportion of the cellular phosphoproteome that can be attributed to this kinase.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This ubiquitously expressed protein kinase is involved in the activation of several pro-oncogenic pathways that are critical for cell proliferation, differentiation, and survival.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> CK2 overexpression has been widely correlated with a poor prognosis for patients with prostate cancer, breast carcinoma, glioblastoma, leukemias, gastric carcinoma, or renal cell carcinoma (see ref <a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> for a recent review). Indeed, CK2 promotes prosurvival and antiapoptotic signals by interfering with NF-κB, Wnt, and Akt pathways.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The crucial role of CK2 as a cancer driver makes it an interesting target in cancer therapy, and CK2 inhibition proved to be an effective method to induce tumor regression.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Optimal activity toward most protein substrates is reached when CK2 is assembled as a tetramer consisting of a dimer of regulatory subunits (CK2β) and two catalytic subunits, CK2α and/or CK2α′.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The catalytic subunit of CK2 is believed to be constitutively active, while the regulatory subunit modulates the selectivity toward a subset of substrate proteins.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> However, there is clear evidence that the catalytic CK2α subunit also exists as a population independent from CK2β in cells.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div><div class="NLM_p">Most of the known CK2 inhibitors bind to the ATP pocket and show an ATP-competitive behavior in enzymatic assays.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> CX-4945 (5-(3-chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic acid, silmitasertib) is one of the most potent CK2 inhibitors (IC<sub>50</sub> = 14 nM) and is currently in phase II clinical trials.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> X-ray crystallographic analysis revealed that CX-4945 binds to the ATP-binding pocket of CK2α in the active conformation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Looking for splicing regulation through phosphorylation of serine/arginine rich (SR) proteins, Kim et al. discovered a CK2-independent implication of CX-4945 in cellular regulation of SR (serine/arginine-rich) protein phosphorylation.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Indeed, this compound was found to be a strong inhibitor of Cdc2-like kinase-2 (Clk-2) (IC<sub>50</sub> = 4 nM), almost 4-fold more potent than toward CK2α (IC<sub>50</sub> = 14 nM).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, CX-4945 was identified as a potent inhibitor of the dual-specificity tyrosine-phosphorylation regulated kinases (Dyrk) 1A and 1B with IC<sub>50</sub> values of 6.8 and 6.4 nM, respectively.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> These off-target activities of silmitasertib, potentially causing adverse effects, underline the need for potent and more selective CK2 inhibitors.</div><div class="NLM_p">Therefore, continuous efforts are spent to identify alternative druggable sites on CK2. Given the large conformational flexibility of CK2α in the glycine-rich loop, the hinge/helix αD region, and the β4β5 loop at the CK2β interface,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> it is likely that several catalytically inactive conformations exist in the dynamic equilibrium, some of which can be stabilized by the binding of small molecule ligands to unique allosteric pockets. Indeed, one such small pocket, termed αD pocket, was identified on the large C-terminal lobe of the catalytic subunit.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The most elaborated αD pocket ligand, CAM4712 (MW = 453 g/mol), exhibited a moderate potency in the cell-free assay (IC<sub>50</sub> = 7 μM) and good efficacy in cells, while the selectivity over other kinases required further optimization.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Recently, we identified 2-aminothiazole derivatives as novel allosteric inhibitors of CK2α;<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> exemplarily shown are compounds <b>1</b>–<b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Using complementary methods, it was demonstrated that compound <b>3</b> binds in an allosteric pocket adjacent to the ATP binding site, between the glycine-rich loop and the αC-helix. A preliminary hit optimization led to compound <b>4</b>, exhibiting an IC<sub>50</sub> of 3.4 μM. However, it had yet to be shown that the new CK2 modulator class can be developed further into more potent drugs, which is often a limitation with allosteric target sites that were not evolutionary designed for high-affinity interactions with small molecules.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Therefore, we carried out a compound optimization guided by a binding model, as will be described below. The cellular effects of the allosteric CK2 modulators were investigated and compared to that of the ATP-competitive reference inhibitor CX-4945. Our results revealed a distinct modulation of several signal transduction pathways by our new compounds, attributable to their novel mode of action.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0001.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of CX-4945 and previously described allosteric inhibitors (<b>1</b>–<b>4</b>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The IC<sub>50</sub> values against human CK2α are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The aminothiazole core was prepared according to Hantzsch-type syntheses from 2-bromoacetophenones and thiourea intermediates (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Most of the 2-bromoacetophenones, <b>6a</b>–<b>n</b>, were commercially available or easily prepared, <b>6a</b>,<b>b</b>, from commercially available acetophenones, <b>5a</b>,<b>b</b>, through a bromination step, as described in the literature.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Thioureas <b>8a</b>–<b>g</b> were obtained after reaction of isothiocyanate intermediates with ammonia solution. The latter compounds were synthesized after reaction of the primary amine of aniline derivatives <b>7a</b>–<b>g</b> with carbon disulfide in the presence of triethylamine, followed by iodine oxidation.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Hantzsch syntheses were carried out in ethanol, and the resulting products were directly obtained as solids after their precipitation with water. Semipreparative HPLC, recrystallization or washing procedures led to the final products with a LC-UV (254 nm) purity higher than 95%. In one case, the ethyl ester derivative was obtained instead of the free carboxylic acid. A saponification step with NaOH was then carried out to obtain the desired product <b>10</b>. In this way, aminothiazoles (<b>9</b>–<b>16</b> and <b>18</b>–<b>27</b>) were obtained in varying yield, with the exception of compound <b>17</b> which was commercially available.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Hantzsch-Type Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Br<sub>2</sub>, CHCl<sub>3</sub>, 40 °C, 5 min or Br<sub>2</sub>, HBr 32% in AcOH, MeOH, 60 °C, 4 h; (ii) CS<sub>2</sub>, Et<sub>3</sub>N in THF/H<sub>2</sub>O 1/1, rt, 24 h, then I<sub>2</sub> in THF, 0 °C to rt, 3 h; (iii) NH<sub>4</sub>OH 30%, rt, 6 h; (iv) EtOH, reflux, 3–12 h.</p></p></figure><div class="NLM_p">Compound <b>30</b> could not be obtained through Hantzsch-type synthesis, maybe due to the spatial proximity between the primary amine and the carboxylic acid of 2-aminobenzoic acid, which prevents the formation of the isothiocyanate intermediate. Consequently, a nucleophilic substitution between 2-bromo-4-(3-nitrophenyl)thiazole (<b>28</b>) and 2-aminobenzoic acid (<b>29</b>) in hydrochloric acid was performed to obtain the desired 2-((4-(3-nitrophenyl)thiazol-2-yl)amino)benzoic acid (<b>30</b>) albeit in a low 2% yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compound <b>30</b> through Aromatic Nucleophilic Substitution<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) HCl<sub>(aq)</sub> 37%, 1,4-dioxane, 90 °C, 48 h.</p></p></figure><div class="NLM_p">Several modifications were considered on the carboxylic acid function (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The methyl ester derivative <b>31</b> was easily obtained through a classical acidic esterification step. Sulfonamide derivatives <b>32</b> and <b>33</b> were obtained according to peptide coupling procedures, whereas acetoxymethyl prodrugs <b>34</b>–<b>36</b> were accessed from carboxylic acid derivatives (<b>2</b> or <b>18</b> and <b>19</b>) and bromomethyl acetate through a previously described method.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Esters and Amides <b>31</b>–<b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) H<sub>2</sub>SO<sub>4</sub> 95% 3 drops, MeOH, reflux, 2 h. (ii) <b>32</b>: HATU, DIPEA, dry DMF, 30 min; NaH, RSO<sub>2</sub>NH<sub>2</sub>, dry THF, rt, 30 min; then rt, 4 h. <b>33</b>: EDC·HCl, DMAP, RSO<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 36 h. (iii) Bromomethyl acetate, Et<sub>3</sub>N, dry DMF, rt, 12 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Optimization of Potency</h3><div class="NLM_p">The preliminary structure–activity relationships (SARs) obtained from a small series of analogs of the original hit compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) had suggested that the three aryl ring system as well as the carboxylic acid function are needed for CK2α inhibition.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">In order to gain further insight into essential key features and to optimize the inhibitory potency, we synthesized a targeted set of derivatives to systematically explore the SAR around the new scaffold. First, we varied the position and number of the essential carboxyl function (compounds <b>9</b> and <b>30</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Although this did not further improve the activity, placing the carboxylic acid group in the <i>ortho</i>-position gave compound <b>30</b>, exhibiting a potency similar to that of the <i>para</i>-regioisomer <b>2</b>. This suggested that different protein side chains might be available for interaction with the carboxylate, which, however, cannot easily reach the carboxylate when it is in the <i>meta</i>-position, since compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was 4 times less potent than <b>2</b> or <b>30</b>. Changing the benzoic acid to a phenylacetic acid moiety (derivative <b>10</b>) was detrimental to the activity, indicative of a specific interaction of the carboxylate that is strictly dependent on the position. Altogether, the <i>p</i>-position appeared most suitable for the placement of the essential acidic function.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Evaluation of the Benzoic Acid Moiety in the Allosteric Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0012.gif" alt="" id="gr1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the mean of ≥2 experiments with SD ≤ 20% except for <b>1</b> and <b>30</b>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">SD ≤ 40%.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>d</sub> values determined by at least three runs, SD < 20%; n.d., not determined.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Included for comparison; previous hit compounds from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>.</p></div></div><div></div></div><div class="NLM_p">Next, we modified the second phenyl ring in the thiazole 4-position while keeping the <i>p</i>-benzoic acid moiety constant (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Various substituents were introduced to modulate the electron density of the phenyl ring: 3-methoxy (compound <b>11</b>), 4-methoxy (compound <b>12</b>), 2,4-dimethoxy (compound <b>13</b>), 2,4-dihydroxy (compound <b>14</b>), and 5-bromo-2-hydroxy (compound <b>15</b>). The rather flat SAR observed with these and previous derivatives indicated that the electron density of the phenyl ring was not relevant to the binding affinity. For example, compounds <b>12</b> and <b>14</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), carrying electron-donating substituents, exhibited the same potency as the 3-nitrophenyl derivative <b>1</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We also synthesized and tested the pyridinyl derivative <b>17</b> in order to explore more polar heterocycles with a ring dipole moment similar to the nitrophenyl compound. However, the measured IC<sub>50</sub> value of 19 μM was unfavorable, suggesting that the polar H-bond acceptor nitrogen in the ring is not complementary to the electrostatic potential of the binding pocket. In the previously synthesized compound <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), bromine as a large hydrophobic substituent had a positive impact on the potency, suggesting that an extension of the aromatic ring (cf. compounds <b>19</b>, <b>20</b>, <b>21</b>, <b>22</b>) or exchange by a bulky substituent such as <i>tert</i>-butyl (compound <b>16</b>) could be tolerated by the binding pocket and further increase the potency. The bulky <i>tert</i>-butyl moiety in <b>16</b> could not successfully replace the aromatic ring, as indicated by the strong decrease of the CK2α inhibition. On the other hand, some of the bicyclic aromatic systems were good substitutes for the potentially unstable or toxic 3-bromophenyl moiety, with the naphthalenyl derivative <b>19</b> being the most potent (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). More polar bicycles, such as chromene (<b>20</b>) and 2-benzofuran (<b>21</b>), were less active than <b>19</b>, underlining the preference of a hydrophobic aromatic moiety by this part of the binding pocket. Interestingly, a plain thiophene ring (<b>18</b>, IC<sub>50</sub> = 5 μM) led to an almost 2-fold increase of potency compared with the original phenyl congener (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). This promising result prompted us to introduce a 5-benzothiophene substituent; however, no significant improvement of the inhibitory activity was noted (<b>22</b>, IC<sub>50</sub> = 4 μM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of the Hydrophobic Moiety in the Thiazolyl-4 Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0013.gif" alt="" id="gr3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the mean of ≥2 experiments with SD ≤ 20%.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>d</sub> values determined by at least three runs, SD < 20%; n.d., not determined.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Included for comparison; previous hit compounds from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>.</p></div></div><div></div></div><div class="NLM_p">So far, the naphthalenyl derivative had shown the highest potency among the arylaminothiazole compounds. In order to obtain insight in the potential binding mode with CK2α, we started docking simulations using the available crystal structures of human CK2α and the CK2α<sub>2</sub>/β<sub>2</sub> holoenzyme. A prior inspection of the different PDB entries revealed a very high mobility of the P-loop, with the tip residue Tyr50 spanning a distance of more than 20 Å (Tyr-OH group) between its extreme locations in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UB7">4UB7</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JWH">1JWH</a>,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> with many intermediate positions showing up in the other CK2 crystal structures. In X-ray structures displaying active CK2α, Tyr50 occludes the lipophilic allosteric pocket (e.g., in the active symmetric CK2α<sub>2</sub>/β<sub>2</sub> tetramer in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MD7">4MD7</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and in the CK2α/AMPPNP complex in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NSZ">3NSZ</a><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a>). Contrastingly, the allosteric pocket was accessible and gave reasonable poses in our preliminary docking runs (data not shown) in the inactive conformations of CK2α, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ">3FWQ</a><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UB7">4UB7</a>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and the holoenzyme structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JWH">1JWH</a><a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DGL">4DGL</a>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> displaying distorted asymmetric CK2α2/β2 tetramers organized in inactive trimers.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Because it was more logical to correlate the alanine scanning mutational analysis (cf. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) with docking simulations both carried out with the isolated CK2α subunit, we selected PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ">3FWQ</a> for further docking studies. The docking poses with the 10 highest scores were evaluated for plausibility taking into account all previous results:<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (i) the binding pocket is located close to the ATP binding site without or with only marginal overlap; (ii) the binding pocket is delimited by residues Val73, Lys74, and Lys77; (iii) the observed pose fits the STD NMR based binding epitope mapping as previously determined with <b>4</b>. The most consistent binding model of <b>19</b> in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ">3FWQ</a> structure (chain B) displayed a tight fitting of the naphthalene ring in the hydrophobic pocket, with an additionally fixed orientation due to a double CH−π interaction of Gly177 with the naphthalene cycle (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A).</div><div class="NLM_p">The predicted tighter fitting of the naphthalene moiety imposed a higher constraint on the orientation of the residual molecule than was the case with compounds <b>1</b>–<b>3</b>, potentially shifting the relative position of the carboxylate. Given that an optimal ionic interaction was crucial for the overall binding affinity, it seemed worthwhile to revisit the carboxylic acid substitution on the 4-naphthalen-2-yl-thiazol-2-ylarylamines. Several derivatives <b>23</b>–<b>27</b> were synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and evaluated for their CK2α inhibitory properties. Compounds <b>23</b> without acid function and <b>24</b> with a 4-cyano substitution were lacking CK2α inhibition, thus confirming the necessity of an acidic function also in the naphthalenyl series. However, in contrast to the situation with the 3-nitrophenyl series (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), where the <i>p</i>-carboxyl derivative was substantially more potent than the <i>meta</i> analog (cf. compounds <b>1</b> and <b>2</b>), the carboxylic acid function was now even slightly preferred in the <i>meta</i> position (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, comparison between <b>25</b> and <b>19</b>). Because our docking simulation had predicted a CH−π interaction of the benzoic acid moiety with Val73, we aimed at increasing the π-electron density using a methoxy subsituent. Compared with the parent compound <b>25</b>, the 6-methoxy-3-benzoic acid analog <b>26</b> exhibited a reduced potency on CK2α, which might be explained by a steric clash of the methoxy group with the binding pocket, unfavorable conformational effects, or the decreased acidity of the essential carboxyl function. To avoid these potential problems while yet increasing both electron density and acidity of the benzoic acid moiety, we synthesized and tested the salicylic acid analog. Salicylic acid is known for its more than 16-fold stronger dissociation in water to the anion compared with benzoic acid,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> which should lead to an enhancement of the ionic interactions. In agreement with these considerations, the salicylic acid derivative <b>27</b> exhibited a 5-fold higher potency compared with the corresponding benzoic acid analog <b>19</b>, reaching a submicromolar IC<sub>50</sub> value (IC<sub>50</sub> = 0.6 μM, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As expected, docking simulations predicted a binding mode for <b>27</b> similar to that of <b>19</b>, with a slightly shifted orientation of the salicylic acid head (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Also considering the higher ionization rate, the binding pose obtained for <b>27</b> was in line with the observed increase in potency.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of the 4-Naphthalen-2-ylthiazol-2-ylarylamine Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0014.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the mean of ≥2 experiments with SD ≤ 20%.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>d</sub> values determined by at least three runs, SD < 20%; n.d., not determined.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Carboxyl Group Replacement and Prodrug Synthesis</h3><div class="NLM_p">Since our goal was to develop inhibitors suitable for cellular studies, we further considered bioisosteric replacements of the carboxylic acid as well as a prodrug approach in order to circumvent problems associated with poor cell permeabilities of carboxylic acid derivatives.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> A set of appropriate derivatives of <b>2</b> and <b>19</b> were synthesized and tested for their cellular efficacy using the clear cell renal cell carcinoma cell line 786-O (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). This cell line was chosen because it displays a strong decrease of cell viability following inhibition of the intracellular CK2.<a onclick="showRef(event, 'ref5 ref34'); return false;" href="javascript:void(0);" class="ref ref5 ref34">(5,34)</a> The acylsulfonamides <b>32</b> and <b>33</b>, which were supposed to preserve the acidic properties (p<i>K</i><sub>a</sub> ≈ 4–5), did not reach the cell-free potency of the parent compound <b>19</b>; however, the tosyl derivative <b>33</b> was more efficient than <b>19</b> in decreasing the cell viability at 25 μM (87% vs 43% reduction) and as efficient as the best compound of this series, <b>27</b>. Altogether, this might indicate a better cellular permeability of the methylbenzenesulfonamide <b>33</b> compared with the carboxylic acid derivatives, as could be expected based on previous experience.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> On the other hand, it could not be ruled out that off-target interactions in the cells in addition to CK2α inhibition could be responsible for the effects on cell viability. Therefore, in light of the markedly higher potency of <b>27</b> toward purified CK2α, we concluded that any effects exerted by this compound in cells will more likely be mediated through CK2 inhibition.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cell-Free and Cellular Effects of Selected Carboxylic Acid Bioisosteres and Prodrugs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0015.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Percent inhibition of recombinant CK2α, SD ≤ 10%.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values are the mean of ≥2 experiments with SD ≤ 20%.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Cells were incubated for 24 h with 25 μM of respective compound or DMSO as a control (set to 100% growth); SD < 10%.</p></div></div><div></div></div><div class="NLM_p last">The acetoxymethyl ester prodrugs<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>34</b>–<b>36</b> were expectedly less potent than the parent compounds under cell-free conditions; however, none of them led to an improvement in cellular efficacy compared with <b>19</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Further experiments evaluating the stability of these prodrugs have to be carried out before envisaging new derivatives.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Investigation of the Mode of Action</h3><div class="NLM_p">Before continuing cellular studies, it was important to verify that our optimized lead compound <b>27</b> still exhibits non-ATP competitive behavior in the CK2α inhibition assay, as demonstrated earlier for the starting compounds <b>2</b> and <b>4</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The Lineweaver–Burk analysis for <b>27</b> is depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, confirming a non-ATP competitive mechanism of CK2 inhibition, with a <i>K</i><sub>i</sub> value of 0.18 μM.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0002.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Enzymatic characterization of compound <b>27</b>. (A) Lineweaver–Burk inhibition plot of human recombinant CK2α by compound <b>27</b> at various concentrations: 0, 0.5, 1, 1.5, 2.5 μM. <i>K</i><sub>i</sub> was determined by plotting the slopes at varying inhibitor concentration from three independent experiments. (B) CK2α and CK2α<sub>2</sub>β<sub>2</sub> activity with two peptide substrates in the presence of increasing concentrations of compound <b>27</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It was also of interest to investigate a potential preference of the inhibitor for either the catalytic CK2α subunit or the holoenzyme CK2α<sub>2</sub>β<sub>2</sub>. In addition, two substrate peptides, representative of differentially recognized CK2 substrate proteins, were also tested: a CK2β-independent peptide substrate (peptide 29) and a CK2β-dependent peptide substrate (peptide M, derived from eIF2β). As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, the resulting three experimental settings gave similar results, indicating that (i) <b>27</b> is able to inhibit CK2α and the holoenzyme complex with the same potency, thereby ruling out any binding to the CK2α-β subunit interface pocket,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and (ii) the inhibition mode is not sensitive against extended substrate interactions as exerted by the eIF2β-derived peptide M.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Binding Characterization Using Surface Plasmon Resonance (SPR) and Isothermal Titration Calorimetry (ITC) Analysis</h3><div class="NLM_p">To determine the affinity constants of our allosteric inhibitors, we performed SPR analysis after coupling CK2α to the biochip surface. Intriguingly, the analysis revealed that the <i>K</i><sub>d</sub> values fully correlated with the IC<sub>50</sub> values of the respective compounds and moreover that both parameters even showed mostly similar absolute values, as indicated by the slope of 1.1 in the IC<sub>50</sub> vs <i>K</i><sub>d</sub> plot (<i>r</i><sup>2</sup> = 0.91, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Figure S1, Supporting Information</a>). Moreover, these findings corroborated that compound binding in the enzymatic inhibition assay was not subject to competition neither with ATP nor substrate peptide, which would have raised the IC<sub>50</sub> over the <i>K</i><sub>d</sub>. In addition, the close correlation between these parameters indicated that the binding of the allosteric ligands consistently leads to full inhibition, in line with the stabilization of an inactive conformation of CK2α.</div><div class="NLM_p">To complement the SPR analysis data, the thermodynamic characteristics of binding were determined for <b>27</b> using ITC (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Under these conditions, we obtained a <i>K</i><sub>d</sub> value of 0.11 μM (±15% SD) for <b>27</b>, which was somewhat lower than that found by SPR analysis (0.3 μM), possibly reflecting that the allosteric binding site was more accessible when the protein was in solution than when it was immobilized on the SPR sensor chip. The thermodynamic parameters calculated for Δ<i>H</i> (−6.9 ± 0.17 kcal/mol) and <i>T</i>Δ<i>S</i> (2.53 ± 0.29 kcal/mol) indicated a mainly enthalpy-driven binding, in agreement with the essential contribution of the ionic interaction to the binding affinity. As described above, the replacement of the carboxylate in <b>2</b> by the methyl ester function in <b>31</b> had abolished the inhibitory potency (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), consistent with a surface localization of the ester function, where water molecules strongly compete with the potential H-bond interactions of the ligand.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0003.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Thermodynamic characterization of binding of the allosteric inhibitor <b>27</b> to CK2α by ITC. The top panel shows the raw heat signal for successive injections of dissolved compound <b>27</b> into a CK2α solution at 25 °C. The bottom panel shows the integrated heats of injections corrected for heats of dilution, with the solid line corresponding to the best fit of the data to a bimolecular binding model. Shown is one experiment out of two that gave similar values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A comparison of the thermodynamic binding signature of <b>27</b> with that of the previously analyzed compound 4-(4-(pyridin-2-yl)thiazol-2-ylamino)benzoic acid (compound <b>9</b> in ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>) (Δ<i>H</i> = −13.3 kcal/mol; <i>T</i>Δ<i>S</i> = −6.6 kcal/mol; <i>K</i><sub>d</sub>(ITC) = 14.4 μM; <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Figure S2</a>) revealed that the increase in binding affinity achieved with <b>27</b> was solely attributable to the enhancement of hydrophobic interaction. The exchange of the too polar pyridin-2-yl moiety by naphthalenyl in <b>27</b> turned the negative entropic contribution to a positive one; however, it can also be seen that this was accompanied by a decrease in binding enthalpy. This phenomenon, known as enthalpy–entropy compensation, is not uncommon in lead optimization programs; based on previous experience, the thermodynamic profile of <b>27</b>, with its still predominant enthalpy term, is in an ideal range for a lead compound, predicting that the binding affinity can be further enhanced by increasing Δ<i>S</i>, which is usually more easily achieved than the subsequent optimization of enthalpy.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Mapping of the Allosteric Binding Site Targeted by <b>27</b></h3><div class="NLM_p">To this end, compound <b>27</b> was screened against a panel of 13 GST-CK2α mutants, possessing point mutations mainly located in the area of the binding site as described previously for compound <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Table S1</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Three CK2α mutants were significantly less sensitive toward inhibition by <b>27</b> than the other mutants or the wild type enzyme, Val73Ala, Lys77Ala, and His160Ala (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), and therefore selected for dose–response experiments. Compared with the wild type GST-CK2α (IC<sub>50</sub> = 0.6 μM), the IC<sub>50</sub> values of compound <b>27</b> were significantly elevated with the following three mutants: a 2.8-fold increase was noted for CK2α-Val73Ala (IC<sub>50</sub> = 1.7 μM), a 4.3-fold increase for CK2α-Lys77Ala (IC<sub>50</sub> = 2.6 μM), and a 1.7-fold increase for CK2α-His160Ala (IC<sub>50</sub> = 1 μM).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0004.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Percentage of inhibition of GST-CK2α (wild type (WT) or single alanine mutant) in the presence of compound <b>27</b> (1 μM); see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Table S1 (Supporting Information)</a> for explicit values. The error bars indicate ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The loss of potency toward the Val73Ala and Lys77Ala mutants can be explained on the basis of the predicted direct interaction of the respective side chains with <b>27</b>, thereby corroborating these docking results (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). The loss of the Lys74 side chain in the silent Lys74Ala mutant might be compensated by Lys77 and Arg191, which could rotate to the former positions of Lys74 and Lys77, respectively. Surprisingly, the exchange of Lys71 by Ala also did not influence the affinity of <b>27</b> to the binding pocket. It could be speculated that this exchange leads to a conformational rearrangement of side chains close to the binding pocket, e.g., involving Ser51 and Leu70, which could then replace the interactions formerly predicted for Lys71 by OH−π and/or CH−π contacts. It is noteworthy that a reduced activity against the Lys77Ala and His160Ala mutants was observed with both <b>27</b> and the previously described analog 4-[4-(3-bromophenyl)thiazol-2-ylamino]benzoic acid (compound <b>7</b> in ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>), corroborating that the compounds were targeting the same binding site. In addition, the repeated identification of His160 in our alanine scan strengthens the previous hypothesis that this residue, being too far away to contact the inhibitor itself, may play a role in the formation and/or stabilization of the allosteric pocket in the inactive conformation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In the original coordinates of the PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ">3FWQ</a>, His160 is relatively close to Tyr50 (∼5.6 Å), and a further convergence of the two residues was observed during the docking simulations (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Thus, at least in some conformations, His160 may have the function to fix the position of Tyr50, which forms one of the pocket walls, thus stabilizing the hydrophobic part of the allosteric binding site. Altogether, the CK2α mutant screening results supported the predicted binding model shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0005.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted binding mode of the naphthalen-2-yl-thiazolamine derivatives in the allosteric pocket. Compounds <b>19</b> (A) and <b>27</b> (B) (cyan) were docked into the hydrophobic pocket between the glycine-rich loop and the αC-helix in the crystallized inactive conformation of CK2α (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ">3FWQ</a>) using MOE. Residues that are potentially relevant to the binding are labeled. Residues that caused a drop of <b>27</b> inhibitory potency when mutated to alanine are colored in magenta. The carboxylate forms salt bridges with Lys74 and Lys77, while the naphthalene ring is buried in the mostly hydrophobic cavity, additionally anchored by cation−π (with Lys71) and/or CH−π interactions (with Gly177/Leu178). A further CH−π interaction was consistently observed between Val73 and the benzoic acid ring. Interactions are indicated by dashed lines (H-bonds/salt bridges, blue; CH−π interactions, brown). The green dashed line denotes the shortest distance between His160 and Tyr50.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Compound <b>27</b> Is a Selective Inhibitor of CK2</h3><div class="NLM_p">Selectivity is an important feature for kinase inhibitors to avoid off-target related side effects.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> Allosteric kinase inhibitors of the so-called type III target binding sites that are less conserved among the protein kinase families than the ATP binding pocket, usually providing high selectivity for the kinase of interest.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Therefore, a pronounced initial selectivity should be observed with an inhibitor targeting an allosteric site, even before optimization of this parameter. For our study, compound <b>27</b> was evaluated against a selected panel of 54 kinases (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Supporting Information Table S2</a>), including closely related kinases from the CMGC family as well as kinases from other branches of the kinome. Only four other kinases besides CK2α were inhibited by more than 50% in the presence of 5 μM <b>27</b> (8.3 times IC<sub>50</sub> against CK2α): ErbB2 (70%), Aurora-B (62%), Pim-1 (60%), and PI3K (53%). It was noteworthy that the main off-targets of CX-4945, Clk2 and Dyrk1A, were not or only weakly inhibited by <b>27</b>, respectively. The overall selectivity of <b>27</b>, as expressed by a Gini coefficient<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> of 0.78, was higher than that of CX-4945 (Gini coefficient of 0.67) and of other CK2 inhibitors described in the literature.<a onclick="showRef(event, 'ref34 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref42 ref43">(34,42,43)</a> The high selectivity of <b>27</b> is consistent with binding to an allosteric site that is not strongly conserved in the human kinome.</div><div class="NLM_p last">The selectivity of the most potent compound from our first study, 4-[4-(3-bromophenyl)thiazol-2-ylamino]benzoic acid (compound <b>7</b> in ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>), was only evaluated in a smaller screening panel (32 kinases); however, comparing the data from the 20 kinases common to both screenings, it can be concluded that our optimization efforts led to an improved selectivity: Under comparable screening conditions, the most strongly affected off-targets from the first study, GSK3β, CK1γ1, ACVR1 (ALK), and Clk4, which were all inhibited from 60% to 70%,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> displayed only 41%, 32%, 0%, and 23% inhibition, respectively, in the presence of <b>27</b>. Further kinases, including Clk2, Abl, CHK2, CDK1/cyclinB, and Clk1, which had shown some weak inhibition (from 20% to 30%) with the previous analogue,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> were not affected by <b>27</b>. Only Pim-1 and EGFR were inhibited slightly stronger by <b>27</b> (60% and 21%, respectively) than by the previous compound<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (43% and 0% inhibition, respectively).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Inhibition of CK2 Cellular Activity and Induction of Apoptosis by <b>27</b></h3><div class="NLM_p">CK2 inhibitors are known to decrease the viability of cancer cells.<a onclick="showRef(event, 'ref5 ref34'); return false;" href="javascript:void(0);" class="ref ref5 ref34">(5,34)</a> Consequently, to assess the cellular potency of <b>27</b>, the compound was screened against several cell lines of diverse tissue origins (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), and the half maximal growth-inhibitory concentration (GI<sub>50</sub>) was determined. Among the tested cancer cell lines, <b>27</b> exhibited GI<sub>50</sub> values ranging from 5 μM in the clear cell renal cell carcinoma cell line 786-O to 20 μM in prostate cancer cells (DU145). Importantly, compound <b>27</b> was clearly less toxic against the noncancerous (benign) kidney cells RPTEC, displaying a 5-fold higher GI<sub>50</sub> (27 μM) than against the kidney cancer cell line 786-O. This result is consistent with the dependency of cancer cells on a high level of CK2α expression for promoting cell growth and survival, as reported earlier.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Of note, the ATP-competitive inhibitor CX-4945, which is currently evaluated in clinical trials, was similarly effective against 786-O cancer cells (GI<sub>50</sub> = 6 μM, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Supporting Information Figure S3</a>) but showed an overall less pronounced tumor cell selectivity than <b>27</b> in our assays. For instance, CX-4945 was acting weaker against the tumor cell lines MCF7, DU145, and U138 than against RPTEC cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Supporting Information Figure S4</a>). Furthermore, while <b>27</b> showed no difference in potency between the nontumor fibrocystic mammary epithelial cell line MCF10A and the mammary tumor cell line MCF7, CX-4945 inhibited the cell growth of MCF10A cells even 5 times stronger than that of the MCF7 tumor cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Figure S4</a>). Overall, the in vitro tumor cell selectivity of <b>27</b> was higher than that of CX-4945.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effect of Compound <b>27</b> on Various Cell Lines<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissue of origin</th><th class="colsep0 rowsep0" align="center">cell name</th><th class="colsep0 rowsep0" align="center"><b>27</b> GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="left">786-O</td><td class="colsep0 rowsep0" align="left">5 (±2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">RPTEC</td><td class="colsep0 rowsep0" align="left">27 (±5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">MCF7</td><td class="colsep0 rowsep0" align="left">10 (±2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MCF10A</td><td class="colsep0 rowsep0" align="left">10 (±3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">H1299</td><td class="colsep0 rowsep0" align="left">9 (±4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">A549</td><td class="colsep0 rowsep0" align="left">12 (±3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">PC3</td><td class="colsep0 rowsep0" align="left">7 (±2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">DU145</td><td class="colsep0 rowsep0" align="left">20 (±6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glioblastoma</td><td class="colsep0 rowsep0" align="left">U138</td><td class="colsep0 rowsep0" align="left">13 (±3)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Cells were grown as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>, and GI<sub>50</sub> values were determined by linear interpolation after transformation to log[c] scale. Standard deviations from a minimum of two independent experiments are shown in parentheses.</p></div></div></div><div class="NLM_p">786-O cells are known to be resistant to classical chemotherapy and are frequently used as a model for clear cell renal cell carcinoma, as they share many characteristics with the clinical tumor cells.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Moreover, it was already demonstrated that the inhibition of CK2α efficiently blocks the growth of these renal cancer cells.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Therefore, the 786-O cell line was selected as a model for the in-depth characterization of the effects of <b>27</b> in cancer cells.</div><div class="NLM_p">First, the potency of <b>27</b> to inhibit the CK2 activity in intact cells was evaluated. Two protein substrates, Akt1 and α-catenin, known to be phosphorylated by CK2 on residues Ser129<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and Ser641,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> respectively, were used as a reporter of CK2 cellular activity. A concentration-dependent decrease in phosphorylation of Akt1 (Ser129) and α-catenin (Ser641) was observed after a 24 h treatment with compound <b>27</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). In addition, numerous dead cells were observed microscopically during the cell viability experiments (data not shown). Since the CK2-catalyzed phosphorylation of Akt1 on Ser129 was associated with a hyperactivation of the latter kinase,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> we analyzed whether Akt downstream signaling was also affected by our CK2 inhibitor. Indeed, the phosphorylation of the Akt1 phosphorylation site (Thr145) on p21/Waf1 was reduced in the presence of <b>27</b> in a concentration-dependent manner (EC<sub>50</sub> = 4.0 μM, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Altogether, we can conclude that compound <b>27</b> inhibited CK2 cellular activity, blocked Akt1 downstream signaling, and decreased cell viability.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0006.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>27</b> inhibits CK2-dependent substrate phosphorylations in cells and induces apoptosis. (A) Cellular inhibition of CK2 by compound <b>27</b>. 786-O cells were plated and incubated for 24 h in the presence of various concentrations of <b>27</b>. The phosphorylation status of the CK2 protein substrates was measured by Western blot analysis of cell extracts. Band intensities were quantified using ImageJ and normalized using anti-GAPDH antibody signals as loading control. <i><sup>a</sup></i>EC<sub>50</sub> calculated assuming that phosphorylation levels will approach zero with increasing concentrations of <b>27</b>. <i><sup>b</sup></i>EC<sub>50</sub> calculated assuming a basal level of nonresponsive P-α-catenin of 50% of the DMSO control. (B) Apoptosis induction upon compound <b>27</b> treatment. Appearance of cleaved PARP and decrease of survivin levels were observed by Western blot analysis of cell extracts. (C) <b>27</b> shows a higher potency to inhibit the STAT3 activation in 786-O cells than CX-4945.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In light of the inhibitory effects of <b>27</b> on the Akt1 activity, we surmised that the observed cell death is due to the induction of apoptosis. Two apoptosis markers, the appearance of cleaved PARP and the decrease in survivin protein levels, were analyzed by Western blotting. Both hallmarks of apoptosis induction were observed simultaneously after a 24 h treatment by compound <b>27</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). The concentration of <b>27</b> needed for apoptosis induction (about 4.6–4.9 μM) was consistent with the GI<sub>50</sub> (about 5 μM) and the cellular inhibition of CK2 activity (about 3 μM as monitored with P-Akt1(Ser129)), suggesting that CK2 inhibition was responsible for the induction of apoptosis and the subsequent cell death. Notably, the EC<sub>50</sub> of <b>27</b> for the inhibition of cellular CK2, at least according to the phospho-Akt1-Ser129 reporter signal (EC<sub>50</sub> = 3.2 μM), was only about 5 times higher than the IC<sub>50</sub> toward purified CK2α (0.6 μM) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). In contrast, under the same experimental conditions, we observed a 70-fold drop of potency with CX-4945 in living cells (IC<sub>50</sub> cellular CK2 ≈ 1 μM/IC<sub>50</sub> cell-free CK2 = 14.7 nM) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C), which is in the expected range for ATP-competitive inhibitors of kinases with <i>K</i><sub>m</sub>(ATP) values in the low μM range<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (<i>K</i><sub>m</sub>(ATP) for CK2 ≈ 10 μM <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>). Assuming that the cellular uptake of both compounds was comparable, the distinct behavior of <b>27</b> added to the evidence that it was acting in a non-ATP competitive manner in living cells. A similar behavior had been observed with CI-1040, a highly selective and non-ATP competitive inhibitor of MEK1/2, which showed a ratio of about 5- to 6-fold between enzymatic potency (IC<sub>50</sub> = 17 nM) and cellular efficacy (EC<sub>50</sub> = 100 nM).<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a></div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0007.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Potency of <b>4</b> but not of CX-4945 to inhibit CK2-catalyzed phosphorylations in cells depends on the substrate. 786-O cells were incubated with various concentrations of <b>4</b> (A, B) or CX-4945 (C, D) for 24 h, and the phosphorylation status of two protein substrates of CK2 was measured by Western blot analysis of the cell extracts. GAPDH was probed as loading control. (B, D) Western blot quantification was performed using ImageJ and fitted to a sigmoid equation using SigmaPlot to determine the EC<sub>50</sub> values. <i><sup>a</sup></i>Half-maximum decrease relating to the basal level of nonresponsive α-catenin phosphorylation (∼50% of the control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> The Inhibitory Potency of the Allosteric Ligands Is Substrate-Dependent</h3><div class="NLM_p">Given that more than 300 proteins were identified as potential CK2 substrates, it is fair to ask how the catalytic activity toward these numerous substrates is regulated.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although CK2β was found to modulate substrate specificity of the catalytic subunit upon complex formation,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> it is unlikely that this is the only physiological mechanism of controlling the CK2 activity.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> On the basis of our data and previous speculations about the potential role of Tyr50 in the transition between CK2 conformational states,<a onclick="showRef(event, 'ref29 ref50'); return false;" href="javascript:void(0);" class="ref ref29 ref50">(29,50)</a> it might be hypothesized that adoption of an inactive conformation is not only artificially induced by our ligands but also has a physiological, regulatory function. With postulation that either active or inactive states of CK2 could be stabilized in vivo by interaction with proteins or other effectors, the binding affinities of different CK2 conformations toward our allosteric inhibitors are expected to vary. In support of this, we obtained first hints from the finding that the phosphorylation of α-catenin-Ser641 in cells was less efficiently suppressed by <b>27</b> than the phosphorylation of Akt1-Ser129 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A), whereas both CK2 target sites were invariantly affected by the bona fide ATP-competitive inhibitor CX-4945 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). To rule out that this result was due to a particularity of <b>27</b>, we repeated the same experiment with the previous, structurally somewhat different compound <b>4</b> <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> that did not contain the naphthalene ring and carried a 3-carboxyphenyl instead of the salicylic acid (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). With <b>4</b>, the differential response of the substrate phosphorylations toward the inhibitor became even more evident (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B): While the phospho-α-catenin(Ser641) signal showed a steep initial decrease (EC<sub>50</sub> for the partial inhibition of 6 μM), about half of the phosphorylations could not be inhibited further by <b>4</b>, or this required much higher concentrations (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), basically confirming the tendency already seen with <b>27</b> (cf. <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). In contrast, the CK2-catalyzed Ser129-phosphorylation on Akt1 could be suppressed to a greater extent by <b>4</b>, exhibiting an overall EC<sub>50</sub> of 16 μM. The latter correlated well with the EC<sub>50</sub> = 25 μM for the growth inhibition of the 786-O cells by this compound (data not shown).</div><div class="NLM_p">Next, we aimed at corroborating the above observations by analyzing the phosphorylation of further known CK2 protein substrates (nucleolin, Six1, and the CK2β subunit), using defined cell-free conditions (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Compound <b>27</b> inhibited the Six1 and the CK2β phosphorylation with about the same efficacy (IC<sub>50</sub> ≈ 1 μM) as the canonical peptide substrate used in the previous dose–response assay (IC<sub>50</sub> = 0.6 μM), whereas a clear drop of potency was observed in the case of nucleolin (IC<sub>50</sub> ≈ 3.8 μM) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Comparable potency differences against Six1 and CK2β phosphorylations on the one hand (IC<sub>50</sub> ≈ 7–8 μM) and nucleolin phosphorylation on the other hand (IC<sub>50</sub> ≈ 42 μM) were also noted for compound <b>4</b>, just shifted to higher concentration ranges (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Figure S5A</a>). Under the same conditions, CX-4945 inhibited the phosphorylation of nucleolin, Six1, and the CK2β subunit with IC<sub>50</sub> values between 2 and 6 nM, in the range of that found with the peptide substrate (IC<sub>50</sub> = 5 nM).</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0008.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Differential effects of the allosteric inhibitor <b>27</b> and the ATP-site directed inhibitor CX-4945 on the CK2-catalyzed phosphorylation of nucleolin and cellular consequences. (A) Phophosphorylation of substrate proteins (● nucleolin, ■ GST-Six1, ▲ CK2β autophosphorylation) by CK2α<sub>2</sub>β<sub>2</sub> in the presence of various concentrations of compound <b>27</b> (upper panel) or the ATP-competitive inhibitor CX-4945 (lower panel). Graphs represent the average of two measurements. (B) HeLa pEGFP-CK2α cell imaging showing the subcellular localization of CK2α after 12 h treatment with DMSO, compound <b>27</b> (15 μM), or CX-4945 (8 μM). Nuclei were stained with Hoechst-33342, and merged images as well as GFP single channel were depicted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The above data were in agreement with the expectation that CX-4945 can enter and block the ATP-binding site in the fully active state of CK2 as well as in less active conformational states. On the other hand, our allosteric inhibitor might bind with reduced affinity when the fully active conformation of the kinase is stabilized through interaction with a particular substrate or other effectors, as it could be the case with nucleolin. Similarly, it can be speculated that a certain part of the cellular α-catenin pool might be associated with CK2 in a tight complex, thereby stabilizing the active conformation of the CK2α subunit and rendering it less sensitive toward allosteric inhibition. It should be noted that an interaction with substrates was proposed earlier by Lolli and Battistutta as a possible mechanism to activate the autoinhibited CK2α2/β2 oligomers found in cells.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p">Another major survival pathway that is constitutively upregulated in cancer with the participation of CK2 is the STAT3 pathway. Because of its importance as a target for potential anticancer therapies, we wondered whether the CK2 recruited to this pathway would be sensitive toward our allosteric inhibitors or show only a low response like in the case of nucleolin. STAT3-Tyr705 phosphorylation is the critical step in triggering the transcription factor activity of STAT3, while Ser727 phosphorylation is involved in the regulation of the phospho-Tyr705 levels.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Inhibition or overexpression of CK2 was shown to influence the Ser727 phosphorylation levels, but dependent on the cell type, either a positive<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> or negative<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> correlation with the Tyr705 phosphorylation status was observed. Because STAT3-Tyr705 phosphorylation had been consistently diminished in all cell types after treatment by CK2 inhibitors, we used an anti-phospho-STAT3-Tyr705 antibody to analyze the effects of <b>27</b> and CX-4945 in 786-O cells. Interestingly, <b>27</b> had a somewhat stronger impact on the STAT3-Tyr705 phosphorylation levels than CX-4945 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C), suggesting that the cellular CK2 pool engaged in the STAT3 activation pathway is (at least in the 786-O renal cancer cells) more amenable to allosteric inhibition than to ATP binding site-directed inhibition.</div><div class="NLM_p last">In summary, our results indicated that the sensitivity of cellular CK2 toward allosteric inibition varied to a considerable extent, depending on the protein substrate and/or the signaling complex environment.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Different Subcellular Localization of CK2 after Treatment of Cells by <b>27</b> vs CX-4945</h3><div class="NLM_p last">Next we analyzed whether the differing sensitivity of the CK2-mediated nucleolin phosphorylation toward allosteric vs ATP-competitive inhibition also translates into a different localization of the nucleolin/CK2 complex in cells after treatment with the two inhibitor types. Nucleolin is an abundant nucleolar protein known to bind to CK2α with very high affinity.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Due to this complex formation, a significant portion of CK2α in growing cells is usually concentrated in the nucleoli.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> CK2 phosphorylates the bipartite nuclear localization signal near the N-terminus of nucleolin, thus promoting the translocation of the nucleolin–CK2 complex to the nucleolus.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In consequence, the phosphorylation status of the CK2 phospho-acceptor site in nucleolin is expected to determine the subcellular localization of the high-affinity complex, which can be monitored by a fluorescent label. Using an EGFP-CK2α construct, we analyzed whether compound <b>27</b> and CX-4945 differently influence the subcellular localization of CK2α in HeLa cells. Indeed, we found that CX-4945 at 8 μM induced a significant translocation of EGFP-CK2α from the nucleoli to the nuclear matrix and the cytoplasm compartments (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B), whereas in the presence of compound <b>27</b>, the nucleolar localization pattern of EGFP-CK2α was mostly retained at a concentration of 15 μM. A comparable difference was also found with <b>4</b>, at a higher concentration (40 μM, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Figure S5B</a>). These results were consistent with the observed potency differences between compound CX-4945 and <b>4</b> or <b>27</b>, respectively, with respect to inhibition of the nucleolin phosphorylation in the cell free assay. Thus, the alternative mode of action of our compounds, which rendered its potency substrate-dependent, further translated into a different impact on the subcellular localization pattern of a high affinity CK2α/substrate complex when compared with the ATP-competitive inhibitor CX-4945.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Supported by a binding model (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), the previous hit compounds<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> were systematically optimized to achieve a submicromolar potency with compound <b>27</b>. Hence, we were able to demonstrate that the allosteric site targeted by our CK2 modulators is druggable and holds the potential for the development of high affinity ligands without having to critically increase the molecular weight. This view is particularly supported by the high cellular efficacy of <b>27</b>: Although the IC<sub>50</sub> of 0.6 μM was still about 40 times higher than that of the CK2 inhibitor CX-4945, which is currently in clinical phase II trials, the cellular potency of <b>27</b> was even superior in one of the analyzed CK2-dependent pathways, the STAT3 activation (EC<sub>50</sub> = 1.6 μM). The comparably high cellular activity of the allosteric inhibitor <b>27</b> can probably be attributed to the absence of binding competition with the high intracellular ATP levels (∼2–5 mM), which severly limited the cellular efficacy of CX-4945 on the other hand. As expected for an inhibitor targeting a non-ATP binding site, the kinase selectivity profile was also superior to that of CX-4945. Although the allosteric inhibitors were modulators of CK2 (also see below) with a varying impact on specific pathways rather than being total blockers of activity, the most important anticancer effects of CK2 inhibitors, i.e., induction of apoptosis and cell growth inhibition, were fully retained. Hence, there is an excellent perspective to develop highly efficient and selective allosteric CK2 inhibitors by optimizing further the binding affinity of the current lead compound <b>27</b>.</div><div class="NLM_p">Most notably, we could demonstrate that the potencies of <b>27</b> and <b>4</b> to inhibit CK2 depend on the individual substrate; particular pools of cellular CK2 that are engaged by different signaling pathways varied in their sensitivity toward allosteric but not ATP binding site-directed inhibition. In view of this particular outcome, the 2-aminothiazolylbenzoic acid derivatives will have a pharmacological profile distinct from any ATP-competitive CK2 inhibitor, which is worth being investigated further in in vivo models. It will also be interesting to examine whether fewer side effects can be expected for the novel compounds due to their less complete CK2 inhibition.</div><div class="NLM_p last">For most kinases, the equilibrium between the active and inactive state of the catalytic domain is regulated by phosphorylation of the activation loop. Nevertheless, it is increasingly recognized that even kinases that were a priori activated through phosphorylation exist in a dynamic equilibrium between multiple conformations in solution.<a onclick="showRef(event, 'ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63 ref64">(61−64)</a> Therefore, it can be assumed that CK2, which is not regulated at all by phosphorylation of a typical regulatory element on the catalytic subunit, also exists in a dynamic equilibrium between different conformations. Other kinases, for which the activation loop phosphorylation is not sufficient or not the only way to fully activate the catalytic domain, include PDK1<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and Aurora-A.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Notably, the active conformation in these cases is stabilized by transient interactions with substrate proteins (PDK1<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a>) or with a complex binding partner, which is the spindle-associated protein Tpx2 in the case of Aurora-A.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Analogously, our data provided first hints that the interactions of CK2 with its substrates might influence the conformational state of the catalytic domain; e.g., nucleolin, one of the substrates analyzed in the present study, might a priori stabilize the active conformation of CK2α, as it was found to counteract the allosteric inhibition by our compounds (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">S5</a>). On the other hand, a substrate-induced conformational stabilization is not necessarily sufficient to ensure steady phosphorylation of the substrate by CK2: in the case of nucleolin, it was reported that an additional interaction between the growth factor FGF-2 and CK2β in the CK2–nucleolin complex was required to trigger the phosphorylation.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Nevertheless, our novel ligands might be useful as tools to probe the conformational state of different CK2 populations bound in complexes with individual substrates, in order to elucidate the relevance of CK2 conformational stabilization for the regulation of its activity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry</h3><div class="NLM_p last">3-((4-(3-Nitrophenyl)thiazol-2-yl)amino)benzoic acid (<b>1</b>), 4-((4-(3-nitrophenyl)thiazol-2-yl)amino)benzoic acid (<b>2</b>), and 3-((4-(pyridin-2-yl)thiazol-2-yl)amino)benzoic acid (<b>17</b>) were purchased from Sigma-Aldrich. All commercially available chemicals, 2-bromo-1-(3-nitrophenyl)ethanone (<b>6c</b>), 2-bromo-1-(2,4-dimethoxyphenyl)ethanone (<b>6d</b>), 2-bromo-1-(2,4-dihydroxyphenyl)ethanone (<b>6e</b>), 2-bromo-1-(4-bromo-2-hydroxyphenyl)ethanone (<b>6f</b>), 1-bromo-3,3-dimethylbutan-2-one (<b>6g</b>), 2-bromo-1-(thiophen-3-yl)ethanone (<b>6h</b>), 2-bromo-1-(naphthalen-2-yl)ethanone (<b>6i</b>), 3-(2-bromoacetyl)-2<i>H</i>-chromen-2-one (<b>6j</b>), 1-(benzofuran-2-yl)-2-bromoethanone (<b>6k</b>), 1-(benzo[<i>b</i>]thiophen-5-yl)-2-bromoethanone (<b>6l</b>), other starting materials, and solvents were purchased from Sigma-Aldrich, Acros Organics, Fischer Scientific, or Alfa Aesar and were used without further purification. Reactions were monitored by thin layer chromatography (TLC silica gel 60 F254) purchased from Merck and observed under UV light (254 nm). Purification by semipreparative HPLC was carried out on an Agilent 1200 series HPLC system (Agilent Technologies) using an Agilent C18 column (30 mm × 100 mm/10 μm) as stationary phase and a gradient of water and acetonitrile as eluent. <sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained in dimethylsulfoxide-<i>d</i><sub>6</sub>, acetone-<i>d</i><sub>6</sub>, or CDCl<sub>3</sub> on a Bruker DRX-500 instrument, operating at 500 MHz for the <sup>1</sup>H and at 125 MHz for the <sup>13</sup>C at 300 K, using residual signal of deuterated NMR solvent as internal reference.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Chemical shifts are reported in parts per million (ppm), and multiplicity of the signals are indicated by lower-case letters (singlet s, doublet d, triplet t, quadruplet q, multiplet m, broad singlet br s, or combination of letters). DEPT 135 was used to determine carbon multiplicity. Analytical HPLC was performed using a SpectraSYSTEM (ThermoFisher) with a Macherey-Nagel C18 column (3 mm × 125 mm/5 μm). The purity of the final compounds was determined using HPLC-coupled electrospray ionization (ESI) mass spectrometry (Finnigan Surveyor MSQ Plus mass spectrometer, ThermoFisher). The UV traces at 254 nm thus obtained were used to calculate the purity of the final compounds, which was at least 95% in all cases. Melting points (mp) of solids were determined by SMP3 melting point apparatus from Bibby Sterling. High-resolution mass spectra (HRMS) were recorded on a Bruker MicroTOF Q mass spectrometer.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure 1 for the Preparation of 2′-Bromoacetophenone Analogs from Acetophenones<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></h3><div class="NLM_p last">Bromine (1 equiv) was added dropwise over 5 min to a stirred and warmed (40 °C) solution of acetophenone derivative (1 equiv) in CHCl<sub>3</sub>. At the end of the addition, the mixture was cooled down at room temperature; Et<sub>2</sub>O was then added, followed by a saturated aqueous solution of NaHCO<sub>3</sub>, and the resulting mixture was then stirred for 30 min. The organic layer was separated, washed with a saturated aqueous solution of NaHCO<sub>3</sub>, dried with Na<sub>2</sub>SO<sub>4</sub>, and filtered. The volatiles were removed under reduced pressure to afford the product as a solid, which was used in the next step without further purification.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2′-Bromo-3-methoxyacetophenone (<b>6a</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1, scale: 3-methoxyacetophenone (3.33 mmol, 459 μL), bromine (3.33 mmol, 172 μL), CHCl<sub>3</sub> (10 mL), Et<sub>2</sub>O (100 mL), to afford the title product as a yellow solid (3.33 mmol, 762 mg). Yield = quantitative. LC-UV purity = 75%. The compound was not ionized by ESI<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 3.70 (s, 3H, CH<sub>3</sub>-O), 4.3 (s, 2H, CH<sub>2</sub>-Br), 6.99 (ddd, <i>J</i> = 1.0; 2.5; 8.2 Hz, 1H), 7.24 (t, <i>J</i> = 8.2 Hz, 1H), 7.34 (dd, <i>J</i> = 1.6, 2.5 Hz, 1H), 7.39 (ddd, <i>J</i> = 1.0, 1.6, 7.6 Hz, 1H); spectral data are in accordance with literature data.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2′-Bromo-4-methoxyacetophenone (<b>6b</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1, scale: 4-methoxyacetophenone (3.33 mmol, 500 mg), bromine (3.33 mmol, 172 μL), CHCl<sub>3</sub> (10 mL), Et<sub>2</sub>O (100 mL), to afford the title product as a gray solid (3.33 mmol, 765 mg). Yield = quantitative. LC-UV purity = 78%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 229.31 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 3.89 (s, 3H, CH<sub>3</sub>-O), 4.40 (s, 2H, CH<sub>2</sub>-Br), 6.95–6.97 (m, 2H), 7.96–7.98 (m, 2H); spectral data are in accordance with literature data.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure 2 for the Preparation of Thiourea Analogs from Amines</h3><div class="NLM_p last">Carbon disulfide (3 equiv) was slowly added to a mixture of aminobenzoic acid derivative (1 equiv) in a 1/1 THF/H<sub>2</sub>O (0.7 mol·L<sup>–1</sup>) solvent mixture and Et<sub>3</sub>N (2.5 equiv). The resulting mixture was stirred at room temperature for 24 h. Then iodine (1.05 equiv) in THF (5 mL) was added dropwise at 0 °C and the mixture was stirred for 3 h. A 1 M HCl aqueous solution (7.5 mL) and Na<sub>2</sub>SO<sub>3</sub> (0.2 equiv) were added, and the stirring was continued for 15 min. The aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed twice with brine (25 mL) and dried on Na<sub>2</sub>SO<sub>4</sub>. After filtration, the volatiles were removed under reduced pressure to give the isothiocyanate intermediate as a slightly yellow solid, which was converted to the thiourea derivative by stirring at room temperature in NH<sub>4</sub>OH (100 mL) for 6 h. NH<sub>4</sub>OH refers to a 35% w/w ammonia solution in water. After removal of the solids by filtration on a sintered-glass funnel, the filtrate was concentrated to afford the thiourea product, which was used in the next step without further purification.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Phenylthiourea (<b>8a</b>)</h3><div class="NLM_p last">Phenyl isothiocyanate (8.37 mmol, 1 mL) was added to a solution of NH<sub>4</sub>OH<sub>(aq)</sub> (40 mL) and stirred at room temperature for 12 h. After removal of volatile in vacuo, the white residue was triturated in water and filtered to obtain the title product as a white solid (8.15 mmol, 1.24 g). Yield = 97%. LC-UV purity >99%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 153.1 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.12 (t, <i>J</i> = 7.3 Hz, 1H), 7.32 (t, <i>J</i> = 7.3 Hz, 2H), 7.40 (d, <i>J</i> = 7.6 Hz, 2H), 9.70 (s, 1H); spectral data are in accordance with literature data.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-(4-Thioureidophenyl)acetic Acid (<b>8b</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 2, scale: 2-(4-aminophenyl)acetic acid (3.31 mmol, 500 mg), to afford the title product as an off-white solid (3.1 mmol, 651 mg). Yield = 93%. LC-UV purity = 97%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 211.05 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 3.34 (s, 2H), 5.00 (br s, 3H), 7.15 (d, <i>J</i> = 8.5 Hz, 2H), 7.30 (d, <i>J</i> = 8.2 Hz, 2H), 7.58 (br s, 1H), 10.2 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 43.0, 122.7, 129.2, 133.4, 137.2, 173.9, 181.0. Mp = 139–141 °C.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-Thioureidobenzoic Acid (<b>8c</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 2, scale: 4-aminobenzoic acid (7.3 mmol, 1 g), to afford the title product as an off-white solid (7.3 mmol, 1.43 g). Yield = quantitative. LC-UV purity = 80%. The compound was not ionized by ESI<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.56–7.58 (m, 2H), 7.80–7.82 (m, 2H); spectral data are in accordance with literature data.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-(4-Cyanophenyl)thiourea (<b>8d</b>)</h3><div class="NLM_p last">A solution of 4-cyanophenyl isothiocyanate (6.24 mmol, 1 g) in NH<sub>4</sub>OH<sub>(aq)</sub> (80 mL) was stirred at room temperature for 12 h. After cooling at 0 °C, the mixture was filtered to afford the title product as an off-white solid (4.85 mmol, 860 mg). Yield = 78%. LC-UV purity >99%. The compound was not ionized by ESI<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.75 (m, 4H), 10.07 (s, 1H); spectral data are in accordance with literature data.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-Thioureidobenzoic Acid (<b>8e</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 2, scale: 3-aminobenzoic acid (7.3 mmol, 1 g), to afford the title product as an off-white solid (7.3 mmol, 1.43 g). Yield = quantitative. LC-UV purity = 96%. The compound was not ionized by ESI<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.28 (t, <i>J</i> = 7.8 Hz, 1H), 7.57–7.59 (m, 2H), 8.04 (d, <i>J</i> = 6.5 Hz, 1H), 8.92 (br s, 1H), 10.96 (br s, 1H). Mp = 183–185 °C.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-Methoxy-3-thioureidobenzoic Acid (<b>8f</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 2, scale: 3-amino-4-methoxybenzoic acid (7.3 mmol, 1.22 g), to afford the title product as an off-white solid (7.3 mmol, 1.65 g). Yield = quant. LC-UV purity = 97%. LC–MS (ESI+) <i>m</i>/<i>z</i> = 226.79 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 3.80 (s, 3H), 5.33 (br s, labile H), 6.97 (d, <i>J</i> = 8.8 Hz, 1H), 7.52 (br s, 1H), 7.70 (dd, <i>J</i> = 1.9, 8.5 Hz, 1H), 8.10 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 55.7, 110.4, 126.5, 127.5, 127.7, 129.6, 154.2, 169.3, 181.6. Mp = 241–243 °C.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Hydroxy-4-thioureidobenzoic Acid (<b>8g</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 2, scale: 4-aminosalicylic acid (7.3 mmol, 1.12 g), to afford the title product as an off-white solid (7.3 mmol, 1.55 g). Yield = quantitative. LC-UV purity = 70%. The compound was not ionized by ESI<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 6.73 (dd, <i>J</i> = 2.2, 8.2 Hz, 1H), 6.96 (s, 1H), 7.30–7.50 (br s, labile H), 7.60 (d, <i>J</i> = 8.2 Hz, 1H), 7.56–7.70 (br s, labile H), 10.00 (s, 1H). Mp = 185–187 °C, melting point is in accordance with lit. data (179–180 °C).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure 3 for the Preparation of 2-Aminothiazole Analogs</h3><div class="NLM_p last">An ethanolic solution of 2′-bromoacetophenone derivative and aryl thiourea derivative at eqimolar ratio, corrected with respect to LC-UV purity, was heated at 80 °C for 3–12 h (reaction monitoring by TLC). The mixture was then cooled down to room temperature, and water (twice more than EtOH v/v) was added. The mixture was stirred for 30 min and then filtered. The obtained solid was washed twice with water to afford the product as a solid. When necessary, purification was performed (i) by recrystallization or washing with boiling MeCN, (ii) by recrystallization or washing in H<sub>2</sub>O/MeOH, (iii) by HPLC preparative to obtain the product with LC-UV purity higher than 95%.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(3-Nitrophenyl)-<i>N</i>-phenylthiazol-2-amine (<b>9</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-3′-nitro-acetophenone (0.66 mmol, 161 mg), phenylthiourea (0.66 mmol, 100 mg), absolute EtOH (5 mL). After removal of the solvents under reduced pressure, water (10 mL) and MeOH (2 mL) were added. The pH of the solution was adjusted to 9 with solid Na<sub>2</sub>CO<sub>3</sub> and then stirred for 1 h. After filtration and washing of the residual solid with water (3 × 5 mL), the product was obtained as a yellow solid (0.66 mmol, 196 mg). Yield = quantitative. LC-UV purity = 99%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 298.06 for [M + H]<sup>+</sup>.<sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 6.99 (t, <i>J</i> = 6.9 Hz, 1H), 7.36 (t, <i>J</i> = 6.6 Hz, 2H), 7.65–7.71 (m, 4H), 8.14 (d, <i>J</i> = 7.3 Hz, 1H), 8.35 (d, <i>J</i> = 6.9 Hz, 1H), 8.69 (s, 1H), 10.39 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 105.6 (CH), 116.9 (2 × CH), 119.8 (CH), 121.4 (CH), 121.9 (CH), 129.0 (2 × CH), 130.1 (CH), 131.7 (CH), 135.9 (C), 140.9 (C), 147.6 (C), 148.2 (C), 163.5 (C). Mp = 136–138 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>12</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 298.0645; found, 298.0633.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(4-(4-(3-Nitrophenyl)thiazol-2-ylamino)phenyl)acetic Acid (<b>10</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-3′-nitroacetophenone (0.48 mmol, 117 mg), 2-(4-thioureidophenyl)acetic acid (0.48 mmol, 100 mg), EtOH (5 mL), to afford ethyl 2-(4-((4-(3-nitrophenyl)thiazol-2-yl)amino)phenyl) (0.41 mmol, 158 mg). Then, a mixture of ethyl 2-(4-((4-(3-nitrophenyl)thiazol-2-yl)amino)phenyl)acetate in THF (5 mL) and NaOH 0.5 M (1.3 mmol, 2.6 mL) was heated at 80 °C for 4 h. After removal of THF under reduced pressure, 1 M HCl<sub>(aq)</sub> was added until pH = 1. The product was obtained after filtration as a black solid (0.22 mmol, 78 mg). Yield = 73%. LC-UV purity = 96%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 355.74 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 3.53 (s, 2H), 7.24 (d, <i>J</i> = 8.2 Hz, 2H), 7.64 (d, <i>J</i> = 8.2 Hz, 2H), 7.69 (s, 1H), 7.73 (t, <i>J</i> = 7.9 Hz, 1H), 8.16 (d, <i>J</i> = 7.9 Hz, 1H), 8.37 (d, <i>J</i> = 7.9 Hz, 1H), 8.70 (s, 1H), 10.43 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 39.7 (CH<sub>2</sub>), 105.5 (CH), 116.9 (CH), 119.8 (CH), 122.0 (CH), 128.0 (C), 129.0 (CH), 130.2 (CH), 131.7 (CH), 135.9 (C), 139.5 (C), 147.6 (C), 148.2 (C), 163.6 (C), 172.8 (C). Mp = 205–207 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>14</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 356.0700; found, 356.0691.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-((4-(3-Methoxyphenyl)thiazol-2-yl)amino)benzoic Acid (<b>11</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-3′-methoxy-acetophenone (0.66 mmol, 152 mg), 4-thioureidobenzoic acid (0.51 mmol, 100 mg), EtOH (10 mL). Purification was performed by washing the residue with boiling MeCN (5 mL) and hot filtration to give a crude solid which was then purified by flash chromatography (cyclohexane/acetone 50/50) to afford the title product as a yellow solid (0.09 mmol, 29 mg). Yield = 17%. LC-UV purity = 96%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 327.10 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 3.83 (s, 3H), 6.91 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 7.36 (t, <i>J</i> = 8.2 Hz, 1H), 7.48 (s, 2H), 7.53 (d, <i>J</i> = 7.9 Hz, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 2H), 7.94 (d, <i>J</i> = 8.8 Hz, 2H), 10.69 (s, 1H), 12.56 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 55.0 (CH<sub>3</sub>), 104.5 (CH), 111.1 (CH), 113.2 (CH), 115.8 (CH), 118.1 (CH), 122.8 (C), 129.7 (CH), 130.8 (CH), 135.6 (C), 144.8 (C), 150.0 (C), 159.5 (C), 162.1 (C), 167.0 (C). Mp = 246–248 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 327.0798; found, 327.0786.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-((4-(4-Methoxyphenyl)thiazol-2-yl)amino)benzoic Acid (<b>12</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-4′-methoxy-acetophenone (0.71 mmol, 163 mg), 4-thioureidobenzoic acid (0.51 mmol, 100 mg), absolute EtOH (10 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford the title product as a gray solid (0.15 mmol, 49 mg). Yield = 29%. LC-UV purity = 96%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 327.09 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 3.80 (s, 3H), 7.00 (d, <i>J</i> = 7.3 Hz, 2H), 7.29 (s, 1H), 7.81 (d, <i>J</i> = 7.9 Hz, 2H), 7.87 (d, <i>J</i> = 7.9 Hz, 2H), 7.93 (d, <i>J</i> = 7.9 Hz, 2H), 10.65 (s, 1H), 12.54 (br s, 1H, O–H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 55.1 (CH<sub>3</sub>), 101.9 (CH), 114.0 (2 × CH), 115.9 (2 × CH), 122.7 (C), 127.1 (2 × CH), 127.2 (C), 130.8 (2 × CH), 145.0 (C), 150.1 (C), 158.9 (C), 162.1 (C), 167.0 (C). Mp = 266–268 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 327.0798; found, 327.0789.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-((4-(2,4-Dimethoxyphenyl)thiazol-2-yl)amino)benzoic Acid (<b>13</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(2,4-dimethoxyphenyl)ethanone (0.38 mmol, 100 mg), 4-thioureidobenzoic acid (0.58 mmol, 114 mg), EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford an off-white solid (0.25 mmol, 89 mg). Yield = 66%. LC-UV purity = 97%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 356.78 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.81 (s, 3H), 3.91 (s, 3H), 6.65–6.67 (m, 2H), 7.31 (s, 1H), 7.81 (td, <i>J</i> = 2.2, 9.1 Hz, 2H), 7.93 (td, <i>J</i> = 2.2 Hz, 8.83 Hz, 2H), 8.08–8.10 (m, 1H), 10.58 (s, 1H), 12.56 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-d6): δ = 55.2 (CH<sub>3</sub>), 55.5 (CH<sub>3</sub>), 98.5 (CH), 105.2 (CH), 105.5 (CH), 115.7 (CH), 115.8 (C), 122.5 (C), 130.2 (CH), 130.7 (CH), 145.0 (C), 146.2 (C), 157.7(C), 159.8 (C), 160.3 (C), 167.0 (C). Mp = 271–273 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 357.0904; found, 357.0902.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-((4-(2,4-Dihydroxyphenyl)thiazol-2-yl)amino)benzoic Acid (<b>14</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(2,4-dihydroxyphenyl)ethanone (0.43 mmol, 100 mg), 4-thioureidobenzoic acid (0.65 mmol, 127 mg), absolute EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford the title product as yellow solid (0.38 mmol, 125 mg). Yield = 89%. LC-UV purity = 95% LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 328.84 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 6.34 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.36 (d, <i>J</i> = 2.3 Hz, 1H), 7.26 (s, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 2H), 7.76 (d, <i>J</i> = 8.2 Hz, 1H), 7.94 (d, <i>J</i> = 8.8 Hz, 2H), 9.48 (br s, 1H), 10.67 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 102.2 (CH), 102.8 (CH), 107.1 (CH), 111.6 (C), 116.0 (CH), 122.9 (C), 129.0 (CH), 130.8 (CH), 144.7 (C), 147.6 (C), 156.2(C), 158.1 (C), 161.2 (C), 166.9 (C). Mp = 367–369 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 329.0591; found, 329.0581.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-((4-(5-Bromo-2-hydroxyphenyl)thiazol-2-yl)amino)benzoic Acid (<b>15</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(5-bromo-2-hydroxyphenyl)ethanone (0.34 mmol, 100 mg), 4-thioureidobenzoic acid (0.51 mmol, 100 mg), absolute EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford a yellow solid (0.31 mmol, 120 mg). Yield = 90%. LC-UV purity = 98%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 390.65/392.62 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 6.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.31 (dd, <i>J</i> = 2.5, 8.5 Hz, 1H), 7.64 (s, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 2H), 7.94 (d, <i>J</i> = 9.1 Hz, 2H), 8.12 (d, <i>J</i> = 2.5 Hz, 1H), 10.74 (s, 1H), 10.84 (s, 1H), 12.60 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 107.7 (CH), 110.3 (C), 116.0 (CH), 118.4 (CH), 122.1 (C), 123.1 (C), 130.3 (CH), 130.8 (CH), 130.9 (CH), 144.6 (C), 145.4 (C), 154.2 (C), 161.4 (C), 166.9 (C). Mp = 312–314 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>12</sub>BrN<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 390.9747; found, 390.9742.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-((4-(<i>tert</i>-Butyl)thiazol-2-yl)amino)benzoic Acid (<b>16</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 1-bromo-3,3-dimethylbutan-2-one (0.45 mmol, 60 μL), 4-thioureidobenzoic acid (0.41 mmol, 80 mg), absolute EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford the title product as a white solid (0.10 mmol, 28 mg). Yield = 25%. LC-UV purity = 96%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 277.04 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 1.28 (s, 9H), 6.53 (s, 1H), 7.70 (d, <i>J</i> = 8.5 Hz, 2H), 7.88 (d, <i>J</i> = 8.5 Hz, 2H), 10.48 (s, 1H), 12.49 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 29.5 (CH<sub>3</sub>), 34.3 (C), 100.5 (CH), 115.5 (CH), 122.3 (C), 130.6 (CH), 145.1 (C), 161.5 (C), 161.6 (C), 166.9 (C). Mp = 280–282 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 277.1005; found, 277.0995.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-((4-(Thiophen-3-yl)thiazol-2-yl)amino)benzoic Acid (<b>18</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(thiophen-3-yl)ethanone (0.41 mmol, 84 mg), 4-thioureidobenzoic acid (0.41 mmol, 80 mg), absolute EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration by hot filtration to afford the title product as a brown solid (0.20 mmol, 59 mg). Yield = 48%. LC-UV purity = 96%.LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 302.86 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.27 (s, 1H), 7.59 (m, 2H), 7.82 (m, 2H), 7.91 (m, 3H), 10.65 (s, 1H), 12.56 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 103.4 (CH), 115.9 (2 × CH), 121.8 (CH), 122.7 (C), 125.9 (CH), 126.8 (CH), 130.7 (2 × CH), 136.6 (C), 144.8 (C), 146.6 (C), 162.1 (C), 166.9 (C). Mp = 278–280 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>11</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> [M + H]<sup>+</sup>, 303.0256; found, 303.0245.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-((4-(Naphthalen-2-yl)thiazol-2-yl)amino)benzoic Acid (<b>19</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(naphthalen-2-yl)ethanone (0.41 mmol, 102 mg), 4-thioureidobenzoic acid (0.41 mmol, 80 mg), absolute EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford the title product as a brown solid (0.17 mmol, 59 mg). Yield = 42%. LC-UV purity = 95%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 346.57 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.53 (m, 2H), 7.60 (s, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 2H), 7.93 (d, <i>J</i> = 7.9 Hz, 2H), 7.98 (m, 3H), 8.04 (d, <i>J</i> = 8.5 Hz, 1H), 8.08 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 8.50 (s, 1H), 10.73 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 104.8 (CH), 116.0 (2 × CH), 122.8 (C), 123.9 (CH), 124.3 (CH), 126.0 (CH), 126.3 (CH), 127.5 (CH), 128.1 (CH),128.2 (CH), 130.8 (2 × CH), 131.7 (C), 132.4 (C), 133.1 (C), 144.8 (C), 150.1 (C), 162.3 (C), 167.0 (C). Mp = 294–296 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 347.0849; found, 347.0838.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-((4-(2-Oxo-2<i>H</i>-chromen-3-yl)thiazol-2-yl)amino)benzoic Acid (<b>20</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 3-(bromoacetyl)coumarin (0.45 mmol, 120 mg), 4-thioureidobenzoic acid (0.54 mmol, 106 mg), EtOH absolute (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford the title product as a yellow solid (0.33 mmol, 120 mg). Yield = 73%. LC-UV purity = 96%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 364.86 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.42 (t, <i>J</i> = 8.2 Hz, 1H), 7.46 (d, <i>J</i> = 8.5 Hz, 2H), 7.64 (t, <i>J</i> = 8.2 Hz, 1H), 7.88 (m, 3H), 7.99 (d, <i>J</i> = 8.8 Hz, 2H), 8.02 (d, <i>J</i> = 7.9 Hz, 1H), 8.75 (s, 1H), 10.75 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 110.8 (CH), 115.8 (CH), 116.2 (CH), 119.2 (C), 120.1 (C), 122.9 (C), 124.6 (CH), 129.0 (CH), 130.9 (CH), 131.7 (CH), 138.9 (CH), 143.6 (C), 144.6 (C), 152.3 (C), 158.7 (C), 161.7 (C), 167.0 (C). Mp = 343–345 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>13</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 365.0591; found, 365.0589.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-((4-(Benzofuran-2-yl)thiazol-2-yl)amino)benzoic Acid (<b>21</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 1-(benzofuran-2-yl)-2-bromoethanone (0.42 mmol, 100 mg), 4-thioureidobenzoic acid (0.50 mmol, 99 mg), absolute EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford a brown solid which was further purified by semipreparative HPLC (H<sub>2</sub>O/MeCN + 0.1% TFA: from 70/30 to 0/100 in 45 min) to afford the title product as a yellow solid (0.19 mmol, 63 mg). Yield = 45%. LC-UV purity = 99%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 336.96 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.28 (m, 2H), 7.34 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 7.45 (s, 1H), 7.62 (d, <i>J</i> = 7.6 Hz, 1H), 7.70 (d, <i>J</i> = 7.3, 1H), 7.84 (d, <i>J</i> = 8.8 Hz, 2H), 7.95 (d, <i>J</i> = 8.8 Hz, 2H), 10.83 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 103.0 (CH), 106.4 (CH), 110.9 (CH), 116.1 (CH), 121.4 (CH), 123.0 (CH), 123.2 (C), 124.7 (CH), 128.4 (C), 130.7 (CH), 141.4 (C), 144.6 (C), 151.6 (C), 154.1 (C), 163.0 (C), 166.9 (C). Mp = 296–298 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 337.0641; found, 337.0630.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-((4-(Benzo[<i>b</i>]thiophen-5-yl)thiazol-2-yl)amino)benzoic Acid (<b>22</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 1-(1-benzothiophen-5-yl)-2-bromo-1-ethanone (0.39 mmol, 100 mg), 4-thioureidobenzoic acid (0.59 mmol, 115 mg), absolute EtOH (5 mL). The obtained solid was stirred in boiling MeCN (20 mL) and filtered. The filtrate layer was concentrated, and the remaining solid was then dissolved in hot MeOH (10 mL). After cooling at room temperature, water (10 mL) was added and the obtained solid was filtered and washed with water (2 × 5 mL) to obtain the title product as a yellow solid (0.15 mmol, 51 mg). Yield = 38%. LC-UV purity = 95%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 352.76 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.48 (s, 1H), 7.56 (d, <i>J</i> = 5.4 Hz, 1H), 7.79 (d, <i>J</i> = 5.4 Hz, 1H), 7.88 (d, <i>J</i> = 8.8 Hz, 2H), 7.94–7.99 (m, 3H), 8.04 (d, <i>J</i> = 8.5 Hz, 1H), 8.48 (d, <i>J</i> = 1.6 Hz, 1H), 10.70 (s, 1H), 12.52 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 103.7 (CH), 115.9 (2 × CH), 120.7 (CH), 122.3 (CH), 122.7 (CH), 122.8 (C), 124.3 (CH), 128.0 (CH), 130.8 (3 × CH), 138.4 (C), 139.9 (C), 144.9 (C), 150.3 (C), 162.2 (C), 167.0 (C). Mp = 353–355 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> [M + H]<sup>+</sup>, 353.0413; found, 353.0400.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-(Naphthalen-2-yl)-<i>N</i>-phenylthiazol-2-amine (<b>23</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(naphthalen-2-yl)ethanone (0.66 mmol, 164 mg), phenylthiourea (0.66 mmol, 100 mg), absolute EtOH (15 mL). After water (25 mL) addition, the pH was adjusted to 9 with aqueous Na<sub>2</sub>CO<sub>3</sub> (1 M). The resulting mixture was cooled at 0 °C and the precipitate was filtered to afford the title product as a white solid (0.65 mmol, 195 mg). Yield = 98%. LC-UV purity> 99%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 302.85 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.00 (t, <i>J</i> = 7.3 Hz, 1H), 7.39 (t, <i>J</i> = 8.2 Hz, 2H), 7.48 (s, 1H), 7.52 (qi, <i>J</i> = 8.2 Hz, 2H), 7.79 (d, <i>J</i> = 7.6 Hz, 2H), 7.91 (d, <i>J</i> = 7.9 Hz, 1H), 7.95 (d, <i>J</i> = 8.8 Hz, 1H), 8.00 (d, <i>J</i> = 7.9 Hz, 1H), 8.07 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 10.32 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 103.6 (CH), 116.8 (CH), 121.2 (CH), 124.0 (CH), 124.1 (CH), 125.9 (CH), 126.3 (CH), 127.5 (CH), 128.0 (CH), 128.1 (CH), 129.0 (CH), 131.9 (C), 132.4 (C), 133.1 (C), 141.1 (C), 150.0 (C), 163.1 (C). Mp = 148–150 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>15</sub>N<sub>2</sub>S [M + H]<sup>+</sup>, 303.0950; found, 303.0939.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-((4-(Naphthalen-2-yl)thiazol-2-yl)amino)benzonitrile (<b>24</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-2′-acetonaphthone (1.41 mmol, 351 mg), 1-(4-cyanophenyl)thiourea (1.41 mmol, 250 mg), EtOH absolute (5 mL). The resulting mixture was cooled at room temperature, and aqueous Na<sub>2</sub>CO<sub>3</sub> (1 M) was added dropwise until pH = 8. After cooling at 0 °C,the precipitate was filtered and washed with H<sub>2</sub>O (2 × 5 mL) to afford the title product as a slightly yellow solid (462 mg, 1.41 mmol). Yield = quantitative. LC-UV purity = 99%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 327.94 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.51 (dt, <i>J</i> = 6.9, 1.3 Hz, 1H), 7.55 (dt, <i>J</i> = 6.9, 1.6 Hz, 1H), 7.61 (s, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 2H), 7.92 (d, <i>J</i> = 8.2 Hz, 1H), 7.96 (m, 3H), 8.01 (d, <i>J</i> = 7.9 Hz, 1H), 8.08 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 101.8 (C), 105.2 (CH), 116.8 (CH), 119.6 (C), 123.9 (CH), 124.3 (CH), 126.0 (CH), 126.4 (CH), 127.5 (CH), 128.1 (CH), 131.6 (C), 132.4 (C), 133.1 (C), 133.5 (2 × CH), 145.2 (C), 150.2 (C), 162.4 (C). Mp = 228–230 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>14</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 328.0903; found, 328.0894.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-((4-(Naphthalen-2-yl)thiazol-2-yl)amino)benzoic Acid (<b>25</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(naphthalen-2-yl)ethanone (0.40 mmol, 100 mg), 3-thioureidobenzoic acid (0.52 mmol, 102 mg), EtOH absolute (5 mL). The title product was obtained pure after filtration as a yellow solid (0.34 mmol, 118 mg). Yield = 86%. LC-UV purity = 98%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 346.80 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.49–7.56 (m, 4H), 7.59 (d, <i>J</i> = 7.6 Hz, 1H), 7.90–7.98 (m, 4H), 8.08 (dd, <i>J</i> = 1.9, 8.5 Hz, 1H), 8.55 (s, 1H), 8.77 (s, 1H), 10.56 (s, 1H), 13.01 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 104.1 (CH), 117.7 (CH), 120.8 (CH), 121.9 (CH), 123.8 (CH), 124.5 (CH), 126.0 (CH), 126.4 (CH), 127.5 (CH), 128.0 (CH), 128.1 (CH), 129.2 (CH), 131.5 (C), 131.8 (C), 132.4 (C), 133.2 (C), 141.3 (C), 149.8 (C), 162.7 (C), 167.4 (C). Mp = 275–277 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 347.0849; found, 347.0843.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-Methoxy-3-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic Acid (<b>26</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(naphthalen-2-yl)ethanone (1 mmol, 250 mg), 4-methoxy-3-thioureidobenzoic acid (1.3 mmol, 294 mg), EtOH absolute (25 mL). Product was obtained pure after filtration as a yellow solid (0.94 mmol, 353 mg). Yield = 94%. LC-UV purity = 97%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 376.82 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.97 (s, 3H), 7.14 (d, <i>J</i> = 8.5 Hz, 1H), 7.49–7.55 (m, 3H), 7.64 (dd, <i>J</i> = 2.2, 8.2 Hz, 1H), 7.91–7.96 (m, 3H), 8.07 (dd, <i>J</i> = 1.9, 8.5 Hz, 1H), 8.60 (d, <i>J</i> = 0.6 Hz, 1H), 9.70 (d, <i>J</i> = 2.2 Hz, 1H), 9.90 (s, 1H), 12.71 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 55.9 (CH<sub>3</sub>), 104.7 (CH), 110.0 (CH), 118.8 (CH), 122.9 (C), 123.5 (CH), 123.6 (CH), 124.5 (CH), 125.9 (CH), 126.3 (CH), 127.5 (CH), 127.9 (CH), 128.0 (CH), 129.9 (C), 131.8 (C), 132.3 (C), 133.2 (C), 149.1 (C), 150.8 (C), 162.7 (C), 167.5 (C). Mp = 256–258 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 377.0954; found, 377.0937.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-Hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic Acid (<b>27</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 3, scale: 2-bromo-1-(naphthalen-2-yl)ethanone (0.50 mmol, 124 mg), 2-hydroxy-4-thioureidobenzoic acid (0.70 mmol, 149 mg), EtOH (5 mL). Purification was performed by washing with boiling MeCN (5 mL) and hot filtration to afford a yellow solid (0.37 mmol, 133 mg). Yield = 73%. LC-UV purity = 96%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 362.84 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.19 (dd, <i>J</i> = 1.9, 8.8 Hz, 1H), 7.49–7.57 (m, 3H), 7.61 (s, 1H), 7.80 (d, <i>J</i> = 8.5 Hz, 1H), 7.92 (d, <i>J</i> = 7.9 Hz, 1H), 7.98 (d, <i>J</i> = 8.2 Hz, 2H), 8.07 (d, <i>J</i> = 8.5 Hz, 1H), 8.46 (s, 1H), 10.75 (s, 1H), 11.8 (br s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 103.0 (CH), 105.2 (CH), 105.6 (C), 108.4 (CH), 124.0 (CH), 124.2 (CH), 126.0 (CH), 126.5 (CH), 127.6 (CH), 128.1 (CH), 128.2 (CH), 131.3 (CH), 131.7 (C), 132.5 (C), 133.1 (C), 147.0 (C), 150.2 (C), 162.1 (C), 162.6 (C), 171.7 (C). Mp = 221–223 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 363.0798; found, 363.0786.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-((4-(3-Nitrophenyl)thiazol-2-yl)amino)benzoic Acid (<b>30</b>)</h3><div class="NLM_p last">A solution of HCl 37% (1 mL) and 1,4-dioxane (5 mL) containing 2-bromo-4-phenylthiazole (2.08 mmol, 500 mg) and 2-aminobenzoic acid (2.08 mmol, 286 mg) was heated at reflux for 60 h. After solvents removal, the residual solid was washed with water (5 mL) and then with cold acetone (5 mL) to obtain a white solid which was further purified by flash chromatography (cyclohexane/EtOAc, from 7/3 to 0/100) to obtain a second white solid containing 75% of product (by HPLC). After a second purification by preparative HPLC (H<sub>2</sub>O/MeCN–1% formic acid, from 70/30 to 0/100), the pure title product was obtain as a white solid (0.04 mmol, 12 mg). Yield = 2%. LC-UV purity = 97%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 297.08 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.07 (t, <i>J</i> = 7.9 Hz, 1H), 7.34 (t, <i>J</i> = 7.6 Hz, 1H), 7.45 (t, <i>J</i> = 7.6 Hz, 2H), 7.53 (s, 1H), 7.69 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.94 (d, <i>J</i> = 6.9 Hz, 2H), 8.02 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H), 8.62 (d, <i>J</i> = 8.5 Hz, 1H), 11.48 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 104.6 (CH), 113.7 (C), 116.9 (CH), 120.4 (CH), 125.7 (CH), 127.8 (CH), 128.6 (CH), 131.4 (CH), 134.1, 134.7 (CH), 142.9 (C), 150.3 (C), 161.8 (C), 170.0 (C). Mp = 95–97 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>12</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 342.0543; found, 342.0538.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Methyl 4-((4-(3-Nitrophenyl)thiazol-2-yl)amino)benzoate (<b>31</b>)</h3><div class="NLM_p last">Three drops of 95% H<sub>2</sub>SO<sub>4</sub> were added to a mixture of 4-((4-(3-nitrophenyl)thiazol-2-yl)amino)benzoic acid (<b>2</b>) (0.14 mmol, 46 mg) in MeOH (5 mL), and the mixture was then heated at reflux for 2 h. Na<sub>2</sub>CO<sub>3</sub> 1 M was then added until pH = 10–11, and MeOH was removed under vacuo. The obtained solid was filtered and washed with water (2 × 5 mL) to afford the title product as a yellow solid (0.14 mmol, 49 mg). Yield = quantitative. LC-UV purity = 97%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 356.01 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 3.82 (s, 3H), 7.74–7.84 (m, 4H), 7.96 (s, 2H), 8.17 (s, 1H), 8.40 (s, 1H), 8.71 (s, 1H), 10.83 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 51.7 (CH<sub>3</sub>), 107.0 (CH), 116.1 (2 × CH), 119.9 (CH), 121.8 (C), 122.1 (CH), 130.3 (CH), 130.6 (2 × CH), 131.9 (CH), 135.7 (C), 144.9 (C), 147.8 (C), 148.3 (C), 162.6 (C), 165.8 (C). Mp = 242–244 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>14</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 356.0700; found, 356.0695.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-(Methylsulfonyl)-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzamide (<b>32</b>)</h3><div class="NLM_p last">A solution of 4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (<b>19</b>) (0.23 mmol, 80 mg), HATU (0.28 mmol, 106 mg), and DIPEA (0.69 mmol, 120 μL) in dry DMF (2 mL) was stirred under N<sub>2</sub> for 30 min. And then it was added to a solution of NaH (0.92 mmol, 22 mg) and MeSO<sub>2</sub>NH<sub>2</sub> (1.15 mmol, 110 mg) in dry THF (2 mL) beforehand stirred at room temperature under N<sub>2</sub> for 30 min. The resulting mixture was stirred at room temperature for 4 h. After removal of solvents under vacuo, residue was purified by semipreparative HPLC (H<sub>2</sub>O/MeCN + 0.1% TFA: from 40/60 to 0/100 in 50 min) followed by a second purification by semipreparative HPLC (H<sub>2</sub>O/MeCN + 0.1% TFA: from 25/75 to 20/80 in 45 min) to obtain the title product as a white solid (0.026 mmol, 11 mg). Yield = 11%. LC-UV purity = 99%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 423.73 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ = 3.40 (s, 3H), 7.48 (s, 1H), 7.49–7.56 (m, 2H), 7.92 (d, <i>J</i> = 7.9 Hz, 1H), 7.96 (d, <i>J</i> = 8.6 Hz, 1H), 7.99 (d, <i>J</i> = 8.0 Hz, 1H), 8.01–8.04 (m, 2H), 8.08–8.12 (m, 3H), 8.56 (s, 1H), 9.89 (brs, 1H), 10.49 (brs, 1H). <sup>13</sup>C NMR (125.7 MHz, acetone-<i>d</i><sub>6</sub>) δ = 42.8 (CH<sub>3</sub>), 106.2 (CH), 118.3 (CH), 126.0 (CH), 126.2 (C), 126.8 (CH), 128.0 (CH), 128.3 (CH), 129.5 (CH), 130.1 (CH), 130.2 (CH), 131.8 (3 × CH), 134.0 (C), 135.1 (C), 135.7 (C), 153.1 (C), 167.1 (C). Mp = 240–242 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub>S<sub>2</sub> [M + H]<sup>+</sup>, 424.0784; found, 424.0784.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-((4-(Naphthalen-2-yl)thiazol-2-yl)amino)-<i>N</i>-tosylbenzamide (<b>33</b>)</h3><div class="NLM_p last">4-Methylbenzenesulfonamide (0.23 mmol, 39.5 mg), <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (0.46 mmol, 88 mg), and 4-dimethylaminopyridine (0.46 mmol, 56 mg) were added to a solution of 4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (<b>19</b>) (0.23 mmol, 80 mg) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The resulting mixture was stirred at room temperature under N<sub>2</sub> atmosphere for 36 h. NH<sub>4</sub>Cl<sub>(aq)</sub> (10 mL) was added and then H<sub>2</sub>O (10 mL). The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL). The combined organic layers were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a brown solid which was further purified by semipreparative HPLC (H<sub>2</sub>O/MeCN + 0.1% TFA: from 30/70 to 0/100 in 45 min) to obtain the title product as a white solid (0.026 mmol, 13 mg). Yield = 11%. LC-UV purity = 97%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 499.79 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ = 2.43 (s, 3H), 7.43 (dt, <i>J</i> = 7.9, 0.6 Hz, 2H), 7.52 (m, 2H), 7.91 (dd, <i>J</i> = 7.9, 0.6 Hz, 1H), 7.94 (d, <i>J</i> = 9.1 Hz, 1H), 7.99 (m, 8H), 8.09 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 8.54 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, acetone-<i>d</i><sub>6</sub>) δ = 22.5 (CH<sub>3</sub>), 118.2 (CH), 125.9 (CH), 126.1 (C), 126.8 (CH), 127.9 (CH), 128.3 (CH), 129.5 (CH), 130.1 (CH), 130.2 (CH), 130.2 (CH), 131.2 (CH), 131.7 (CH), 133.9 (C), 135.0 (C), 135.6 (C), 139.2 (C), 146.3 (C), 147.3 (C), 152.8 (C), 164.2 (C), 165.9 (C). Mp = 223–225 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>S<sub>2</sub> [M + H]<sup>+</sup>, 500.1044; found, 500.1046.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> General Procedure 4 for the Preparation of Acetoxymethyl Prodrug</h3><div class="NLM_p last">To a solution of the acid derivative (1 equiv) in dry DMF (5 mL) under N<sub>2</sub> flow were added triethylamine (5 equiv) and bromomethyl acetate (3 equiv). After stirring for 12 h, water (10 mL) was added and a precipitate occurred. The solid obtained after filtration was washed three times with water (5 mL) and further purified by semipreparative HPLC (H<sub>2</sub>O/MeCN: from 40/60 to 0/100 in 50 min) to obtain the desired product.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Acetoxymethyl 4-((4-(3-Nitrophenyl)thiazol-2-yl)amino)benzoate (<b>34</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 4, scale: 4-((4-(3-nitrophenyl)thiazol-2-yl)amino)benzoic acid (<b>2</b>) (0.26 mmol, 90 mg), Et<sub>3</sub>N (1.3 mmol, 183 μL), bromomethyl acetate (0.79 mmol, 78 μL), DMF (5 mL), then H<sub>2</sub>O (10 mL). After purification by semipreparative HPLC, the product was obtained as an orange solid (0.11 mmol, 46 mg). Yield = 43%. LC-UV purity >99%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 413.60 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 2.11 (s, 3H), 5.91 (s, 2H), 7.73 (t, <i>J</i> = 8.2 Hz, 1H), 7.80 (s, 1H), 7.86 (d, <i>J</i> = 8.8 Hz, 2H), 7.97 (d, <i>J</i> = 8.8 Hz, 2H), 8.16 (ddd, <i>J</i> = 8.2, 2.2, 1.0 Hz, 1H), 8.40 (dt, <i>J</i> = 8.2, 1.0 Hz, 1H), 8.70 (t, <i>J</i> = 1.9 Hz, 1H), 10.94 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 20.5 (CH<sub>3</sub>), 79.4 (CH<sub>2</sub>), 107.2 (CH), 116.2 (CH), 119.9 (CH), 120.4 (C), 122.1 (CH), 130.3 (CH), 131.1 (CH), 131.9 (CH), 135.7 (C), 145.6 (C), 147.8 (C), 148.3 (C), 162.4 (C), 164.0 (C), 169.4 (C). Mp = 169–171 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>16</sub>N<sub>3</sub>O<sub>6</sub>S [M + H]<sup>+</sup>, 414.0754; found, 414.0738.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Acetoxymethyl 4-((4-(Thiophen-3-yl)thiazol-2-yl)amino)benzoate (<b>35</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 4, scale: 4-((4-(thiophen-3-yl)thiazol-2-yl)amino)benzoic acid (<b>18</b>) (0.25 mmol, 77 mg), Et<sub>3</sub>N (1.25 mmol, 176 μL), bromomethyl acetate (0.76 mmol, 75 μL), DMF (5 mL), then H<sub>2</sub>O (10 mL). After purification by semipreparative HPLC, the product was obtained as an off-white solid (0.04 mmol, 14 mg). Yield = 16%. LC-UV purity = 96%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 374.66 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ = 2.10 (s, 3H), 5.96 (s, 2H), 7.15 (s, 1H), 7.51 (dd, <i>J</i> = 5.0, 3.2 Hz, 1H), 7.60 (dd, <i>J</i> = 5.0, 1.3 Hz, 1H), 7.93 (dd, <i>J</i> = 3.2, 1.3 Hz, 1H), 7.98 (d, <i>J</i> = 9.0 Hz, 2H), 8.03 (d, <i>J</i> = 9.0 Hz, 2H),, 9.83 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, acetone-<i>d</i><sub>6</sub>) δ = 21.6 (CH<sub>3</sub>), 81.2 (CH2), 105.0 (CH), 118.3 (CH), 123.2 (C), 123.8 (CH), 127.7 (CH), 128.1 (CH), 133.1 (CH), 139.0 (C), 148.0 (C), 149.5 (C), 164.2 (C), 166.2 (C), 171.7 (C). Mp = 136–138 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup>, 375.0387; found, 375.0388.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Acetoxymethyl 4-((4-(Naphthalen-2-yl)thiazol-2-yl)amino)benzoate (<b>36</b>)</h3><div class="NLM_p last">The reaction was carried out according to the general procedure 4, scale: 4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (<b>19</b>) (0.14 mmol, 50 mg), Et<sub>3</sub>N (0.7 mmol, 98 μL), bromomethyl acetate (0.43 mmol, 42 μL), DMF (5 mL), then H<sub>2</sub>O (10 mL). After purification by semipreparative HPLC, the product was obtained as an off-white solid (0.098 mmol, 41 mg). Yield = 70%. LC-UV purity = 95%. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> = 418.61 for [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz,acetone-<i>d</i><sub>6</sub>) δ = 2.11 (s, 3H), 5.98 (s, 2H), 7.47 (s, 1H), 7.49–7.55 (m, 2H), 7.91 (d, <i>J</i> = 8.2 Hz, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 8.03–8.06 (m, 5H), 8.12 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 8.59 (s, 1H), 9.90 (s, 1H). <sup>13</sup>C NMR (125.7 MHz, acetone-<i>d</i><sub>6</sub>) δ = 21.6 (CH<sub>3</sub>), 81.2 (CH<sub>2</sub>), 106.2 (CH), 118.3 (CH), 123.3 (C), 125.9 (CH), 126.8 (CH), 127.9 (CH), 128.2 (CH), 129.5 (CH), 130.1 (CH), 130.3 (CH), 133.2 (CH), 134.04 (C), 135.1 (C), 135.7 (C), 148.0 (C), 153.2 (C), 164.3 (C), 166.2 (C), 171.1 (C). Mp = 148–150 °C. HRMS (ESI<sup>+</sup>): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 419.0992; found, 419.0990.</div></div><div id="sec4_40_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Biology and Modeling. Radiometric Kinase Assays</h3><div class="NLM_p last">CK2 radiometric kinase assay was performed as previously described by Prudent et al.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Production and purification of GST-rhCK2α mutants were performed as described in the paper of Moucadel et al.,<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> and inhibitors were tested following the CK2 radiometric kinase assay procedure. ATP concentrations were 100 μM if not stated otherwise. Substrate dependent phosphorylation assays on nucleolin, GST-Six1 and CK2β autophosphorylation were performed following the CK2 radiometric kinase assay with CK2α<sub>2</sub>β<sub>2</sub>. The reaction was quenched by Laemmli buffer, and samples were submitted to electrophoresis in NuPAGE buffer (150 V for 75 min) using precast 4–12% gradient gel (Bio-Rad). Proteins were stained using Coomassie blue (InstantBlue, Expedeon, Cambridgeshire, U.K.) and phosphorylation status was measured using a phosphorimager PMI (BIO-RAD) and quantified with ImageJ. Nucleolin protein was purified as described previously.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The GST C-terminal HSIX1 fusion protein was induced and purified on glutathione beads as described.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div></div><div id="sec4_40_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Surface Plasmon Resonance Analysis</h3><div class="NLM_p last">SPR binding studies were performed using a Reichert SR7000DC instrument optical biosensor (Reichert Technologies) equipped with a CMD500m sensor chip obtained from XanTec Bioanalytics. CK2α was immobilized by a capturing approach using a monoclonal anti-GST antibody (27 kDa, clone GST-R 6G9 produced in rat, SAB4200055, Sigma-Aldrich). Prior to use, the anti-GST antibodies were purified twice by microdialysis at 4 °C (membrane: dialysis tubing benzoylated, 9 mm, D2272–5FT) in 10 mM sodium acetate, pH = 5. Anti-GST antibodies were immobilized using amine-coupling chemistry at 12 °C. The surfaces of all two flow cells were activated for 7 min with a 1:1 mixture of 0.1 M NHS (<i>N</i>-hydroxysuccinimide) and 0.1 M EDC (3-(<i>N</i>,<i>N</i>-dimethylamino)propyl-<i>N</i>-ethylcarbodiimide) at a flow rate of 10 μL/min. The antibody at a concentration of 30 μg/mL in 10 mM sodium acetate, pH 5.0, was immobilized at a density of 2000 RU on flow cell 2; flow cell 1 was left blank to serve as a reference surface. All the surfaces were blocked with a 3 min injection at 10 μL/min of 1 M ethanolamine, pH 8.0. GST tagged CK2α at a concentration of 50 μg/mL in 10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.005% (v/v) polysorbate 20, pH = 7.4, was captured at a density of 900 RU on flow cell 2.</div></div><div id="sec4_40_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>K</i><sub>d</sub> Determination by Surface Plasmon Resonance (SPR) Analysis</h3><div class="NLM_p last">To collect kinetic binding data, analytes in 10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.005% (v/v) polysorbate 20, 1% DMSO (v/v), pH = 7.4, were injected over the two flow cells at concentrations of 3, 1.5, 0.75, 0.375, 0.187, 0.094 μM at a flow rate of 25 μL/min and at a temperature of 25 °C. The complex was allowed to associate and dissociate for 120 s. Duplicate injections (in random order) of each sample and a buffer blank were flowed over the two surfaces. Affinities were obtained after treatments (DMSO calibration, blank and references subtractions) using the software Scrubber 2.0c.</div></div><div id="sec4_40_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Isothermal Titration Calorimetry (iTC)</h3><div class="NLM_p last">ITC experiments were performed on an Auto-iTC200 instrument (Malvern Instruments, U.K.) at 25 °C. 30 μM human CK2α<sup>1–335</sup> in 50 mM Tris-HCl, pH 8.5, 500 mM NaCl was placed into the cell. Compound <b>27</b> was used at a concentration of 300 μM and solubilized in the same buffer as CK2α<sup>1–335</sup>, with the ligand solution placed in the syringe. Each titration experiment consisted of 20 injections of 2 μL every 120 s, with stirring at 1000 rpm. A tiny first injection of 0.2 μL injection was performed during each titration, and the data were omitted from analysis. DMSO was used at a final concentration of 5% (v/v). Data were fitted to a one-site model and analyzed using the MicroCal Origin software.</div></div><div id="sec4_40_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Cell Culture</h3><div class="NLM_p last">The human kidney carcinoma cell line (786-O) was cultured in RPMI 1640 medium (Gibco) supplemented with 10% (v/v) fetal calf serum, penicillin (100 U/mL), and streptomycin (100 μg/mL) at 37 °C in 5% CO<sub>2</sub> atmosphere. Experiments were performed in RPMI 1640 (GIBCO) supplemented with 0.1% or 0.5% (v/v) fetal serum, penicillin (100 U/mL), and streptomycin (100 μg/mL) 37 °C in 5% CO<sub>2</sub> atmosphere.</div></div><div id="sec4_40_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Cell Viability Assay</h3><div class="NLM_p last">Cells were plated into 96-well plates at 1 × 10<sup>4</sup> cells/well. The following day, the culture medium was replaced with fresh medium containing the inhibitors at various concentrations. DMSO (0.25%) and cell free wells were used as control. After 24 h, an amount of 50 μL of (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) solution in PBS (5 mg/mL) was added in each well and the plate incubated for 2 h at 37 °C in 5% CO<sub>2</sub> atmosphere. Then, an amount of 80 μL of SDS (10%) containing 0.01 M HCl was added in each well and gently stirred at room temperature for 4 h. Absorbance was measured at 570 nm with a microplate reader (Infinite 200 Pro, Tecan). Results are the average of a triplicate experiments with a standard deviation lower than 10%. EC<sub>50</sub> was determined by linear interpolation after transformation to log[c] scale.</div></div><div id="sec4_40_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> CK2 Inhibition in Cells</h3><div class="NLM_p last">Cells were plated into 6-well plates at 3 × 10<sup>5</sup> cells/well. The following day, the culture medium was replaced with fresh medium containing the inhibitors at various concentrations or DMSO (0.5%) as reference. After incubation for 24 h, medium was removed, cells were washed with cold PBS and frozen at −80 °C. The phosphorylation status of two protein substrates of CK2 (α-catenin and Akt1) was measured by Western blot analysis of cell extracts.</div></div><div id="sec4_40_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Western Blot Analysis</h3><div class="NLM_p last">Primary antibodies were α-catenin (phospho-Ser641) antibody from SAB Signalway Antibody, Akt1-(phosphor-Ser129) antibody from Abgent, anti-GAPDH mAb from Ambion, Akt1, α-catenin, PARP, STAT3, and STAT3-(phosphor-Tyr705) antibodies from Cell Signaling, survivin antibody from Novus Biological, p21-(phosphor-Thr145) antibody from Abcam. Secondary antibodies were peroxidase-conjugated affinity pure goat anti-rabbit IgG (no. 111035003) and peroxidase-conjugated affinity pure goat anti-mouse IgG (no. 115035003) from Jackson Immuno Research. Cells were lysed in RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% DOC, and 1 mM EDTA) containing both protease- and phosphatase-inhibitor cocktails (Sigma-Aldrich; P8340, P2850, P5726). Cell homogenates were quantified using BCA protein assay kit (Thermo Scientific). SDS–PAGE was performed using precast 4–12% gradient gel (Bio-Rad) and submitted to electrophoresis in NuPAGE buffer (150 V for 75 min). Separated proteins at 20 μg/lane were transferred to PVDF membranes (100 V for 60 min). Blotted membranes were blocked during 1 h at room temperature with saturation buffer (1% BSA in Tris buffer saline 10 mM, Tween 0.1% (TBST)) and then incubated with primary antibody diluted in saturation buffer for 2 h or overnight. After 3 washes with TBST, secondary antibodies were added for 1 h. Luminata Forte Western HRP substrate (Millipore) was added, and membranes were read with Fusion Fx7 (PerkinElmer). Anti-GAPDH was used as loading control. Images were analyzed and band intensities were quantified using ImageJ software.</div></div><div id="sec4_40_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Molecular Docking Procedure</h3><div class="NLM_p last">In silico docking simulations were performed using MOE2010 as previously described.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Side chains in the putative allosteric binding pocket in PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ">3FWQ</a> (chain B) were defined as flexible within a radius of 8 Å. The initial binding poses were evaluated for compatibility with the experimental data reported previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Suitable poses were used to define a pharmacophore comprising the position of the naphthalenyl ring and of the benzoic acid ring within a tolerance radius of 1.3 Å and refined through targeted re-docking using the pharmacophore definition. The final docking pose with the highest score was optimized using energy minimization of the protein–ligand complex followed by the LigX routine implemented in MOE, using the OPLS-AA force field.</div></div><div id="sec4_40_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Cell Transfection and Imaging</h3><div class="NLM_p last">The cDNA encoding GFP-CK2α was subcloned from a pEGFP-CK2α vector into the pMSCV-puro plasmid.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Viral particles were produced and stable expression of EGFP-CK2α was accomplished by transfection of HeLa cells followed by 1 μg/mL puromycin-mediated selection. HeLa pEGFP-CK2α cells were seeded on Lab-Tek slides. After treatment with DMSO, compound <b>4</b> (40 μM), compound <b>27</b> (15 μM), or CX-4945 (8 μM) for 12 h, cells were washed twice with PBS and fixed with 4% paraformaldehyde for 10 min at 20 °C. Nuclei were stained with Hoechst-33342 (Sigma-Aldrich) for 30 min, and cells were washed with PBS (3 × 15 min). Images were acquired with a Zeiss ApoTome microscope and analyzed using Zen software. Fluorescence intensity, exposure times, and postacquisition modifications were kept identical for all the samples.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01765" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06734" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06734" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01765" class="ext-link">10.1021/acs.jmedchem.8b01765</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Inhibition of GST-CK2α wild type vs single alanine mutants by compound <b>27</b>; residual kinase activity in the presence of compound <b>27</b> (5 μM); correlation between biochemical inhibition (IC<sub>50</sub>) and binding affinity constants; isothermal titration calorimetry of CK2α with compound <b>9</b>; viability of the kidney cancer cell line 786-O in the presence of CX-4945; cell growth inhibition of various cell lines by <b>27</b> vs CX-4945; differential effects of the allosteric inhibitor <b>4</b> and the ATP-site directed inhibitor CX-4945 on the CK2-catalyzed phosphorylation of nucleolin and cellular consequences; <sup>1</sup>H and <sup>13</sup>C NMR spectra for compounds <b>8b</b>, <b>8f</b>, <b>9</b>–<b>16</b>, <b>18</b>–<b>27</b>, <b>30</b>–<b>36</b>; HPLC chromatograms and mass spectra of key compounds <b>12</b>, <b>15</b>, <b>18</b>, <b>19</b>, <b>22</b>, <b>25</b> and <b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">3D coordinates from docking model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">3D coordinates from docking model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf">jm8b01765_si_001.pdf (6.55 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_002.csv">jm8b01765_si_002.csv (2.2 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_003.pdb">jm8b01765_si_003.pdb (453.15 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_004.pdb">jm8b01765_si_004.pdb (453.66 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01765" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Engel</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5065-8634" title="Orcid link">http://orcid.org/0000-0001-5065-8634</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5e333f703b30393b321e3326702b3037732d3f3f2c323f303a703a3b"><span class="__cf_email__" data-cfemail="99f4f8b7fcf7fefcf5d9f4e1b7ecf7f0b4eaf8f8ebf5f8f7fdb7fdfc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoît Bestgen</span> - <span class="hlFld-Affiliation affiliation">Université
de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB,
EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé
Lyon-Est CNRS UMS3453, INSERM US7, 69373 Lyon Cedex 8, France</span>; 
    <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
National de la Santé et de la Recherche Médicale, U1036, 38000 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">Commissariat à
l’Energie Atomique, Institute of Life Sciences Research and
Technologies, Biology of Cancer and Infection, 38000 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">Unité
Mixte de Recherche-S1036, University of
Grenoble Alpes, 38000 Grenoble, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2019-2113" title="Orcid link">http://orcid.org/0000-0002-2019-2113</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina Kufareva</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School
of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9083-7039" title="Orcid link">http://orcid.org/0000-0001-9083-7039</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiguang Seetoh</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1138-6581" title="Orcid link">http://orcid.org/0000-0002-1138-6581</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris Abell</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9174-1987" title="Orcid link">http://orcid.org/0000-0001-9174-1987</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rolf W. Hartmann</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Design and Optimization, Helmholtz
Institute for Pharmaceutical Research Saarland (HIPS), Campus C2.3, 66123 Saarbrücken, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5871-5231" title="Orcid link">http://orcid.org/0000-0002-5871-5231</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben Abagyan</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School
of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9309-2976" title="Orcid link">http://orcid.org/0000-0001-9309-2976</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Le Borgne</span> - <span class="hlFld-Affiliation affiliation">Université
de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB,
EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé
Lyon-Est CNRS UMS3453, INSERM US7, 69373 Lyon Cedex 8, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1398-075X" title="Orcid link">http://orcid.org/0000-0003-1398-075X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Odile Filhol</span> - <span class="hlFld-Affiliation affiliation">Institut
National de la Santé et de la Recherche Médicale, U1036, 38000 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">Commissariat à
l’Energie Atomique, Institute of Life Sciences Research and
Technologies, Biology of Cancer and Infection, 38000 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">Unité
Mixte de Recherche-S1036, University of
Grenoble Alpes, 38000 Grenoble, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1964-7958" title="Orcid link">http://orcid.org/0000-0003-1964-7958</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claude Cochet</span> - <span class="hlFld-Affiliation affiliation">Institut
National de la Santé et de la Recherche Médicale, U1036, 38000 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">Commissariat à
l’Energie Atomique, Institute of Life Sciences Research and
Technologies, Biology of Cancer and Infection, 38000 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">Unité
Mixte de Recherche-S1036, University of
Grenoble Alpes, 38000 Grenoble, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1772-4270" title="Orcid link">http://orcid.org/0000-0002-1772-4270</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Lomberget</span> - <span class="hlFld-Affiliation affiliation">Université
de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB,
EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé
Lyon-Est CNRS UMS3453, INSERM US7, 69373 Lyon Cedex 8, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4071-0002" title="Orcid link">http://orcid.org/0000-0002-4071-0002</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">M.E. received funding from the Deutsche Forschungsgemeinschaft (DFG) (Grant EN381/2-3). B.B., T.L., and M.L.B. received financial support from “Région Rhône-Alpes” (Grant “ARC 1 Santé” 12-008707-01). B.B. received funding from the “Cancéropôle Lyon Rhône-Alpes Auvergne (CLARA)” for a fellowship “Mobilité Jeunes Chercheurs” (INCA Grant 2011-097). I.K. is supported by NIH R01 grants GM117424, AI118985, and NS102432, and NIH R35 HL135737A. R.A. is supported by NIH R01 GM071872. The authors acknowledge Heide Ford for the GST-Six1 plasmid.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AMPPNP</td><td class="NLM_def"><p class="first last">adenosine-5′-[(β,γ)-imido]triphosphate</p></td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">Ak mouse thymoma</p></td></tr><tr><td class="NLM_term">CK2</td><td class="NLM_def"><p class="first last">casein kinase 2</p></td></tr><tr><td class="NLM_term">Clk</td><td class="NLM_def"><p class="first last">Cdc2-like kinase</p></td></tr><tr><td class="NLM_term">Cpd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">Dyrk</td><td class="NLM_def"><p class="first last">dual specificity tyrosine-regulated kinase</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">EGFP</td><td class="NLM_def"><p class="first last">enhanced green fluorescent protein</p></td></tr><tr><td class="NLM_term">eIF2β</td><td class="NLM_def"><p class="first last">β subunit of eukaryotic translation initiation factor 2</p></td></tr><tr><td class="NLM_term">ErbB2</td><td class="NLM_def"><p class="first last">erythroblastic leukemia viral oncogene homolog 2</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal growth-inhibitory concentration</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">MEK1/2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase/extracellular signal-regulated protein kinase 1 and 2</p></td></tr><tr><td class="NLM_term">p21/Waf1</td><td class="NLM_def"><p class="first last">21 kDa protein wild-type activating fragment 1</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PDK1</td><td class="NLM_def"><p class="first last">3-phosphoinositide-dependent protein kinase 1</p></td></tr><tr><td class="NLM_term">Pim-1</td><td class="NLM_def"><p class="first last">proviral integration site for moloney murine leukemia virus 1</p></td></tr><tr><td class="NLM_term">Six1</td><td class="NLM_def"><p class="first last">sine oculis-related homeobox 1</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">SR</td><td class="NLM_def"><p class="first last">serine/arginine-rich</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">STD</td><td class="NLM_def"><p class="first last">saturation-transfer difference</p></td></tr><tr><td class="NLM_term">TPX2</td><td class="NLM_def"><p class="first last">targeting protein for Xklp2</p></td></tr><tr><td class="NLM_term">Wnt</td><td class="NLM_def"><p class="first last">wingless-related integration site</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 81 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">One-thousand-and-one substrates of protein kinase CK2?</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1096/fj.02-0473rev</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1096%2Ffj.02-0473rev" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=12631575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=349-368&author=F.+Meggioauthor=L.+A.+Pinna&title=One-thousand-and-one+substrates+of+protein+kinase+CK2%3F&doi=10.1096%2Ffj.02-0473rev"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">One-thousand-and-one substrates of protein kinase CK2?</span></div><div class="casAuthors">Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-368</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review.  CK2 (formerly termed "casein kinase 2") is a ubiquitous, highly pleiotropic and constitutively active Ser/Thr protein kinase whose implication in neoplasia, cell survival, and virus infection is supported by an increasing no. of arguments.  Here an updated inventory of 307 CK2 protein substrates is presented.  More than one-third of these are implicated in gene expression and protein synthesis as being either transcriptional factors (60) or effectors of DNA/RNA structure (50) or translational elements.  Also numerous are signaling proteins and proteins of viral origin or essential to virus life cycle.  In comparison, only a minority of CK2 targets (a dozen or so) are classical metabolic enzymes.  An anal. of 308 sites phosphorylated by CK2 highlights the paramount relevance of neg. charged side chains that are (by far) predominant over any other residues at positions n+3 (the most crucial one), n+1, and n+2.  Based on this signature, it is predictable that proteins phosphorylated by CK2 are much more numerous than those identified to date, and it is possible that CK2 alone contributes to the generation of the eukaryotic phosphoproteome more so than any other individual protein kinase.  The possibility that CK2 phosphosites play some global role, e.g., by destabilizing α helices, counteracting caspase cleavage, and generating adhesive motifs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6sfPYsWeCNrVg90H21EOLACvtfcHk0lh20UzQjDoEDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D&md5=0b11315ac9652e8866a1ed99a7010b68</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1096%2Ffj.02-0473rev&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.02-0473rev%26sid%3Dliteratum%253Aachs%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOne-thousand-and-one%2520substrates%2520of%2520protein%2520kinase%2520CK2%253F%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D349%26epage%3D368%26doi%3D10.1096%2Ffj.02-0473rev" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, D. W.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2: structure, regulation and role in cellular decisions of life and death</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1042/bj20021469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1042%2Fbj20021469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=12396231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFSht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2003&pages=1-15&author=D.+W.+Litchfield&title=Protein+kinase+CK2%3A+structure%2C+regulation+and+role+in+cellular+decisions+of+life+and+death&doi=10.1042%2Fbj20021469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: structure, regulation and role in cellular decisions of life and death</span></div><div class="casAuthors">Litchfield, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 (casein kinase II) has traditionally been classified as a messenger-independent protein serine/threonine kinase that is typically found in tetrameric complexes consisting of 2 catalytic (α and/or α') subunits and 2 regulatory β subunits.  Accumulated biochem. and genetic evidence indicates that CK2 has a vast array of candidate physiol. targets and participates in a complex series of cellular functions, including the maintenance of cell viability.  This review summarizes current knowledge of the structural and enzymic features of CK2, and discusses advances that challenge traditional views of this enzyme.  For example, the recent demonstrations that individual CK2 subunits exist outside tetrameric complexes and that CK2 displays dual-specificity kinase activity raises new prospects for the precise elucidation of its regulation and cellular functions.  This review also discusses a no. of the mechanisms that contribute to the regulation of CK2 in cells, and highlights emerging insights into the role of CK2 in cellular decisions of life and death.  In this latter respect, recent evidence suggests that CK2 can exert an anti-apoptotic role by protecting regulatory proteins from caspase-mediated degrdn.  The mechanistic basis of the observation that CK2 is essential for viability may reside in part in this ability to protect cellular proteins from caspase action.  Furthermore, this anti-apoptotic function of CK2 may contribute to its ability to participate in transformation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ-fky3V2xzbVg90H21EOLACvtfcHk0ljE_GENadCj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFSht78%253D&md5=6602b3ef19303264fd291bb57382be3c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2Fbj20021469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021469%26sid%3Dliteratum%253Aachs%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3DProtein%2520kinase%2520CK2%253A%2520structure%252C%2520regulation%2520and%2520role%2520in%2520cellular%2520decisions%2520of%2520life%2520and%2520death%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D369%26spage%3D1%26epage%3D15%26doi%3D10.1042%2Fbj20021469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chua, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheikh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Rassoul, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartshorn, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, I.</span></span> <span> </span><span class="NLM_article-title">CK2 in cancer: cellular and biochemical mechanisms and potential therapeutic target</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.3390/ph10010018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.3390%2Fph10010018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=18&author=M.+M.+Chuaauthor=C.+E.+Ortegaauthor=A.+Sheikhauthor=M.+Leeauthor=H.+Abdul-Rassoulauthor=K.+L.+Hartshornauthor=I.+Dominguez&title=CK2+in+cancer%3A+cellular+and+biochemical+mechanisms+and+potential+therapeutic+target&doi=10.3390%2Fph10010018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fph10010018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10010018%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DM.%2BM.%26aulast%3DOrtega%26aufirst%3DC.%2BE.%26aulast%3DSheikh%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DAbdul-Rassoul%26aufirst%3DH.%26aulast%3DHartshorn%26aufirst%3DK.%2BL.%26aulast%3DDominguez%26aufirst%3DI.%26atitle%3DCK2%2520in%2520cancer%253A%2520cellular%2520and%2520biochemical%2520mechanisms%2520and%2520potential%2520therapeutic%2520target%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26spage%3D18%26doi%3D10.3390%2Fph10010018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Addiction to protein kinase CK2: a common denominator of diverse cancer cells?</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.bbapap.2009.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19665589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=499-504&author=M.+Ruzzeneauthor=L.+A.+Pinna&title=Addiction+to+protein+kinase+CK2%3A+a+common+denominator+of+diverse+cancer+cells%3F&doi=10.1016%2Fj.bbapap.2009.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Addiction to protein kinase CK2: A common denominator of diverse cancer cells?</span></div><div class="casAuthors">Ruzzene, Maria; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">499-504</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  At variance with most oncogenic protein kinases whose malignancy is generally due to genetic alterations conferring constitutive activity, CK2 is a highly pleiotropic Ser/Thr protein kinase naturally endowed with constitutive activity and lacking gain-of-function mutants.  Nonetheless CK2 is abnormally elevated in a wide variety of tumors and there is strong evidence that it operates as a cancer driver by creating a cellular environment favorable to neoplasia: notably, CK2 plays a global role as an anti-apoptotic and pro-survival agent, it enhances the multi-drug resistance (MDR) phenotype, it assists the chaperone machinery which protects the "onco-kinome" and it promotes neo-angiogenesis.  Based on this scenario we propose that the implication of CK2 in neoplasia is an example of "non oncogene addiction", i.e. over reliance of the perturbed cellular signaling network on high CK2 level for its own maintenance.  Consistent with this, an ample spectrum of diverse types of cancer cells have been already shown to rely on high CK2 level for their survival, as judged from their response to specific CK2 inhibitors and silencing of endogenous CK2 catalytic subunits.  Remarkably, among these are cells whose cancer phenotype arises from the genetic alteration of onco-kinases (e.g. Abl and Alk) different from CK2 and insensitive to the CK2 inhibitors used in those expts.  Based on these premises, CK2 could represent a "multi-purpose" target for the treatment of different kinds of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryaRBb7mWsWrVg90H21EOLACvtfcHk0ljE_GENadCj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D&md5=a8088e387d13469774ce9aef315d0ae5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DAddiction%2520to%2520protein%2520kinase%2520CK2%253A%2520a%2520common%2520denominator%2520of%2520diverse%2520cancer%2520cells%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D499%26epage%3D504%26doi%3D10.1016%2Fj.bbapap.2009.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span> <span> </span><span class="NLM_article-title">CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">10288</span>– <span class="NLM_lpage">10298</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1158%2F0008-5472.CAN-10-1893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=21159648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10288-10298&author=A.+Siddiqui-Jainauthor=D.+Dryginauthor=N.+Streinerauthor=P.+Chuaauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=J.+Bliesathauthor=M.+Omoriauthor=N.+Huserauthor=C.+Hoauthor=C.+Proffittauthor=M.+K.+Schwaebeauthor=D.+M.+Ryckmanauthor=W.+G.+Riceauthor=K.+Anderes&title=CX-4945%2C+an+orally+bioavailable+selective+inhibitor+of+protein+kinase+CK2%2C+inhibits+prosurvival+and+angiogenic+signaling+and+exhibits+antitumor+efficacy&doi=10.1158%2F0008-5472.CAN-10-1893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Drygin, Denis; Streiner, Nicole; Chua, Peter; Pierre, Fabrice; O'Brien, Sean E.; Bliesath, Josh; Omori, Mayuko; Huser, Nanni; Ho, Caroline; Proffitt, Chris; Schwaebe, Michael K.; Ryckman, David M.; Rice, William G.; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10288-10298</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Malignant transformation and maintenance of the malignant phenotype depends on oncogenic and non-oncogenic proteins that are essential to mediate oncogene signaling and to support the altered physiol. demands induced by transformation.  Protein kinase CK2 supports key prosurvival signaling pathways and represents a prototypical non-oncogene.  In this study, we describe CX-4945, a potent and selective orally bioavailable small mol. inhibitor of CK2.  The antiproliferative activity of CX-4945 against cancer cells correlated with expression levels of the CK2α catalytic subunit.  Attenuation of PI3K/Akt signaling by CX-4945 was evidenced by dephosphorylation of Akt on the CK2-specific S129 site and the canonical S473 and T308 regulatory sites.  CX-4945 caused cell-cycle arrest and selectively induced apoptosis in cancer cells relative to normal cells.  In models of angiogenesis, CX-4945 inhibited human umbilical vein endothelial cell migration, tube formation, and blocked CK2-dependent hypoxia-induced factor 1 alpha (HIF-1α) transcription in cancer cells.  When administered orally in murine xenograft models, CX-4945 was well tolerated and demonstrated robust antitumor activity with concomitant redns. of the mechanism-based biomarker phospho-p21 (T145).  The obsd. antiproliferative and anti-angiogenic responses to CX-4945 in tumor cells and endothelial cells collectively illustrate that this compd. exerts its antitumor effects through inhibition of CK2-dependent signaling in multiple pathways.  Finally, CX-4945 is the first orally bioavailable small mol. inhibitor of CK2 to advance into human clin. trials, thereby paving the way for an entirely new class of targeted treatment for cancer.  Cancer Res; 70(24); 10288-98.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8s0Sa3hOwtbVg90H21EOLACvtfcHk0lgsxiqlG1mupA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK&md5=bfcfe06730e099719e752574a6636dfb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1893%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DChua%26aufirst%3DP.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DCX-4945%252C%2520an%2520orally%2520bioavailable%2520selective%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%252C%2520inhibits%2520prosurvival%2520and%2520angiogenic%2520signaling%2520and%2520exhibits%2520antitumor%2520efficacy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10288%26epage%3D10298%26doi%3D10.1158%2F0008-5472.CAN-10-1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermakowa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5320</span>– <span class="NLM_lpage">5331</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.19.5320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1093%2Femboj%2F20.19.5320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=11574463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5320-5331&author=K.+Niefindauthor=B.+Guerraauthor=I.+Ermakowaauthor=O.+G.+Issinger&title=Crystal+structure+of+human+protein+kinase+CK2%3A+insights+into+basic+properties+of+the+CK2+holoenzyme&doi=10.1093%2Femboj%2F20.19.5320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme</span></div><div class="casAuthors">Niefind, Karsten; Guerra, Barbara; Ermakowa, Inessa; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5320-5331</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The crystal structure of a fully active form of human protein kinase CK2 (casein kinase 2) consisting of two C-terminally truncated catalytic and two regulatory subunits has been detd. at 3.1 Å resoln. (Protein Data Bank code: 1JWH).  In the CK2 complex the regulatory subunits form a stable dimer linking the two catalytic subunits, which make no direct contact with one another.  Each catalytic subunit interacts with both regulatory chains, predominantly via an extended C-terminal tail of the regulatory subunit.  The CK2 structure is consistent with its constitutive activity and with a flexible role of the regulatory subunit as a docking partner for various protein kinases.  Furthermore it shows an inter-domain mobility in the catalytic subunit known to be functionally important in protein kinases and detected here for the first time directly within one crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIE9V_A2xVYrVg90H21EOLACvtfcHk0lgsxiqlG1mupA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVSrtQ%253D%253D&md5=4b3e3487991e63805aab7aa39c34f346</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.19.5320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.19.5320%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DErmakowa%26aufirst%3DI.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520human%2520protein%2520kinase%2520CK2%253A%2520insights%2520into%2520basic%2520properties%2520of%2520the%2520CK2%2520holoenzyme%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D5320%26epage%3D5331%26doi%3D10.1093%2Femboj%2F20.19.5320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, D. W.</span></span> <span> </span><span class="NLM_article-title">The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2β</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.7150/ijbs.1.67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.7150%2Fijbs.1.67" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=15951851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1eltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=67-79&author=A.+C.+Bibbyauthor=D.+W.+Litchfield&title=The+multiple+personalities+of+the+regulatory+subunit+of+protein+kinase+CK2%3A+CK2+dependent+and+CK2+independent+roles+reveal+a+secret+identity+for+CK2%CE%B2&doi=10.7150%2Fijbs.1.67"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2β</span></div><div class="casAuthors">Bibby, Ashley C.; Litchfield, David W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-79</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 (formerly casein kinase II), an enzyme that participates in a wide variety of cellular processes, has traditionally been classified as a stable tetrameric complex consisting of 2 catalytic CK2α or CK2α' subunits and 2 regulatory CK2β subunits.  While consideration of CK2 as a tetrameric complex remains relevant, significant evidence has emerged to challenge the view that its individual subunits exist exclusively within these complexes.  Here, the authors summarize biochem. and genetic evidence indicating that the regulatory CK2β subunit exists and performs functions independently of CK2 tetramers.  For example, unbalanced expression of catalytic and regulatory CK2 subunits has been obsd. in a variety of tissues and tumors.  Furthermore, localization studies including live cell imaging have demonstrated that while the catalytic and regulatory subunits of CK2 exhibit extensive co-localization, independent mobility of the individual CK2 subunits can also be obsd. within cells.  Identification of proteins that interact with CK2β in the absence of catalytic CK2 subunits reinforces the notion that CK2β has functions distinct from CK2 and begins to offer insights into these CK2-independent functions.  In this respect, the discovery that CK2β can interact with and modulate the activity of a no. of other serine/threonine protein kinases including A-Raf, c-Mos, and Chk1 is particularly striking.  The authors discuss the interactions between CK2β and these protein kinases with special emphasis on the properties of CK2β that mediate these interactions and on the implications of these interactions in yielding new prospects for elucidation of the cellular functions of CK2β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMBEnJw_vl8bVg90H21EOLACvtfcHk0lgsxiqlG1mupA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1eltb8%253D&md5=4d1c203b8dee2aa908590eb3b0a34f71</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.7150%2Fijbs.1.67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.1.67%26sid%3Dliteratum%253Aachs%26aulast%3DBibby%26aufirst%3DA.%2BC.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3DThe%2520multiple%2520personalities%2520of%2520the%2520regulatory%2520subunit%2520of%2520protein%2520kinase%2520CK2%253A%2520CK2%2520dependent%2520and%2520CK2%2520independent%2520roles%2520reveal%2520a%2520secret%2520identity%2520for%2520CK2%25CE%25B2%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2005%26volume%3D1%26spage%3D67%26epage%3D79%26doi%3D10.7150%2Fijbs.1.67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Dynamic localization/association of protein kinase CK2 subunits in living cells: a role in its cellular regulation?</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>973</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2002.tb04648.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1111%2Fj.1749-6632.2002.tb04648.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=973&publication_year=2002&pages=272-277&author=V.+Martelauthor=O.+Filholauthor=A.+Nuedaauthor=C.+Cochet&title=Dynamic+localization%2Fassociation+of+protein+kinase+CK2+subunits+in+living+cells%3A+a+role+in+its+cellular+regulation%3F&doi=10.1111%2Fj.1749-6632.2002.tb04648.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2002.tb04648.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2002.tb04648.x%26sid%3Dliteratum%253Aachs%26aulast%3DMartel%26aufirst%3DV.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DDynamic%2520localization%252Fassociation%2520of%2520protein%2520kinase%2520CK2%2520subunits%2520in%2520living%2520cells%253A%2520a%2520role%2520in%2520its%2520cellular%2520regulation%253F%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2002%26volume%3D973%26spage%3D272%26epage%3D277%26doi%3D10.1111%2Fj.1749-6632.2002.tb04648.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 and its role in cellular proliferation, development and pathology</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10197447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK1MXit1antr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=391-408&author=B.+Guerraauthor=O.+G.+Issinger&title=Protein+kinase+CK2+and+its+role+in+cellular+proliferation%2C+development+and+pathology&doi=10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 and its role in cellular proliferation, development, and pathology</span></div><div class="casAuthors">Guerra, Barbara; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">391-408</span>CODEN:
                <span class="NLM_cas:coden">ELCTDN</span>;
        ISSN:<span class="NLM_cas:issn">0173-0835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review is given with 171 refs.  Protein kinase CK2 is a pleiotropic, ubiquitous, and constitutively active protein kinase that can use both ATP and GTP as phosphoryl doriors with specificity for Ser/Thr residues in the vicinity of acidic amino acids.  Recent results show that the enzyme is involved in transcription, signaling, proliferation and in various steps of development.  The tetrameric holoenzyme (α2β2) consists of 2 catalytic α-subunits and 2 regulatory β-subunits.  The structure of the catalytic subunit with the fixed positioning of the activation segment in the active conformation through its own aminoterminal region suggests a regulation at the transcriptional level making a regulation by 2nd messengers unlikely.  The high conservation of the catalytic subunit from yeast to man and its role in the tetrameric complex supports this notion.  The regulatory β-subunit was far less conserved throughout evolution.  Furthermore the existence of different CK2β-related proteins together with the observation of deregulated CK2β levels in tumor cells and the reported assocn. of CK2β protein with key proteins in signal transduction, e.g. A-Raf, Mos, p90rsk etc. are suggestive for an addnl. physiol. role of CK2β protein beside being the regulatory compd. in the tetrameric holoenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAm6hjZTVByrVg90H21EOLACvtfcHk0lgOk5MzX8fHpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1antr8%253D&md5=1ea146efc1817b5af0890102f5940f9b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291522-2683%252819990201%252920%253A2%253C391%253A%253AAID-ELPS391%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DProtein%2520kinase%2520CK2%2520and%2520its%2520role%2520in%2520cellular%2520proliferation%252C%2520development%2520and%2520pathology%26jtitle%3DElectrophoresis%26date%3D1999%26volume%3D20%26spage%3D391%26epage%3D408%26doi%3D10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span> <span> </span><span class="NLM_article-title">The dark side of protein kinase CK2 inhibition</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2884</span>, <span class="refDoi"> DOI: 10.2174/092986711796150423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.2174%2F092986711796150423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=21651492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2rtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2867-2884&author=G.+Cozzaauthor=F.+Meggioauthor=S.+Moro&title=The+dark+side+of+protein+kinase+CK2+inhibition&doi=10.2174%2F092986711796150423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The dark side of protein kinase CK2 inhibition</span></div><div class="casAuthors">Cozza, G.; Meggio, F.; Moro, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2867-2884</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Casein kinase 2 (CK2) is a ubiquitous, highly pleiotropic and essential protein kinase whose abnormally high constitutive activity has been implicated in several human diseases.  In the last decade, several ATP competitive inhibitors of CK2, characterized by an in vitro activity that ranges from micromolar to nanomolar, have been discovered.  However, until now only one drug candidate has been entered in Phase I clin. trial as a potential anticancer drug.  Why this constitutively active kinase is so undruggable.  Can ATP competitive inhibitors be considered the most promising drug candidates for the near future.  In this review, we would like to underline how targeting binding sites outside the conventional ATP-binding could represent a new promising strategy to inhibit CK2 activity and, consequently, bear a great potentiality in discovering new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCxbmCM1_QFbVg90H21EOLACvtfcHk0lgOk5MzX8fHpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2rtbs%253D&md5=3fa07cd8c46d4e54fcd58abf6bf2d1da</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986711796150423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796150423%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DThe%2520dark%2520side%2520of%2520protein%2520kinase%2520CK2%2520inhibition%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2867%26epage%3D2884%26doi%3D10.2174%2F092986711796150423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P.</span>; <span class="NLM_string-name">Pierre, F.</span>; <span class="NLM_string-name">Whitten, J.</span></span>, <span> </span><span class="NLM_article-title">Serine-Threonine Protein Kinase and Parp Modulators</span>. <span class="NLM_patent">WO/2008/028168</span>, <span class="NLM_year">2008</span>; <a href="http://patentscope.wipo.int/search/en/WO2008028168" class="extLink">http://patentscope.wipo.int/search/en/WO2008028168</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Chua&author=F.+Pierre&author=J.+Whitten&title=Serine-Threonine+Protein+Kinase+and+Parp+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DP.%26atitle%3DSerine-Threonine%2520Protein%2520Kinase%2520and%2520Parp%2520Modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmann, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span> <span> </span><span class="NLM_article-title">Structural basis of CX-4945 binding to human protein kinase CK2</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2010.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.febslet.2010.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=21093442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=104-110&author=A.+D.+Fergusonauthor=P.+R.+Shethauthor=A.+D.+Bassoauthor=S.+Paliwalauthor=K.+Grayauthor=T.+O.+Fischmannauthor=H.+V.+Le&title=Structural+basis+of+CX-4945+binding+to+human+protein+kinase+CK2&doi=10.1016%2Fj.febslet.2010.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of CX-4945 binding to human protein kinase CK2</span></div><div class="casAuthors">Ferguson, Andrew D.; Sheth, Payal R.; Basso, Andrea D.; Paliwal, Sunil; Gray, Kimberly; Fischmann, Thierry O.; Le, Hung V.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-110</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein kinase CK2 (CK2), a constitutively active serine/threonine kinase, is involved in a variety of roles essential to the maintenance of cellular homeostasis.  Elevated levels of CK2 expression results in the dysregulation of key signaling pathways that regulate transcription, and has been implicated in cancer.  The adenosine-5'-triphosphate-competitive inhibitor CX-4945 (I) has been reported to show broad spectrum anti-proliferative activity in multiple cancer cell lines.  Although the enzymic IC50 of CX-4945 has been reported, the thermodn. and structural basis of binding to CK2α remained elusive.  Presented here are the crystal structures of human CK2α in complex with CX-4945 and adenylyl phosphoramidate at 2.7 and 1.3 Å, resp.  Biophys. anal. of CX-4945 binding is also described.  This data provides the structural rationale for the design of more potent inhibitors against this emerging cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ79g72x8-abVg90H21EOLACvtfcHk0lgOk5MzX8fHpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D&md5=b2fab5a9e6d75362c339ddbfa1035315</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2010.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2010.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DSheth%26aufirst%3DP.%2BR.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DLe%26aufirst%3DH.%2BV.%26atitle%3DStructural%2520basis%2520of%2520CX-4945%2520binding%2520to%2520human%2520protein%2520kinase%2520CK2%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D104%26epage%3D110%26doi%3D10.1016%2Fj.febslet.2010.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel function of CX-4945 as a splicing regulator</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e94978</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0094978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1371%2Fjournal.pone.0094978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=24743259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Kimauthor=K.+Choiauthor=H.+Kangauthor=S.+Y.+Leeauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+Songauthor=D.+Imauthor=Y.+Choiauthor=S.+Cho&title=Identification+of+a+novel+function+of+CX-4945+as+a+splicing+regulator&doi=10.1371%2Fjournal.pone.0094978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel function of CX-4945 as a splicing regulator</span></div><div class="casAuthors">Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-wook; Lee, Min-sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94978/1-e94978/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene.  The significance of alternative splicing has been confirmed by the increasing no. of human diseases that are caused by misregulation of splicing events.  Very few compds., however, have been reported to act as inhibitors of alternative splicing, and their potential clin. use needs to be evaluated.  Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a mol. currently in clin. trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner.  Transcriptome-wide anal. using exon array also showed a widespread alteration in alternative splicing of numerous genes.  We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells.  Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date.  Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner.  Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmZdGtUZUe7Vg90H21EOLACvtfcHk0lhl2bYJC5ZMpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL&md5=5edb2338401d950cddbcba7d35e57c04</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094978%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520function%2520of%2520CX-4945%2520as%2520a%2520splicing%2520regulator%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0094978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1242/dmm.025668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1242%2Fdmm.025668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=27483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=839-848&author=H.+Kimauthor=K.+S.+Leeauthor=A.+K.+Kimauthor=M.+Choiauthor=K.+Choiauthor=M.+Kangauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+S.+Leeauthor=S.+Y.+Leeauthor=W.+J.+Songauthor=K.+Yuauthor=S.+Cho&title=A+chemical+with+proven+clinical+safety+rescues+Down-syndrome-related+phenotypes+in+through+DYRK1A+inhibition&doi=10.1242%2Fdmm.025668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical with proven clinical safety rescues Down-syndromerelated phenotypes in through DYRK1A inhibition</span></div><div class="casAuthors">Kim, Hyeongki; Lee, Kyu-Sun; Kim, Ae-Kyeong; Choi, Miri; Choi, Kwangman; Kang, Mingu; Chi, Seung-Wook; Lee, Min-Sung; Lee, Jeong-Soo; Lee, So-Young; Song, Woo-Joo; Yu, Kweon; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">Disease Models & Mechanisms</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">839-848</span>CODEN:
                <span class="NLM_cas:coden">DMMIAX</span>;
        ISSN:<span class="NLM_cas:issn">1754-8403</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">DYRK1A is important in neuronal development and function, and its excessive activity is considered a significant pathogenic factor in Down syndrome and Alzheimer's disease.  Thus, inhibition of DYRK1A has been suggested to be a new strategy to modify the disease.  Very few compds., however, have been reported to act as inhibitors, and their potential clin. uses require further evaluation.  Here,we newly identify CX-4945, the safety of which has been already proven in the clin. setting, as a potent inhibitor ofDYRK1A that acts in an ATP-competitive manner.  The inhibitory potency of CX-4945 on DYRK1A (IC50=6.8 nM) in vitro was higher than that of harmine, INDY or proINDY, which are well-known potent inhibitors of DYRK1A.  CX-4945 effectively reverses the aberrant phosphorylation of Tau, amyloid precursor protein (APP) and presenilin 1 (PS1) inmammalian cells.  To our surprise, feedingwith CX-4945 significantly restored the neurol. and phenotypic defects induced by the overexpression of minibrain, an ortholog of human DYRK1A, in the Drosophila model.  Moreover, oral administration of CX-4945 acutely suppressed Tau hyperphosphorylation in the hippocampus of DYRK1A-overexpressing mice.  Our research results demonstrate that CX-4945 is a potent DYRK1A inhibitor and also suggest that it has therapeutic potential for DYRK1A-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwgsUZXI8Gj7Vg90H21EOLACvtfcHk0lhl2bYJC5ZMpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN&md5=bfc074ed6a4162a09435959405fa0529</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1242%2Fdmm.025668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.025668%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DA.%2BK.%26aulast%3DChoi%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DA%2520chemical%2520with%2520proven%2520clinical%2520safety%2520rescues%2520Down-syndrome-related%2520phenotypes%2520in%2520through%2520DYRK1A%2520inhibition%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2016%26volume%3D9%26spage%3D839%26epage%3D848%26doi%3D10.1242%2Fdmm.025668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tama, F.</span></span> <span> </span><span class="NLM_article-title">Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1002/prot.25444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2Fprot.25444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=29243286" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=344-353&author=A.+Srivastavaauthor=T.+Hirotaauthor=S.+Irleauthor=F.+Tama&title=Conformational+dynamics+of+human+protein+kinase+CK2%CE%B1+and+its+effect+on+function+and+inhibition&doi=10.1002%2Fprot.25444"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fprot.25444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.25444%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DHirota%26aufirst%3DT.%26aulast%3DIrle%26aufirst%3DS.%26aulast%3DTama%26aufirst%3DF.%26atitle%3DConformational%2520dynamics%2520of%2520human%2520protein%2520kinase%2520CK2%25CE%25B1%2520and%2520its%2520effect%2520on%2520function%2520and%2520inhibition%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2018%26volume%3D86%26spage%3D344%26epage%3D353%26doi%3D10.1002%2Fprot.25444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span> <span> </span><span class="NLM_article-title">Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.bbapap.2009.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19796713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=484-492&author=K.+Niefindauthor=O.+G.+Issinger&title=Conformational+plasticity+of+the+catalytic+subunit+of+protein+kinase+CK2+and+its+consequences+for+regulation+and+drug+design&doi=10.1016%2Fj.bbapap.2009.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design</span></div><div class="casAuthors">Niefind, Karsten; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-492</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  At 1st glance, protein kinase 2α (CK2α), the catalytic subunit of CK2, is a rigid mol.; in contrast to many eukaryotic protein kinases, in CK2α the canonical regulatory key elements like the activation segment occur exclusively in their typical active conformations.  This observation fits well to the constitutive activity of the enzyme, meaning, its independence from phosphorylation or other characteristic control factors.  Most CK2α structures are based on the enzyme from Zea mays, supplemented by an increasing no. of human CK2α structures.  In the latter a surprising plasticity of important ATP-binding elements, including the interdomain hinge region and the glycine-rich loop, was discovered.  In fully active CK2α the hinge region is open and does not anchor the ATP ribose moiety, but alternatively it can adopt a closed conformation, form H-bonds to the ribose moiety and thus retract the γ-phospho group from its functional position.  In addn. to this partially inactive state, human CK2α was recently found in a fully inactive conformation.  It is incompatible with ATP binding due to a combination of a closed hinge and a collapse of the glycine-rich loop into the ATP cavity.  These conformational transitions are apparently correlated with the occupation state of a remote docking site located at the interface to the non-catalytic subunit CK2β: if CK2β blocks this site, the fully active conformation of CK2α is stabilized, while the binding of certain small mol. seems to favor the partially and fully inactive states.  This observation may be exploited to design effective and selective CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa5N1vWFbU7Vg90H21EOLACvtfcHk0lhxDGUwmPto7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7s%253D&md5=31313e981d6fd83a66a77dfa083c239d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DConformational%2520plasticity%2520of%2520the%2520catalytic%2520subunit%2520of%2520protein%2520kinase%2520CK2%2520and%2520its%2520consequences%2520for%2520regulation%2520and%2520drug%2520design%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D484%26epage%3D492%26doi%3D10.1016%2Fj.bbapap.2009.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2007.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.chembiol.2007.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18291315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlKitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=111-117&author=J.+Raafauthor=E.+Brunsteinauthor=O.+G.+Issingerauthor=K.+Niefind&title=The+CK2+alpha%2FCK2+beta+interface+of+human+protein+kinase+CK2+harbors+a+binding+pocket+for+small+molecules&doi=10.1016%2Fj.chembiol.2007.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The CK2α/CK2β Interface of Human Protein Kinase CK2 Harbors a Binding Pocket for Small Molecules</span></div><div class="casAuthors">Raaf, Jennifer; Brunstein, Elena; Issinger, Olaf-Georg; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-117</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Ser/Thr kinase CK2 (previously called casein kinase 2) is composed of two catalytic chains (CK2α) attached to a dimer of noncatalytic subunits (CK2β).  CK2 is involved in suppression of apoptosis, cell survival, and tumorigenesis.  To investigate these activities and possibly affect them, selective CK2 inhibitors are required.  An often-used CK2 inhibitor is 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB).  In a complex structure with human CK2α, DRB binds to the canonical ATP cleft, but addnl. it occupies an allosteric site that can be alternatively filled by glycerol.  Inhibition kinetic studies corroborate the dual binding mode of the inhibitor.  Structural comparisons reveal a surprising conformational plasticity of human CK2α around both DRB binding sites.  After local rearrangement, the allosteric site serves as a CK2β interface.  This opens the potential to construct mols. interfering with the CK2α/CK2β interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUX3xcjrAqAbVg90H21EOLACvtfcHk0lhxDGUwmPto7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlKitbw%253D&md5=221ac03a17608de6cee508c04835d5cd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DBrunstein%26aufirst%3DE.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DThe%2520CK2%2520alpha%252FCK2%2520beta%2520interface%2520of%2520human%2520protein%2520kinase%2520CK2%2520harbors%2520a%2520binding%2520pocket%2520for%2520small%2520molecules%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D111%26epage%3D117%26doi%3D10.1016%2Fj.chembiol.2007.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=A+fragment-based+approach+leading+to+the+discovery+of+a+novel+binding+site+and+the+selective+CK2+inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0lhxDGUwmPto7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520fragment-based%2520approach%2520leading%2520to%2520the%2520discovery%2520of%2520a%2520novel%2520binding%2520site%2520and%2520the%2520selective%2520CK2%2520inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Second-generation CK2α inhibitors targeting the αD pocket</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3041</span>– <span class="NLM_lpage">3049</span>, <span class="refDoi"> DOI: 10.1039/C7SC05122K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1039%2FC7SC05122K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=29732088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3041-3049&author=J.+Iegreauthor=P.+Brearauthor=C.+De+Fuscoauthor=M.+Yoshidaauthor=S.+L.+Mitchellauthor=M.+Rossmannauthor=L.+Carroauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Second-generation+CK2%CE%B1+inhibitors+targeting+the+%CE%B1D+pocket&doi=10.1039%2FC7SC05122K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation CK2α inhibitors targeting the αD pocket</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; De Fusco, Claudia; Yoshida, Masao; Mitchell, Sophie L.; Rossmann, Maxim; Carro, Laura; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3041-3049</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CK2 is a crit. cell cycle regulator that also promotes various anti-apoptotic mechanisms.  Development of ATP-non-competitive inhibitors of CK2 is a very attractive strategy considering that the ATP binding site is highly conserved among other kinases.  We have previously utilized a pocket outside the active site to develop a novel CK2 inhibitor, CAM4066.  While CAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2α inhibitor that binds completely outside the active site.  This second generation αD-site binding inhibitor, compd. CAM4712 (IC50 = 7μM, GI50 = 10.0 ± 3.6μM), has numerous advantages over the previously reported CAM4066, including a redn. in the no. of rotatable bonds, the absence of amide groups susceptible to the action of proteases and improved cellular permeability.  Unlike with CAM4066, there was no need to facilitate cellular uptake by making a prodrug.  Moreover, CAM4712 displayed no drop off between its ability to inhibit the kinase in vitro (IC50) and the ability to inhibit cell proliferation (GI50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPLu-nG6dLLVg90H21EOLACvtfcHk0lhgWNTtA1BAzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D&md5=4d57e89546e1c7bcac4868e3a02ba2f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2FC7SC05122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC05122K%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRossmann%26aufirst%3DM.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSecond-generation%2520CK2%25CE%25B1%2520inhibitors%2520targeting%2520the%2520%25CE%25B1D%2520pocket%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D3041%26epage%3D3049%26doi%3D10.1039%2FC7SC05122K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span>; <span class="NLM_string-name">Krimm, I.</span>; <span class="NLM_string-name">Kufareva, I.</span>; <span class="NLM_string-name">Kamal, A. A. M.</span>; <span class="NLM_string-name">Seetoh, W.-G.</span>; <span class="NLM_string-name">Abell, C.</span>; <span class="NLM_string-name">Hartmann, R. W.</span>; <span class="NLM_string-name">Abagyan, R.</span>; <span class="NLM_string-name">Cochet, C.</span>; <span class="NLM_string-name">Le Borgne, M.</span>; <span class="NLM_string-name">Engel, M.</span>; <span class="NLM_string-name">Lomberget, T.</span></span> <span> </span><span class="NLM_article-title">2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. 1. Identification of an allosteric binding site</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01766</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01766" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=B.+Bestgen&author=I.+Krimm&author=I.+Kufareva&author=A.+A.+M.+Kamal&author=W.-G.+Seetoh&author=C.+Abell&author=R.+W.+Hartmann&author=R.+Abagyan&author=C.+Cochet&author=M.+Le+Borgne&author=M.+Engel&author=T.+Lomberget&title=2-Aminothiazole+derivatives+as+selective+allosteric+modulators+of+the+protein+kinase+CK2.+1.+Identification+of+an+allosteric+binding+site&doi=10.1021%2Facs.jmedchem.8b01766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01766%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26atitle%3D2-Aminothiazole%2520derivatives%2520as%2520selective%2520allosteric%2520modulators%2520of%2520the%2520protein%2520kinase%2520CK2.%25201.%2520Identification%2520of%2520an%2520allosteric%2520binding%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26doi%3D10.1021%2Facs.jmedchem.8b01766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, J.</span></span> <span> </span><span class="NLM_article-title">Whence cometh the allosterome?</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">10533</span>– <span class="NLM_lpage">10535</span>, <span class="refDoi"> DOI: 10.1073/pnas.0604452103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1073%2Fpnas.0604452103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10533-10535&author=J.+E.+Lindsleyauthor=J.+Rutter&title=Whence+cometh+the+allosterome%3F&doi=10.1073%2Fpnas.0604452103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604452103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604452103%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DJ.%2BE.%26aulast%3DRutter%26aufirst%3DJ.%26atitle%3DWhence%2520cometh%2520the%2520allosterome%253F%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10533%26epage%3D10535%26doi%3D10.1073%2Fpnas.0604452103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span> <span> </span><span class="NLM_article-title">Druggability predictions: methods, limitations, and applications</span>. <i>WIREs Comput. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1002/wcms.1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2Fwcms.1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ntrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=327-338&author=X.+Barril&title=Druggability+predictions%3A+methods%2C+limitations%2C+and+applications&doi=10.1002%2Fwcms.1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability predictions: methods, limitations, and applications</span></div><div class="casAuthors">Barril, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Wiley Interdisciplinary Reviews: Computational Molecular Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">WIRCAH</span>;
        ISSN:<span class="NLM_cas:issn">1759-0884</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Pharmacol. treatment with small org. mols. offers important medical, economic, and practical advantages over other therapeutic approaches.  However, such small mols. can only elicit an effect when they bind to a biol. component at the appropriate site and with sufficient affinity to modify its behavior.  Druggability predictions assess the ability of a given binding site to host drug-like org. mols.  Combined with information about the involvement of such component in a disease, druggability predictions can be used to prioritize therapeutic targets and are particularly useful when moving beyond the traditional target classes.  In the last few years, significant progress has been made to understand the mol. basis of druggability, to compile datasets of targets with various degrees of druggability, and to develop a diverse set of computational prediction methods.  These tools offer a better prospect for target-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqmc-TqoJErLVg90H21EOLACvtfcHk0lgUazjpqhFCtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ntrfM&md5=a3719a5f195506c4dc23712c99a9f1f5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fwcms.1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fwcms.1134%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26atitle%3DDruggability%2520predictions%253A%2520methods%252C%2520limitations%252C%2520and%2520applications%26jtitle%3DWIREs%2520Comput.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D3%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fwcms.1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clive, D. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisaindee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coltart, D. M.</span></span> <span> </span><span class="NLM_article-title">Derivatized amino acids relevant to native peptide synthesis by chemical ligation and acyl transfer</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">9247</span>– <span class="NLM_lpage">9254</span>, <span class="refDoi"> DOI: 10.1021/jo030192r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo030192r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=9247-9254&author=D.+L.+J.+Cliveauthor=S.+Hisaindeeauthor=D.+M.+Coltart&title=Derivatized+amino+acids+relevant+to+native+peptide+synthesis+by+chemical+ligation+and+acyl+transfer&doi=10.1021%2Fjo030192r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo030192r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo030192r%26sid%3Dliteratum%253Aachs%26aulast%3DClive%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DHisaindee%26aufirst%3DS.%26aulast%3DColtart%26aufirst%3DD.%2BM.%26atitle%3DDerivatized%2520amino%2520acids%2520relevant%2520to%2520native%2520peptide%2520synthesis%2520by%2520chemical%2520ligation%2520and%2520acyl%2520transfer%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D9247%26epage%3D9254%26doi%3D10.1021%2Fjo030192r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marzabadi, M. R.</span>; <span class="NLM_string-name">Wong, W. C.</span>; <span class="NLM_string-name">Noble, S. A.</span>; <span class="NLM_string-name">Desai, M. N.</span></span> <span> </span><span class="NLM_article-title">Selective NPY (Y5) Antagonists</span>. <span class="NLM_patent">US6989379B1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+R.+Marzabadi&author=W.+C.+Wong&author=S.+A.+Noble&author=M.+N.+Desai&title=Selective+NPY+%28Y5%29+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarzabadi%26aufirst%3DM.%2BR.%26atitle%3DSelective%2520NPY%2520%2528Y5%2529%2520Antagonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, S.</span>; <span class="NLM_string-name">Saito, D.</span></span> <span> </span><span class="NLM_article-title">Method for Producing Isothiocyanate Compound Having Carboxyl Group</span>. <span class="NLM_patent">US8367857B2</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Nakano&author=D.+Saito&title=Method+for+Producing+Isothiocyanate+Compound+Having+Carboxyl+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DS.%26atitle%3DMethod%2520for%2520Producing%2520Isothiocyanate%2520Compound%2520Having%2520Carboxyl%2520Group%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Garcia, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busschots, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9817</span>– <span class="NLM_lpage">9830</span>, <span class="refDoi"> DOI: 10.1021/jm3010477</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9817-9830&author=A.+Wilhelmauthor=L.+A.+Lopez-Garciaauthor=K.+Busschotsauthor=W.+Fr%C3%B6hnerauthor=F.+Maurerauthor=S.+Boettcherauthor=H.+Zhangauthor=J.+O.+Schulzeauthor=R.+M.+Biondiauthor=M.+Engel&title=2-%283-Oxo-1%2C3-diphenylpropyl%29malonic+acids+as+potent+allosteric+ligands+of+the+PIF+pocket+of+phosphoinositide-dependent+kinase-1%3A+development+and+prodrug+concept&doi=10.1021%2Fjm3010477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm3010477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010477%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DA.%26aulast%3DLopez-Garcia%26aufirst%3DL.%2BA.%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DFr%25C3%25B6hner%26aufirst%3DW.%26aulast%3DMaurer%26aufirst%3DF.%26aulast%3DBoettcher%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSchulze%26aufirst%3DJ.%2BO.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3D2-%25283-Oxo-1%252C3-diphenylpropyl%2529malonic%2520acids%2520as%2520potent%2520allosteric%2520ligands%2520of%2520the%2520PIF%2520pocket%2520of%2520phosphoinositide-dependent%2520kinase-1%253A%2520development%2520and%2520prodrug%2520concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9817%26epage%3D9830%26doi%3D10.1021%2Fjm3010477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bdzhola, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmoluk, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">A Note of caution on the role of halogen bonds for protein kinase/inhibitor recognition suggested by high- and low-salt CK2α complex structures</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1654</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00235</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00235" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1654-1660&author=B.+Guerraauthor=N.+Bischoffauthor=V.+G.+Bdzholaauthor=S.+M.+Yarmolukauthor=O.+G.+Issingerauthor=A.+G.+Golubauthor=K.+Niefind&title=A+Note+of+caution+on+the+role+of+halogen+bonds+for+protein+kinase%2Finhibitor+recognition+suggested+by+high-+and+low-salt+CK2%CE%B1+complex+structures&doi=10.1021%2Facschembio.5b00235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures</span></div><div class="casAuthors">Guerra, Barbara; Bischoff, Nils; Bdzhola, Volodymyr G.; Yarmoluk, Sergiy M.; Issinger, Olaf-Georg; Golub, Andriy G.; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1654-1660</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a Ser/Thr kinase recruited by tumor cells to avoid cell death.  4'-Carboxy-6,8-dibromo-flavonol (FLC26) is a nanomolar CK2 inhibitor reducing the physiol. phosphorylation of CK2 biomarkers and inducing cell death.  Its binding mode to the ATP site was predicted to depend primarily on noncovalent interactions not comprising halogen bonds.  We confirm this by two independent cocrystal structures which addnl. show that FLC26 is selective for an open, protein kinase-untypical conformation of the hinge/helix αD region.  The structures suggest how the bromo substituents, found previously in lead optimization studies, contribute to the inhibitory efficacy.  In this context, one of the complex structures, obtained by crystn. with the kosmotropic salt NaCl, revealed an unconventional π-halogen bond between the 8-bromo substituent of FLC26 and an arom. side chain which is absent under low-salt conditions.  The kosmotropic salt sensitivity of π-halogen bonds is a novel feature which requires attention in structural comparisons and halogen-bond-based explanations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolnSDoVENUrbVg90H21EOLACvtfcHk0lgUazjpqhFCtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D&md5=88774b705a45a2fe08917c44545fcd04</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00235%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DBdzhola%26aufirst%3DV.%2BG.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DGolub%26aufirst%3DA.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DA%2520Note%2520of%2520caution%2520on%2520the%2520role%2520of%2520halogen%2520bonds%2520for%2520protein%2520kinase%252Finhibitor%2520recognition%2520suggested%2520by%2520high-%2520and%2520low-salt%2520CK2%25CE%25B1%2520complex%2520structures%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1654%26epage%3D1660%26doi%3D10.1021%2Facschembio.5b00235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1021/cb400771y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400771y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=366-371&author=G.+Lolliauthor=A.+Ranchioauthor=R.+Battistutta&title=Active+form+of+the+protein+kinase+CK2+%CE%B12%CE%B22+holoenzyme+is+a+strong+complex+with+symmetric+architecture&doi=10.1021%2Fcb400771y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fcb400771y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400771y%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DRanchio%26aufirst%3DA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DActive%2520form%2520of%2520the%2520protein%2520kinase%2520CK2%2520%25CE%25B12%25CE%25B22%2520holoenzyme%2520is%2520a%2520strong%2520complex%2520with%2520symmetric%2520architecture%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D366%26epage%3D371%26doi%3D10.1021%2Fcb400771y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>386</i></span>,  <span class="NLM_fpage">1212</span>– <span class="NLM_lpage">1221</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.jmb.2009.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19361447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFanurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2009&pages=1212-1221&author=J.+Raafauthor=O.+G.+Issingerauthor=K.+Niefind&title=First+inactive+conformation+of+CK2+alpha%2C+the+catalytic+subunit+of+protein+kinase+CK2&doi=10.1016%2Fj.jmb.2009.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">First Inactive Conformation of CK2α, the Catalytic Subunit of Protein Kinase CK2</span></div><div class="casAuthors">Raaf, Jennifer; Issinger, Olaf-Georg; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1212-1221</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Ser/Thr kinase casein kinase 2 (CK2) is a heterotetrameric enzyme composed of two catalytic chains (CK2α, catalytic subunit of CK2) attached to a dimer of two noncatalytic subunits (CK2β, noncatalytic subunit of CK2).  CK2α belongs to the superfamily of eukaryotic protein kinases (EPKs).  To function as regulatory key components, EPKs normally exist in inactive ground states and are activated only upon specific signals.  Typically, this activation is accompanied by large conformational changes in helix αC and in the activation segment, leading to a characteristic arrangement of catalytic key elements.  For CK2α however, no strict physiol. control of activity is known.  Accordingly, CK2α has been found so far exclusively in the characteristic conformation of active EPKs, which in this case, exhibits addnl. stabilization by a unique intramol. contact between the N-terminal segment on one side, and helix αC and the activation segment on the other side.  We report here the structure of a C-terminally truncated variant of human CK2α in which the enzyme adopts a decidedly inactive conformation for the first time.  In this CK2α structure, those regulatory key regions still are in their active positions.  Yet the glycine-rich ATP-binding loop, which is normally part of the canonical anti-parallel β-sheet, has collapsed into the ATP-binding site so that ATP is excluded from binding; specifically, the side chain of Arg47 occupies the ribose region of the ATP site and Tyr50, the space required by the triphospho moiety.  We discuss some factors that may support or disfavor this inactive conformation, among them coordination of small mols. at a remote cavity at the CK2α/CK2β interaction region and binding of a CK2β dimer.  The latter stabilizes the glycine-rich loop in the extended active conformation known from the majority of CK2α structures.  Thus, the novel inactive conformation of CK2α provides for the first time a structural basis for the stimulatory impact of CK2β on CK2α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxx8RkUAZk0rVg90H21EOLACvtfcHk0lhHWEKYm5WBZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFanurs%253D&md5=e923adf7438b04721617e79f9650f073</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DFirst%2520inactive%2520conformation%2520of%2520CK2%2520alpha%252C%2520the%2520catalytic%2520subunit%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D386%26spage%3D1212%26epage%3D1221%26doi%3D10.1016%2Fj.jmb.2009.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">Structural determinants of protein kinase CK2 regulation by autoinhibitory polymerization</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1158</span>– <span class="NLM_lpage">1163</span>, <span class="refDoi"> DOI: 10.1021/cb300054n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300054n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1158-1163&author=G.+Lolliauthor=L.+A.+Pinnaauthor=R.+Battistutta&title=Structural+determinants+of+protein+kinase+CK2+regulation+by+autoinhibitory+polymerization&doi=10.1021%2Fcb300054n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcb300054n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300054n%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DStructural%2520determinants%2520of%2520protein%2520kinase%2520CK2%2520regulation%2520by%2520autoinhibitory%2520polymerization%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D1158%26epage%3D1163%26doi%3D10.1021%2Fcb300054n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, F. L.</span></span> <span> </span><span class="NLM_article-title">Effect of intramolecular hydrogen bonding on ionization constants of substituted salicylic acids</span>. <i>Can. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1139/v66-188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1139%2Fv66-188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1966&pages=1261-1269&author=G.+E.+Dunnauthor=F.+L.+Kung&title=Effect+of+intramolecular+hydrogen+bonding+on+ionization+constants+of+substituted+salicylic+acids&doi=10.1139%2Fv66-188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1139%2Fv66-188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv66-188%26sid%3Dliteratum%253Aachs%26aulast%3DDunn%26aufirst%3DG.%2BE.%26aulast%3DKung%26aufirst%3DF.%2BL.%26atitle%3DEffect%2520of%2520intramolecular%2520hydrogen%2520bonding%2520on%2520ionization%2520constants%2520of%2520substituted%2520salicylic%2520acids%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1966%26volume%3D44%26spage%3D1261%26epage%3D1269%26doi%3D10.1139%2Fv66-188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, M. P.</span></span> <span> </span><span class="NLM_article-title">Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/tx020013l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx020013l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFWksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=1309-1317&author=C.+Liauthor=L.+Z.+Benetauthor=M.+P.+Grillo&title=Studies+on+the+chemical+reactivity+of+2-phenylpropionic+acid+1-O-acyl+glucuronide+and+S-acyl-CoA+thioester+metabolites&doi=10.1021%2Ftx020013l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the Chemical Reactivity of 2-Phenylpropionic Acid 1-O-Acyl Glucuronide and S-Acyl-CoA Thioester Metabolites</span></div><div class="casAuthors">Li, Chunze; Benet, Leslie Z.; Grillo, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1309-1317</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. reactive species formed from the metab. of carboxylic acid-contg. compds. have been proposed as mediators of their toxic side-effects.  Two alternative metabolic pathways known to be involved in the generation of reactive acylating metabolites of carboxylic acids are acyl glucuronidation and acyl-CoA formation.  Here, we present studies with 2-phenylpropionic acid focused on evaluating the relative abilities of acyl glucuronides vs. acyl-CoA derivs. to transacylate the nucleophilic cysteinyl-thiol of glutathione.  Thus, synthetic 2-phenylpropionyl-S-acyl-CoA (2-PPA-SCoA) and biosynthetic 2-phenylpropionyl-1-O-acyl glucuronide (2-PPA-1-O-G) were incubated sep., and at varying concns. (15.6-500 nM as well as at 0.1 mM), with GSH (1, 5, and 10 mM) in buffer (pH 7.4, 37), and formation of the transacylation product, 2-phenylpropionyl-S-acyl-glutathione (2-PPA-SG), was quantified by reverse-phase HPLC and LC-MS.  HPLC anal. of the products from both the reaction of 2-PPA-SCoA and 2-PPA-1-O-G with GSH showed the presence of 2-PPA-SG, which was confirmed by coelution with authentic 2-PPA-SG as well as by its LC/MS mass spectrum.  The formation of 2-PPA-SG was time- and concn.-dependent with a formation rate const. of (1.9±0.2) × 10-2 M-1·s-1 from reactions of GSH with 2-PPA-SCoA, and (2.7±0.4) × 10-4 M-1·s-1 from reactions of GSH with 2-PPA-1-O-G. Therefore, the reactivity of 2-PPA-SCoA with GSH was 70 times greater than the reactivity of GSH with 2-PPA-1-O-G, which was found to acyl-migrate to less reactive isomers.  Anal. of the in vitro stability of 2-PPA-SCoA and 2-PPA-1-O-G in the absence of GSH showed the CoA esters to be completely stable after 24 h, whereas the acyl glucuronides decompd. by 50% in 1.3 and 2.4 h of incubation at pH 7.4 and 37 for (R)- and (S)-2-PPA-1-O-G, resp.  In addn., studies of the reactivity of 2-PPA-SCoA with bovine serum albumin showed time- and pH-dependent covalent binding to the protein in vitro.  These results support the hypothesis that xenobiotic acyl-CoA thioesters are reactive acylating species that, in addn. to acyl glucuronides, may contribute to xenobiotic acid-protein adduct formation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1AAYKAMN6D7Vg90H21EOLACvtfcHk0lhHWEKYm5WBZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFWksLw%253D&md5=52af38fb112c54ae17261412f366df94</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Ftx020013l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx020013l%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DGrillo%26aufirst%3DM.%2BP.%26atitle%3DStudies%2520on%2520the%2520chemical%2520reactivity%2520of%25202-phenylpropionic%2520acid%25201-O-acyl%2520glucuronide%2520and%2520S-acyl-CoA%2520thioester%2520metabolites%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D1309%26epage%3D1317%26doi%3D10.1021%2Ftx020013l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Acyl glucuronides: the good, the bad and the ugly</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/bdd.720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2Fbdd.720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=20830700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=367-395&author=S.+L.+Reganauthor=J.+L.+Maggsauthor=T.+G.+Hammondauthor=C.+Lambertauthor=D.+P.+Williamsauthor=B.+K.+Park&title=Acyl+glucuronides%3A+the+good%2C+the+bad+and+the+ugly&doi=10.1002%2Fbdd.720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl glucuronides: the good, the bad and the ugly</span></div><div class="casAuthors">Regan, Sophie L.; Maggs, James L.; Hammond, Thomas G.; Lambert, Craig; Williams, Dominic P.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">367-395</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Acyl glucuronidation is the major metabolic conjugation reaction of most carboxylic acid drugs in mammals.  The physiol. consequences of this biotransformation have been investigated incompletely but include effects on drug metab., protein binding, distribution and clearance that impact upon pharmacol. and toxicol. outcomes.  In marked contrast, the exceptional but widely disparate chem. reactivity of acyl glucuronides has attracted far greater attention.  Specifically, the complex transacylation and glycation reactions with proteins have provoked much inconclusive debate over the safety of drugs metabolised to acyl glucuronides.  It has been hypothesised that these covalent modifications could initiate idiosyncratic adverse drug reactions.  However, despite a large body of in vitro data on the reactions of acyl glucuronides with protein, evidence for adduct formation from acyl glucuronides in vivo is limited and potentially ambiguous.  The causal connection of protein adduction to adverse drug reactions remains uncertain.  This review has assessed the intrinsic reactivity, metabolic stability and pharmacokinetic properties of acyl glucuronides in the context of physiol., pharmacol. and toxicol. perspectives.  Although numerous expts. have characterised the reactions of acyl glucuronides with proteins, these might be attenuated substantially in vivo by rapid clearance of the conjugates.  Consequently, to delineate a relationship between acyl glucuronide formation and toxicol. phenomena, detailed pharmacokinetic anal. of systemic exposure to the acyl glucuronide should be undertaken adjacent to detg. protein adduct concns. in vivo.  Further investigation is required to ascertain whether acyl glucuronide clearance is sufficient to prevent covalent modification of endogenous proteins and consequentially a potential immunol. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1hIcbM_oZ7Vg90H21EOLACvtfcHk0liDh1YYbEIipQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L&md5=8c45d4dbb68c12bd128af1dba7a08c16</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fbdd.720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.720%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAcyl%2520glucuronides%253A%2520the%2520good%252C%2520the%2520bad%2520and%2520the%2520ugly%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D367%26epage%3D395%26doi%3D10.1002%2Fbdd.720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianoncelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1042/BJ20090069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1042%2FBJ20090069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19432557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=387-395&author=G.+Cozzaauthor=M.+Mazzoranaauthor=E.+Papinuttoauthor=J.+Bainauthor=M.+Elliottauthor=G.+di+Mairaauthor=A.+Gianoncelliauthor=M.+A.+Paganoauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=R.+Battistuttaauthor=F.+Meggioauthor=S.+Moroauthor=G.+Zagottoauthor=L.+A.+Pinna&title=Quinalizarin+as+a+potent%2C+selective+and+cell-permeable+inhibitor+of+protein+kinase+CK2&doi=10.1042%2FBJ20090069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span></div><div class="casAuthors">Cozza, Giorgio; Mazzorana, Marco; Papinutto, Elena; Bain, Jenny; Elliott, Matthew; di Maira, Giovanni; Gianoncelli, Alessandra; Pagano, Mario A.; Sarno, Stefania; Ruzzene, Maria; Battistutta, Roberto; Meggio, Flavio; Moro, Stefano; Zagotto, Giuseppe; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-395</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) is a moderately potent and poorly selective inhibitor of protein kinase CK2, one of the most pleiotropic serine/threonine protein kinases, implicated in neoplasia and in other global diseases.  By virtual screening of the MMS (Mol. Modeling Section) database, we have now identified quinalizarin (1,2,5,8-tetrahydroxyanthraquinone) as an inhibitor of CK2 that is more potent and selective than emodin.  CK2 inhibition by quinalizarin is competitive with respect to ATP, with a Ki value of approx. 50 nM.  Tested at 1 μM concn. on a panel of 75 protein kinases, quinalizarin drastically inhibits only CK2, with a promiscuity score (11.1), which is the lowest ever reported so far for a CK2 inhibitor.  Esp. remarkable is the ability of quinalizarin to discriminate between CK2 and a no. of kinases, notably DYRK1a (dual-specificity tyrosine-phosphorylated and -regulated kinase), PIM (provirus integration site for Moloney murine leukemia virus) 1, 2 and 3, HIPK2 (homeodomain-interacting protein kinase-2), MNK1 [MAPK (mitogen-activated protein kinase)-interacting kinase 1], ERK8 (extracellular-signal-regulated kinase 8) and PKD1 (protein kinase D 1), which conversely tend to be inhibited as drastically as CK2 by com. available CK2 inhibitors.  The detn. of the crystal structure of a complex between quinalizarin and CK2α subunit highlights the relevance of polar interactions in stabilizing the binding, an unusual characteristic for a CK2 inhibitor, and disclose other structural features which may account for the narrow selectivity of this compd.  Tested on Jurkat cells, quinalizarin proved able to inhibit endogenous CK2 and to induce apoptosis more efficiently than the commonly used CK2 inhibitors TBB (4,5,6,7-tetrabromo-1H-benzotriazole) and DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbz80w9Hmd9LVg90H21EOLACvtfcHk0liDh1YYbEIipQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D&md5=dc127c347d7e47419bee4594ff7572fb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1042%2FBJ20090069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20090069%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3Ddi%2BMaira%26aufirst%3DG.%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DQuinalizarin%2520as%2520a%2520potent%252C%2520selective%2520and%2520cell-permeable%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D387%26epage%3D395%26doi%3D10.1042%2FBJ20090069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0liDh1YYbEIipQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belaid-Choucair, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">In search of small molecule inhibitors targeting the flexible CK2 subunit interface</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.3390/ph10010016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.3390%2Fph10010016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVWrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=16&author=B.+Bestgenauthor=Z.+Belaid-Choucairauthor=T.+Lombergetauthor=M.+Le+Borgneauthor=O.+Filholauthor=C.+Cochet&title=In+search+of+small+molecule+inhibitors+targeting+the+flexible+CK2+subunit+interface&doi=10.3390%2Fph10010016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">In search of small molecule inhibitors targeting the flexible CK2 subunit interface</span></div><div class="casAuthors">Bestgen, Benoit; Belaid-Choucair, Zakia; Lomberget, Thierry; Le Borgne, Marc; Filhol, Odile; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16/1-16/15</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Protein kinase CK2 is a tetrameric holoenzyme composed of two catalytic (α and/or α') subunits and two regulatory (β) subunits.  Crystallog. data paired with fluorescence imaging techniques have suggested that the formation of the CK2 holoenzyme complex within cells is a dynamic process.  Although the monomeric CK2α subunit is endowed with a constitutive catalytic activity, many of the plethora of CK2 substrates are exclusively phosphorylated by the CK2 holoenzyme.  This means that the spatial and high affinity interaction between CK2α and CK2β subunits is critically important and that its disruption may provide a powerful and selective way to block the phosphorylation of substrates requiring the presence of CK2β.  In search of compds. inhibiting this crit. protein-protein interaction, we previously designed an active cyclic peptide (Pc) derived from the CK2β carboxy-terminal domain that can efficiently antagonize the CK2 subunit interaction.  To understand the functional significance of this interaction, we generated cell-permeable versions of Pc, exploring its mol. mechanisms of action and the perturbations of the signaling pathways that it induces in intact cells.  The identification of small mols. inhibitors of this crit. interaction may represent the first-choice approach to manipulate CK2 in an unconventional way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjtCoeeLRdDrVg90H21EOLACvtfcHk0liDh1YYbEIipQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVWrtLo%253D&md5=f638a3d79356538b88b453a745c43ad7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3390%2Fph10010016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10010016%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DBelaid-Choucair%26aufirst%3DZ.%26aulast%3DLomberget%26aufirst%3DT.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DIn%2520search%2520of%2520small%2520molecule%2520inhibitors%2520targeting%2520the%2520flexible%2520CK2%2520subunit%2520interface%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26spage%3D16%26doi%3D10.3390%2Fph10010016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poletto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilardell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falqués, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span> <span> </span><span class="NLM_article-title">The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">8317</span>– <span class="NLM_lpage">8325</span>, <span class="refDoi"> DOI: 10.1021/bi800216d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800216d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1aht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=8317-8325&author=G.+Polettoauthor=J.+Vilardellauthor=O.+Marinauthor=M.+A.+Paganoauthor=G.+Cozzaauthor=S.+Sarnoauthor=A.+Falqu%C3%A9sauthor=E.+Itarteauthor=L.+A.+Pinnaauthor=F.+Meggio&title=The+regulatory+beta+subunit+of+protein+kinase+CK2+contributes+to+the+recognition+of+the+substrate+consensus+sequence.+A+study+with+an+eIF2+beta-derived+peptide&doi=10.1021%2Fbi800216d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The Regulatory β Subunit of Protein Kinase CK2 Contributes to the Recognition of the Substrate Consensus Sequence. A Study with an eIF2β-Derived Peptide</span></div><div class="casAuthors">Poletto, Giorgia; Vilardell, Jordi; Marin, Oriano; Pagano, Mario A.; Cozza, Giorgio; Sarno, Stefania; Falques, Antoni; Itarte, Emilio; Pinna, Lorenzo A.; Meggio, Flavio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8317-8325</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a ubiquitous and pleiotropic Ser/Thr-specific protein kinase that phosphorylates more than 300 protein substrates at sites specified by an acidic consensus sequence in which positions n + 3 and n + 1 are particularly important.  Recognition of substrates by CK2 is known to rely on basic residues located in the catalytic site of the α subunit which make electrostatic contacts with the neg. charges in the substrate consensus sequence, thereby assuring optimal binding; the regulatory β subunit is believed to play a protective and stabilizing role.  We describe a biochem. and structural anal. of CK2-mediated phosphorylation of a 22-mer synthetic peptide corresponding to the N-terminal tail of the eukaryotic translation initiation factor eIF2β.  Results demonstrate that this peptide still displays phosphorylation features similar to full-length eIF2β and the CK2 β subunit also contributes to recognition of the protein substrate by establishing both polar and hydrophobic interactions with specificity determinants located downstream from the phosphoacceptor site.  In particular, the N-terminal domain of the β subunit appears to be of crucial importance for optimizing high-affinity phosphorylation of the eIF2β peptide.  This domain includes an acidic cluster whose electrostatic contacts with basic residues of the substrate attenuate intrasteric pseudosubstrate inhibition while strengthening substrate-kinase binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjBbq0JxBw9rVg90H21EOLACvtfcHk0ljuEAYb4RrH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1aht7s%253D&md5=713be1b95815a9409af4bc170fe51e00</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbi800216d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800216d%26sid%3Dliteratum%253Aachs%26aulast%3DPoletto%26aufirst%3DG.%26aulast%3DVilardell%26aufirst%3DJ.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DFalqu%25C3%25A9s%26aufirst%3DA.%26aulast%3DItarte%26aufirst%3DE.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26atitle%3DThe%2520regulatory%2520beta%2520subunit%2520of%2520protein%2520kinase%2520CK2%2520contributes%2520to%2520the%2520recognition%2520of%2520the%2520substrate%2520consensus%2520sequence.%2520A%2520study%2520with%2520an%2520eIF2%2520beta-derived%2520peptide%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D8317%26epage%3D8325%26doi%3D10.1021%2Fbi800216d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Adding calorimetric data to decision making in lead discovery: a hot tip</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrd3054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnrd3054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19960014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=23-27&author=J.+E.+Ladburyauthor=G.+Klebeauthor=E.+Freire&title=Adding+calorimetric+data+to+decision+making+in+lead+discovery%3A+a+hot+tip&doi=10.1038%2Fnrd3054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Adding calorimetric data to decision making in lead discovery: A hot tip</span></div><div class="casAuthors">Ladbury, John E.; Klebe, Gerhard; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recognition of the limitations of high-throughput screening approaches in the discovery of candidate drugs has reawakened interest in structure-based and other rational design methods.  Here, the authors describe how isothermal titrn. calorimetry can be used to obtain thermodn. data on the binding of compds. to protein targets.  The authors propose that these data - particularly the change in enthalpy - could provide a valuable, complementary addn. to established tools for selecting compds. in lead discovery and for aiding lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph3qvp2E8fbLVg90H21EOLACvtfcHk0ljuEAYb4RrH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM&md5=e8446b6db983c35580e9010899eb40eb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd3054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3054%26sid%3Dliteratum%253Aachs%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DAdding%2520calorimetric%2520data%2520to%2520decision%2520making%2520in%2520lead%2520discovery%253A%2520a%2520hot%2520tip%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D23%26epage%3D27%26doi%3D10.1038%2Fnrd3054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0ljuEAYb4RrH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastassiadis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarajan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J. R.</span></span> <span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1045</span>, <span class="refDoi"> DOI: 10.1038/nbt.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0lgT5WB5knbrxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1039%26epage%3D1045%26doi%3D10.1038%2Fnbt.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, P. P.</span></span> <span> </span><span class="NLM_article-title">Gini Coefficient: A new way to express selectivity of kinase inhibitors against a family of kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5773</span>– <span class="NLM_lpage">5779</span>, <span class="refDoi"> DOI: 10.1021/jm070562u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070562u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5773-5779&author=P.+P.+Graczyk&title=Gini+Coefficient%3A+A+new+way+to+express+selectivity+of+kinase+inhibitors+against+a+family+of+kinases&doi=10.1021%2Fjm070562u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Gini Coefficient: A New Way To Express Selectivity of Kinase Inhibitors against a Family of Kinases</span></div><div class="casAuthors">Graczyk, Piotr P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5773-5779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel application of the Gini coeff. for expressing selectivity of kinase inhibitors against a panel of kinases is proposed.  This has been illustrated using single-point inhibition data for 40 com. available kinase inhibitors screened against 85 kinases.  Nonselective inhibitors are characterized by Gini values close to zero (Staurosporine, Gini 0.150).  Highly selective compds. exhibit Gini values close to 1 (PD184352 Gini 0.905).  The relative selectivity of inhibitors does not depend on the ATP concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUHpmF-C9u7Vg90H21EOLACvtfcHk0lgT5WB5knbrxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL&md5=51f4902e49196dfef8e135c4a09182d7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm070562u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070562u%26sid%3Dliteratum%253Aachs%26aulast%3DGraczyk%26aufirst%3DP.%2BP.%26atitle%3DGini%2520Coefficient%253A%2520A%2520new%2520way%2520to%2520express%2520selectivity%2520of%2520kinase%2520inhibitors%2520against%2520a%2520family%2520of%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5773%26epage%3D5779%26doi%3D10.1021%2Fjm070562u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">8478</span>– <span class="NLM_lpage">8488</span>, <span class="refDoi"> DOI: 10.1021/bi2008382</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2008382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=8478-8488&author=R.+Battistuttaauthor=G.+Cozzaauthor=F.+Pierreauthor=E.+Papinuttoauthor=G.+Lolliauthor=S.+Sarnoauthor=S.+E.+O%E2%80%99Brienauthor=A.+Siddiqui-Jainauthor=M.+Haddachauthor=K.+Anderesauthor=D.+M.+Ryckmanauthor=F.+Meggioauthor=L.+A.+Pinna&title=Unprecedented+selectivity+and+structural+determinants+of+a+new+class+of+protein+kinase+CK2+inhibitors+in+clinical+trials+for+the+treatment+of+cancer&doi=10.1021%2Fbi2008382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer</span></div><div class="casAuthors">Battistutta, Roberto; Cozza, Giorgio; Pierre, Fabrice; Papinutto, Elena; Lolli, Graziano; Sarno, Stefania; O'Brien, Sean E.; Siddiqui-Jain, Adam; Haddach, Mustapha; Anderes, Kenna; Ryckman, David M.; Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">8478-8488</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clin. stage inhibitor of protein kinase CK2 for the treatment of cancer, is representative of a new class of CK2 inhibitors with Ki values in the low nanomolar range and unprecedented selectivity vs. other kinases.  Here we present the crystal structure of the complexes of CX-4945 and two analogs (CX-5011 and CX-5279) with the catalytic subunit of human CK2.  Consistent with their ATP-competitive mode of inhibition, all three compds. bind in the active site of CK2 (type I inhibitors).  The tricyclic scaffold of the inhibitors superposes on the adenine of ATP, establishing multiple hydrophobic interactions with the binding cavity.  The more extended scaffold, as compared to that of ATP, allows the carboxylic function, shared by all three ligands, to penetrate into the deepest part of the active site where it makes interactions with conserved water W1 and Lys-68, thus accounting for the crucial role of this neg. charged group in conferring high potency to this class of inhibitors.  The presence of a pyrimidine in CX-5011 and in CX-5279 instead of a pyridine (as in CX-4945) ring is likely to account for the higher specificity of these compds. whose Gini coeffs., calcd. by profiling them against panels of 102 and/or 235 kinases, are significantly higher than that of CX-4945 (0.735 and 0.755, resp., vs 0.615), marking the highest selectivity ever reported for CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjndr5Zz11z7Vg90H21EOLACvtfcHk0lgT5WB5knbrxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK&md5=4f399675d86d48b88cbfefa6b8c13edb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi2008382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2008382%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DUnprecedented%2520selectivity%2520and%2520structural%2520determinants%2520of%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520CK2%2520inhibitors%2520in%2520clinical%2520trials%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D8478%26epage%3D8488%26doi%3D10.1021%2Fbi2008382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzeszko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">The selectivity of inhibitors of protein kinase CK2: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1042/BJ20080309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1042%2FBJ20080309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18588507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CmsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2008&pages=353-365&author=M.+A.+Paganoauthor=J.+Bainauthor=Z.+Kazimierczukauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=G.+Di+Mairaauthor=M.+Elliottauthor=A.+Orzeszkoauthor=G.+Cozzaauthor=F.+Meggioauthor=L.+A.+Pinna&title=The+selectivity+of+inhibitors+of+protein+kinase+CK2%3A+an+update&doi=10.1042%2FBJ20080309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of inhibitors of protein kinase CK2: an update</span></div><div class="casAuthors">Pagano, Mario A.; Bain, Jenny; Kazimierczuk, Zygmunt; Sarno, Stefania; Ruzzene, Maria; Di maira, Giovanni; Elliott, Matthew; Orzeszko, Andrzej; Cozza, Giorgio; Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-365</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">CK2 (casein kinase 2) is a very pleiotropic serine/threonine protein kinase whose abnormally high constitutive activity has often been correlated to pathol. conditions with special ref. to neoplasia.  The two most widely used cell permeable CK2 inhibitors, TBB (4,5,6,7-tetrabromo-1H-benzotriazole) and DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole), are marketed as quite specific CK2 blockers.  In the present study the authors show, by using a panel of approx. 80 protein kinases, that DMAT and its parent compd. TBI (or TBBz; 4,5,6,7-tetrabromo-1H-benzimidazole) are potent inhibitors of several other kinases, with special ref. to PIM (provirus integration site for Moloney murine leukemia virus)1, PIM2, PIM3, PKD1 (protein kinase D1), HIPK2 (homeodomain-interacting protein kinase 2) and DYRK1a (dual-specificity tyrosine-phosphorylated and -regulated kinase 1a).  In contrast, TBB is significantly more selective toward CK2, although it also inhibits PIM1 and PIM3.  To improve selectivity towards CK2 a library of 68 TBB/TBI-related compds. have been tested for their ability to discriminate between CK2, PIM1, HIPK2 and DYRK1a, ending up with seven compds. whose efficacy toward CK2 is markedly higher than that toward the second most inhibited kinase.  Two of these, K64 (3,4,5,6,7-pentabromo-1H-indazole) and K66 (1-carboxymethyl-2-dimethylamino-4,5,6,7-tetrabromo-benzimidazole), display an overall selectivity much higher than TBB and DMAT when tested on a panel of 80 kinases and display similar efficacy as inducers of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6m0pQ0Dz7b7Vg90H21EOLACvtfcHk0ljs7LZcp5V6Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CmsrnJ&md5=2a7bee7f29c2a500458240fd92fd2e3a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1042%2FBJ20080309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20080309%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520selectivity%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D415%26spage%3D353%26epage%3D365%26doi%3D10.1042%2FBJ20080309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodaczewska, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczylik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiedorowicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnecka, A. M.</span></span> <span> </span><span class="NLM_article-title">Choosing the right cell line for renal cell cancer research</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">83</span>, <span class="refDoi"> DOI: 10.1186/s12943-016-0565-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1186%2Fs12943-016-0565-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=27993170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFWisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=83&author=K.+K.+Brodaczewskaauthor=C.+Szczylikauthor=M.+Fiedorowiczauthor=C.+Portaauthor=A.+M.+Czarnecka&title=Choosing+the+right+cell+line+for+renal+cell+cancer+research&doi=10.1186%2Fs12943-016-0565-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Choosing the right cell line for renal cell cancer research</span></div><div class="casAuthors">Brodaczewska, Klaudia K.; Szczylik, Cezary; Fiedorowicz, Michal; Porta, Camillo; Czarnecka, Anna M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83/1-83/15</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Cell lines are still a tool of choice for many fields of biomedical research, including oncol.  Although cancer is a very complex disease, many discoveries have been made using monocultures of established cell lines.  Therefore, the proper use of in vitro models is crucial to enhance our understanding of cancer.  Therapeutics against renal cell cancer (RCC) are also screened with the use of cell lines.  Multiple RCC in vitro cultures are available, allowing in vivo heterogeneity in the lab., but at the same time, these can be a source of errors.  In this review, we tried to sum up the data on the RCC cell lines used currently.  An increasing amt. of data on RCC shed new light on the mol. background of the disease; however, it revealed how much still needs to be done.  As new types of RCC are being distinguished, novel cell lines and the re-exploration of old ones seems to be indispensable to create effective in vitro tools for drug screening and more.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSTyM5-NwfMbVg90H21EOLACvtfcHk0ljs7LZcp5V6Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFWisLc%253D&md5=7b01e396028776a5111436dd71864885</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1186%2Fs12943-016-0565-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-016-0565-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrodaczewska%26aufirst%3DK.%2BK.%26aulast%3DSzczylik%26aufirst%3DC.%26aulast%3DFiedorowicz%26aufirst%3DM.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DCzarnecka%26aufirst%3DA.%2BM.%26atitle%3DChoosing%2520the%2520right%2520cell%2520line%2520for%2520renal%2520cell%2520cancer%2520research%26jtitle%3DMol.%2520Cancer%26date%3D2016%26volume%3D15%26spage%3D83%26doi%3D10.1186%2Fs12943-016-0565-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singer, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchalik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span> <span> </span><span class="NLM_article-title">Evolving therapeutic targets in renal cell carcinoma</span>. <i>Curr. Opin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1097/CCO.0b013e32835fc857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1097%2FCCO.0b013e32835fc857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=23455028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ant7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=273-280&author=E.+A.+Singerauthor=G.+N.+Guptaauthor=D.+Marchalikauthor=R.+Srinivasan&title=Evolving+therapeutic+targets+in+renal+cell+carcinoma&doi=10.1097%2FCCO.0b013e32835fc857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving therapeutic targets in renal cell carcinoma</span></div><div class="casAuthors">Singer, Eric A.; Gupta, Gopal N.; Marchalik, Daniel; Srinivasan, Ramaprasad</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-280</span>CODEN:
                <span class="NLM_cas:coden">CUOOE8</span>;
        ISSN:<span class="NLM_cas:issn">1040-8746</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Recent developments in the treatment of advanced renal cell carcinoma (RCC) will be discussed, with emphasis on data published over the past year.  The genetics and mol. biol. of the various histol. subtypes of kidney cancer will be reviewed, as these subtle yet important genomic and metabolic alterations provide the opportunity for rational drug development and personalized treatment regimens.  Recent findings: Addnl. targeted agents continue to be added to the uro-oncologist's armamentarium in the fight against metastatic kidney cancer.  Targeting the vascular endothelial growth factor and its receptor, or the mammalian target of rapamycin complex, remains the foundation of systemic treatment.  In clear cell RCC, increased emphasis is being placed on target selectivity and affinity in a bid to diminish off-target toxicity without compromising efficacy.  Combination strategies targeting multiple pathways simultaneously continue to be explored.  Histol.-specific protocols testing later generation and novel agents in nonclear cell RCC should be made a priority, as there is still not a single drug approved specifically for a nonclear cell indication.  Summary: The no. of approved treatments for advanced RCC continues to grow, but addnl. work is needed to further delineate the optimal drug, combination of agents, or sequence best suited to each subtype of RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQcPAHufUgQrVg90H21EOLACvtfcHk0ljs7LZcp5V6Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ant7g%253D&md5=65474ecfd9debafb0d131954bc174ad2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1097%2FCCO.0b013e32835fc857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCCO.0b013e32835fc857%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DE.%2BA.%26aulast%3DGupta%26aufirst%3DG.%2BN.%26aulast%3DMarchalik%26aufirst%3DD.%26aulast%3DSrinivasan%26aufirst%3DR.%26atitle%3DEvolving%2520therapeutic%2520targets%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D2013%26volume%3D25%26spage%3D273%26epage%3D280%26doi%3D10.1097%2FCCO.0b013e32835fc857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roelants, C.</span>; <span class="NLM_string-name">Giacosa, S.</span>; <span class="NLM_string-name">Duchemin-Pelletier, E.</span>; <span class="NLM_string-name">McLeer-Florin, A.</span>; <span class="NLM_string-name">Tisseyre, C.</span>; <span class="NLM_string-name">Aubert, C.</span>; <span class="NLM_string-name">Champelovier, P.</span>; <span class="NLM_string-name">Boutonnat, J.</span>; <span class="NLM_string-name">Descotes, J. L.</span>; <span class="NLM_string-name">Rambeaud, J.-J.</span>; <span class="NLM_string-name">Arnoux, V.</span>; <span class="NLM_string-name">Long, J.-A.</span>; <span class="NLM_string-name">Pasquier, D.</span>; <span class="NLM_string-name">Laramas, M.</span>; <span class="NLM_string-name">Kassem, M.</span>; <span class="NLM_string-name">David-Boudet, L.</span>; <span class="NLM_string-name">Schoutteten, L.</span>; <span class="NLM_string-name">Bestgen, B.</span>; <span class="NLM_string-name">Pillet, C.</span>; <span class="NLM_string-name">Cochet, C.</span>; <span class="NLM_string-name">Filhol, O.</span></span> <span> </span><span class="NLM_article-title">Dysregulated Expression of Protein Kinase CK2 in Renal Cancer</span>. In  <i>Protein Kinase CK2 Cellular Function in Normal and Disease States</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span>, <span class="NLM_string-name">Issinger, O.-G.</span>, <span class="NLM_string-name">Szyszka, R.</span></span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-14544-0_14</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2F978-3-319-14544-0_14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=241-257&author=C.+Roelants&author=S.+Giacosa&author=E.+Duchemin-Pelletier&author=A.+McLeer-Florin&author=C.+Tisseyre&author=C.+Aubert&author=P.+Champelovier&author=J.+Boutonnat&author=J.+L.+Descotes&author=J.-J.+Rambeaud&author=V.+Arnoux&author=J.-A.+Long&author=D.+Pasquier&author=M.+Laramas&author=M.+Kassem&author=L.+David-Boudet&author=L.+Schoutteten&author=B.+Bestgen&author=C.+Pillet&author=C.+Cochet&author=O.+Filholauthor=K.+Ahmed&author=O.-G.+Issinger&author=R.+Szyszka&title=Protein+Kinase+CK2+Cellular+Function+in+Normal+and+Disease+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-14544-0_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-14544-0_14%26sid%3Dliteratum%253Aachs%26aulast%3DRoelants%26aufirst%3DC.%26atitle%3DDysregulated%2520Expression%2520of%2520Protein%2520Kinase%2520CK2%2520in%2520Renal%2520Cancer%26btitle%3DProtein%2520Kinase%2520CK2%2520Cellular%2520Function%2520in%2520Normal%2520and%2520Disease%2520States%26aulast%3DAhmed%26aufirst%3DK.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2015%26spage%3D241%26epage%3D257%26doi%3D10.1007%2F978-3-319-14544-0_14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrigoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brustolon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fsj.cdd.4401604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=15818404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=668-677&author=G.+Di%0AMairaauthor=M.+Salviauthor=G.+Arrigoniauthor=O.+Marinauthor=S.+Sarnoauthor=F.+Brustolonauthor=L.+A.+Pinnaauthor=M.+Ruzzene&title=Protein+kinase+CK2+phosphorylates+and+upregulates+Akt%2FPKB&doi=10.1038%2Fsj.cdd.4401604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span></div><div class="casAuthors">Di Maira, G.; Salvi, M.; Arrigoni, G.; Marin, O.; Sarno, S.; Brustolon, F.; Pinna, L. A.; Ruzzene, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-677</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment of Jurkat cells with specific inhibitors of protein kinase CK2 induces apoptosis.  Here we provide evidence that the antiapoptotic effect of CK2 can be at least partially mediated by upregulation of the Akt/PKB pathway.  Such a conclusion is based on the following observations: (1) inhibition of CK2 by cell treatment with two structurally unrelated CK2 inhibitors induces downregulation of Akt/PKB, as judged from decreased phosphorylation of its physiol. targets, and immunoppt. kinase assay; (2) similar results are obsd. upon redn. of CK2 catalytic subunit by the RNA-interference technique; (3) Akt/PKB Ser129 is phosphorylated by CK2 in vitro and in vivo; (4) such a phosphorylation of activated Akt/PKB correlates with a further increase in catalytic activity.  These data disclose an unanticipated mechanism by which constitutive phosphorylation by CK2 may be required for maximal activation of Akt/PKB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEFAKQPYl_7Vg90H21EOLACvtfcHk0lj0QinTwI0Vlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D&md5=04f583a966bd2ed26f315a2395370db9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401604%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DArrigoni%26aufirst%3DG.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DBrustolon%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26atitle%3DProtein%2520kinase%2520CK2%2520phosphorylates%2520and%2520upregulates%2520Akt%252FPKB%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26spage%3D668%26epage%3D677%26doi%3D10.1038%2Fsj.cdd.4401604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keezer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldape, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span> <span> </span><span class="NLM_article-title">EGF-induced ERK activation promotes CK2-mediated disassociation of α-catenin from β-catenin and transactivation of β-catenin</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.molcel.2009.09.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=547-559&author=H.+Jiauthor=J.+Wangauthor=H.+Nikaauthor=D.+Hawkeauthor=S.+Keezerauthor=Q.+Geauthor=B.+Fangauthor=X.+Fangauthor=D.+Fangauthor=D.+W.+Litchfieldauthor=K.+Aldapeauthor=Z.+Lu&title=EGF-induced+ERK+activation+promotes+CK2-mediated+disassociation+of+%CE%B1-catenin+from+%CE%B2-catenin+and+transactivation+of+%CE%B2-catenin&doi=10.1016%2Fj.molcel.2009.09.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DNika%26aufirst%3DH.%26aulast%3DHawke%26aufirst%3DD.%26aulast%3DKeezer%26aufirst%3DS.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DZ.%26atitle%3DEGF-induced%2520ERK%2520activation%2520promotes%2520CK2-mediated%2520disassociation%2520of%2520%25CE%25B1-catenin%2520from%2520%25CE%25B2-catenin%2520and%2520transactivation%2520of%2520%25CE%25B2-catenin%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D36%26spage%3D547%26epage%3D559%26doi%3D10.1016%2Fj.molcel.2009.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2005.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2005.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lj0QinTwI0Vlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637%26doi%3D10.1016%2Fj.chembiol.2005.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allende, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allende, C. C.</span></span> <span> </span><span class="NLM_article-title">Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1096/fasebj.9.5.7896000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1096%2Ffasebj.9.5.7896000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=313-323&author=J.+E.+Allendeauthor=C.+C.+Allende&title=Protein+kinases.+4.+Protein+kinase+CK2%3A+an+enzyme+with+multiple+substrates+and+a+puzzling+regulation&doi=10.1096%2Ffasebj.9.5.7896000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.5.7896000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.5.7896000%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DJ.%2BE.%26aulast%3DAllende%26aufirst%3DC.%2BC.%26atitle%3DProtein%2520kinases.%25204.%2520Protein%2520kinase%2520CK2%253A%2520an%2520enzyme%2520with%2520multiple%2520substrates%2520and%2520a%2520puzzling%2520regulation%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D313%26epage%3D323%26doi%3D10.1096%2Ffasebj.9.5.7896000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt-Leopold, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tecle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltiel, A. R.</span></span> <span> </span><span class="NLM_article-title">Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1038/10533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2F10533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10395327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=810-816&author=J.+S.+Sebolt-Leopoldauthor=D.+T.+Dudleyauthor=R.+Herreraauthor=K.+Van+Becelaereauthor=A.+Wilandauthor=R.+C.+Gowanauthor=H.+Tecleauthor=S.+D.+Barrettauthor=A.+Bridgesauthor=S.+Przybranowskiauthor=W.+R.+Leopoldauthor=A.+R.+Saltiel&title=Blockade+of+the+MAP+kinase+pathway+suppresses+growth+of+colon+tumors+in+vivo&doi=10.1038%2F10533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo</span></div><div class="casAuthors">Sebolt-Leopold, Judith S.; Dudley, David T.; Herrera, Roman; Van Becelaere, Keri; Wiland, Amy; Gowan, Richard C.; Tecle, Haile; Barrett, Stephen D.; Bridges, Alexander; Przybranowski, Sally; Leopold, W. R.; Saltiel, Alan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">810-816</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase pathway is thought to be essential in cellular growth and differentiation.  Here we report the discovery of PD 184352 (2-(2-chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide), a highly potent and selective inhibitor of the upstream kinase MEK, that is orally active.  Tumor growth was inhibited as much as 80% in mice with colon carcinomas of both mouse and human origin after treatment with this inhibitor.  Efficacy was achieved with a wide range of doses with no signs of toxicity, and correlated with a redn. in the levels of activated mitogen-activated protein kinase in excised tumors.  These data indicate that MEK inhibitors represent a promising, noncytotoxic approach to the clin. management of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSoqGxnzGBrLVg90H21EOLACvtfcHk0lhkHgGssDTOyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCrs7k%253D&md5=16d2f88b7fcd82521e9ff4d8ca4342f6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2F10533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10533%26sid%3Dliteratum%253Aachs%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%2BS.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DHerrera%26aufirst%3DR.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DWiland%26aufirst%3DA.%26aulast%3DGowan%26aufirst%3DR.%2BC.%26aulast%3DTecle%26aufirst%3DH.%26aulast%3DBarrett%26aufirst%3DS.%2BD.%26aulast%3DBridges%26aufirst%3DA.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26atitle%3DBlockade%2520of%2520the%2520MAP%2520kinase%2520pathway%2520suppresses%2520growth%2520of%2520colon%2520tumors%2520in%2520vivo%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D810%26epage%3D816%26doi%3D10.1038%2F10533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratilas, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt-Leopold, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span> <span> </span><span class="NLM_article-title">BRAF mutation predicts sensitivity to MEK inhibition</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>439</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1038/nature04304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnature04304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=16273091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2006&pages=358-362&author=D.+B.+Solitauthor=L.+A.+Garrawayauthor=C.+A.+Pratilasauthor=A.+Sawaiauthor=G.+Getzauthor=A.+Bassoauthor=Q.+Yeauthor=J.+M.+Loboauthor=Y.+Sheauthor=I.+Osmanauthor=T.+R.+Golubauthor=J.+Sebolt-Leopoldauthor=W.+R.+Sellersauthor=N.+Rosen&title=BRAF+mutation+predicts+sensitivity+to+MEK+inhibition&doi=10.1038%2Fnature04304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF mutation predicts sensitivity to MEK inhibition</span></div><div class="casAuthors">Solit, David B.; Garraway, Levi A.; Pratilas, Christine A.; Sawai, Ayana; Getz, Gad; Basso, Andrea; Ye, Qing; Lobo, Jose M.; She, Yuhong; Osman, Iman; Golub, Todd R.; Sebolt-Leopold, Judith; Sellers, William R.; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">7074</span>),
    <span class="NLM_cas:pages">358-362</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The kinase pathway comprising RAS, RAF, mitogen-activated protein kinase kinase (MEK) and extracellular signal regulated kinase (ERK) is activated in most human tumors, often through gain-of-function mutations of RAS and RAF family members.  Using small-mol. inhibitors of MEK and an integrated genetic and pharmacol. anal., we find that mutation of BRAF is assocd. with enhanced and selective sensitivity to MEK inhibition when compared to either 'wild-type' cells or cells harboring a RAS mutation.  This MEK dependency was obsd. in BRAF mutant cells regardless of tissue lineage, and correlated with both downregulation of cyclin D1 protein expression and the induction of G1 arrest.  Pharmacol. MEK inhibition completely abrogated tumor growth in BRAF mutant xenografts, whereas RAS mutant tumors were only partially inhibited.  These data suggest an exquisite dependency on MEK activity in BRAF mutant tumors, and offer a rational therapeutic strategy for this genetically defined tumor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpBpONOvd0vbVg90H21EOLACvtfcHk0lhkHgGssDTOyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvF2mtw%253D%253D&md5=37c8976aa5bb371ef5580aab2a91f89e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature04304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04304%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DPratilas%26aufirst%3DC.%2BA.%26aulast%3DSawai%26aufirst%3DA.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DLobo%26aufirst%3DJ.%2BM.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DBRAF%2520mutation%2520predicts%2520sensitivity%2520to%2520MEK%2520inhibition%26jtitle%3DNature%26date%3D2006%26volume%3D439%26spage%3D358%26epage%3D362%26doi%3D10.1038%2Fnature04304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 in health and disease: Cellular functions of protein kinase CK2: a dynamic affair</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1830</span>– <span class="NLM_lpage">1839</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-9151-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2Fs00018-009-9151-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19387551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1830-1839&author=O.+Filholauthor=C.+Cochet&title=Protein+kinase+CK2+in+health+and+disease%3A+Cellular+functions+of+protein+kinase+CK2%3A+a+dynamic+affair&doi=10.1007%2Fs00018-009-9151-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular functions of protein kinase CK2: a dynamic affair</span></div><div class="casAuthors">Filhol, O.; Cochet, C.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1830-1839</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 targets a vast array of substrates located in a no. of cellular compartments, making the challenge of discriminating among these substrates a daunting task.  However, as a signaling protein, CK2 could be targeted to different cellular compartments in response to various stress stimuli such as heat shock, UV irradn., hypoxia, DNA damage, and viral infections.  Here, the authors focus on evidence that the dynamic assocn. of CK2 subunits and the substrate-dependent subcellular targeting of the enzyme are a likely point of regulation in response to a variety of signaling events.  The authors propose that in addn. to enzymic substrate recognition, regulated CK2 localization to specific compartments should help to provide the exquisite specificity required for robust signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql95K9Q2RaMLVg90H21EOLACvtfcHk0ljFVyP8NZjGUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs70%253D&md5=460fb26b64bc1e38b37211606375b422</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9151-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9151-1%26sid%3Dliteratum%253Aachs%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520health%2520and%2520disease%253A%2520Cellular%2520functions%2520of%2520protein%2520kinase%2520CK2%253A%2520a%2520dynamic%2520affair%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D1830%26epage%3D1839%26doi%3D10.1007%2Fs00018-009-9151-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span>; <span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of CK2 Regulation by Autoinhibitory Oligomerization</span>. In  <i>Protein Kinase CK2 Cellular Function in Normal and Disease States</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span>, <span class="NLM_string-name">Issinger, O.</span>, <span class="NLM_string-name">Szyszka, R.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">12</span>, pp  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-14544-0_3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2F978-3-319-14544-0_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=35-47&author=G.+Lolli&author=R.+Battistuttaauthor=K.+Ahmed&author=O.+Issinger&author=R.+Szyszka&title=Protein+Kinase+CK2+Cellular+Function+in+Normal+and+Disease+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-14544-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-14544-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DG.%26atitle%3DStructural%2520Basis%2520of%2520CK2%2520Regulation%2520by%2520Autoinhibitory%2520Oligomerization%26btitle%3DProtein%2520Kinase%2520CK2%2520Cellular%2520Function%2520in%2520Normal%2520and%2520Disease%2520States%26aulast%3DAhmed%26aufirst%3DK.%26pub%3DSpringer%26date%3D2015%26volume%3D12%26spage%3D35%26epage%3D47%26doi%3D10.1007%2F978-3-319-14544-0_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhowmik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, M. K.</span></span> <span> </span><span class="NLM_article-title">Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1725</span>– <span class="NLM_lpage">1734</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.cellsig.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=24726840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1725-1734&author=T.+Mandalauthor=A.+Bhowmikauthor=A.+Chatterjeeauthor=U.+Chatterjeeauthor=S.+Chatterjeeauthor=M.+K.+Ghosh&title=Reduced+phosphorylation+of+Stat3+at+Ser-727+mediated+by+casein+kinase+2+-+protein+phosphatase+2A+enhances+Stat3+Tyr-705+induced+tumorigenic+potential+of+glioma+cells&doi=10.1016%2Fj.cellsig.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - Protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells</span></div><div class="casAuthors">Mandal, Tapashi; Bhowmik, Arijit; Chatterjee, Anirban; Chatterjee, Uttara; Chatterjee, Sandip; Ghosh, Mrinal Kanti</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1725-1734</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Signal transducer and activator of transcription 3 (Stat3) is a transcription factor that is involved in cell survival and proliferation and has been found to be persistently activated in most human cancers mainly through its phosphorylation at Tyr-705.  However, the role and regulation of Stat3 Ser-727 phosphorylation in cancer cells have not been clearly evaluated.  In our findings, correlation studies on the expression of CK2 and Stat3 Ser-727 phosphorylation levels in human glioma patient samples as well as rat orthotopic tumor model show a degree of neg. correlation.  Moreover, brain tumor cell lines were treated with various pharmacol. inhibitors to inactivate the CK2 pathway.  Here, increased Stat3 Ser-727 phosphorylation upon CK2 inhibition was obsd.  Overexpression of CK2 (α, α' or β subunits) by transient transfection resulted in decreased Stat3 Ser-727 phosphorylation.  Stat3 Tyr-705 residue was conversely phosphorylated in similar situations.  Interestingly, we found PP2A, a protein phosphatase, to be a mediator in the neg. regulation of Stat3 Ser-727 phosphorylation by CK2.  In vitro assays prove that Ser-727 phosphorylation of Stat3 affects the transcriptional activity of its downstream targets like SOCS3, bcl-xl and Cyclin D1.  Stable cell lines constitutively expressing Stat3 S727A mutant showed increased survival, proliferation and invasion which are characteristics of a cancer cell.  Rat tumor models generated with the Stat3 S727A mutant cell line formed more aggressive tumors when compared to the Stat3 WT expressing stable cell line.  Thus, in glioma, reduced Stat3 Ser-727 phosphorylation enhances tumorigenicity which may be regulated in part by CK2-PP2A pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-XyYE5bbxHbVg90H21EOLACvtfcHk0ljFVyP8NZjGUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVartrk%253D&md5=28ecac000a9c855cc01a5cd52a516e41</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DT.%26aulast%3DBhowmik%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DU.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DM.%2BK.%26atitle%3DReduced%2520phosphorylation%2520of%2520Stat3%2520at%2520Ser-727%2520mediated%2520by%2520casein%2520kinase%25202%2520-%2520protein%2520phosphatase%25202A%2520enhances%2520Stat3%2520Tyr-705%2520induced%2520tumorigenic%2520potential%2520of%2520glioma%2520cells%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D1725%26epage%3D1734%26doi%3D10.1016%2Fj.cellsig.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancalion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubi, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colpo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappellesso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maggio, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, F.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e75280</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0075280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1371%2Fjournal.pone.0075280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=24086494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOntLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=S.+Manniauthor=A.+Brancalionauthor=E.+Mandatoauthor=L.+Q.+Tubiauthor=A.+Colpoauthor=M.+Pizziauthor=R.+Cappellessoauthor=F.+Zaffinoauthor=S.+A.+Di+Maggioauthor=A.+Cabrelleauthor=F.+Marinoauthor=R.+Zambelloauthor=L.+Trentinauthor=F.+Adamiauthor=C.+Gurrieriauthor=G.+Semenzatoauthor=F.+Piazza&title=Protein+kinase+CK2+inhibition+down+modulates+the+NF-%CE%BAB+and+STAT3+survival+pathways%2C+enhances+the+cellular+proteotoxic+stress+and+synergistically+boosts+the+cytotoxic+effect+of+bortezomib+on+multiple+myeloma+and+mantle+cell+lymphoma+cells&doi=10.1371%2Fjournal.pone.0075280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 inhibition down modulates the NF-κB and Stat3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells</span></div><div class="casAuthors">Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Pizzi, Marco; Cappellesso, Rocco; Zaffino, Fortunato; Di Maggio, Speranza Antonia; Cabrelle, Anna; Marino, Filippo; Zambello, Renato; Trentin, Livio; Adami, Fausto; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e75280</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">CK2 is a pivotal pro-survival protein kinase in multiple myeloma that may likely impinge on bortezomib-regulated cellular pathways.  In the present study, we investigated CK2 expression in multiple myeloma and mantle cell lymphoma, two bortezomib-responsive B cell tumors, as well as its involvement in bortezomib-induced cytotoxicity and signaling cascades potentially mediating bortezomib resistance.  In both tumors, CK2 expression correlated with that of its activated targets NF-κB and STAT3 transcription factors.  Bortezomib-induced proliferation arrest and apoptosis were significantly amplified by the simultaneous inhibition of CK2 with two inhibitors (CX-4945 and K27) in multiple myeloma and mantle cell lymphoma cell lines, in a model of multiple myeloma bone marrow microenvironment and in cells isolated from patients.  CK2 inhibition empowered bortezomib-triggered mitochondrial-dependent cell death.  Phosphorylation of NF-κB p65 on Ser529 (a CK2 target site) and rise of the levels of the endoplasmic reticulum stress kinase/endoribonuclease Ire1α were markedly reduced upon CK2 inhibition, as were STAT3 phospho Ser727 levels.  On the contrary, CK2 inhibition increased phospho Ser51 eIF2α levels and enhanced the bortezomib-dependent accumulation of poly-ubiquitylated proteins and of the proteotoxic stress-assocd. chaperone Hsp70.  Our data suggest that CK2 over expression in multiple myeloma and mantle cell lymphoma cells might sustain survival signaling cascades and can antagonize bortezomib-induced apoptosis at different levels.  CK2 inhibitors could be useful in bortezomib-based combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfX_mz9rmfrLVg90H21EOLACvtfcHk0lj9Wlxi7lFCmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOntLbN&md5=8360a9d311aa953f3353fe86ac54606f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0075280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0075280%26sid%3Dliteratum%253Aachs%26aulast%3DManni%26aufirst%3DS.%26aulast%3DBrancalion%26aufirst%3DA.%26aulast%3DMandato%26aufirst%3DE.%26aulast%3DTubi%26aufirst%3DL.%2BQ.%26aulast%3DColpo%26aufirst%3DA.%26aulast%3DPizzi%26aufirst%3DM.%26aulast%3DCappellesso%26aufirst%3DR.%26aulast%3DZaffino%26aufirst%3DF.%26aulast%3DDi%2BMaggio%26aufirst%3DS.%2BA.%26aulast%3DCabrelle%26aufirst%3DA.%26aulast%3DMarino%26aufirst%3DF.%26aulast%3DZambello%26aufirst%3DR.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DAdami%26aufirst%3DF.%26aulast%3DGurrieri%26aufirst%3DC.%26aulast%3DSemenzato%26aufirst%3DG.%26aulast%3DPiazza%26aufirst%3DF.%26atitle%3DProtein%2520kinase%2520CK2%2520inhibition%2520down%2520modulates%2520the%2520NF-%25CE%25BAB%2520and%2520STAT3%2520survival%2520pathways%252C%2520enhances%2520the%2520cellular%2520proteotoxic%2520stress%2520and%2520synergistically%2520boosts%2520the%2520cytotoxic%2520effect%2520of%2520bortezomib%2520on%2520multiple%2520myeloma%2520and%2520mantle%2520cell%2520lymphoma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0075280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonanni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioetto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span> <span> </span><span class="NLM_article-title">Multiple myeloma cell survival relies on high activity of protein kinase CK2</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1182/blood-2005-11-013672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1182%2Fblood-2005-11-013672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=16684960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Slurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=1698-1707&author=F.+A.+Piazzaauthor=M.+Ruzzeneauthor=C.+Gurrieriauthor=B.+Montiniauthor=L.+Bonanniauthor=G.+Chioettoauthor=G.+Di+Mairaauthor=F.+Barbonauthor=A.+Cabrelleauthor=R.+Zambelloauthor=F.+Adamiauthor=L.+Trentinauthor=L.+A.+Pinnaauthor=G.+Semenzato&title=Multiple+myeloma+cell+survival+relies+on+high+activity+of+protein+kinase+CK2&doi=10.1182%2Fblood-2005-11-013672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple myeloma cell survival relies on high activity of protein kinase CK2</span></div><div class="casAuthors">Piazza, Francesco A.; Ruzzene, Maria; Gurrieri, Carmela; Montini, Barbara; Bonanni, Luca; Chioetto, Gino; Di Maira, Giovanni; Barbon, Francesca; Cabrelle, Anna; Zambello, Renato; Adami, Fausto; Trentin, Livio; Pinna, Lorenzo A.; Semenzato, Gianpietro</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1698-1707</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Casein kinase 2 (CK2) is a ubiquitous cellular serine-threonine kinase that regulates relevant biol. processes, many of which are dysregulated in malignant plasma cells.  Here we investigated its role in multiple myeloma (MM).  Anal. of MM cell lines and highly purified malignant plasma cells in patients with MM revealed higher protein and CK2 activity levels than in controls (normal in vitro-generated polyclonal plasma cells and B lymphocytes).  The inhibition of CK2 with specific synthetic compds. or by means of RNA interference caused a cytotoxic effect on MM plasma cells that could not be overcome by IL-6 or IGF-I and that was assocd. with the activation with the activation of extrinsic and intrinsic caspase cascades.  CK2 blockage lowered the sensitivity threshold of MM plasma cells to the cytotoxic effect of melphalan.  CK2 inhibition also resulted in impaired IL-6-dependent STAT3 activation and in decreased basal and TNF-α-dependent IκBα degrdn. and NF-κB-driven transcription.  Our data show that CK2 was involved in the pathophysiol. of MM, suggesting that it might play a crucial role in controlling survival and sensitivity to chemotherapeutics of malignant plasma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKkI1sKi35X7Vg90H21EOLACvtfcHk0lj9Wlxi7lFCmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Slurw%253D&md5=3b4e57e59d6479d916b5dfbf779fd6fc</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-11-013672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-11-013672%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DF.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DGurrieri%26aufirst%3DC.%26aulast%3DMontini%26aufirst%3DB.%26aulast%3DBonanni%26aufirst%3DL.%26aulast%3DChioetto%26aufirst%3DG.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DBarbon%26aufirst%3DF.%26aulast%3DCabrelle%26aufirst%3DA.%26aulast%3DZambello%26aufirst%3DR.%26aulast%3DAdami%26aufirst%3DF.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DSemenzato%26aufirst%3DG.%26atitle%3DMultiple%2520myeloma%2520cell%2520survival%2520relies%2520on%2520high%2520activity%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26spage%3D1698%26epage%3D1707%26doi%3D10.1182%2Fblood-2005-11-013672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrowolska, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, E. G.</span></span> <span> </span><span class="NLM_article-title">The physical association of casein kinase 2 with nucleolin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">15662</span>– <span class="NLM_lpage">15668</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.26.15662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1074%2Fjbc.271.26.15662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=15662-15668&author=D.+Liauthor=G.+Dobrowolskaauthor=E.+G.+Krebs&title=The+physical+association+of+casein+kinase+2+with+nucleolin&doi=10.1074%2Fjbc.271.26.15662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.26.15662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.26.15662%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DDobrowolska%26aufirst%3DG.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DThe%2520physical%2520association%2520of%2520casein%2520kinase%25202%2520with%2520nucleolin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D15662%26epage%3D15668%26doi%3D10.1074%2Fjbc.271.26.15662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderer, F. A.</span></span> <span> </span><span class="NLM_article-title">Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>969</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/0167-4889(88)90093-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2F0167-4889%2888%2990093-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=3280036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaL1cXhvValsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=969&publication_year=1988&pages=100-109&author=M.+Pfaffauthor=F.+A.+Anderer&title=Casein+kinase+II+accumulation+in+the+nucleolus+and+its+role+in+nucleolar+phosphorylation&doi=10.1016%2F0167-4889%2888%2990093-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation</span></div><div class="casAuthors">Pfaff, Martin; Anderer, F. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">969</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-9</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    </div><div class="casAbstract">A rabbit antiserum against highly purified casein kinase II from mouse tumor cells was used for immunolocalization of the enzyme in fixed, permeabilized mouse cells.  Casein kinase II was highly accumulated in nucleoli compared to the extranucleolar space of the nucleus or to the cytoplasm.  Casein kinase II samples highly purified from the cytoplasm, from the extranucleolar fraction of the nucleus, or from nucleoli exhibited no differences with respect to structure and function.  All samples originally had an α2β2 structure [α, 42 kilodaltons (kDa); β, 24 kDa], showing formation of the α'-chain (36 kDa) only in the late steps of purifn.  The pI of the α-chain of all 3 samples was 7.7 and that of the β-chain was 6.4-6.6.  With ATP or GTP, all 3 casein kinase II samples gave the same results of max. phosphorylation of purified nucleolar marker phosphoproteins pp105/C23, pp135, and B23, yielding pp135 as one of the most highly phosphorylated proteins with an incorporation of ∼75 phosphate groups/mol. pp135.  Studies on optimum conditions of phosphorylation of nucleolar phosphoproteins by casein kinase II revealed that each of the protein substrates individually responded to alterations of assay parameters such as pH and concns. of Mg2+ and NaCl, indicating that predominantly individual structural criteria were responsible for optimum phosphorylation.  The detn. of the apparent Km of casein kinase II for purified nucleolar phosphoproteins yielded values of 0.15 μM (pp105/C23), 0.1 μM (pp135), and 1.0 μM (B23), identifying them as high-affinity substrates of casein kinase II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof5BbIsQayerVg90H21EOLACvtfcHk0liWNb_JJYT9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvValsb4%253D&md5=fc0dda6f7c622db7faee1d086b7ded99</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0167-4889%2888%2990093-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4889%252888%252990093-6%26sid%3Dliteratum%253Aachs%26aulast%3DPfaff%26aufirst%3DM.%26aulast%3DAnderer%26aufirst%3DF.%2BA.%26atitle%3DCasein%2520kinase%2520II%2520accumulation%2520in%2520the%2520nucleolus%2520and%2520its%2520role%2520in%2520nucleolar%2520phosphorylation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D1988%26volume%3D969%26spage%3D100%26epage%3D109%26doi%3D10.1016%2F0167-4889%2888%2990093-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreyer, C.</span></span> <span> </span><span class="NLM_article-title">Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin</span>. <i>Eur. J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=9270871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVyktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1997&pages=287-297&author=M.+S.+Schwabauthor=C.+Dreyer&title=Protein+phosphorylation+sites+regulate+the+function+of+the+bipartite+NLS+of+nucleolin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin</span></div><div class="casAuthors">Schwab, Markus S.; Dreyer, Christine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Wissenschaftliche Verlagsgesellschaft</span>)
        </div><div class="casAbstract">Nucleolin is a major component of the nucleolus.  In Xenopus laevis, a maternal store of nucleolin is accumulated in the multiple nucleoli generated during oogenesis.  This maternal nucleolin is distributed throughout the cytoplasm of the egg during oocyte maturation and after fertilization it is gradually reaccumulated in the nuclei of the embryo.  Cytoplasmic localization of nucleolin coincides with massive phosphorylation by p34cdc2 kinase, and nuclear translocation is accompanied by net dephosphorylation.  Multiple phosphorylation consensus sites for the cell cycle-dependent p34cdc2 kinase and for protein kinase CK2 are clustered in the N-terminal domain of nucleolin.  To assess the efficiency of the bipartite nuclear localization signal, fusion proteins were constructed consisting of maltose binding protein (MBP) and the nuclear localization signal of nucleolin.  In addn., either an acidic domain of nucleolin without phosphorylation sites, or an acidic domain contg. 4 CK2 sites, or a cluster of 5 cdc2 sites was fused to the MBP-nuclear localization signal (MBP-NLS).  Nuclear translocation of these constructs was tested in an in vitro system consisting of Xenopus egg ext. and sperm nuclei.  Nuclear targetting of MBP by the bipartite nuclear localization signal of nucleolin became more efficient after addn. of either CK2 sites or cdc2 sites to the MBP-NLS construct.  Yet the cdc2 sites play a dual role.  They enhance nuclear translocation exclusively in their dephosphorylated state and promote cytoplasmic localization when phosphorylated, thereby providing a powerful cell cycle-dependent regulatory element of the nuclear localization signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoShFjXIY2oGLVg90H21EOLACvtfcHk0liWNb_JJYT9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVyktbo%253D&md5=5bc8211fed444c7c061c4e1ca1c11ba2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%2BS.%26aulast%3DDreyer%26aufirst%3DC.%26atitle%3DProtein%2520phosphorylation%2520sites%2520regulate%2520the%2520function%2520of%2520the%2520bipartite%2520NLS%2520of%2520nucleolin%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D1997%26volume%3D73%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wales, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochrein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyn, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banu
Ozkan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithgall, T. E.</span></span> <span> </span><span class="NLM_article-title">Structure and dynamic regulation of Src-family kinases</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">3058</span>– <span class="NLM_lpage">3073</span>, <span class="refDoi"> DOI: 10.1007/s00018-008-8122-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2Fs00018-008-8122-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18563293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOjtrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=3058-3073&author=J.+R.+Engenauthor=T.+E.+Walesauthor=J.+M.+Hochreinauthor=M.+A.+Meynauthor=S.+Banu%0AOzkanauthor=I.+Baharauthor=T.+E.+Smithgall&title=Structure+and+dynamic+regulation+of+Src-family+kinases&doi=10.1007%2Fs00018-008-8122-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and dynamic regulation of Src-family kinases</span></div><div class="casAuthors">Engen, J. R.; Wales, T. E.; Hochrein, J. M.; Meyn, M. A., III; Banu Ozkan, S.; Bahar, I.; Smithgall, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3058-3073</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Src-family kinases are modular signaling proteins involved in a diverse array of cellular processes.  All members of the Src family share the same domain organization, with modular SH3, SH2, and kinase domains followed by a C-terminal neg. regulatory tail.  X-ray crystallog. analyses of several Src family members have revealed crit. roles for the SH3 and SH2 domains in the down-regulation of the kinase domain.  Here, the authors focus on biol., biophys., and computational studies that reveal conformationally distinct active states within this unique kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoh3f-1iz9LVg90H21EOLACvtfcHk0liWNb_JJYT9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOjtrjO&md5=0f3fed01f1c5bc97d511ab5bfce7bffb</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8122-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8122-2%26sid%3Dliteratum%253Aachs%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWales%26aufirst%3DT.%2BE.%26aulast%3DHochrein%26aufirst%3DJ.%2BM.%26aulast%3DMeyn%26aufirst%3DM.%2BA.%26aulast%3DBanu%2BOzkan%26aufirst%3DS.%26aulast%3DBahar%26aufirst%3DI.%26aulast%3DSmithgall%26aufirst%3DT.%2BE.%26atitle%3DStructure%2520and%2520dynamic%2520regulation%2520of%2520Src-family%2520kinases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D3058%26epage%3D3073%26doi%3D10.1007%2Fs00018-008-8122-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeliger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">A conserved protonation-dependent switch controls drug binding in the Abl kinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1073/pnas.0811223106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1073%2Fpnas.0811223106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19109437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltF2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=139-144&author=Y.+Shanauthor=M.+A.+Seeligerauthor=M.+P.+Eastwoodauthor=F.+Frankauthor=H.+Xuauthor=M.+Jensenauthor=R.+O.+Drorauthor=J.+Kuriyanauthor=D.+E.+Shaw&title=A+conserved+protonation-dependent+switch+controls+drug+binding+in+the+Abl+kinase&doi=10.1073%2Fpnas.0811223106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved protonation-dependent switch controls drug binding in the Abl kinase</span></div><div class="casAuthors">Shan, Yibing; Seeliger, Markus A.; Eastwood, Michael P.; Frank, Filipp; Xu, Huafeng; Jensen, Morten O.; Dror, Ron O.; Kuriyan, John; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-144</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In many protein kinases, a characteristic conformational change (the "DFG flip") connects catalytically active and inactive conformations.  Many kinase inhibitors - including the cancer drug imatinib - selectively target a specific DFG conformation, but the function and mechanism of the flip remain unclear.  Using long mol. dynamics (MD) simulations of the Abl kinase, we visualized the DFG flip in at.-level detail and formulated an energetic model predicting that protonation of the DFG aspartate controls the flip.  Consistent with our model's predictions, we demonstrated exptl. that the kinetics of imatinib binding to Abl kinase have a pH dependence that disappears when the DFG aspartate is mutated.  Our model suggests a possible explanation for the high degree of conservation of the DFG motif: that the flip, modulated by electrostatic changes inherent to the catalytic cycle, allows the kinase to access flexible conformations facilitating nucleotide binding and release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof7hx2l1lxt7Vg90H21EOLACvtfcHk0lill0oljgbttw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltF2ntg%253D%253D&md5=73e6156334ecf731cb1f5e535cd7f978</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0811223106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0811223106%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DY.%26aulast%3DSeeliger%26aufirst%3DM.%2BA.%26aulast%3DEastwood%26aufirst%3DM.%2BP.%26aulast%3DFrank%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DM.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DA%2520conserved%2520protonation-dependent%2520switch%2520controls%2520drug%2520binding%2520in%2520the%2520Abl%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D139%26epage%3D144%26doi%3D10.1073%2Fpnas.0811223106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasio, F. L.</span></span> <span> </span><span class="NLM_article-title">The effect of a widespread cancer-causing mutation on the inactive to active dynamics of the B-Raf kinase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">5280</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b01421</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b01421" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=5280-5283&author=K.+A.+Marinoauthor=L.+Suttoauthor=F.+L.+Gervasio&title=The+effect+of+a+widespread+cancer-causing+mutation+on+the+inactive+to+active+dynamics+of+the+B-Raf+kinase&doi=10.1021%2Fjacs.5b01421"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b01421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b01421%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DK.%2BA.%26aulast%3DSutto%26aufirst%3DL.%26aulast%3DGervasio%26aufirst%3DF.%2BL.%26atitle%3DThe%2520effect%2520of%2520a%2520widespread%2520cancer-causing%2520mutation%2520on%2520the%2520inactive%2520to%2520active%2520dynamics%2520of%2520the%2520B-Raf%2520kinase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D5280%26epage%3D5283%26doi%3D10.1021%2Fjacs.5b01421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morando, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucheta-Martinez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Torrecuadrada, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saladino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasio, F. L.</span></span> <span> </span><span class="NLM_article-title">Towards a molecular understanding of the link between imatinib resistance and kinase conformational dynamics</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e1004578</span> <span class="refDoi"> DOI: 10.1371/journal.pcbi.1004578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1371%2Fjournal.pcbi.1004578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=26606374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlGlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&author=S.+Loveraauthor=M.+Morandoauthor=E.+Pucheta-Martinezauthor=J.+L.+Martinez-Torrecuadradaauthor=G.+Saladinoauthor=F.+L.+Gervasio&title=Towards+a+molecular+understanding+of+the+link+between+imatinib+resistance+and+kinase+conformational+dynamics&doi=10.1371%2Fjournal.pcbi.1004578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a molecular understanding of the link between imatinib resistance and kinase conformational dynamics</span></div><div class="casAuthors">Lovera, Silvia; Morando, Maria; Pucheta-Martinez, Encarna; Martinez-Torrecuadrada, Jorge L.; Saladino, Giorgio; Gervasio, Francesco L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1004578/1-e1004578/19</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Due to its inhibition of the Abl kinase domain in the BCR-ABL fusion protein, imatinib is strikingly effective in the initial stage of chronic myeloid leukemia with more than 90% of the patients showing complete remission.  However, as in the case of most targeted anticancer therapies, the emergence of drug resistance is a serious concern.  Several drugresistant mutations affecting the catalytic domain of Abl and other tyrosine kinases are now known.  But, despite their importance and the adverse effect that they have on the prognosis of the cancer patients harboring them, the mol. mechanism of these mutations is still debated.  Here by using long mol. dynamics simulations and large-scale free energy calcns. complemented by in vitro mutagenesis and microcalorimetry expts., we model the effect of several widespread drug-resistant mutations of Abl.  By comparing the conformational free energy landscape of the mutants with those of the wild-type tyrosine kinases we clarify their mode of action.  It involves significant and complex changes in the inactive-to-active dynamics and entropy/enthalpy balance of two functional elements: the activation-loop and the conserved DFG motif.What is more the T315I gatekeeper mutant has a significant impact on the binding mechanism itself and on the binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ZlGqINU3t7Vg90H21EOLACvtfcHk0lill0oljgbttw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlGlurc%253D&md5=43300d858e4e11207b8ac4f10dfc2450</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1004578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1004578%26sid%3Dliteratum%253Aachs%26aulast%3DLovera%26aufirst%3DS.%26aulast%3DMorando%26aufirst%3DM.%26aulast%3DPucheta-Martinez%26aufirst%3DE.%26aulast%3DMartinez-Torrecuadrada%26aufirst%3DJ.%2BL.%26aulast%3DSaladino%26aufirst%3DG.%26aulast%3DGervasio%26aufirst%3DF.%2BL.%26atitle%3DTowards%2520a%2520molecular%2520understanding%2520of%2520the%2520link%2520between%2520imatinib%2520resistance%2520and%2520kinase%2520conformational%2520dynamics%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2015%26volume%3D11%26doi%3D10.1371%2Fjournal.pcbi.1004578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmanouilidi, A.</span>; <span class="NLM_string-name">Falasca, M.</span></span> <span> </span><span class="NLM_article-title">3-Phosphoinositide-Dependent Kinase 1 (PDK1)</span>. In  <i>Encyclopedia of Signaling Molecules</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-67199-4_101748</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2F978-3-319-67199-4_101748" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=1-4&author=A.+Emmanouilidi&author=M.+Falascaauthor=S.+Choi&title=Encyclopedia+of+Signaling+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-67199-4_101748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-67199-4_101748%26sid%3Dliteratum%253Aachs%26aulast%3DEmmanouilidi%26aufirst%3DA.%26atitle%3D3-Phosphoinositide-Dependent%2520Kinase%25201%2520%2528PDK1%2529%26btitle%3DEncyclopedia%2520of%2520Signaling%2520Molecules%26aulast%3DChoi%26aufirst%3DS.%26pub%3DSpringer%26date%3D2017%26spage%3D1%26epage%3D4%26doi%3D10.1007%2F978-3-319-67199-4_101748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyphers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruff, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chodera, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, N. M.</span></span> <span> </span><span class="NLM_article-title">A water-mediated allosteric network governs activation of Aurora kinase A</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnchembio.2296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=28166210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2hsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=402-408&author=S.+Cyphersauthor=E.+F.+Ruffauthor=J.+M.+Behrauthor=J.+D.+Choderaauthor=N.+M.+Levinson&title=A+water-mediated+allosteric+network+governs+activation+of+Aurora+kinase+A&doi=10.1038%2Fnchembio.2296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A water-mediated allosteric network governs activation of Aurora kinase A</span></div><div class="casAuthors">Cyphers, Soreen; Ruff, Emily F.; Behr, Julie M.; Chodera, John D.; Levinson, Nicholas M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-408</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The catalytic activity of many protein kinases is controlled by conformational changes of a conserved Asp-Phe-Gly (DFG) motif.  Here, the authors used an IR probe to track the DFG motif of mitotic Aurora-A kinase (AurA) and found that allosteric activation by spindle-assocd. protein Tpx2 involves an equil. shift toward the active DFG-in state.  FRET expts. showed that the activation loop underwent a nanometer-scale movement that was tightly coupled to the DFG equil.  Tpx2 further activated AurA by stabilizing a water-mediated allosteric network that links the C-helix to the active site through an unusual polar residue in the regulatory spine.  The polar spine residue and water network of AurA were essential for phosphorylation-driven activation, but an alternative form of the water network found in related kinases could support Tpx2-driven activation, suggesting that variations in the water-mediated H-bond network-mediated regulatory diversification in protein kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ1smGynvpv7Vg90H21EOLACvtfcHk0lh9T5CjRQ4G4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2hsLg%253D&md5=d9ccdb368be8b3c367a94990280c8a52</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2296%26sid%3Dliteratum%253Aachs%26aulast%3DCyphers%26aufirst%3DS.%26aulast%3DRuff%26aufirst%3DE.%2BF.%26aulast%3DBehr%26aufirst%3DJ.%2BM.%26aulast%3DChodera%26aufirst%3DJ.%2BD.%26aulast%3DLevinson%26aufirst%3DN.%2BM.%26atitle%3DA%2520water-mediated%2520allosteric%2520network%2520governs%2520activation%2520of%2520Aurora%2520kinase%2520A%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D402%26epage%3D408%26doi%3D10.1038%2Fnchembio.2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, E.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Aurora-A activation by TPX2 at the mitotic spindle</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(03)00392-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2FS1097-2765%2803%2900392-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=851-862&author=R.+Baylissauthor=T.+Sardonauthor=I.+Vernosauthor=E.+Conti&title=Structural+basis+of+Aurora-A+activation+by+TPX2+at+the+mitotic+spindle&doi=10.1016%2FS1097-2765%2803%2900392-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900392-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900392-7%26sid%3Dliteratum%253Aachs%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DSardon%26aufirst%3DT.%26aulast%3DVernos%26aufirst%3DI.%26aulast%3DConti%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520of%2520Aurora-A%2520activation%2520by%2520TPX2%2520at%2520the%2520mitotic%2520spindle%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26spage%3D851%26epage%3D862%26doi%3D10.1016%2FS1097-2765%2803%2900392-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truchet, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brethenou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amalric, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouche, G.</span></span> <span> </span><span class="NLM_article-title">Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">24781</span>– <span class="NLM_lpage">24787</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.40.24781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1074%2Fjbc.271.40.24781" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=24781-24787&author=H.+Bonnetauthor=O.+Filholauthor=I.+Truchetauthor=P.+Brethenouauthor=C.+Cochetauthor=F.+Amalricauthor=G.+Bouche&title=Fibroblast+growth+factor-2+binds+to+the+regulatory+beta+subunit+of+CK2+and+directly+stimulates+CK2+activity+toward+nucleolin&doi=10.1074%2Fjbc.271.40.24781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.40.24781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.40.24781%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DH.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DTruchet%26aufirst%3DI.%26aulast%3DBrethenou%26aufirst%3DP.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DAmalric%26aufirst%3DF.%26aulast%3DBouche%26aufirst%3DG.%26atitle%3DFibroblast%2520growth%2520factor-2%2520binds%2520to%2520the%2520regulatory%2520beta%2520subunit%2520of%2520CK2%2520and%2520directly%2520stimulates%2520CK2%2520activity%2520toward%2520nucleolin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D24781%26epage%3D24787%26doi%3D10.1074%2Fjbc.271.40.24781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span> <span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7515</span>, <span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0lguK2tRTWwPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pravst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavber, S.</span></span> <span> </span><span class="NLM_article-title">Halogenation of ketones with N-halosuccinimides under solvent-free reaction conditions</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">5191</span>– <span class="NLM_lpage">5199</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2008.03.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.tet.2008.03.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=5191-5199&author=I.+Pravstauthor=M.+Zupanauthor=S.+Stavber&title=Halogenation+of+ketones+with+N-halosuccinimides+under+solvent-free+reaction+conditions&doi=10.1016%2Fj.tet.2008.03.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Halogenation of ketones with N-halosuccinimides under solvent-free reaction conditions</span></div><div class="casAuthors">Pravst, Igor; Zupan, Marko; Stavber, Stojan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5191-5199</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several aryl substituted ketones, cyclic ketones, 1,3-diketones and a β-ketoamide were halogenated with N-halosuccinimides under solvent-free reaction conditions (SFRC) at various temps. (20-80 °C), whereas less enolized ketones required the presence of an acid catalyst (p-toluenesulfonic acid, PTSA).  Bromination of substituted acetophenones obeys first order kinetics v=kBr[ketone] and the following correlation with the keto-enol equil. const.: log kBr = 0.3pKE + C1, less enolized substrates being more reactive; the moderate pos. charge developed in the rate detg. step was confirmed by the Hammett correlation (ρ=-0.5).  On the other hand, in cyclic ketones an opposite relation was obsd.: log kBr = -0.6pKE + C2, indicating higher reactivity of substrates with higher enolization const. (KE).  The important role of the nature of the solvent (MeCN, MeOH) in preorganization of the ketone-NBS-PTSA mixt. prior to SFRC bromination was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo35JXYLNG53LVg90H21EOLACvtfcHk0lguK2tRTWwPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSntLo%253D&md5=aad1479063c77f95515b962d7e89c80d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2008.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2008.03.048%26sid%3Dliteratum%253Aachs%26aulast%3DPravst%26aufirst%3DI.%26aulast%3DZupan%26aufirst%3DM.%26aulast%3DStavber%26aufirst%3DS.%26atitle%3DHalogenation%2520of%2520ketones%2520with%2520N-halosuccinimides%2520under%2520solvent-free%2520reaction%2520conditions%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D5191%26epage%3D5199%26doi%3D10.1016%2Fj.tet.2008.03.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulangiappar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulandainathan, M. A.</span></span> <span> </span><span class="NLM_article-title">Convenient electrochemical method for the synthesis of α-bromo alkyl aryl ketones</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1736</span>– <span class="NLM_lpage">1742</span>, <span class="refDoi"> DOI: 10.1080/00397910903161710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1080%2F00397910903161710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=1736-1742&author=R.+S.+Kumarauthor=K.+Kulangiapparauthor=M.+A.+Kulandainathan&title=Convenient+electrochemical+method+for+the+synthesis+of+%CE%B1-bromo+alkyl+aryl+ketones&doi=10.1080%2F00397910903161710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient electrochemical method for the synthesis of α-bromo alkyl aryl ketones</span></div><div class="casAuthors">Kumar, R. Senthil; Kulangiappar, K.; Kulandainathan, M. Anbu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1736-1742</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">An electrochem. procedure for the effective α-bromination of alkyl aryl ketones in excellent yield was reported.  The simple exptl. procedure, catalyst-free conversion, and excellent yield of mono-brominated products are the advantages of this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRc4QUrbBO77Vg90H21EOLACvtfcHk0lguK2tRTWwPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCntbw%253D&md5=e211ad0b8c822a1d685d265189c6319d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1080%2F00397910903161710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910903161710%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%2BS.%26aulast%3DKulangiappar%26aufirst%3DK.%26aulast%3DKulandainathan%26aufirst%3DM.%2BA.%26atitle%3DConvenient%2520electrochemical%2520method%2520for%2520the%2520synthesis%2520of%2520%25CE%25B1-bromo%2520alkyl%2520aryl%2520ketones%26jtitle%3DSynth.%2520Commun.%26date%3D2010%26volume%3D40%26spage%3D1736%26epage%3D1742%26doi%3D10.1080%2F00397910903161710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borowitz, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnes, H.</span></span> <span> </span><span class="NLM_article-title">Kinetics and mechanism of the reaction of triphenylphosphine with alpha-haloacetophenones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3560</span>– <span class="NLM_lpage">3564</span>, <span class="refDoi"> DOI: 10.1021/jo01286a060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01286a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=3560-3564&author=I.+J.+Borowitzauthor=H.+Parnes&title=Kinetics+and+mechanism+of+the+reaction+of+triphenylphosphine+with+alpha-haloacetophenones&doi=10.1021%2Fjo01286a060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjo01286a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01286a060%26sid%3Dliteratum%253Aachs%26aulast%3DBorowitz%26aufirst%3DI.%2BJ.%26aulast%3DParnes%26aufirst%3DH.%26atitle%3DKinetics%2520and%2520mechanism%2520of%2520the%2520reaction%2520of%2520triphenylphosphine%2520with%2520alpha-haloacetophenones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D3560%26epage%3D3564%26doi%3D10.1021%2Fjo01286a060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirichenko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogovoy, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kister, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of mono- and N,N-disubstituted thioureas and N-acylthioureas</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>, (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1799</span>– <span class="NLM_lpage">1805</span>, <span class="refDoi"> DOI: 10.1055/s-2004-829127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1055%2Fs-2004-829127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1799-1805&issue=11&author=A.+R.+Katritzkyauthor=N.+Kirichenkoauthor=B.+V.+Rogovoyauthor=J.+Kisterauthor=H.+Tao&title=Synthesis+of+mono-+and+N%2CN-disubstituted+thioureas+and+N-acylthioureas&doi=10.1055%2Fs-2004-829127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of mono- and N,N-disubstituted thioureas and N-acylthioureas</span></div><div class="casAuthors">Katritzky, Alan R.; Kirichenko, Nataliya; Rogovoy, Boris V.; Kister, Jeremy; Tao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1799-1805</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">1-Benzotriazole-1-carbothioamide, prepd. from 1-cyanobenzotriazole and hydrogen sulfide, reacts with amines to give thioureas R1NR2CSNH2 (R1 = MeOC6H4, Bn, pyrrolidinyl, Ph, PhNH; R2 = H, Bn).  Reactions of (benzotriazol-1-yl)carboximidamides and acyl- or arylaminocarbonyl(benzotriazol-1-yl)carboximidamides with hydrogen sulfide give the corresponding thioureas, N-acylthioureas, or N-carbamoylthioureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8squ9HXgX2rVg90H21EOLACvtfcHk0lh1z0PWEq7HHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeisLk%253D&md5=fbc625fdd9d1b689ec39889d04df507b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-829127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-829127%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DKirichenko%26aufirst%3DN.%26aulast%3DRogovoy%26aufirst%3DB.%2BV.%26aulast%3DKister%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520mono-%2520and%2520N%252CN-disubstituted%2520thioureas%2520and%2520N-acylthioureas%26jtitle%3DSynthesis%26date%3D2004%26issue%3D11%26spage%3D1799%26epage%3D1805%26doi%3D10.1055%2Fs-2004-829127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha-Sircar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, K. K.</span></span> <span> </span><span class="NLM_article-title">Preparation of antibacterials from organomercurials</span>. <i>J. Indian Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaG3MXjtlyltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1950&pages=535-538&author=S.+Guha-Sircarauthor=K.+K.+Patnaik&title=Preparation+of+antibacterials+from+organomercurials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of antibacterials from organomercurials. II</span></div><div class="casAuthors">Guha-Sircar, S. S.; Patnaik, Khirod Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Indian Chemical Society</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">535-8</span>CODEN:
                <span class="NLM_cas:coden">JICSAH</span>;
        ISSN:<span class="NLM_cas:issn">0019-4522</span>.
    </div><div class="casAbstract">cf. C.A. 45, 3997i.  Carboxyphenylureas (I) were prepd. by adding 1 mol. KNCO to a soln. of 1 mol. H2NC6H4CO2H in hot water.  I were purified by pptg. their solns. in NaOH with AcOH and crystg. from alc.  The m.ps. of I are: ο- 294°; m- 265°; p- softens 180° then solidifies.  Hg derivs. of I were not obtained pure.  Phenyl-, tolyl-, and m-nitrophenylurea with equimol. amts. of (AcO)2Hg in dil. AcOH give the mono-Hg derivs., probably in the p-position, 2-naphthylurea (II) gives a mixt. of mono- and di-Hg compd., sepd. by crystn. from AcOH; 1-naphthylurea (III) gives only the di-Hg compd.  The following monoacetoxymercuri compds. and their decompn. temps. are given: phenylurea 125°; tolylurea, ο- 200°, m- 215°, p-238°; chlorophenylurea, ο- 158°, m- 163°, p- (IV) 172°; II, 182°; m-nitrophenylurea 202°; m-carboxyphenylurea 256°; p-carboxyphenylurea 270°; diacetoxymercuri compds.: II 284°; III 210°.  Carboxyphenylthioureas (V), m. ο-181°, m-185°, p-194°.  On mercuration one obtains the di-Hg derivs. of phenyl- and tolylthioureas and the mono-Hg derivs. of V.  The mercurated phenylthioureas are unstable to heat and light and were not tested for bactericidal action; the diacetoxymercuric compds. of III and IV have high activity against Bacillus coli, and may be useful for paper, glue, and leather industries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn14cCnsQcoLVg90H21EOLACvtfcHk0lh1z0PWEq7HHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3MXjtlyltA%253D%253D&md5=78a4ae8866922b5449ab2f54cff3c72d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuha-Sircar%26aufirst%3DS.%26aulast%3DPatnaik%26aufirst%3DK.%2BK.%26atitle%3DPreparation%2520of%2520antibacterials%2520from%2520organomercurials%26jtitle%3DJ.%2520Indian%2520Chem.%2520Soc.%26date%3D1950%26volume%3D27%26spage%3D535%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">4-Pyridylanilinothiazoles that selectively target von Hippel–Lindau deficient renal cell carcinoma cells by inducing autophagic cell death</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">797</span>, <span class="refDoi"> DOI: 10.1021/jm901457w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901457w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=787-797&author=M.+P.+Hayauthor=S.+Turcotteauthor=J.+U.+Flanaganauthor=M.+Bonnetauthor=D.+A.+Chanauthor=P.+D.+Sutphinauthor=P.+Nguyenauthor=A.+J.+Giacciaauthor=W.+A.+Denny&title=4-Pyridylanilinothiazoles+that+selectively+target+von+Hippel%E2%80%93Lindau+deficient+renal+cell+carcinoma+cells+by+inducing+autophagic+cell+death&doi=10.1021%2Fjm901457w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm901457w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901457w%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DM.%2BP.%26aulast%3DTurcotte%26aufirst%3DS.%26aulast%3DFlanagan%26aufirst%3DJ.%2BU.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DSutphin%26aufirst%3DP.%2BD.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D4-Pyridylanilinothiazoles%2520that%2520selectively%2520target%2520von%2520Hippel%25E2%2580%2593Lindau%2520deficient%2520renal%2520cell%2520carcinoma%2520cells%2520by%2520inducing%2520autophagic%2520cell%2520death%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D787%26epage%3D797%26doi%3D10.1021%2Fjm901457w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seligman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bost, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, R. L.</span></span> <span> </span><span class="NLM_article-title">Some derivatives of <i>p</i>-aminosalicylic acid</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">6334</span>– <span class="NLM_lpage">6335</span>, <span class="refDoi"> DOI: 10.1021/ja01120a533</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01120a533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1953&pages=6334-6335&author=R.+B.+Seligmanauthor=R.+W.+Bostauthor=R.+L.+McKee&title=Some+derivatives+of+p-aminosalicylic+acid&doi=10.1021%2Fja01120a533"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fja01120a533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01120a533%26sid%3Dliteratum%253Aachs%26aulast%3DSeligman%26aufirst%3DR.%2BB.%26aulast%3DBost%26aufirst%3DR.%2BW.%26aulast%3DMcKee%26aufirst%3DR.%2BL.%26atitle%3DSome%2520derivatives%2520of%2520p-aminosalicylic%2520acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1953%26volume%3D75%26spage%3D6334%26epage%3D6335%26doi%3D10.1021%2Fja01120a533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prudent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moucadel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafanechère, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasenknopf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bareyt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacôte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorimbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouzerh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2008.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.chembiol.2008.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18635005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=683-692&author=R.+Prudentauthor=V.+Moucadelauthor=B.+Laudetauthor=C.+Baretteauthor=L.+Lafanech%C3%A8reauthor=B.+Hasenknopfauthor=J.+Liauthor=S.+Bareytauthor=E.+Lac%C3%B4teauthor=S.+Thorimbertauthor=M.+Malacriaauthor=P.+Gouzerhauthor=C.+Cochet&title=Identification+of+polyoxometalates+as+nanomolar+noncompetitive+inhibitors+of+protein+kinase+CK2&doi=10.1016%2Fj.chembiol.2008.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Polyoxometalates as Nanomolar Noncompetitive Inhibitors of Protein Kinase CK2</span></div><div class="casAuthors">Prudent, Renaud; Moucadel, Virginie; Laudet, Beatrice; Barette, Caroline; Lafanechere, Laurence; Hasenknopf, Bernold; Li, Joaquim; Bareyt, Sebastian; Lacote, Emmanuel; Thorimbert, Serge; Malacria, Max; Gouzerh, Pierre; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinase CK2 is a multifunctional kinase of medical importance that is dysregulated in many cancers.  In this study, polyoxometalates were identified as original CK2 inhibitors.  [P2Mo18O62]6- has the most potent activity.  It inhibits the kinase in the nanomolar range by targeting key structural elements located outside the ATP- and peptide substrate-binding sites.  Several polyoxometalate derivs. exhibit strong inhibitory efficiency, with IC50 values ≤ 10 nM.  Furthermore, these inorg. compds. show a striking specificity for CK2 when tested in a panel of 29 kinases.  Therefore, polyoxometalates are effective CK2 inhibitors in terms of both efficiency and selectivity and represent nonclassical kinase inhibitors that interact with CK2 in a unique way.  This binding mode may provide an exploitable mechanism for developing potent drugs with desirable properties, such as enhanced selectivity relative to ATP-mimetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpquaeD8GOuLVg90H21EOLACvtfcHk0lhshZfF70vjkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGmtLs%253D&md5=6ab0bdaaed74103f6eddbba9ead0dea4</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DLaudet%26aufirst%3DB.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanech%25C3%25A8re%26aufirst%3DL.%26aulast%3DHasenknopf%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBareyt%26aufirst%3DS.%26aulast%3DLac%25C3%25B4te%26aufirst%3DE.%26aulast%3DThorimbert%26aufirst%3DS.%26aulast%3DMalacria%26aufirst%3DM.%26aulast%3DGouzerh%26aufirst%3DP.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520polyoxometalates%2520as%2520nanomolar%2520noncompetitive%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D683%26epage%3D692%26doi%3D10.1016%2Fj.chembiol.2008.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moucadel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teillet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafanechere, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Receveur-Brechot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Antitumoral activity of allosteric inhibitors of protein kinase CK2</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.18632%2Foncotarget.361" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=997-1010&author=V.+Moucadelauthor=R.+Prudentauthor=C.+F.+Sautelauthor=F.+Teilletauthor=C.+Baretteauthor=L.+Lafanechereauthor=V.+Receveur-Brechotauthor=C.+Cochet&title=Antitumoral+activity+of+allosteric+inhibitors+of+protein+kinase+CK2&doi=10.18632%2Foncotarget.361"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.361%26sid%3Dliteratum%253Aachs%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DTeillet%26aufirst%3DF.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DReceveur-Brechot%26aufirst%3DV.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DAntitumoral%2520activity%2520of%2520allosteric%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D997%26epage%3D1010%26doi%3D10.18632%2Foncotarget.361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ford, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landesman-Bollag, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacwag, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukenberg, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardee, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">22245</span>– <span class="NLM_lpage">22254</span>, <span class="refDoi"> DOI: 10.1074/jbc.M002446200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1074%2Fjbc.M002446200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22245-22254&author=H.+L.+Fordauthor=E.+Landesman-Bollagauthor=C.+S.+Dacwagauthor=P.+T.+Stukenbergauthor=A.+B.+Pardeeauthor=D.+C.+Seldin&title=Cell+cycle-regulated+phosphorylation+of+the+human+SIX1+homeodomain+protein&doi=10.1074%2Fjbc.M002446200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M002446200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M002446200%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DH.%2BL.%26aulast%3DLandesman-Bollag%26aufirst%3DE.%26aulast%3DDacwag%26aufirst%3DC.%2BS.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26atitle%3DCell%2520cycle-regulated%2520phosphorylation%2520of%2520the%2520human%2520SIX1%2520homeodomain%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22245%26epage%3D22254%26doi%3D10.1074%2Fjbc.M002446200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ElHady, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">Development of selective Clk1 and -4 inhibitors for cellular depletion of cancer-relevant proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5377</span>– <span class="NLM_lpage">5391</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5377-5391&author=A.+K.+ElHadyauthor=M.+Abdel-Halimauthor=A.+H.+Abadiauthor=M.+Engel&title=Development+of+selective+Clk1+and+-4+inhibitors+for+cellular+depletion+of+cancer-relevant+proteins&doi=10.1021%2Facs.jmedchem.6b01915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01915%26sid%3Dliteratum%253Aachs%26aulast%3DElHady%26aufirst%3DA.%2BK.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520selective%2520Clk1%2520and%2520-4%2520inhibitors%2520for%2520cellular%2520depletion%2520of%2520cancer-relevant%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5377%26epage%3D5391%26doi%3D10.1021%2Facs.jmedchem.6b01915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber-Scokaert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souchier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saoudi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.3.975-987.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1128%2FMCB.23.3.975-987.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=12529402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFGgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=975-987&author=O.+Filholauthor=A.+Nuedaauthor=V.+Martelauthor=D.+Gerber-Scokaertauthor=M.+J.+Benitezauthor=C.+Souchierauthor=Y.+Saoudiauthor=C.+Cochet&title=Live-cell+fluorescence+imaging+reveals+the+dynamics+of+protein+kinase+CK2+individual+subunits&doi=10.1128%2FMCB.23.3.975-987.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits</span></div><div class="casAuthors">Filhol, Odile; Nueda, Arsenio; Martel, Veronique; Gerber-Scokaert, Delphine; Benitez, Maria Jose; Souchier, Catherine; Saoudi, Yasmina; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">975-987</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Protein kinase CK2 is a multifunctional enzyme which has long been described as a stable heterotetrameric complex resulting from the assocn. of two catalytic (α or α') and two regulatory (β) subunits.  To track the spatiotemporal dynamics of CK2 in living cells, we fused its catalytic α and regulatory β subunits with green fluorescent protein (GFP).  Both CK2 subunits contain nuclear localization domains that target them independently to the nucleus.  Imaging of stable cell lines expressing low levels of GFP-CK2α or GFP-CK2β revealed the existence of CK2 subunit subpopulations exhibiting differential dynamics.  Once in the nucleus, they diffuse randomly at different rates.  Unlike CK2β, CK2α can shuttle, showing the dynamic nature of the nucleocytoplasmic trafficking of the kinase.  When microinjected in the cytoplasm, the isolated CK2 subunits are rapidly translocated into the nucleus, whereas the holoenzyme complex remains in this cell compartment, suggesting an intramol. masking of the nuclear localization sequences that suppresses nuclear accumulation.  However, binding of FGF-2 to the holoenzyme triggers its nuclear translocation.  Since the substrate specificity of CK2α is dramatically changed by its assocn. with CK2β, the control of the nucleocytoplasmic distribution of each subunit may represent a unique potential regulatory mechanism for CK2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOX24rfZrRYLVg90H21EOLACvtfcHk0lglBkQFQLIReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFGgtA%253D%253D&md5=76aab588fce500428ff849a3c24fcf7f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.3.975-987.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.3.975-987.2003%26sid%3Dliteratum%253Aachs%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DMartel%26aufirst%3DV.%26aulast%3DGerber-Scokaert%26aufirst%3DD.%26aulast%3DBenitez%26aufirst%3DM.%2BJ.%26aulast%3DSouchier%26aufirst%3DC.%26aulast%3DSaoudi%26aufirst%3DY.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DLive-cell%2520fluorescence%2520imaging%2520reveals%2520the%2520dynamics%2520of%2520protein%2520kinase%2520CK2%2520individual%2520subunits%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D975%26epage%3D987%26doi%3D10.1128%2FMCB.23.3.975-987.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Paul Brear, Darby Ball, Katherine Stott, Sheena D’Arcy, <span class="NLM_string-name hlFld-ContribAuthor">Marko Hyvönen</span>. </span><span class="cited-content_cbyCitation_article-title">Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12786-12798. <a href="https://doi.org/10.1021/acs.jmedchem.0c01173" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01173%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProposed%252BAllosteric%252BInhibitors%252BBind%252Bto%252Bthe%252BATP%252BSite%252Bof%252BCK2%2525CE%2525B1%26aulast%3DBrear%26aufirst%3DPaul%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D29102020%26volume%3D63%26issue%3D21%26spage%3D12786%26epage%3D12798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dirk Lindenblatt, Anna Nickelsen, Violetta M. Applegate, Joachim Jose, <span class="NLM_string-name hlFld-ContribAuthor">Karsten Niefind</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7766-7772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00587" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00587%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Band%252BMechanistic%252BBasis%252Bof%252Bthe%252BInhibitory%252BPotency%252Bof%252BSelected%252B2-Aminothiazole%252BCompounds%252Bon%252BProtein%252BKinase%252BCK2%26aulast%3DLindenblatt%26aufirst%3DDirk%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09042020%26date%3D14072020%26date%3D26062020%26volume%3D63%26issue%3D14%26spage%3D7766%26epage%3D7772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olívia  Pontes</span>, <span class="hlFld-ContribAuthor ">Sofia  Oliveira-Pinto</span>, <span class="hlFld-ContribAuthor ">Fátima  Baltazar</span>, <span class="hlFld-ContribAuthor ">Marta  Costa</span>. </span><span class="cited-content_cbyCitation_article-title">Renal cell carcinoma therapy: Current and new drug candidates. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>75 </em><a href="https://doi.org/10.1016/j.drudis.2021.07.009" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRenal%252Bcell%252Bcarcinoma%252Btherapy%25253A%252BCurrent%252Band%252Bnew%252Bdrug%252Bcandidates%26aulast%3DPontes%26aufirst%3DOl%25C3%25ADvia%26date%3D2021%26volume%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Iegre</span>, <span class="hlFld-ContribAuthor ">Eleanor L.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Paul D.  Brear</span>, <span class="hlFld-ContribAuthor ">Bethany M.  Cooper</span>, <span class="hlFld-ContribAuthor ">Marko  Hyvönen</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical probes targeting the kinase CK2: a journey outside the catalytic box. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (20)
                                     , 4380-4396. <a href="https://doi.org/10.1039/D1OB00257K" title="DOI URL">https://doi.org/10.1039/D1OB00257K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00257K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00257K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DChemical%252Bprobes%252Btargeting%252Bthe%252Bkinase%252BCK2%25253A%252Ba%252Bjourney%252Boutside%252Bthe%252Bcatalytic%252Bbox%26aulast%3DIegre%26aufirst%3DJessica%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D20%26spage%3D4380%26epage%3D4396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyedeh Roya  Alizadeh</span>, <span class="hlFld-ContribAuthor ">Seyedeh Mahdieh  Hashemi</span>. </span><span class="cited-content_cbyCitation_article-title">Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (4)
                                     , 771-806. <a href="https://doi.org/10.1007/s00044-020-02686-2" title="DOI URL">https://doi.org/10.1007/s00044-020-02686-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02686-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02686-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDevelopment%252Band%252Btherapeutic%252Bpotential%252Bof%252B2-aminothiazole%252Bderivatives%252Bin%252Banticancer%252Bdrug%252Bdiscovery%26aulast%3DAlizadeh%26aufirst%3DSeyedeh%2BRoya%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D4%26spage%3D771%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleanor L.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Jessica  Iegre</span>, <span class="hlFld-ContribAuthor ">Paul D.  Brear</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Zhabina</span>, <span class="hlFld-ContribAuthor ">Marko  Hyvönen</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1977. <a href="https://doi.org/10.3390/molecules26071977" title="DOI URL">https://doi.org/10.3390/molecules26071977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071977%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDownfalls%252Bof%252BChemical%252BProbes%252BActing%252Bat%252Bthe%252BKinase%252BATP-Site%25253A%252BCK2%252Bas%252Ba%252BCase%252BStudy%26aulast%3DAtkinson%26aufirst%3DEleanor%2BL.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario Daniel  Caba-Flores</span>, <span class="hlFld-ContribAuthor ">Delia  Hernández-Romero</span>, <span class="hlFld-ContribAuthor ">Aracely  López-Monteon</span>, <span class="hlFld-ContribAuthor ">Esmeralda  Sánchez-Pavón</span>, <span class="hlFld-ContribAuthor ">Diana Carolina  Valdez-Ortega</span>, <span class="hlFld-ContribAuthor ">Jaime  López-Domínguez</span>, <span class="hlFld-ContribAuthor ">Víctor Adolfo  Romero-Cruz</span>, <span class="hlFld-ContribAuthor ">Alberto Yair  Limón-Flores</span>, <span class="hlFld-ContribAuthor ">Ángel  Trigos</span>, <span class="hlFld-ContribAuthor ">Angel  Ramos-Ligonio</span>. </span><span class="cited-content_cbyCitation_article-title">Activity In Vitro of 2-Chloro-N-[4-(4-Chlorophenyl)-2-Thiazolyl]Acetamide Against Promastigotes of Leishmania mexicana: An Apoptosis Inducer. </span><span class="cited-content_cbyCitation_journal-name">Acta Parasitologica</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1007/s11686-020-00328-6" title="DOI URL">https://doi.org/10.1007/s11686-020-00328-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11686-020-00328-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11686-020-00328-6%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Parasitologica%26atitle%3DActivity%252BIn%252BVitro%252Bof%252B2-Chloro-N-%25255B4-%2525284-Chlorophenyl%252529-2-Thiazolyl%25255DAcetamide%252BAgainst%252BPromastigotes%252Bof%252BLeishmania%252Bmexicana%25253A%252BAn%252BApoptosis%252BInducer%26aulast%3DCaba-Flores%26aufirst%3DMario%2BDaniel%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Doller</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00057-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00057-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00057-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00057-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252BModulation%26aulast%3DDoller%26aufirst%3DDario%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Nagarajaiah</span>, <span class="hlFld-ContribAuthor ">N. L.  Prasad</span>, <span class="hlFld-ContribAuthor ">Noor Shahina  Begum</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential One-Pot Synthesis of 2-Aminothiazoles Using Corresponding Ketones: Insights into Their Structural Features. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2020,</strong> <em> </em>, 1-11. <a href="https://doi.org/10.1080/10406638.2020.1821228" title="DOI URL">https://doi.org/10.1080/10406638.2020.1821228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1821228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1821228%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DSequential%252BOne-Pot%252BSynthesis%252Bof%252B2-Aminothiazoles%252BUsing%252BCorresponding%252BKetones%25253A%252BInsights%252Binto%252BTheir%252BStructural%252BFeatures%26aulast%3DNagarajaiah%26aufirst%3DH.%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolan  Chen</span>, <span class="hlFld-ContribAuthor ">Chunqiong  Li</span>, <span class="hlFld-ContribAuthor ">Dada  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Na  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 870. <a href="https://doi.org/10.3390/molecules25040870" title="DOI URL">https://doi.org/10.3390/molecules25040870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25040870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25040870%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDiscovery%252Bof%252BCK2%252BAllosteric%252BInhibitors%25253A%252BFrom%252BTraditional%252BScreening%252Bto%252BStructure-Based%252BDesign%26aulast%3DChen%26aufirst%3DXiaolan%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunqiong  Li</span>, <span class="hlFld-ContribAuthor ">Xuewen  Zhang</span>, <span class="hlFld-ContribAuthor ">Na  Zhang</span>, <span class="hlFld-ContribAuthor ">Yue  Zhou</span>, <span class="hlFld-ContribAuthor ">Guohui  Sun</span>, <span class="hlFld-ContribAuthor ">Lijiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 237. <a href="https://doi.org/10.3390/molecules25010237" title="DOI URL">https://doi.org/10.3390/molecules25010237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25010237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25010237%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIdentification%252Band%252BBiological%252BEvaluation%252Bof%252BCK2%252BAllosteric%252BFragments%252Bthrough%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DLi%26aufirst%3DChunqiong%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0001.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of CX-4945 and previously described allosteric inhibitors (<b>1</b>–<b>4</b>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The IC<sub>50</sub> values against human CK2α are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Hantzsch-Type Synthesis<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Br<sub>2</sub>, CHCl<sub>3</sub>, 40 °C, 5 min or Br<sub>2</sub>, HBr 32% in AcOH, MeOH, 60 °C, 4 h; (ii) CS<sub>2</sub>, Et<sub>3</sub>N in THF/H<sub>2</sub>O 1/1, rt, 24 h, then I<sub>2</sub> in THF, 0 °C to rt, 3 h; (iii) NH<sub>4</sub>OH 30%, rt, 6 h; (iv) EtOH, reflux, 3–12 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compound <b>30</b> through Aromatic Nucleophilic Substitution<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) HCl<sub>(aq)</sub> 37%, 1,4-dioxane, 90 °C, 48 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Esters and Amides <b>31</b>–<b>36</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) H<sub>2</sub>SO<sub>4</sub> 95% 3 drops, MeOH, reflux, 2 h. (ii) <b>32</b>: HATU, DIPEA, dry DMF, 30 min; NaH, RSO<sub>2</sub>NH<sub>2</sub>, dry THF, rt, 30 min; then rt, 4 h. <b>33</b>: EDC·HCl, DMAP, RSO<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 36 h. (iii) Bromomethyl acetate, Et<sub>3</sub>N, dry DMF, rt, 12 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0002.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Enzymatic characterization of compound <b>27</b>. (A) Lineweaver–Burk inhibition plot of human recombinant CK2α by compound <b>27</b> at various concentrations: 0, 0.5, 1, 1.5, 2.5 μM. <i>K</i><sub>i</sub> was determined by plotting the slopes at varying inhibitor concentration from three independent experiments. (B) CK2α and CK2α<sub>2</sub>β<sub>2</sub> activity with two peptide substrates in the presence of increasing concentrations of compound <b>27</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0003.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Thermodynamic characterization of binding of the allosteric inhibitor <b>27</b> to CK2α by ITC. The top panel shows the raw heat signal for successive injections of dissolved compound <b>27</b> into a CK2α solution at 25 °C. The bottom panel shows the integrated heats of injections corrected for heats of dilution, with the solid line corresponding to the best fit of the data to a bimolecular binding model. Shown is one experiment out of two that gave similar values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0004.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Percentage of inhibition of GST-CK2α (wild type (WT) or single alanine mutant) in the presence of compound <b>27</b> (1 μM); see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf" class="ext-link">Table S1 (Supporting Information)</a> for explicit values. The error bars indicate ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0005.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted binding mode of the naphthalen-2-yl-thiazolamine derivatives in the allosteric pocket. Compounds <b>19</b> (A) and <b>27</b> (B) (cyan) were docked into the hydrophobic pocket between the glycine-rich loop and the αC-helix in the crystallized inactive conformation of CK2α (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ">3FWQ</a>) using MOE. Residues that are potentially relevant to the binding are labeled. Residues that caused a drop of <b>27</b> inhibitory potency when mutated to alanine are colored in magenta. The carboxylate forms salt bridges with Lys74 and Lys77, while the naphthalene ring is buried in the mostly hydrophobic cavity, additionally anchored by cation−π (with Lys71) and/or CH−π interactions (with Gly177/Leu178). A further CH−π interaction was consistently observed between Val73 and the benzoic acid ring. Interactions are indicated by dashed lines (H-bonds/salt bridges, blue; CH−π interactions, brown). The green dashed line denotes the shortest distance between His160 and Tyr50.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0006.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>27</b> inhibits CK2-dependent substrate phosphorylations in cells and induces apoptosis. (A) Cellular inhibition of CK2 by compound <b>27</b>. 786-O cells were plated and incubated for 24 h in the presence of various concentrations of <b>27</b>. The phosphorylation status of the CK2 protein substrates was measured by Western blot analysis of cell extracts. Band intensities were quantified using ImageJ and normalized using anti-GAPDH antibody signals as loading control. <i><sup>a</sup></i>EC<sub>50</sub> calculated assuming that phosphorylation levels will approach zero with increasing concentrations of <b>27</b>. <i><sup>b</sup></i>EC<sub>50</sub> calculated assuming a basal level of nonresponsive P-α-catenin of 50% of the DMSO control. (B) Apoptosis induction upon compound <b>27</b> treatment. Appearance of cleaved PARP and decrease of survivin levels were observed by Western blot analysis of cell extracts. (C) <b>27</b> shows a higher potency to inhibit the STAT3 activation in 786-O cells than CX-4945.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0007.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Potency of <b>4</b> but not of CX-4945 to inhibit CK2-catalyzed phosphorylations in cells depends on the substrate. 786-O cells were incubated with various concentrations of <b>4</b> (A, B) or CX-4945 (C, D) for 24 h, and the phosphorylation status of two protein substrates of CK2 was measured by Western blot analysis of the cell extracts. GAPDH was probed as loading control. (B, D) Western blot quantification was performed using ImageJ and fitted to a sigmoid equation using SigmaPlot to determine the EC<sub>50</sub> values. <i><sup>a</sup></i>Half-maximum decrease relating to the basal level of nonresponsive α-catenin phosphorylation (∼50% of the control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/medium/jm-2018-017654_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0008.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Differential effects of the allosteric inhibitor <b>27</b> and the ATP-site directed inhibitor CX-4945 on the CK2-catalyzed phosphorylation of nucleolin and cellular consequences. (A) Phophosphorylation of substrate proteins (● nucleolin, ■ GST-Six1, ▲ CK2β autophosphorylation) by CK2α<sub>2</sub>β<sub>2</sub> in the presence of various concentrations of compound <b>27</b> (upper panel) or the ATP-competitive inhibitor CX-4945 (lower panel). Graphs represent the average of two measurements. (B) HeLa pEGFP-CK2α cell imaging showing the subcellular localization of CK2α after 12 h treatment with DMSO, compound <b>27</b> (15 μM), or CX-4945 (8 μM). Nuclei were stained with Hoechst-33342, and merged images as well as GFP single channel were depicted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01765/20190221/images/large/jm-2018-017654_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01765&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 81 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">One-thousand-and-one substrates of protein kinase CK2?</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1096/fj.02-0473rev</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1096%2Ffj.02-0473rev" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=12631575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=349-368&author=F.+Meggioauthor=L.+A.+Pinna&title=One-thousand-and-one+substrates+of+protein+kinase+CK2%3F&doi=10.1096%2Ffj.02-0473rev"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">One-thousand-and-one substrates of protein kinase CK2?</span></div><div class="casAuthors">Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-368</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review.  CK2 (formerly termed "casein kinase 2") is a ubiquitous, highly pleiotropic and constitutively active Ser/Thr protein kinase whose implication in neoplasia, cell survival, and virus infection is supported by an increasing no. of arguments.  Here an updated inventory of 307 CK2 protein substrates is presented.  More than one-third of these are implicated in gene expression and protein synthesis as being either transcriptional factors (60) or effectors of DNA/RNA structure (50) or translational elements.  Also numerous are signaling proteins and proteins of viral origin or essential to virus life cycle.  In comparison, only a minority of CK2 targets (a dozen or so) are classical metabolic enzymes.  An anal. of 308 sites phosphorylated by CK2 highlights the paramount relevance of neg. charged side chains that are (by far) predominant over any other residues at positions n+3 (the most crucial one), n+1, and n+2.  Based on this signature, it is predictable that proteins phosphorylated by CK2 are much more numerous than those identified to date, and it is possible that CK2 alone contributes to the generation of the eukaryotic phosphoproteome more so than any other individual protein kinase.  The possibility that CK2 phosphosites play some global role, e.g., by destabilizing α helices, counteracting caspase cleavage, and generating adhesive motifs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6sfPYsWeCNrVg90H21EOLACvtfcHk0lj33yrA_3MtCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFeitbk%253D&md5=0b11315ac9652e8866a1ed99a7010b68</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1096%2Ffj.02-0473rev&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.02-0473rev%26sid%3Dliteratum%253Aachs%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOne-thousand-and-one%2520substrates%2520of%2520protein%2520kinase%2520CK2%253F%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D349%26epage%3D368%26doi%3D10.1096%2Ffj.02-0473rev" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, D. W.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2: structure, regulation and role in cellular decisions of life and death</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1042/bj20021469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1042%2Fbj20021469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=12396231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFSht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2003&pages=1-15&author=D.+W.+Litchfield&title=Protein+kinase+CK2%3A+structure%2C+regulation+and+role+in+cellular+decisions+of+life+and+death&doi=10.1042%2Fbj20021469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: structure, regulation and role in cellular decisions of life and death</span></div><div class="casAuthors">Litchfield, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 (casein kinase II) has traditionally been classified as a messenger-independent protein serine/threonine kinase that is typically found in tetrameric complexes consisting of 2 catalytic (α and/or α') subunits and 2 regulatory β subunits.  Accumulated biochem. and genetic evidence indicates that CK2 has a vast array of candidate physiol. targets and participates in a complex series of cellular functions, including the maintenance of cell viability.  This review summarizes current knowledge of the structural and enzymic features of CK2, and discusses advances that challenge traditional views of this enzyme.  For example, the recent demonstrations that individual CK2 subunits exist outside tetrameric complexes and that CK2 displays dual-specificity kinase activity raises new prospects for the precise elucidation of its regulation and cellular functions.  This review also discusses a no. of the mechanisms that contribute to the regulation of CK2 in cells, and highlights emerging insights into the role of CK2 in cellular decisions of life and death.  In this latter respect, recent evidence suggests that CK2 can exert an anti-apoptotic role by protecting regulatory proteins from caspase-mediated degrdn.  The mechanistic basis of the observation that CK2 is essential for viability may reside in part in this ability to protect cellular proteins from caspase action.  Furthermore, this anti-apoptotic function of CK2 may contribute to its ability to participate in transformation and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ-fky3V2xzbVg90H21EOLACvtfcHk0lhPGZ38NerrJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFSht78%253D&md5=6602b3ef19303264fd291bb57382be3c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1042%2Fbj20021469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021469%26sid%3Dliteratum%253Aachs%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3DProtein%2520kinase%2520CK2%253A%2520structure%252C%2520regulation%2520and%2520role%2520in%2520cellular%2520decisions%2520of%2520life%2520and%2520death%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D369%26spage%3D1%26epage%3D15%26doi%3D10.1042%2Fbj20021469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chua, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheikh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Rassoul, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartshorn, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, I.</span></span> <span> </span><span class="NLM_article-title">CK2 in cancer: cellular and biochemical mechanisms and potential therapeutic target</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.3390/ph10010018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.3390%2Fph10010018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=18&author=M.+M.+Chuaauthor=C.+E.+Ortegaauthor=A.+Sheikhauthor=M.+Leeauthor=H.+Abdul-Rassoulauthor=K.+L.+Hartshornauthor=I.+Dominguez&title=CK2+in+cancer%3A+cellular+and+biochemical+mechanisms+and+potential+therapeutic+target&doi=10.3390%2Fph10010018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fph10010018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10010018%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DM.%2BM.%26aulast%3DOrtega%26aufirst%3DC.%2BE.%26aulast%3DSheikh%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DAbdul-Rassoul%26aufirst%3DH.%26aulast%3DHartshorn%26aufirst%3DK.%2BL.%26aulast%3DDominguez%26aufirst%3DI.%26atitle%3DCK2%2520in%2520cancer%253A%2520cellular%2520and%2520biochemical%2520mechanisms%2520and%2520potential%2520therapeutic%2520target%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26spage%3D18%26doi%3D10.3390%2Fph10010018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Addiction to protein kinase CK2: a common denominator of diverse cancer cells?</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.bbapap.2009.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19665589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=499-504&author=M.+Ruzzeneauthor=L.+A.+Pinna&title=Addiction+to+protein+kinase+CK2%3A+a+common+denominator+of+diverse+cancer+cells%3F&doi=10.1016%2Fj.bbapap.2009.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Addiction to protein kinase CK2: A common denominator of diverse cancer cells?</span></div><div class="casAuthors">Ruzzene, Maria; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">499-504</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  At variance with most oncogenic protein kinases whose malignancy is generally due to genetic alterations conferring constitutive activity, CK2 is a highly pleiotropic Ser/Thr protein kinase naturally endowed with constitutive activity and lacking gain-of-function mutants.  Nonetheless CK2 is abnormally elevated in a wide variety of tumors and there is strong evidence that it operates as a cancer driver by creating a cellular environment favorable to neoplasia: notably, CK2 plays a global role as an anti-apoptotic and pro-survival agent, it enhances the multi-drug resistance (MDR) phenotype, it assists the chaperone machinery which protects the "onco-kinome" and it promotes neo-angiogenesis.  Based on this scenario we propose that the implication of CK2 in neoplasia is an example of "non oncogene addiction", i.e. over reliance of the perturbed cellular signaling network on high CK2 level for its own maintenance.  Consistent with this, an ample spectrum of diverse types of cancer cells have been already shown to rely on high CK2 level for their survival, as judged from their response to specific CK2 inhibitors and silencing of endogenous CK2 catalytic subunits.  Remarkably, among these are cells whose cancer phenotype arises from the genetic alteration of onco-kinases (e.g. Abl and Alk) different from CK2 and insensitive to the CK2 inhibitors used in those expts.  Based on these premises, CK2 could represent a "multi-purpose" target for the treatment of different kinds of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryaRBb7mWsWrVg90H21EOLACvtfcHk0lhPGZ38NerrJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7k%253D&md5=a8088e387d13469774ce9aef315d0ae5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DAddiction%2520to%2520protein%2520kinase%2520CK2%253A%2520a%2520common%2520denominator%2520of%2520diverse%2520cancer%2520cells%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D499%26epage%3D504%26doi%3D10.1016%2Fj.bbapap.2009.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span> <span> </span><span class="NLM_article-title">CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">10288</span>– <span class="NLM_lpage">10298</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1158%2F0008-5472.CAN-10-1893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=21159648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10288-10298&author=A.+Siddiqui-Jainauthor=D.+Dryginauthor=N.+Streinerauthor=P.+Chuaauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=J.+Bliesathauthor=M.+Omoriauthor=N.+Huserauthor=C.+Hoauthor=C.+Proffittauthor=M.+K.+Schwaebeauthor=D.+M.+Ryckmanauthor=W.+G.+Riceauthor=K.+Anderes&title=CX-4945%2C+an+orally+bioavailable+selective+inhibitor+of+protein+kinase+CK2%2C+inhibits+prosurvival+and+angiogenic+signaling+and+exhibits+antitumor+efficacy&doi=10.1158%2F0008-5472.CAN-10-1893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Drygin, Denis; Streiner, Nicole; Chua, Peter; Pierre, Fabrice; O'Brien, Sean E.; Bliesath, Josh; Omori, Mayuko; Huser, Nanni; Ho, Caroline; Proffitt, Chris; Schwaebe, Michael K.; Ryckman, David M.; Rice, William G.; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10288-10298</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Malignant transformation and maintenance of the malignant phenotype depends on oncogenic and non-oncogenic proteins that are essential to mediate oncogene signaling and to support the altered physiol. demands induced by transformation.  Protein kinase CK2 supports key prosurvival signaling pathways and represents a prototypical non-oncogene.  In this study, we describe CX-4945, a potent and selective orally bioavailable small mol. inhibitor of CK2.  The antiproliferative activity of CX-4945 against cancer cells correlated with expression levels of the CK2α catalytic subunit.  Attenuation of PI3K/Akt signaling by CX-4945 was evidenced by dephosphorylation of Akt on the CK2-specific S129 site and the canonical S473 and T308 regulatory sites.  CX-4945 caused cell-cycle arrest and selectively induced apoptosis in cancer cells relative to normal cells.  In models of angiogenesis, CX-4945 inhibited human umbilical vein endothelial cell migration, tube formation, and blocked CK2-dependent hypoxia-induced factor 1 alpha (HIF-1α) transcription in cancer cells.  When administered orally in murine xenograft models, CX-4945 was well tolerated and demonstrated robust antitumor activity with concomitant redns. of the mechanism-based biomarker phospho-p21 (T145).  The obsd. antiproliferative and anti-angiogenic responses to CX-4945 in tumor cells and endothelial cells collectively illustrate that this compd. exerts its antitumor effects through inhibition of CK2-dependent signaling in multiple pathways.  Finally, CX-4945 is the first orally bioavailable small mol. inhibitor of CK2 to advance into human clin. trials, thereby paving the way for an entirely new class of targeted treatment for cancer.  Cancer Res; 70(24); 10288-98.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8s0Sa3hOwtbVg90H21EOLACvtfcHk0ljxgYMU8QHkJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK&md5=bfcfe06730e099719e752574a6636dfb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1893%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DChua%26aufirst%3DP.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DCX-4945%252C%2520an%2520orally%2520bioavailable%2520selective%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%252C%2520inhibits%2520prosurvival%2520and%2520angiogenic%2520signaling%2520and%2520exhibits%2520antitumor%2520efficacy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10288%26epage%3D10298%26doi%3D10.1158%2F0008-5472.CAN-10-1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermakowa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5320</span>– <span class="NLM_lpage">5331</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.19.5320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1093%2Femboj%2F20.19.5320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=11574463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5320-5331&author=K.+Niefindauthor=B.+Guerraauthor=I.+Ermakowaauthor=O.+G.+Issinger&title=Crystal+structure+of+human+protein+kinase+CK2%3A+insights+into+basic+properties+of+the+CK2+holoenzyme&doi=10.1093%2Femboj%2F20.19.5320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme</span></div><div class="casAuthors">Niefind, Karsten; Guerra, Barbara; Ermakowa, Inessa; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5320-5331</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The crystal structure of a fully active form of human protein kinase CK2 (casein kinase 2) consisting of two C-terminally truncated catalytic and two regulatory subunits has been detd. at 3.1 Å resoln. (Protein Data Bank code: 1JWH).  In the CK2 complex the regulatory subunits form a stable dimer linking the two catalytic subunits, which make no direct contact with one another.  Each catalytic subunit interacts with both regulatory chains, predominantly via an extended C-terminal tail of the regulatory subunit.  The CK2 structure is consistent with its constitutive activity and with a flexible role of the regulatory subunit as a docking partner for various protein kinases.  Furthermore it shows an inter-domain mobility in the catalytic subunit known to be functionally important in protein kinases and detected here for the first time directly within one crystal structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIE9V_A2xVYrVg90H21EOLACvtfcHk0ljxgYMU8QHkJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVSrtQ%253D%253D&md5=4b3e3487991e63805aab7aa39c34f346</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.19.5320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.19.5320%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DErmakowa%26aufirst%3DI.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520human%2520protein%2520kinase%2520CK2%253A%2520insights%2520into%2520basic%2520properties%2520of%2520the%2520CK2%2520holoenzyme%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D5320%26epage%3D5331%26doi%3D10.1093%2Femboj%2F20.19.5320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, D. W.</span></span> <span> </span><span class="NLM_article-title">The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2β</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.7150/ijbs.1.67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.7150%2Fijbs.1.67" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=15951851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1eltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=67-79&author=A.+C.+Bibbyauthor=D.+W.+Litchfield&title=The+multiple+personalities+of+the+regulatory+subunit+of+protein+kinase+CK2%3A+CK2+dependent+and+CK2+independent+roles+reveal+a+secret+identity+for+CK2%CE%B2&doi=10.7150%2Fijbs.1.67"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2β</span></div><div class="casAuthors">Bibby, Ashley C.; Litchfield, David W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-79</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 (formerly casein kinase II), an enzyme that participates in a wide variety of cellular processes, has traditionally been classified as a stable tetrameric complex consisting of 2 catalytic CK2α or CK2α' subunits and 2 regulatory CK2β subunits.  While consideration of CK2 as a tetrameric complex remains relevant, significant evidence has emerged to challenge the view that its individual subunits exist exclusively within these complexes.  Here, the authors summarize biochem. and genetic evidence indicating that the regulatory CK2β subunit exists and performs functions independently of CK2 tetramers.  For example, unbalanced expression of catalytic and regulatory CK2 subunits has been obsd. in a variety of tissues and tumors.  Furthermore, localization studies including live cell imaging have demonstrated that while the catalytic and regulatory subunits of CK2 exhibit extensive co-localization, independent mobility of the individual CK2 subunits can also be obsd. within cells.  Identification of proteins that interact with CK2β in the absence of catalytic CK2 subunits reinforces the notion that CK2β has functions distinct from CK2 and begins to offer insights into these CK2-independent functions.  In this respect, the discovery that CK2β can interact with and modulate the activity of a no. of other serine/threonine protein kinases including A-Raf, c-Mos, and Chk1 is particularly striking.  The authors discuss the interactions between CK2β and these protein kinases with special emphasis on the properties of CK2β that mediate these interactions and on the implications of these interactions in yielding new prospects for elucidation of the cellular functions of CK2β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMBEnJw_vl8bVg90H21EOLACvtfcHk0lgwdEADkOpCNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1eltb8%253D&md5=4d1c203b8dee2aa908590eb3b0a34f71</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.7150%2Fijbs.1.67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.1.67%26sid%3Dliteratum%253Aachs%26aulast%3DBibby%26aufirst%3DA.%2BC.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3DThe%2520multiple%2520personalities%2520of%2520the%2520regulatory%2520subunit%2520of%2520protein%2520kinase%2520CK2%253A%2520CK2%2520dependent%2520and%2520CK2%2520independent%2520roles%2520reveal%2520a%2520secret%2520identity%2520for%2520CK2%25CE%25B2%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2005%26volume%3D1%26spage%3D67%26epage%3D79%26doi%3D10.7150%2Fijbs.1.67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Dynamic localization/association of protein kinase CK2 subunits in living cells: a role in its cellular regulation?</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>973</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2002.tb04648.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1111%2Fj.1749-6632.2002.tb04648.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=973&publication_year=2002&pages=272-277&author=V.+Martelauthor=O.+Filholauthor=A.+Nuedaauthor=C.+Cochet&title=Dynamic+localization%2Fassociation+of+protein+kinase+CK2+subunits+in+living+cells%3A+a+role+in+its+cellular+regulation%3F&doi=10.1111%2Fj.1749-6632.2002.tb04648.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2002.tb04648.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2002.tb04648.x%26sid%3Dliteratum%253Aachs%26aulast%3DMartel%26aufirst%3DV.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DDynamic%2520localization%252Fassociation%2520of%2520protein%2520kinase%2520CK2%2520subunits%2520in%2520living%2520cells%253A%2520a%2520role%2520in%2520its%2520cellular%2520regulation%253F%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2002%26volume%3D973%26spage%3D272%26epage%3D277%26doi%3D10.1111%2Fj.1749-6632.2002.tb04648.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 and its role in cellular proliferation, development and pathology</span>. <i>Electrophoresis</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10197447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK1MXit1antr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=391-408&author=B.+Guerraauthor=O.+G.+Issinger&title=Protein+kinase+CK2+and+its+role+in+cellular+proliferation%2C+development+and+pathology&doi=10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 and its role in cellular proliferation, development, and pathology</span></div><div class="casAuthors">Guerra, Barbara; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Electrophoresis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">391-408</span>CODEN:
                <span class="NLM_cas:coden">ELCTDN</span>;
        ISSN:<span class="NLM_cas:issn">0173-0835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review is given with 171 refs.  Protein kinase CK2 is a pleiotropic, ubiquitous, and constitutively active protein kinase that can use both ATP and GTP as phosphoryl doriors with specificity for Ser/Thr residues in the vicinity of acidic amino acids.  Recent results show that the enzyme is involved in transcription, signaling, proliferation and in various steps of development.  The tetrameric holoenzyme (α2β2) consists of 2 catalytic α-subunits and 2 regulatory β-subunits.  The structure of the catalytic subunit with the fixed positioning of the activation segment in the active conformation through its own aminoterminal region suggests a regulation at the transcriptional level making a regulation by 2nd messengers unlikely.  The high conservation of the catalytic subunit from yeast to man and its role in the tetrameric complex supports this notion.  The regulatory β-subunit was far less conserved throughout evolution.  Furthermore the existence of different CK2β-related proteins together with the observation of deregulated CK2β levels in tumor cells and the reported assocn. of CK2β protein with key proteins in signal transduction, e.g. A-Raf, Mos, p90rsk etc. are suggestive for an addnl. physiol. role of CK2β protein beside being the regulatory compd. in the tetrameric holoenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAm6hjZTVByrVg90H21EOLACvtfcHk0lgwdEADkOpCNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1antr8%253D&md5=1ea146efc1817b5af0890102f5940f9b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291522-2683%252819990201%252920%253A2%253C391%253A%253AAID-ELPS391%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DProtein%2520kinase%2520CK2%2520and%2520its%2520role%2520in%2520cellular%2520proliferation%252C%2520development%2520and%2520pathology%26jtitle%3DElectrophoresis%26date%3D1999%26volume%3D20%26spage%3D391%26epage%3D408%26doi%3D10.1002%2F%28SICI%291522-2683%2819990201%2920%3A2%3C391%3A%3AAID-ELPS391%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span> <span> </span><span class="NLM_article-title">The dark side of protein kinase CK2 inhibition</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2884</span>, <span class="refDoi"> DOI: 10.2174/092986711796150423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.2174%2F092986711796150423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=21651492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2rtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2867-2884&author=G.+Cozzaauthor=F.+Meggioauthor=S.+Moro&title=The+dark+side+of+protein+kinase+CK2+inhibition&doi=10.2174%2F092986711796150423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The dark side of protein kinase CK2 inhibition</span></div><div class="casAuthors">Cozza, G.; Meggio, F.; Moro, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2867-2884</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Casein kinase 2 (CK2) is a ubiquitous, highly pleiotropic and essential protein kinase whose abnormally high constitutive activity has been implicated in several human diseases.  In the last decade, several ATP competitive inhibitors of CK2, characterized by an in vitro activity that ranges from micromolar to nanomolar, have been discovered.  However, until now only one drug candidate has been entered in Phase I clin. trial as a potential anticancer drug.  Why this constitutively active kinase is so undruggable.  Can ATP competitive inhibitors be considered the most promising drug candidates for the near future.  In this review, we would like to underline how targeting binding sites outside the conventional ATP-binding could represent a new promising strategy to inhibit CK2 activity and, consequently, bear a great potentiality in discovering new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCxbmCM1_QFbVg90H21EOLACvtfcHk0lj3JZdnkTI63w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2rtbs%253D&md5=3fa07cd8c46d4e54fcd58abf6bf2d1da</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986711796150423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796150423%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DThe%2520dark%2520side%2520of%2520protein%2520kinase%2520CK2%2520inhibition%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2867%26epage%3D2884%26doi%3D10.2174%2F092986711796150423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P.</span>; <span class="NLM_string-name">Pierre, F.</span>; <span class="NLM_string-name">Whitten, J.</span></span>, <span> </span><span class="NLM_article-title">Serine-Threonine Protein Kinase and Parp Modulators</span>. <span class="NLM_patent">WO/2008/028168</span>, <span class="NLM_year">2008</span>; <a href="http://patentscope.wipo.int/search/en/WO2008028168" class="extLink">http://patentscope.wipo.int/search/en/WO2008028168</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Chua&author=F.+Pierre&author=J.+Whitten&title=Serine-Threonine+Protein+Kinase+and+Parp+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DP.%26atitle%3DSerine-Threonine%2520Protein%2520Kinase%2520and%2520Parp%2520Modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paliwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmann, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span> <span> </span><span class="NLM_article-title">Structural basis of CX-4945 binding to human protein kinase CK2</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2010.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.febslet.2010.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=21093442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=104-110&author=A.+D.+Fergusonauthor=P.+R.+Shethauthor=A.+D.+Bassoauthor=S.+Paliwalauthor=K.+Grayauthor=T.+O.+Fischmannauthor=H.+V.+Le&title=Structural+basis+of+CX-4945+binding+to+human+protein+kinase+CK2&doi=10.1016%2Fj.febslet.2010.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of CX-4945 binding to human protein kinase CK2</span></div><div class="casAuthors">Ferguson, Andrew D.; Sheth, Payal R.; Basso, Andrea D.; Paliwal, Sunil; Gray, Kimberly; Fischmann, Thierry O.; Le, Hung V.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-110</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein kinase CK2 (CK2), a constitutively active serine/threonine kinase, is involved in a variety of roles essential to the maintenance of cellular homeostasis.  Elevated levels of CK2 expression results in the dysregulation of key signaling pathways that regulate transcription, and has been implicated in cancer.  The adenosine-5'-triphosphate-competitive inhibitor CX-4945 (I) has been reported to show broad spectrum anti-proliferative activity in multiple cancer cell lines.  Although the enzymic IC50 of CX-4945 has been reported, the thermodn. and structural basis of binding to CK2α remained elusive.  Presented here are the crystal structures of human CK2α in complex with CX-4945 and adenylyl phosphoramidate at 2.7 and 1.3 Å, resp.  Biophys. anal. of CX-4945 binding is also described.  This data provides the structural rationale for the design of more potent inhibitors against this emerging cancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ79g72x8-abVg90H21EOLACvtfcHk0lj3JZdnkTI63w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1amtg%253D%253D&md5=b2fab5a9e6d75362c339ddbfa1035315</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2010.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2010.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DSheth%26aufirst%3DP.%2BR.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DPaliwal%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DFischmann%26aufirst%3DT.%2BO.%26aulast%3DLe%26aufirst%3DH.%2BV.%26atitle%3DStructural%2520basis%2520of%2520CX-4945%2520binding%2520to%2520human%2520protein%2520kinase%2520CK2%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D104%26epage%3D110%26doi%3D10.1016%2Fj.febslet.2010.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel function of CX-4945 as a splicing regulator</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e94978</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0094978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1371%2Fjournal.pone.0094978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=24743259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Kimauthor=K.+Choiauthor=H.+Kangauthor=S.+Y.+Leeauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+Songauthor=D.+Imauthor=Y.+Choiauthor=S.+Cho&title=Identification+of+a+novel+function+of+CX-4945+as+a+splicing+regulator&doi=10.1371%2Fjournal.pone.0094978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel function of CX-4945 as a splicing regulator</span></div><div class="casAuthors">Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-wook; Lee, Min-sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94978/1-e94978/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene.  The significance of alternative splicing has been confirmed by the increasing no. of human diseases that are caused by misregulation of splicing events.  Very few compds., however, have been reported to act as inhibitors of alternative splicing, and their potential clin. use needs to be evaluated.  Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a mol. currently in clin. trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner.  Transcriptome-wide anal. using exon array also showed a widespread alteration in alternative splicing of numerous genes.  We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells.  Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date.  Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner.  Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmZdGtUZUe7Vg90H21EOLACvtfcHk0lj3JZdnkTI63w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL&md5=5edb2338401d950cddbcba7d35e57c04</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094978%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520function%2520of%2520CX-4945%2520as%2520a%2520splicing%2520regulator%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0094978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1242/dmm.025668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1242%2Fdmm.025668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=27483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=839-848&author=H.+Kimauthor=K.+S.+Leeauthor=A.+K.+Kimauthor=M.+Choiauthor=K.+Choiauthor=M.+Kangauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+S.+Leeauthor=S.+Y.+Leeauthor=W.+J.+Songauthor=K.+Yuauthor=S.+Cho&title=A+chemical+with+proven+clinical+safety+rescues+Down-syndrome-related+phenotypes+in+through+DYRK1A+inhibition&doi=10.1242%2Fdmm.025668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical with proven clinical safety rescues Down-syndromerelated phenotypes in through DYRK1A inhibition</span></div><div class="casAuthors">Kim, Hyeongki; Lee, Kyu-Sun; Kim, Ae-Kyeong; Choi, Miri; Choi, Kwangman; Kang, Mingu; Chi, Seung-Wook; Lee, Min-Sung; Lee, Jeong-Soo; Lee, So-Young; Song, Woo-Joo; Yu, Kweon; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">Disease Models & Mechanisms</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">839-848</span>CODEN:
                <span class="NLM_cas:coden">DMMIAX</span>;
        ISSN:<span class="NLM_cas:issn">1754-8403</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">DYRK1A is important in neuronal development and function, and its excessive activity is considered a significant pathogenic factor in Down syndrome and Alzheimer's disease.  Thus, inhibition of DYRK1A has been suggested to be a new strategy to modify the disease.  Very few compds., however, have been reported to act as inhibitors, and their potential clin. uses require further evaluation.  Here,we newly identify CX-4945, the safety of which has been already proven in the clin. setting, as a potent inhibitor ofDYRK1A that acts in an ATP-competitive manner.  The inhibitory potency of CX-4945 on DYRK1A (IC50=6.8 nM) in vitro was higher than that of harmine, INDY or proINDY, which are well-known potent inhibitors of DYRK1A.  CX-4945 effectively reverses the aberrant phosphorylation of Tau, amyloid precursor protein (APP) and presenilin 1 (PS1) inmammalian cells.  To our surprise, feedingwith CX-4945 significantly restored the neurol. and phenotypic defects induced by the overexpression of minibrain, an ortholog of human DYRK1A, in the Drosophila model.  Moreover, oral administration of CX-4945 acutely suppressed Tau hyperphosphorylation in the hippocampus of DYRK1A-overexpressing mice.  Our research results demonstrate that CX-4945 is a potent DYRK1A inhibitor and also suggest that it has therapeutic potential for DYRK1A-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwgsUZXI8Gj7Vg90H21EOLACvtfcHk0livM97oEIw4-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN&md5=bfc074ed6a4162a09435959405fa0529</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1242%2Fdmm.025668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.025668%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DA.%2BK.%26aulast%3DChoi%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DA%2520chemical%2520with%2520proven%2520clinical%2520safety%2520rescues%2520Down-syndrome-related%2520phenotypes%2520in%2520through%2520DYRK1A%2520inhibition%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2016%26volume%3D9%26spage%3D839%26epage%3D848%26doi%3D10.1242%2Fdmm.025668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tama, F.</span></span> <span> </span><span class="NLM_article-title">Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1002/prot.25444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2Fprot.25444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=29243286" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=344-353&author=A.+Srivastavaauthor=T.+Hirotaauthor=S.+Irleauthor=F.+Tama&title=Conformational+dynamics+of+human+protein+kinase+CK2%CE%B1+and+its+effect+on+function+and+inhibition&doi=10.1002%2Fprot.25444"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fprot.25444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.25444%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DHirota%26aufirst%3DT.%26aulast%3DIrle%26aufirst%3DS.%26aulast%3DTama%26aufirst%3DF.%26atitle%3DConformational%2520dynamics%2520of%2520human%2520protein%2520kinase%2520CK2%25CE%25B1%2520and%2520its%2520effect%2520on%2520function%2520and%2520inhibition%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2018%26volume%3D86%26spage%3D344%26epage%3D353%26doi%3D10.1002%2Fprot.25444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span> <span> </span><span class="NLM_article-title">Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.bbapap.2009.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19796713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=484-492&author=K.+Niefindauthor=O.+G.+Issinger&title=Conformational+plasticity+of+the+catalytic+subunit+of+protein+kinase+CK2+and+its+consequences+for+regulation+and+drug+design&doi=10.1016%2Fj.bbapap.2009.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design</span></div><div class="casAuthors">Niefind, Karsten; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">484-492</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  At 1st glance, protein kinase 2α (CK2α), the catalytic subunit of CK2, is a rigid mol.; in contrast to many eukaryotic protein kinases, in CK2α the canonical regulatory key elements like the activation segment occur exclusively in their typical active conformations.  This observation fits well to the constitutive activity of the enzyme, meaning, its independence from phosphorylation or other characteristic control factors.  Most CK2α structures are based on the enzyme from Zea mays, supplemented by an increasing no. of human CK2α structures.  In the latter a surprising plasticity of important ATP-binding elements, including the interdomain hinge region and the glycine-rich loop, was discovered.  In fully active CK2α the hinge region is open and does not anchor the ATP ribose moiety, but alternatively it can adopt a closed conformation, form H-bonds to the ribose moiety and thus retract the γ-phospho group from its functional position.  In addn. to this partially inactive state, human CK2α was recently found in a fully inactive conformation.  It is incompatible with ATP binding due to a combination of a closed hinge and a collapse of the glycine-rich loop into the ATP cavity.  These conformational transitions are apparently correlated with the occupation state of a remote docking site located at the interface to the non-catalytic subunit CK2β: if CK2β blocks this site, the fully active conformation of CK2α is stabilized, while the binding of certain small mol. seems to favor the partially and fully inactive states.  This observation may be exploited to design effective and selective CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa5N1vWFbU7Vg90H21EOLACvtfcHk0lhdgudXGG7wKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu7s%253D&md5=31313e981d6fd83a66a77dfa083c239d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DConformational%2520plasticity%2520of%2520the%2520catalytic%2520subunit%2520of%2520protein%2520kinase%2520CK2%2520and%2520its%2520consequences%2520for%2520regulation%2520and%2520drug%2520design%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D484%26epage%3D492%26doi%3D10.1016%2Fj.bbapap.2009.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2007.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.chembiol.2007.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18291315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlKitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=111-117&author=J.+Raafauthor=E.+Brunsteinauthor=O.+G.+Issingerauthor=K.+Niefind&title=The+CK2+alpha%2FCK2+beta+interface+of+human+protein+kinase+CK2+harbors+a+binding+pocket+for+small+molecules&doi=10.1016%2Fj.chembiol.2007.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The CK2α/CK2β Interface of Human Protein Kinase CK2 Harbors a Binding Pocket for Small Molecules</span></div><div class="casAuthors">Raaf, Jennifer; Brunstein, Elena; Issinger, Olaf-Georg; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-117</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Ser/Thr kinase CK2 (previously called casein kinase 2) is composed of two catalytic chains (CK2α) attached to a dimer of noncatalytic subunits (CK2β).  CK2 is involved in suppression of apoptosis, cell survival, and tumorigenesis.  To investigate these activities and possibly affect them, selective CK2 inhibitors are required.  An often-used CK2 inhibitor is 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB).  In a complex structure with human CK2α, DRB binds to the canonical ATP cleft, but addnl. it occupies an allosteric site that can be alternatively filled by glycerol.  Inhibition kinetic studies corroborate the dual binding mode of the inhibitor.  Structural comparisons reveal a surprising conformational plasticity of human CK2α around both DRB binding sites.  After local rearrangement, the allosteric site serves as a CK2β interface.  This opens the potential to construct mols. interfering with the CK2α/CK2β interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUX3xcjrAqAbVg90H21EOLACvtfcHk0lhdgudXGG7wKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlKitbw%253D&md5=221ac03a17608de6cee508c04835d5cd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DBrunstein%26aufirst%3DE.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DThe%2520CK2%2520alpha%252FCK2%2520beta%2520interface%2520of%2520human%2520protein%2520kinase%2520CK2%2520harbors%2520a%2520binding%2520pocket%2520for%2520small%2520molecules%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D111%26epage%3D117%26doi%3D10.1016%2Fj.chembiol.2007.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.bmc.2017.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=28495381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3471-3482&author=C.+De%0AFuscoauthor=P.+Brearauthor=J.+Iegreauthor=K.+H.+Georgiouauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=A+fragment-based+approach+leading+to+the+discovery+of+a+novel+binding+site+and+the+selective+CK2+inhibitor+CAM4066&doi=10.1016%2Fj.bmc.2017.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066</span></div><div class="casAuthors">De Fusco, Claudia; Brear, Paul; Iegre, Jessica; Georgiou, Kathy Hadje; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3471-3482</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently the authors reported the discovery of a potent and selective CK2α inhibitor CAM4066.  This compd. inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket).  Here the authors describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy.  Specifically, the authors aimed to develop inhibitors by linking a high-affinity fragment anchored in the αD site to a weakly binding warhead fragment occupying the ATP site.  Moreover, the authors describe the remarkable impact that mol. modeling had on the development of this novel chem. tool.  The work described herein shows potential for the development of a novel class of CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-es_MXrRt5bVg90H21EOLACvtfcHk0lhdgudXGG7wKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWktbc%253D&md5=2c4bf2e6b0528149dc09d04badfdeab3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DGeorgiou%26aufirst%3DK.%2BH.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DA%2520fragment-based%2520approach%2520leading%2520to%2520the%2520discovery%2520of%2520a%2520novel%2520binding%2520site%2520and%2520the%2520selective%2520CK2%2520inhibitor%2520CAM4066%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3471%26epage%3D3482%26doi%3D10.1016%2Fj.bmc.2017.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iegre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brear, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Fusco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvönen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Second-generation CK2α inhibitors targeting the αD pocket</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3041</span>– <span class="NLM_lpage">3049</span>, <span class="refDoi"> DOI: 10.1039/C7SC05122K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1039%2FC7SC05122K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=29732088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3041-3049&author=J.+Iegreauthor=P.+Brearauthor=C.+De+Fuscoauthor=M.+Yoshidaauthor=S.+L.+Mitchellauthor=M.+Rossmannauthor=L.+Carroauthor=H.+F.+Soreauthor=M.+Hyv%C3%B6nenauthor=D.+R.+Spring&title=Second-generation+CK2%CE%B1+inhibitors+targeting+the+%CE%B1D+pocket&doi=10.1039%2FC7SC05122K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation CK2α inhibitors targeting the αD pocket</span></div><div class="casAuthors">Iegre, Jessica; Brear, Paul; De Fusco, Claudia; Yoshida, Masao; Mitchell, Sophie L.; Rossmann, Maxim; Carro, Laura; Sore, Hannah F.; Hyvonen, Marko; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3041-3049</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CK2 is a crit. cell cycle regulator that also promotes various anti-apoptotic mechanisms.  Development of ATP-non-competitive inhibitors of CK2 is a very attractive strategy considering that the ATP binding site is highly conserved among other kinases.  We have previously utilized a pocket outside the active site to develop a novel CK2 inhibitor, CAM4066.  While CAM4066 bound to this new pocket it was also interacting with the ATP site: herein, we describe an example of a CK2α inhibitor that binds completely outside the active site.  This second generation αD-site binding inhibitor, compd. CAM4712 (IC50 = 7μM, GI50 = 10.0 ± 3.6μM), has numerous advantages over the previously reported CAM4066, including a redn. in the no. of rotatable bonds, the absence of amide groups susceptible to the action of proteases and improved cellular permeability.  Unlike with CAM4066, there was no need to facilitate cellular uptake by making a prodrug.  Moreover, CAM4712 displayed no drop off between its ability to inhibit the kinase in vitro (IC50) and the ability to inhibit cell proliferation (GI50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPLu-nG6dLLVg90H21EOLACvtfcHk0lg5a1EASY10zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGls7w%253D&md5=4d57e89546e1c7bcac4868e3a02ba2f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2FC7SC05122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7SC05122K%26sid%3Dliteratum%253Aachs%26aulast%3DIegre%26aufirst%3DJ.%26aulast%3DBrear%26aufirst%3DP.%26aulast%3DDe%2BFusco%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRossmann%26aufirst%3DM.%26aulast%3DCarro%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DHyv%25C3%25B6nen%26aufirst%3DM.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DSecond-generation%2520CK2%25CE%25B1%2520inhibitors%2520targeting%2520the%2520%25CE%25B1D%2520pocket%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26spage%3D3041%26epage%3D3049%26doi%3D10.1039%2FC7SC05122K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span>; <span class="NLM_string-name">Krimm, I.</span>; <span class="NLM_string-name">Kufareva, I.</span>; <span class="NLM_string-name">Kamal, A. A. M.</span>; <span class="NLM_string-name">Seetoh, W.-G.</span>; <span class="NLM_string-name">Abell, C.</span>; <span class="NLM_string-name">Hartmann, R. W.</span>; <span class="NLM_string-name">Abagyan, R.</span>; <span class="NLM_string-name">Cochet, C.</span>; <span class="NLM_string-name">Le Borgne, M.</span>; <span class="NLM_string-name">Engel, M.</span>; <span class="NLM_string-name">Lomberget, T.</span></span> <span> </span><span class="NLM_article-title">2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. 1. Identification of an allosteric binding site</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01766</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01766" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=B.+Bestgen&author=I.+Krimm&author=I.+Kufareva&author=A.+A.+M.+Kamal&author=W.-G.+Seetoh&author=C.+Abell&author=R.+W.+Hartmann&author=R.+Abagyan&author=C.+Cochet&author=M.+Le+Borgne&author=M.+Engel&author=T.+Lomberget&title=2-Aminothiazole+derivatives+as+selective+allosteric+modulators+of+the+protein+kinase+CK2.+1.+Identification+of+an+allosteric+binding+site&doi=10.1021%2Facs.jmedchem.8b01766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01766%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26atitle%3D2-Aminothiazole%2520derivatives%2520as%2520selective%2520allosteric%2520modulators%2520of%2520the%2520protein%2520kinase%2520CK2.%25201.%2520Identification%2520of%2520an%2520allosteric%2520binding%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26doi%3D10.1021%2Facs.jmedchem.8b01766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, J.</span></span> <span> </span><span class="NLM_article-title">Whence cometh the allosterome?</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">10533</span>– <span class="NLM_lpage">10535</span>, <span class="refDoi"> DOI: 10.1073/pnas.0604452103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1073%2Fpnas.0604452103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10533-10535&author=J.+E.+Lindsleyauthor=J.+Rutter&title=Whence+cometh+the+allosterome%3F&doi=10.1073%2Fpnas.0604452103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604452103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604452103%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DJ.%2BE.%26aulast%3DRutter%26aufirst%3DJ.%26atitle%3DWhence%2520cometh%2520the%2520allosterome%253F%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10533%26epage%3D10535%26doi%3D10.1073%2Fpnas.0604452103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span> <span> </span><span class="NLM_article-title">Druggability predictions: methods, limitations, and applications</span>. <i>WIREs Comput. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1002/wcms.1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2Fwcms.1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ntrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=327-338&author=X.+Barril&title=Druggability+predictions%3A+methods%2C+limitations%2C+and+applications&doi=10.1002%2Fwcms.1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability predictions: methods, limitations, and applications</span></div><div class="casAuthors">Barril, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Wiley Interdisciplinary Reviews: Computational Molecular Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">WIRCAH</span>;
        ISSN:<span class="NLM_cas:issn">1759-0884</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Pharmacol. treatment with small org. mols. offers important medical, economic, and practical advantages over other therapeutic approaches.  However, such small mols. can only elicit an effect when they bind to a biol. component at the appropriate site and with sufficient affinity to modify its behavior.  Druggability predictions assess the ability of a given binding site to host drug-like org. mols.  Combined with information about the involvement of such component in a disease, druggability predictions can be used to prioritize therapeutic targets and are particularly useful when moving beyond the traditional target classes.  In the last few years, significant progress has been made to understand the mol. basis of druggability, to compile datasets of targets with various degrees of druggability, and to develop a diverse set of computational prediction methods.  These tools offer a better prospect for target-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqmc-TqoJErLVg90H21EOLACvtfcHk0lg5a1EASY10zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ntrfM&md5=a3719a5f195506c4dc23712c99a9f1f5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fwcms.1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fwcms.1134%26sid%3Dliteratum%253Aachs%26aulast%3DBarril%26aufirst%3DX.%26atitle%3DDruggability%2520predictions%253A%2520methods%252C%2520limitations%252C%2520and%2520applications%26jtitle%3DWIREs%2520Comput.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D3%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fwcms.1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clive, D. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisaindee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coltart, D. M.</span></span> <span> </span><span class="NLM_article-title">Derivatized amino acids relevant to native peptide synthesis by chemical ligation and acyl transfer</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">9247</span>– <span class="NLM_lpage">9254</span>, <span class="refDoi"> DOI: 10.1021/jo030192r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo030192r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=9247-9254&author=D.+L.+J.+Cliveauthor=S.+Hisaindeeauthor=D.+M.+Coltart&title=Derivatized+amino+acids+relevant+to+native+peptide+synthesis+by+chemical+ligation+and+acyl+transfer&doi=10.1021%2Fjo030192r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo030192r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo030192r%26sid%3Dliteratum%253Aachs%26aulast%3DClive%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DHisaindee%26aufirst%3DS.%26aulast%3DColtart%26aufirst%3DD.%2BM.%26atitle%3DDerivatized%2520amino%2520acids%2520relevant%2520to%2520native%2520peptide%2520synthesis%2520by%2520chemical%2520ligation%2520and%2520acyl%2520transfer%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D9247%26epage%3D9254%26doi%3D10.1021%2Fjo030192r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marzabadi, M. R.</span>; <span class="NLM_string-name">Wong, W. C.</span>; <span class="NLM_string-name">Noble, S. A.</span>; <span class="NLM_string-name">Desai, M. N.</span></span> <span> </span><span class="NLM_article-title">Selective NPY (Y5) Antagonists</span>. <span class="NLM_patent">US6989379B1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+R.+Marzabadi&author=W.+C.+Wong&author=S.+A.+Noble&author=M.+N.+Desai&title=Selective+NPY+%28Y5%29+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarzabadi%26aufirst%3DM.%2BR.%26atitle%3DSelective%2520NPY%2520%2528Y5%2529%2520Antagonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, S.</span>; <span class="NLM_string-name">Saito, D.</span></span> <span> </span><span class="NLM_article-title">Method for Producing Isothiocyanate Compound Having Carboxyl Group</span>. <span class="NLM_patent">US8367857B2</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Nakano&author=D.+Saito&title=Method+for+Producing+Isothiocyanate+Compound+Having+Carboxyl+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DS.%26atitle%3DMethod%2520for%2520Producing%2520Isothiocyanate%2520Compound%2520Having%2520Carboxyl%2520Group%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Garcia, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busschots, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fröhner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettcher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9817</span>– <span class="NLM_lpage">9830</span>, <span class="refDoi"> DOI: 10.1021/jm3010477</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9817-9830&author=A.+Wilhelmauthor=L.+A.+Lopez-Garciaauthor=K.+Busschotsauthor=W.+Fr%C3%B6hnerauthor=F.+Maurerauthor=S.+Boettcherauthor=H.+Zhangauthor=J.+O.+Schulzeauthor=R.+M.+Biondiauthor=M.+Engel&title=2-%283-Oxo-1%2C3-diphenylpropyl%29malonic+acids+as+potent+allosteric+ligands+of+the+PIF+pocket+of+phosphoinositide-dependent+kinase-1%3A+development+and+prodrug+concept&doi=10.1021%2Fjm3010477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm3010477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010477%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DA.%26aulast%3DLopez-Garcia%26aufirst%3DL.%2BA.%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DFr%25C3%25B6hner%26aufirst%3DW.%26aulast%3DMaurer%26aufirst%3DF.%26aulast%3DBoettcher%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSchulze%26aufirst%3DJ.%2BO.%26aulast%3DBiondi%26aufirst%3DR.%2BM.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3D2-%25283-Oxo-1%252C3-diphenylpropyl%2529malonic%2520acids%2520as%2520potent%2520allosteric%2520ligands%2520of%2520the%2520PIF%2520pocket%2520of%2520phosphoinositide-dependent%2520kinase-1%253A%2520development%2520and%2520prodrug%2520concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9817%26epage%3D9830%26doi%3D10.1021%2Fjm3010477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bdzhola, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmoluk, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">A Note of caution on the role of halogen bonds for protein kinase/inhibitor recognition suggested by high- and low-salt CK2α complex structures</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1654</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00235</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00235" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1654-1660&author=B.+Guerraauthor=N.+Bischoffauthor=V.+G.+Bdzholaauthor=S.+M.+Yarmolukauthor=O.+G.+Issingerauthor=A.+G.+Golubauthor=K.+Niefind&title=A+Note+of+caution+on+the+role+of+halogen+bonds+for+protein+kinase%2Finhibitor+recognition+suggested+by+high-+and+low-salt+CK2%CE%B1+complex+structures&doi=10.1021%2Facschembio.5b00235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures</span></div><div class="casAuthors">Guerra, Barbara; Bischoff, Nils; Bdzhola, Volodymyr G.; Yarmoluk, Sergiy M.; Issinger, Olaf-Georg; Golub, Andriy G.; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1654-1660</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a Ser/Thr kinase recruited by tumor cells to avoid cell death.  4'-Carboxy-6,8-dibromo-flavonol (FLC26) is a nanomolar CK2 inhibitor reducing the physiol. phosphorylation of CK2 biomarkers and inducing cell death.  Its binding mode to the ATP site was predicted to depend primarily on noncovalent interactions not comprising halogen bonds.  We confirm this by two independent cocrystal structures which addnl. show that FLC26 is selective for an open, protein kinase-untypical conformation of the hinge/helix αD region.  The structures suggest how the bromo substituents, found previously in lead optimization studies, contribute to the inhibitory efficacy.  In this context, one of the complex structures, obtained by crystn. with the kosmotropic salt NaCl, revealed an unconventional π-halogen bond between the 8-bromo substituent of FLC26 and an arom. side chain which is absent under low-salt conditions.  The kosmotropic salt sensitivity of π-halogen bonds is a novel feature which requires attention in structural comparisons and halogen-bond-based explanations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolnSDoVENUrbVg90H21EOLACvtfcHk0lhoWLmrNclReQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVemtLw%253D&md5=88774b705a45a2fe08917c44545fcd04</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00235%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DN.%26aulast%3DBdzhola%26aufirst%3DV.%2BG.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DGolub%26aufirst%3DA.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DA%2520Note%2520of%2520caution%2520on%2520the%2520role%2520of%2520halogen%2520bonds%2520for%2520protein%2520kinase%252Finhibitor%2520recognition%2520suggested%2520by%2520high-%2520and%2520low-salt%2520CK2%25CE%25B1%2520complex%2520structures%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1654%26epage%3D1660%26doi%3D10.1021%2Facschembio.5b00235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1021/cb400771y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400771y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=366-371&author=G.+Lolliauthor=A.+Ranchioauthor=R.+Battistutta&title=Active+form+of+the+protein+kinase+CK2+%CE%B12%CE%B22+holoenzyme+is+a+strong+complex+with+symmetric+architecture&doi=10.1021%2Fcb400771y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fcb400771y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400771y%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DRanchio%26aufirst%3DA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DActive%2520form%2520of%2520the%2520protein%2520kinase%2520CK2%2520%25CE%25B12%25CE%25B22%2520holoenzyme%2520is%2520a%2520strong%2520complex%2520with%2520symmetric%2520architecture%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D366%26epage%3D371%26doi%3D10.1021%2Fcb400771y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issinger, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niefind, K.</span></span> <span> </span><span class="NLM_article-title">First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>386</i></span>,  <span class="NLM_fpage">1212</span>– <span class="NLM_lpage">1221</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.jmb.2009.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19361447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFanurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2009&pages=1212-1221&author=J.+Raafauthor=O.+G.+Issingerauthor=K.+Niefind&title=First+inactive+conformation+of+CK2+alpha%2C+the+catalytic+subunit+of+protein+kinase+CK2&doi=10.1016%2Fj.jmb.2009.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">First Inactive Conformation of CK2α, the Catalytic Subunit of Protein Kinase CK2</span></div><div class="casAuthors">Raaf, Jennifer; Issinger, Olaf-Georg; Niefind, Karsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1212-1221</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Ser/Thr kinase casein kinase 2 (CK2) is a heterotetrameric enzyme composed of two catalytic chains (CK2α, catalytic subunit of CK2) attached to a dimer of two noncatalytic subunits (CK2β, noncatalytic subunit of CK2).  CK2α belongs to the superfamily of eukaryotic protein kinases (EPKs).  To function as regulatory key components, EPKs normally exist in inactive ground states and are activated only upon specific signals.  Typically, this activation is accompanied by large conformational changes in helix αC and in the activation segment, leading to a characteristic arrangement of catalytic key elements.  For CK2α however, no strict physiol. control of activity is known.  Accordingly, CK2α has been found so far exclusively in the characteristic conformation of active EPKs, which in this case, exhibits addnl. stabilization by a unique intramol. contact between the N-terminal segment on one side, and helix αC and the activation segment on the other side.  We report here the structure of a C-terminally truncated variant of human CK2α in which the enzyme adopts a decidedly inactive conformation for the first time.  In this CK2α structure, those regulatory key regions still are in their active positions.  Yet the glycine-rich ATP-binding loop, which is normally part of the canonical anti-parallel β-sheet, has collapsed into the ATP-binding site so that ATP is excluded from binding; specifically, the side chain of Arg47 occupies the ribose region of the ATP site and Tyr50, the space required by the triphospho moiety.  We discuss some factors that may support or disfavor this inactive conformation, among them coordination of small mols. at a remote cavity at the CK2α/CK2β interaction region and binding of a CK2β dimer.  The latter stabilizes the glycine-rich loop in the extended active conformation known from the majority of CK2α structures.  Thus, the novel inactive conformation of CK2α provides for the first time a structural basis for the stimulatory impact of CK2β on CK2α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxx8RkUAZk0rVg90H21EOLACvtfcHk0li4JH5tKrntkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFanurs%253D&md5=e923adf7438b04721617e79f9650f073</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26aulast%3DNiefind%26aufirst%3DK.%26atitle%3DFirst%2520inactive%2520conformation%2520of%2520CK2%2520alpha%252C%2520the%2520catalytic%2520subunit%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D386%26spage%3D1212%26epage%3D1221%26doi%3D10.1016%2Fj.jmb.2009.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">Structural determinants of protein kinase CK2 regulation by autoinhibitory polymerization</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1158</span>– <span class="NLM_lpage">1163</span>, <span class="refDoi"> DOI: 10.1021/cb300054n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300054n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1158-1163&author=G.+Lolliauthor=L.+A.+Pinnaauthor=R.+Battistutta&title=Structural+determinants+of+protein+kinase+CK2+regulation+by+autoinhibitory+polymerization&doi=10.1021%2Fcb300054n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcb300054n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300054n%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DStructural%2520determinants%2520of%2520protein%2520kinase%2520CK2%2520regulation%2520by%2520autoinhibitory%2520polymerization%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D1158%26epage%3D1163%26doi%3D10.1021%2Fcb300054n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, F. L.</span></span> <span> </span><span class="NLM_article-title">Effect of intramolecular hydrogen bonding on ionization constants of substituted salicylic acids</span>. <i>Can. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1966</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1139/v66-188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1139%2Fv66-188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1966&pages=1261-1269&author=G.+E.+Dunnauthor=F.+L.+Kung&title=Effect+of+intramolecular+hydrogen+bonding+on+ionization+constants+of+substituted+salicylic+acids&doi=10.1139%2Fv66-188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1139%2Fv66-188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv66-188%26sid%3Dliteratum%253Aachs%26aulast%3DDunn%26aufirst%3DG.%2BE.%26aulast%3DKung%26aufirst%3DF.%2BL.%26atitle%3DEffect%2520of%2520intramolecular%2520hydrogen%2520bonding%2520on%2520ionization%2520constants%2520of%2520substituted%2520salicylic%2520acids%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1966%26volume%3D44%26spage%3D1261%26epage%3D1269%26doi%3D10.1139%2Fv66-188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillo, M. P.</span></span> <span> </span><span class="NLM_article-title">Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/tx020013l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx020013l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFWksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=1309-1317&author=C.+Liauthor=L.+Z.+Benetauthor=M.+P.+Grillo&title=Studies+on+the+chemical+reactivity+of+2-phenylpropionic+acid+1-O-acyl+glucuronide+and+S-acyl-CoA+thioester+metabolites&doi=10.1021%2Ftx020013l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the Chemical Reactivity of 2-Phenylpropionic Acid 1-O-Acyl Glucuronide and S-Acyl-CoA Thioester Metabolites</span></div><div class="casAuthors">Li, Chunze; Benet, Leslie Z.; Grillo, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1309-1317</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. reactive species formed from the metab. of carboxylic acid-contg. compds. have been proposed as mediators of their toxic side-effects.  Two alternative metabolic pathways known to be involved in the generation of reactive acylating metabolites of carboxylic acids are acyl glucuronidation and acyl-CoA formation.  Here, we present studies with 2-phenylpropionic acid focused on evaluating the relative abilities of acyl glucuronides vs. acyl-CoA derivs. to transacylate the nucleophilic cysteinyl-thiol of glutathione.  Thus, synthetic 2-phenylpropionyl-S-acyl-CoA (2-PPA-SCoA) and biosynthetic 2-phenylpropionyl-1-O-acyl glucuronide (2-PPA-1-O-G) were incubated sep., and at varying concns. (15.6-500 nM as well as at 0.1 mM), with GSH (1, 5, and 10 mM) in buffer (pH 7.4, 37), and formation of the transacylation product, 2-phenylpropionyl-S-acyl-glutathione (2-PPA-SG), was quantified by reverse-phase HPLC and LC-MS.  HPLC anal. of the products from both the reaction of 2-PPA-SCoA and 2-PPA-1-O-G with GSH showed the presence of 2-PPA-SG, which was confirmed by coelution with authentic 2-PPA-SG as well as by its LC/MS mass spectrum.  The formation of 2-PPA-SG was time- and concn.-dependent with a formation rate const. of (1.9±0.2) × 10-2 M-1·s-1 from reactions of GSH with 2-PPA-SCoA, and (2.7±0.4) × 10-4 M-1·s-1 from reactions of GSH with 2-PPA-1-O-G. Therefore, the reactivity of 2-PPA-SCoA with GSH was 70 times greater than the reactivity of GSH with 2-PPA-1-O-G, which was found to acyl-migrate to less reactive isomers.  Anal. of the in vitro stability of 2-PPA-SCoA and 2-PPA-1-O-G in the absence of GSH showed the CoA esters to be completely stable after 24 h, whereas the acyl glucuronides decompd. by 50% in 1.3 and 2.4 h of incubation at pH 7.4 and 37 for (R)- and (S)-2-PPA-1-O-G, resp.  In addn., studies of the reactivity of 2-PPA-SCoA with bovine serum albumin showed time- and pH-dependent covalent binding to the protein in vitro.  These results support the hypothesis that xenobiotic acyl-CoA thioesters are reactive acylating species that, in addn. to acyl glucuronides, may contribute to xenobiotic acid-protein adduct formation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1AAYKAMN6D7Vg90H21EOLACvtfcHk0lhmckj57gDKSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFWksLw%253D&md5=52af38fb112c54ae17261412f366df94</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Ftx020013l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx020013l%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DGrillo%26aufirst%3DM.%2BP.%26atitle%3DStudies%2520on%2520the%2520chemical%2520reactivity%2520of%25202-phenylpropionic%2520acid%25201-O-acyl%2520glucuronide%2520and%2520S-acyl-CoA%2520thioester%2520metabolites%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D1309%26epage%3D1317%26doi%3D10.1021%2Ftx020013l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Acyl glucuronides: the good, the bad and the ugly</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/bdd.720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1002%2Fbdd.720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=20830700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=367-395&author=S.+L.+Reganauthor=J.+L.+Maggsauthor=T.+G.+Hammondauthor=C.+Lambertauthor=D.+P.+Williamsauthor=B.+K.+Park&title=Acyl+glucuronides%3A+the+good%2C+the+bad+and+the+ugly&doi=10.1002%2Fbdd.720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Acyl glucuronides: the good, the bad and the ugly</span></div><div class="casAuthors">Regan, Sophie L.; Maggs, James L.; Hammond, Thomas G.; Lambert, Craig; Williams, Dominic P.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">367-395</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Acyl glucuronidation is the major metabolic conjugation reaction of most carboxylic acid drugs in mammals.  The physiol. consequences of this biotransformation have been investigated incompletely but include effects on drug metab., protein binding, distribution and clearance that impact upon pharmacol. and toxicol. outcomes.  In marked contrast, the exceptional but widely disparate chem. reactivity of acyl glucuronides has attracted far greater attention.  Specifically, the complex transacylation and glycation reactions with proteins have provoked much inconclusive debate over the safety of drugs metabolised to acyl glucuronides.  It has been hypothesised that these covalent modifications could initiate idiosyncratic adverse drug reactions.  However, despite a large body of in vitro data on the reactions of acyl glucuronides with protein, evidence for adduct formation from acyl glucuronides in vivo is limited and potentially ambiguous.  The causal connection of protein adduction to adverse drug reactions remains uncertain.  This review has assessed the intrinsic reactivity, metabolic stability and pharmacokinetic properties of acyl glucuronides in the context of physiol., pharmacol. and toxicol. perspectives.  Although numerous expts. have characterised the reactions of acyl glucuronides with proteins, these might be attenuated substantially in vivo by rapid clearance of the conjugates.  Consequently, to delineate a relationship between acyl glucuronide formation and toxicol. phenomena, detailed pharmacokinetic anal. of systemic exposure to the acyl glucuronide should be undertaken adjacent to detg. protein adduct concns. in vivo.  Further investigation is required to ascertain whether acyl glucuronide clearance is sufficient to prevent covalent modification of endogenous proteins and consequentially a potential immunol. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1hIcbM_oZ7Vg90H21EOLACvtfcHk0lhmckj57gDKSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3L&md5=8c45d4dbb68c12bd128af1dba7a08c16</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fbdd.720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.720%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DS.%2BL.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DLambert%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAcyl%2520glucuronides%253A%2520the%2520good%252C%2520the%2520bad%2520and%2520the%2520ugly%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D367%26epage%3D395%26doi%3D10.1002%2Fbdd.720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianoncelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1042/BJ20090069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1042%2FBJ20090069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19432557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=387-395&author=G.+Cozzaauthor=M.+Mazzoranaauthor=E.+Papinuttoauthor=J.+Bainauthor=M.+Elliottauthor=G.+di+Mairaauthor=A.+Gianoncelliauthor=M.+A.+Paganoauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=R.+Battistuttaauthor=F.+Meggioauthor=S.+Moroauthor=G.+Zagottoauthor=L.+A.+Pinna&title=Quinalizarin+as+a+potent%2C+selective+and+cell-permeable+inhibitor+of+protein+kinase+CK2&doi=10.1042%2FBJ20090069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2</span></div><div class="casAuthors">Cozza, Giorgio; Mazzorana, Marco; Papinutto, Elena; Bain, Jenny; Elliott, Matthew; di Maira, Giovanni; Gianoncelli, Alessandra; Pagano, Mario A.; Sarno, Stefania; Ruzzene, Maria; Battistutta, Roberto; Meggio, Flavio; Moro, Stefano; Zagotto, Giuseppe; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-395</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) is a moderately potent and poorly selective inhibitor of protein kinase CK2, one of the most pleiotropic serine/threonine protein kinases, implicated in neoplasia and in other global diseases.  By virtual screening of the MMS (Mol. Modeling Section) database, we have now identified quinalizarin (1,2,5,8-tetrahydroxyanthraquinone) as an inhibitor of CK2 that is more potent and selective than emodin.  CK2 inhibition by quinalizarin is competitive with respect to ATP, with a Ki value of approx. 50 nM.  Tested at 1 μM concn. on a panel of 75 protein kinases, quinalizarin drastically inhibits only CK2, with a promiscuity score (11.1), which is the lowest ever reported so far for a CK2 inhibitor.  Esp. remarkable is the ability of quinalizarin to discriminate between CK2 and a no. of kinases, notably DYRK1a (dual-specificity tyrosine-phosphorylated and -regulated kinase), PIM (provirus integration site for Moloney murine leukemia virus) 1, 2 and 3, HIPK2 (homeodomain-interacting protein kinase-2), MNK1 [MAPK (mitogen-activated protein kinase)-interacting kinase 1], ERK8 (extracellular-signal-regulated kinase 8) and PKD1 (protein kinase D 1), which conversely tend to be inhibited as drastically as CK2 by com. available CK2 inhibitors.  The detn. of the crystal structure of a complex between quinalizarin and CK2α subunit highlights the relevance of polar interactions in stabilizing the binding, an unusual characteristic for a CK2 inhibitor, and disclose other structural features which may account for the narrow selectivity of this compd.  Tested on Jurkat cells, quinalizarin proved able to inhibit endogenous CK2 and to induce apoptosis more efficiently than the commonly used CK2 inhibitors TBB (4,5,6,7-tetrabromo-1H-benzotriazole) and DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbz80w9Hmd9LVg90H21EOLACvtfcHk0lhoPPg5Xag1Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2hurk%253D&md5=dc127c347d7e47419bee4594ff7572fb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1042%2FBJ20090069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20090069%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3Ddi%2BMaira%26aufirst%3DG.%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DQuinalizarin%2520as%2520a%2520potent%252C%2520selective%2520and%2520cell-permeable%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D387%26epage%3D395%26doi%3D10.1042%2FBJ20090069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhoPPg5Xag1Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belaid-Choucair, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomberget, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">In search of small molecule inhibitors targeting the flexible CK2 subunit interface</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.3390/ph10010016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.3390%2Fph10010016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVWrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=16&author=B.+Bestgenauthor=Z.+Belaid-Choucairauthor=T.+Lombergetauthor=M.+Le+Borgneauthor=O.+Filholauthor=C.+Cochet&title=In+search+of+small+molecule+inhibitors+targeting+the+flexible+CK2+subunit+interface&doi=10.3390%2Fph10010016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">In search of small molecule inhibitors targeting the flexible CK2 subunit interface</span></div><div class="casAuthors">Bestgen, Benoit; Belaid-Choucair, Zakia; Lomberget, Thierry; Le Borgne, Marc; Filhol, Odile; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16/1-16/15</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Protein kinase CK2 is a tetrameric holoenzyme composed of two catalytic (α and/or α') subunits and two regulatory (β) subunits.  Crystallog. data paired with fluorescence imaging techniques have suggested that the formation of the CK2 holoenzyme complex within cells is a dynamic process.  Although the monomeric CK2α subunit is endowed with a constitutive catalytic activity, many of the plethora of CK2 substrates are exclusively phosphorylated by the CK2 holoenzyme.  This means that the spatial and high affinity interaction between CK2α and CK2β subunits is critically important and that its disruption may provide a powerful and selective way to block the phosphorylation of substrates requiring the presence of CK2β.  In search of compds. inhibiting this crit. protein-protein interaction, we previously designed an active cyclic peptide (Pc) derived from the CK2β carboxy-terminal domain that can efficiently antagonize the CK2 subunit interaction.  To understand the functional significance of this interaction, we generated cell-permeable versions of Pc, exploring its mol. mechanisms of action and the perturbations of the signaling pathways that it induces in intact cells.  The identification of small mols. inhibitors of this crit. interaction may represent the first-choice approach to manipulate CK2 in an unconventional way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjtCoeeLRdDrVg90H21EOLACvtfcHk0lhoPPg5Xag1Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVWrtLo%253D&md5=f638a3d79356538b88b453a745c43ad7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3390%2Fph10010016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph10010016%26sid%3Dliteratum%253Aachs%26aulast%3DBestgen%26aufirst%3DB.%26aulast%3DBelaid-Choucair%26aufirst%3DZ.%26aulast%3DLomberget%26aufirst%3DT.%26aulast%3DLe%2BBorgne%26aufirst%3DM.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DIn%2520search%2520of%2520small%2520molecule%2520inhibitors%2520targeting%2520the%2520flexible%2520CK2%2520subunit%2520interface%26jtitle%3DPharmaceuticals%26date%3D2017%26volume%3D10%26spage%3D16%26doi%3D10.3390%2Fph10010016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poletto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilardell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falqués, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span> <span> </span><span class="NLM_article-title">The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">8317</span>– <span class="NLM_lpage">8325</span>, <span class="refDoi"> DOI: 10.1021/bi800216d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800216d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1aht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=8317-8325&author=G.+Polettoauthor=J.+Vilardellauthor=O.+Marinauthor=M.+A.+Paganoauthor=G.+Cozzaauthor=S.+Sarnoauthor=A.+Falqu%C3%A9sauthor=E.+Itarteauthor=L.+A.+Pinnaauthor=F.+Meggio&title=The+regulatory+beta+subunit+of+protein+kinase+CK2+contributes+to+the+recognition+of+the+substrate+consensus+sequence.+A+study+with+an+eIF2+beta-derived+peptide&doi=10.1021%2Fbi800216d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The Regulatory β Subunit of Protein Kinase CK2 Contributes to the Recognition of the Substrate Consensus Sequence. A Study with an eIF2β-Derived Peptide</span></div><div class="casAuthors">Poletto, Giorgia; Vilardell, Jordi; Marin, Oriano; Pagano, Mario A.; Cozza, Giorgio; Sarno, Stefania; Falques, Antoni; Itarte, Emilio; Pinna, Lorenzo A.; Meggio, Flavio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8317-8325</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CK2 is a ubiquitous and pleiotropic Ser/Thr-specific protein kinase that phosphorylates more than 300 protein substrates at sites specified by an acidic consensus sequence in which positions n + 3 and n + 1 are particularly important.  Recognition of substrates by CK2 is known to rely on basic residues located in the catalytic site of the α subunit which make electrostatic contacts with the neg. charges in the substrate consensus sequence, thereby assuring optimal binding; the regulatory β subunit is believed to play a protective and stabilizing role.  We describe a biochem. and structural anal. of CK2-mediated phosphorylation of a 22-mer synthetic peptide corresponding to the N-terminal tail of the eukaryotic translation initiation factor eIF2β.  Results demonstrate that this peptide still displays phosphorylation features similar to full-length eIF2β and the CK2 β subunit also contributes to recognition of the protein substrate by establishing both polar and hydrophobic interactions with specificity determinants located downstream from the phosphoacceptor site.  In particular, the N-terminal domain of the β subunit appears to be of crucial importance for optimizing high-affinity phosphorylation of the eIF2β peptide.  This domain includes an acidic cluster whose electrostatic contacts with basic residues of the substrate attenuate intrasteric pseudosubstrate inhibition while strengthening substrate-kinase binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjBbq0JxBw9rVg90H21EOLACvtfcHk0likjRNE_jW2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1aht7s%253D&md5=713be1b95815a9409af4bc170fe51e00</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbi800216d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800216d%26sid%3Dliteratum%253Aachs%26aulast%3DPoletto%26aufirst%3DG.%26aulast%3DVilardell%26aufirst%3DJ.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DFalqu%25C3%25A9s%26aufirst%3DA.%26aulast%3DItarte%26aufirst%3DE.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26atitle%3DThe%2520regulatory%2520beta%2520subunit%2520of%2520protein%2520kinase%2520CK2%2520contributes%2520to%2520the%2520recognition%2520of%2520the%2520substrate%2520consensus%2520sequence.%2520A%2520study%2520with%2520an%2520eIF2%2520beta-derived%2520peptide%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D8317%26epage%3D8325%26doi%3D10.1021%2Fbi800216d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">Adding calorimetric data to decision making in lead discovery: a hot tip</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrd3054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnrd3054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19960014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=23-27&author=J.+E.+Ladburyauthor=G.+Klebeauthor=E.+Freire&title=Adding+calorimetric+data+to+decision+making+in+lead+discovery%3A+a+hot+tip&doi=10.1038%2Fnrd3054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Adding calorimetric data to decision making in lead discovery: A hot tip</span></div><div class="casAuthors">Ladbury, John E.; Klebe, Gerhard; Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recognition of the limitations of high-throughput screening approaches in the discovery of candidate drugs has reawakened interest in structure-based and other rational design methods.  Here, the authors describe how isothermal titrn. calorimetry can be used to obtain thermodn. data on the binding of compds. to protein targets.  The authors propose that these data - particularly the change in enthalpy - could provide a valuable, complementary addn. to established tools for selecting compds. in lead discovery and for aiding lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph3qvp2E8fbLVg90H21EOLACvtfcHk0likjRNE_jW2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWjt7bM&md5=e8446b6db983c35580e9010899eb40eb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd3054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3054%26sid%3Dliteratum%253Aachs%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DAdding%2520calorimetric%2520data%2520to%2520decision%2520making%2520in%2520lead%2520discovery%253A%2520a%2520hot%2520tip%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D23%26epage%3D27%26doi%3D10.1038%2Fnrd3054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0likjRNE_jW2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastassiadis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devarajan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J. R.</span></span> <span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1045</span>, <span class="refDoi"> DOI: 10.1038/nbt.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0limj_FAhnlRxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1039%26epage%3D1045%26doi%3D10.1038%2Fnbt.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graczyk, P. P.</span></span> <span> </span><span class="NLM_article-title">Gini Coefficient: A new way to express selectivity of kinase inhibitors against a family of kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5773</span>– <span class="NLM_lpage">5779</span>, <span class="refDoi"> DOI: 10.1021/jm070562u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070562u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5773-5779&author=P.+P.+Graczyk&title=Gini+Coefficient%3A+A+new+way+to+express+selectivity+of+kinase+inhibitors+against+a+family+of+kinases&doi=10.1021%2Fjm070562u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Gini Coefficient: A New Way To Express Selectivity of Kinase Inhibitors against a Family of Kinases</span></div><div class="casAuthors">Graczyk, Piotr P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5773-5779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel application of the Gini coeff. for expressing selectivity of kinase inhibitors against a panel of kinases is proposed.  This has been illustrated using single-point inhibition data for 40 com. available kinase inhibitors screened against 85 kinases.  Nonselective inhibitors are characterized by Gini values close to zero (Staurosporine, Gini 0.150).  Highly selective compds. exhibit Gini values close to 1 (PD184352 Gini 0.905).  The relative selectivity of inhibitors does not depend on the ATP concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUHpmF-C9u7Vg90H21EOLACvtfcHk0limj_FAhnlRxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL&md5=51f4902e49196dfef8e135c4a09182d7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm070562u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070562u%26sid%3Dliteratum%253Aachs%26aulast%3DGraczyk%26aufirst%3DP.%2BP.%26atitle%3DGini%2520Coefficient%253A%2520A%2520new%2520way%2520to%2520express%2520selectivity%2520of%2520kinase%2520inhibitors%2520against%2520a%2520family%2520of%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5773%26epage%3D5779%26doi%3D10.1021%2Fjm070562u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papinutto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">8478</span>– <span class="NLM_lpage">8488</span>, <span class="refDoi"> DOI: 10.1021/bi2008382</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2008382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=8478-8488&author=R.+Battistuttaauthor=G.+Cozzaauthor=F.+Pierreauthor=E.+Papinuttoauthor=G.+Lolliauthor=S.+Sarnoauthor=S.+E.+O%E2%80%99Brienauthor=A.+Siddiqui-Jainauthor=M.+Haddachauthor=K.+Anderesauthor=D.+M.+Ryckmanauthor=F.+Meggioauthor=L.+A.+Pinna&title=Unprecedented+selectivity+and+structural+determinants+of+a+new+class+of+protein+kinase+CK2+inhibitors+in+clinical+trials+for+the+treatment+of+cancer&doi=10.1021%2Fbi2008382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer</span></div><div class="casAuthors">Battistutta, Roberto; Cozza, Giorgio; Pierre, Fabrice; Papinutto, Elena; Lolli, Graziano; Sarno, Stefania; O'Brien, Sean E.; Siddiqui-Jain, Adam; Haddach, Mustapha; Anderes, Kenna; Ryckman, David M.; Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">8478-8488</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clin. stage inhibitor of protein kinase CK2 for the treatment of cancer, is representative of a new class of CK2 inhibitors with Ki values in the low nanomolar range and unprecedented selectivity vs. other kinases.  Here we present the crystal structure of the complexes of CX-4945 and two analogs (CX-5011 and CX-5279) with the catalytic subunit of human CK2.  Consistent with their ATP-competitive mode of inhibition, all three compds. bind in the active site of CK2 (type I inhibitors).  The tricyclic scaffold of the inhibitors superposes on the adenine of ATP, establishing multiple hydrophobic interactions with the binding cavity.  The more extended scaffold, as compared to that of ATP, allows the carboxylic function, shared by all three ligands, to penetrate into the deepest part of the active site where it makes interactions with conserved water W1 and Lys-68, thus accounting for the crucial role of this neg. charged group in conferring high potency to this class of inhibitors.  The presence of a pyrimidine in CX-5011 and in CX-5279 instead of a pyridine (as in CX-4945) ring is likely to account for the higher specificity of these compds. whose Gini coeffs., calcd. by profiling them against panels of 102 and/or 235 kinases, are significantly higher than that of CX-4945 (0.735 and 0.755, resp., vs 0.615), marking the highest selectivity ever reported for CK2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjndr5Zz11z7Vg90H21EOLACvtfcHk0liU29I2ergZbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7vK&md5=4f399675d86d48b88cbfefa6b8c13edb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi2008382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2008382%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DLolli%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DUnprecedented%2520selectivity%2520and%2520structural%2520determinants%2520of%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520CK2%2520inhibitors%2520in%2520clinical%2520trials%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D8478%26epage%3D8488%26doi%3D10.1021%2Fbi2008382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzeszko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">The selectivity of inhibitors of protein kinase CK2: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1042/BJ20080309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1042%2FBJ20080309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18588507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CmsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2008&pages=353-365&author=M.+A.+Paganoauthor=J.+Bainauthor=Z.+Kazimierczukauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=G.+Di+Mairaauthor=M.+Elliottauthor=A.+Orzeszkoauthor=G.+Cozzaauthor=F.+Meggioauthor=L.+A.+Pinna&title=The+selectivity+of+inhibitors+of+protein+kinase+CK2%3A+an+update&doi=10.1042%2FBJ20080309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of inhibitors of protein kinase CK2: an update</span></div><div class="casAuthors">Pagano, Mario A.; Bain, Jenny; Kazimierczuk, Zygmunt; Sarno, Stefania; Ruzzene, Maria; Di maira, Giovanni; Elliott, Matthew; Orzeszko, Andrzej; Cozza, Giorgio; Meggio, Flavio; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-365</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">CK2 (casein kinase 2) is a very pleiotropic serine/threonine protein kinase whose abnormally high constitutive activity has often been correlated to pathol. conditions with special ref. to neoplasia.  The two most widely used cell permeable CK2 inhibitors, TBB (4,5,6,7-tetrabromo-1H-benzotriazole) and DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole), are marketed as quite specific CK2 blockers.  In the present study the authors show, by using a panel of approx. 80 protein kinases, that DMAT and its parent compd. TBI (or TBBz; 4,5,6,7-tetrabromo-1H-benzimidazole) are potent inhibitors of several other kinases, with special ref. to PIM (provirus integration site for Moloney murine leukemia virus)1, PIM2, PIM3, PKD1 (protein kinase D1), HIPK2 (homeodomain-interacting protein kinase 2) and DYRK1a (dual-specificity tyrosine-phosphorylated and -regulated kinase 1a).  In contrast, TBB is significantly more selective toward CK2, although it also inhibits PIM1 and PIM3.  To improve selectivity towards CK2 a library of 68 TBB/TBI-related compds. have been tested for their ability to discriminate between CK2, PIM1, HIPK2 and DYRK1a, ending up with seven compds. whose efficacy toward CK2 is markedly higher than that toward the second most inhibited kinase.  Two of these, K64 (3,4,5,6,7-pentabromo-1H-indazole) and K66 (1-carboxymethyl-2-dimethylamino-4,5,6,7-tetrabromo-benzimidazole), display an overall selectivity much higher than TBB and DMAT when tested on a panel of 80 kinases and display similar efficacy as inducers of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6m0pQ0Dz7b7Vg90H21EOLACvtfcHk0liU29I2ergZbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CmsrnJ&md5=2a7bee7f29c2a500458240fd92fd2e3a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1042%2FBJ20080309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20080309%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520selectivity%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D415%26spage%3D353%26epage%3D365%26doi%3D10.1042%2FBJ20080309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodaczewska, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczylik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiedorowicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarnecka, A. M.</span></span> <span> </span><span class="NLM_article-title">Choosing the right cell line for renal cell cancer research</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">83</span>, <span class="refDoi"> DOI: 10.1186/s12943-016-0565-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1186%2Fs12943-016-0565-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=27993170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFWisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=83&author=K.+K.+Brodaczewskaauthor=C.+Szczylikauthor=M.+Fiedorowiczauthor=C.+Portaauthor=A.+M.+Czarnecka&title=Choosing+the+right+cell+line+for+renal+cell+cancer+research&doi=10.1186%2Fs12943-016-0565-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Choosing the right cell line for renal cell cancer research</span></div><div class="casAuthors">Brodaczewska, Klaudia K.; Szczylik, Cezary; Fiedorowicz, Michal; Porta, Camillo; Czarnecka, Anna M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83/1-83/15</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Cell lines are still a tool of choice for many fields of biomedical research, including oncol.  Although cancer is a very complex disease, many discoveries have been made using monocultures of established cell lines.  Therefore, the proper use of in vitro models is crucial to enhance our understanding of cancer.  Therapeutics against renal cell cancer (RCC) are also screened with the use of cell lines.  Multiple RCC in vitro cultures are available, allowing in vivo heterogeneity in the lab., but at the same time, these can be a source of errors.  In this review, we tried to sum up the data on the RCC cell lines used currently.  An increasing amt. of data on RCC shed new light on the mol. background of the disease; however, it revealed how much still needs to be done.  As new types of RCC are being distinguished, novel cell lines and the re-exploration of old ones seems to be indispensable to create effective in vitro tools for drug screening and more.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSTyM5-NwfMbVg90H21EOLACvtfcHk0lgDFNoZnI6aug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFWisLc%253D&md5=7b01e396028776a5111436dd71864885</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1186%2Fs12943-016-0565-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-016-0565-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrodaczewska%26aufirst%3DK.%2BK.%26aulast%3DSzczylik%26aufirst%3DC.%26aulast%3DFiedorowicz%26aufirst%3DM.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DCzarnecka%26aufirst%3DA.%2BM.%26atitle%3DChoosing%2520the%2520right%2520cell%2520line%2520for%2520renal%2520cell%2520cancer%2520research%26jtitle%3DMol.%2520Cancer%26date%3D2016%26volume%3D15%26spage%3D83%26doi%3D10.1186%2Fs12943-016-0565-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singer, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchalik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span> <span> </span><span class="NLM_article-title">Evolving therapeutic targets in renal cell carcinoma</span>. <i>Curr. Opin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1097/CCO.0b013e32835fc857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1097%2FCCO.0b013e32835fc857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=23455028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ant7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=273-280&author=E.+A.+Singerauthor=G.+N.+Guptaauthor=D.+Marchalikauthor=R.+Srinivasan&title=Evolving+therapeutic+targets+in+renal+cell+carcinoma&doi=10.1097%2FCCO.0b013e32835fc857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving therapeutic targets in renal cell carcinoma</span></div><div class="casAuthors">Singer, Eric A.; Gupta, Gopal N.; Marchalik, Daniel; Srinivasan, Ramaprasad</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-280</span>CODEN:
                <span class="NLM_cas:coden">CUOOE8</span>;
        ISSN:<span class="NLM_cas:issn">1040-8746</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Recent developments in the treatment of advanced renal cell carcinoma (RCC) will be discussed, with emphasis on data published over the past year.  The genetics and mol. biol. of the various histol. subtypes of kidney cancer will be reviewed, as these subtle yet important genomic and metabolic alterations provide the opportunity for rational drug development and personalized treatment regimens.  Recent findings: Addnl. targeted agents continue to be added to the uro-oncologist's armamentarium in the fight against metastatic kidney cancer.  Targeting the vascular endothelial growth factor and its receptor, or the mammalian target of rapamycin complex, remains the foundation of systemic treatment.  In clear cell RCC, increased emphasis is being placed on target selectivity and affinity in a bid to diminish off-target toxicity without compromising efficacy.  Combination strategies targeting multiple pathways simultaneously continue to be explored.  Histol.-specific protocols testing later generation and novel agents in nonclear cell RCC should be made a priority, as there is still not a single drug approved specifically for a nonclear cell indication.  Summary: The no. of approved treatments for advanced RCC continues to grow, but addnl. work is needed to further delineate the optimal drug, combination of agents, or sequence best suited to each subtype of RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQcPAHufUgQrVg90H21EOLACvtfcHk0lgDFNoZnI6aug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ant7g%253D&md5=65474ecfd9debafb0d131954bc174ad2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1097%2FCCO.0b013e32835fc857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCCO.0b013e32835fc857%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DE.%2BA.%26aulast%3DGupta%26aufirst%3DG.%2BN.%26aulast%3DMarchalik%26aufirst%3DD.%26aulast%3DSrinivasan%26aufirst%3DR.%26atitle%3DEvolving%2520therapeutic%2520targets%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DCurr.%2520Opin.%2520Oncol.%26date%3D2013%26volume%3D25%26spage%3D273%26epage%3D280%26doi%3D10.1097%2FCCO.0b013e32835fc857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roelants, C.</span>; <span class="NLM_string-name">Giacosa, S.</span>; <span class="NLM_string-name">Duchemin-Pelletier, E.</span>; <span class="NLM_string-name">McLeer-Florin, A.</span>; <span class="NLM_string-name">Tisseyre, C.</span>; <span class="NLM_string-name">Aubert, C.</span>; <span class="NLM_string-name">Champelovier, P.</span>; <span class="NLM_string-name">Boutonnat, J.</span>; <span class="NLM_string-name">Descotes, J. L.</span>; <span class="NLM_string-name">Rambeaud, J.-J.</span>; <span class="NLM_string-name">Arnoux, V.</span>; <span class="NLM_string-name">Long, J.-A.</span>; <span class="NLM_string-name">Pasquier, D.</span>; <span class="NLM_string-name">Laramas, M.</span>; <span class="NLM_string-name">Kassem, M.</span>; <span class="NLM_string-name">David-Boudet, L.</span>; <span class="NLM_string-name">Schoutteten, L.</span>; <span class="NLM_string-name">Bestgen, B.</span>; <span class="NLM_string-name">Pillet, C.</span>; <span class="NLM_string-name">Cochet, C.</span>; <span class="NLM_string-name">Filhol, O.</span></span> <span> </span><span class="NLM_article-title">Dysregulated Expression of Protein Kinase CK2 in Renal Cancer</span>. In  <i>Protein Kinase CK2 Cellular Function in Normal and Disease States</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span>, <span class="NLM_string-name">Issinger, O.-G.</span>, <span class="NLM_string-name">Szyszka, R.</span></span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-14544-0_14</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2F978-3-319-14544-0_14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=241-257&author=C.+Roelants&author=S.+Giacosa&author=E.+Duchemin-Pelletier&author=A.+McLeer-Florin&author=C.+Tisseyre&author=C.+Aubert&author=P.+Champelovier&author=J.+Boutonnat&author=J.+L.+Descotes&author=J.-J.+Rambeaud&author=V.+Arnoux&author=J.-A.+Long&author=D.+Pasquier&author=M.+Laramas&author=M.+Kassem&author=L.+David-Boudet&author=L.+Schoutteten&author=B.+Bestgen&author=C.+Pillet&author=C.+Cochet&author=O.+Filholauthor=K.+Ahmed&author=O.-G.+Issinger&author=R.+Szyszka&title=Protein+Kinase+CK2+Cellular+Function+in+Normal+and+Disease+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-14544-0_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-14544-0_14%26sid%3Dliteratum%253Aachs%26aulast%3DRoelants%26aufirst%3DC.%26atitle%3DDysregulated%2520Expression%2520of%2520Protein%2520Kinase%2520CK2%2520in%2520Renal%2520Cancer%26btitle%3DProtein%2520Kinase%2520CK2%2520Cellular%2520Function%2520in%2520Normal%2520and%2520Disease%2520States%26aulast%3DAhmed%26aufirst%3DK.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2015%26spage%3D241%26epage%3D257%26doi%3D10.1007%2F978-3-319-14544-0_14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrigoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brustolon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1038/sj.cdd.4401604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fsj.cdd.4401604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=15818404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=668-677&author=G.+Di%0AMairaauthor=M.+Salviauthor=G.+Arrigoniauthor=O.+Marinauthor=S.+Sarnoauthor=F.+Brustolonauthor=L.+A.+Pinnaauthor=M.+Ruzzene&title=Protein+kinase+CK2+phosphorylates+and+upregulates+Akt%2FPKB&doi=10.1038%2Fsj.cdd.4401604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span></div><div class="casAuthors">Di Maira, G.; Salvi, M.; Arrigoni, G.; Marin, O.; Sarno, S.; Brustolon, F.; Pinna, L. A.; Ruzzene, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-677</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment of Jurkat cells with specific inhibitors of protein kinase CK2 induces apoptosis.  Here we provide evidence that the antiapoptotic effect of CK2 can be at least partially mediated by upregulation of the Akt/PKB pathway.  Such a conclusion is based on the following observations: (1) inhibition of CK2 by cell treatment with two structurally unrelated CK2 inhibitors induces downregulation of Akt/PKB, as judged from decreased phosphorylation of its physiol. targets, and immunoppt. kinase assay; (2) similar results are obsd. upon redn. of CK2 catalytic subunit by the RNA-interference technique; (3) Akt/PKB Ser129 is phosphorylated by CK2 in vitro and in vivo; (4) such a phosphorylation of activated Akt/PKB correlates with a further increase in catalytic activity.  These data disclose an unanticipated mechanism by which constitutive phosphorylation by CK2 may be required for maximal activation of Akt/PKB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEFAKQPYl_7Vg90H21EOLACvtfcHk0lic7lHtBlkq1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D&md5=04f583a966bd2ed26f315a2395370db9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401604%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DArrigoni%26aufirst%3DG.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DBrustolon%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26atitle%3DProtein%2520kinase%2520CK2%2520phosphorylates%2520and%2520upregulates%2520Akt%252FPKB%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26spage%3D668%26epage%3D677%26doi%3D10.1038%2Fsj.cdd.4401604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nika, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keezer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litchfield, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldape, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span> <span> </span><span class="NLM_article-title">EGF-induced ERK activation promotes CK2-mediated disassociation of α-catenin from β-catenin and transactivation of β-catenin</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.molcel.2009.09.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=547-559&author=H.+Jiauthor=J.+Wangauthor=H.+Nikaauthor=D.+Hawkeauthor=S.+Keezerauthor=Q.+Geauthor=B.+Fangauthor=X.+Fangauthor=D.+Fangauthor=D.+W.+Litchfieldauthor=K.+Aldapeauthor=Z.+Lu&title=EGF-induced+ERK+activation+promotes+CK2-mediated+disassociation+of+%CE%B1-catenin+from+%CE%B2-catenin+and+transactivation+of+%CE%B2-catenin&doi=10.1016%2Fj.molcel.2009.09.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DNika%26aufirst%3DH.%26aulast%3DHawke%26aufirst%3DD.%26aulast%3DKeezer%26aufirst%3DS.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DZ.%26atitle%3DEGF-induced%2520ERK%2520activation%2520promotes%2520CK2-mediated%2520disassociation%2520of%2520%25CE%25B1-catenin%2520from%2520%25CE%25B2-catenin%2520and%2520transactivation%2520of%2520%25CE%25B2-catenin%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D36%26spage%3D547%26epage%3D559%26doi%3D10.1016%2Fj.molcel.2009.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2005.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2005.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lic7lHtBlkq1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637%26doi%3D10.1016%2Fj.chembiol.2005.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allende, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allende, C. C.</span></span> <span> </span><span class="NLM_article-title">Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1096/fasebj.9.5.7896000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1096%2Ffasebj.9.5.7896000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=313-323&author=J.+E.+Allendeauthor=C.+C.+Allende&title=Protein+kinases.+4.+Protein+kinase+CK2%3A+an+enzyme+with+multiple+substrates+and+a+puzzling+regulation&doi=10.1096%2Ffasebj.9.5.7896000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.5.7896000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.5.7896000%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DJ.%2BE.%26aulast%3DAllende%26aufirst%3DC.%2BC.%26atitle%3DProtein%2520kinases.%25204.%2520Protein%2520kinase%2520CK2%253A%2520an%2520enzyme%2520with%2520multiple%2520substrates%2520and%2520a%2520puzzling%2520regulation%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D313%26epage%3D323%26doi%3D10.1096%2Ffasebj.9.5.7896000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt-Leopold, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Becelaere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tecle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltiel, A. R.</span></span> <span> </span><span class="NLM_article-title">Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1038/10533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2F10533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10395327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=810-816&author=J.+S.+Sebolt-Leopoldauthor=D.+T.+Dudleyauthor=R.+Herreraauthor=K.+Van+Becelaereauthor=A.+Wilandauthor=R.+C.+Gowanauthor=H.+Tecleauthor=S.+D.+Barrettauthor=A.+Bridgesauthor=S.+Przybranowskiauthor=W.+R.+Leopoldauthor=A.+R.+Saltiel&title=Blockade+of+the+MAP+kinase+pathway+suppresses+growth+of+colon+tumors+in+vivo&doi=10.1038%2F10533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo</span></div><div class="casAuthors">Sebolt-Leopold, Judith S.; Dudley, David T.; Herrera, Roman; Van Becelaere, Keri; Wiland, Amy; Gowan, Richard C.; Tecle, Haile; Barrett, Stephen D.; Bridges, Alexander; Przybranowski, Sally; Leopold, W. R.; Saltiel, Alan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">810-816</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase pathway is thought to be essential in cellular growth and differentiation.  Here we report the discovery of PD 184352 (2-(2-chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide), a highly potent and selective inhibitor of the upstream kinase MEK, that is orally active.  Tumor growth was inhibited as much as 80% in mice with colon carcinomas of both mouse and human origin after treatment with this inhibitor.  Efficacy was achieved with a wide range of doses with no signs of toxicity, and correlated with a redn. in the levels of activated mitogen-activated protein kinase in excised tumors.  These data indicate that MEK inhibitors represent a promising, noncytotoxic approach to the clin. management of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSoqGxnzGBrLVg90H21EOLACvtfcHk0lgoaDLBvMbQ9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCrs7k%253D&md5=16d2f88b7fcd82521e9ff4d8ca4342f6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2F10533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F10533%26sid%3Dliteratum%253Aachs%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%2BS.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DHerrera%26aufirst%3DR.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DWiland%26aufirst%3DA.%26aulast%3DGowan%26aufirst%3DR.%2BC.%26aulast%3DTecle%26aufirst%3DH.%26aulast%3DBarrett%26aufirst%3DS.%2BD.%26aulast%3DBridges%26aufirst%3DA.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26atitle%3DBlockade%2520of%2520the%2520MAP%2520kinase%2520pathway%2520suppresses%2520growth%2520of%2520colon%2520tumors%2520in%2520vivo%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D810%26epage%3D816%26doi%3D10.1038%2F10533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratilas, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt-Leopold, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span> <span> </span><span class="NLM_article-title">BRAF mutation predicts sensitivity to MEK inhibition</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>439</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1038/nature04304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnature04304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=16273091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2006&pages=358-362&author=D.+B.+Solitauthor=L.+A.+Garrawayauthor=C.+A.+Pratilasauthor=A.+Sawaiauthor=G.+Getzauthor=A.+Bassoauthor=Q.+Yeauthor=J.+M.+Loboauthor=Y.+Sheauthor=I.+Osmanauthor=T.+R.+Golubauthor=J.+Sebolt-Leopoldauthor=W.+R.+Sellersauthor=N.+Rosen&title=BRAF+mutation+predicts+sensitivity+to+MEK+inhibition&doi=10.1038%2Fnature04304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF mutation predicts sensitivity to MEK inhibition</span></div><div class="casAuthors">Solit, David B.; Garraway, Levi A.; Pratilas, Christine A.; Sawai, Ayana; Getz, Gad; Basso, Andrea; Ye, Qing; Lobo, Jose M.; She, Yuhong; Osman, Iman; Golub, Todd R.; Sebolt-Leopold, Judith; Sellers, William R.; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">7074</span>),
    <span class="NLM_cas:pages">358-362</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The kinase pathway comprising RAS, RAF, mitogen-activated protein kinase kinase (MEK) and extracellular signal regulated kinase (ERK) is activated in most human tumors, often through gain-of-function mutations of RAS and RAF family members.  Using small-mol. inhibitors of MEK and an integrated genetic and pharmacol. anal., we find that mutation of BRAF is assocd. with enhanced and selective sensitivity to MEK inhibition when compared to either 'wild-type' cells or cells harboring a RAS mutation.  This MEK dependency was obsd. in BRAF mutant cells regardless of tissue lineage, and correlated with both downregulation of cyclin D1 protein expression and the induction of G1 arrest.  Pharmacol. MEK inhibition completely abrogated tumor growth in BRAF mutant xenografts, whereas RAS mutant tumors were only partially inhibited.  These data suggest an exquisite dependency on MEK activity in BRAF mutant tumors, and offer a rational therapeutic strategy for this genetically defined tumor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpBpONOvd0vbVg90H21EOLACvtfcHk0lgoaDLBvMbQ9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvF2mtw%253D%253D&md5=37c8976aa5bb371ef5580aab2a91f89e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature04304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04304%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DPratilas%26aufirst%3DC.%2BA.%26aulast%3DSawai%26aufirst%3DA.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DLobo%26aufirst%3DJ.%2BM.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DBRAF%2520mutation%2520predicts%2520sensitivity%2520to%2520MEK%2520inhibition%26jtitle%3DNature%26date%3D2006%26volume%3D439%26spage%3D358%26epage%3D362%26doi%3D10.1038%2Fnature04304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 in health and disease: Cellular functions of protein kinase CK2: a dynamic affair</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1830</span>– <span class="NLM_lpage">1839</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-9151-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2Fs00018-009-9151-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19387551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1830-1839&author=O.+Filholauthor=C.+Cochet&title=Protein+kinase+CK2+in+health+and+disease%3A+Cellular+functions+of+protein+kinase+CK2%3A+a+dynamic+affair&doi=10.1007%2Fs00018-009-9151-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular functions of protein kinase CK2: a dynamic affair</span></div><div class="casAuthors">Filhol, O.; Cochet, C.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1830-1839</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 targets a vast array of substrates located in a no. of cellular compartments, making the challenge of discriminating among these substrates a daunting task.  However, as a signaling protein, CK2 could be targeted to different cellular compartments in response to various stress stimuli such as heat shock, UV irradn., hypoxia, DNA damage, and viral infections.  Here, the authors focus on evidence that the dynamic assocn. of CK2 subunits and the substrate-dependent subcellular targeting of the enzyme are a likely point of regulation in response to a variety of signaling events.  The authors propose that in addn. to enzymic substrate recognition, regulated CK2 localization to specific compartments should help to provide the exquisite specificity required for robust signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql95K9Q2RaMLVg90H21EOLACvtfcHk0lgv8Q3sd60gMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs70%253D&md5=460fb26b64bc1e38b37211606375b422</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9151-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9151-1%26sid%3Dliteratum%253Aachs%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520health%2520and%2520disease%253A%2520Cellular%2520functions%2520of%2520protein%2520kinase%2520CK2%253A%2520a%2520dynamic%2520affair%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D1830%26epage%3D1839%26doi%3D10.1007%2Fs00018-009-9151-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, G.</span>; <span class="NLM_string-name">Battistutta, R.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of CK2 Regulation by Autoinhibitory Oligomerization</span>. In  <i>Protein Kinase CK2 Cellular Function in Normal and Disease States</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K.</span>, <span class="NLM_string-name">Issinger, O.</span>, <span class="NLM_string-name">Szyszka, R.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">12</span>, pp  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-14544-0_3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2F978-3-319-14544-0_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=35-47&author=G.+Lolli&author=R.+Battistuttaauthor=K.+Ahmed&author=O.+Issinger&author=R.+Szyszka&title=Protein+Kinase+CK2+Cellular+Function+in+Normal+and+Disease+States"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-14544-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-14544-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DLolli%26aufirst%3DG.%26atitle%3DStructural%2520Basis%2520of%2520CK2%2520Regulation%2520by%2520Autoinhibitory%2520Oligomerization%26btitle%3DProtein%2520Kinase%2520CK2%2520Cellular%2520Function%2520in%2520Normal%2520and%2520Disease%2520States%26aulast%3DAhmed%26aufirst%3DK.%26pub%3DSpringer%26date%3D2015%26volume%3D12%26spage%3D35%26epage%3D47%26doi%3D10.1007%2F978-3-319-14544-0_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhowmik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, M. K.</span></span> <span> </span><span class="NLM_article-title">Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1725</span>– <span class="NLM_lpage">1734</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.cellsig.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=24726840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1725-1734&author=T.+Mandalauthor=A.+Bhowmikauthor=A.+Chatterjeeauthor=U.+Chatterjeeauthor=S.+Chatterjeeauthor=M.+K.+Ghosh&title=Reduced+phosphorylation+of+Stat3+at+Ser-727+mediated+by+casein+kinase+2+-+protein+phosphatase+2A+enhances+Stat3+Tyr-705+induced+tumorigenic+potential+of+glioma+cells&doi=10.1016%2Fj.cellsig.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - Protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells</span></div><div class="casAuthors">Mandal, Tapashi; Bhowmik, Arijit; Chatterjee, Anirban; Chatterjee, Uttara; Chatterjee, Sandip; Ghosh, Mrinal Kanti</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1725-1734</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Signal transducer and activator of transcription 3 (Stat3) is a transcription factor that is involved in cell survival and proliferation and has been found to be persistently activated in most human cancers mainly through its phosphorylation at Tyr-705.  However, the role and regulation of Stat3 Ser-727 phosphorylation in cancer cells have not been clearly evaluated.  In our findings, correlation studies on the expression of CK2 and Stat3 Ser-727 phosphorylation levels in human glioma patient samples as well as rat orthotopic tumor model show a degree of neg. correlation.  Moreover, brain tumor cell lines were treated with various pharmacol. inhibitors to inactivate the CK2 pathway.  Here, increased Stat3 Ser-727 phosphorylation upon CK2 inhibition was obsd.  Overexpression of CK2 (α, α' or β subunits) by transient transfection resulted in decreased Stat3 Ser-727 phosphorylation.  Stat3 Tyr-705 residue was conversely phosphorylated in similar situations.  Interestingly, we found PP2A, a protein phosphatase, to be a mediator in the neg. regulation of Stat3 Ser-727 phosphorylation by CK2.  In vitro assays prove that Ser-727 phosphorylation of Stat3 affects the transcriptional activity of its downstream targets like SOCS3, bcl-xl and Cyclin D1.  Stable cell lines constitutively expressing Stat3 S727A mutant showed increased survival, proliferation and invasion which are characteristics of a cancer cell.  Rat tumor models generated with the Stat3 S727A mutant cell line formed more aggressive tumors when compared to the Stat3 WT expressing stable cell line.  Thus, in glioma, reduced Stat3 Ser-727 phosphorylation enhances tumorigenicity which may be regulated in part by CK2-PP2A pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-XyYE5bbxHbVg90H21EOLACvtfcHk0lgv8Q3sd60gMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVartrk%253D&md5=28ecac000a9c855cc01a5cd52a516e41</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DT.%26aulast%3DBhowmik%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DU.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DM.%2BK.%26atitle%3DReduced%2520phosphorylation%2520of%2520Stat3%2520at%2520Ser-727%2520mediated%2520by%2520casein%2520kinase%25202%2520-%2520protein%2520phosphatase%25202A%2520enhances%2520Stat3%2520Tyr-705%2520induced%2520tumorigenic%2520potential%2520of%2520glioma%2520cells%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D1725%26epage%3D1734%26doi%3D10.1016%2Fj.cellsig.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancalion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubi, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colpo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappellesso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaffino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maggio, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, F.</span></span> <span> </span><span class="NLM_article-title">Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e75280</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0075280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1371%2Fjournal.pone.0075280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=24086494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOntLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=S.+Manniauthor=A.+Brancalionauthor=E.+Mandatoauthor=L.+Q.+Tubiauthor=A.+Colpoauthor=M.+Pizziauthor=R.+Cappellessoauthor=F.+Zaffinoauthor=S.+A.+Di+Maggioauthor=A.+Cabrelleauthor=F.+Marinoauthor=R.+Zambelloauthor=L.+Trentinauthor=F.+Adamiauthor=C.+Gurrieriauthor=G.+Semenzatoauthor=F.+Piazza&title=Protein+kinase+CK2+inhibition+down+modulates+the+NF-%CE%BAB+and+STAT3+survival+pathways%2C+enhances+the+cellular+proteotoxic+stress+and+synergistically+boosts+the+cytotoxic+effect+of+bortezomib+on+multiple+myeloma+and+mantle+cell+lymphoma+cells&doi=10.1371%2Fjournal.pone.0075280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 inhibition down modulates the NF-κB and Stat3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells</span></div><div class="casAuthors">Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Pizzi, Marco; Cappellesso, Rocco; Zaffino, Fortunato; Di Maggio, Speranza Antonia; Cabrelle, Anna; Marino, Filippo; Zambello, Renato; Trentin, Livio; Adami, Fausto; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e75280</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">CK2 is a pivotal pro-survival protein kinase in multiple myeloma that may likely impinge on bortezomib-regulated cellular pathways.  In the present study, we investigated CK2 expression in multiple myeloma and mantle cell lymphoma, two bortezomib-responsive B cell tumors, as well as its involvement in bortezomib-induced cytotoxicity and signaling cascades potentially mediating bortezomib resistance.  In both tumors, CK2 expression correlated with that of its activated targets NF-κB and STAT3 transcription factors.  Bortezomib-induced proliferation arrest and apoptosis were significantly amplified by the simultaneous inhibition of CK2 with two inhibitors (CX-4945 and K27) in multiple myeloma and mantle cell lymphoma cell lines, in a model of multiple myeloma bone marrow microenvironment and in cells isolated from patients.  CK2 inhibition empowered bortezomib-triggered mitochondrial-dependent cell death.  Phosphorylation of NF-κB p65 on Ser529 (a CK2 target site) and rise of the levels of the endoplasmic reticulum stress kinase/endoribonuclease Ire1α were markedly reduced upon CK2 inhibition, as were STAT3 phospho Ser727 levels.  On the contrary, CK2 inhibition increased phospho Ser51 eIF2α levels and enhanced the bortezomib-dependent accumulation of poly-ubiquitylated proteins and of the proteotoxic stress-assocd. chaperone Hsp70.  Our data suggest that CK2 over expression in multiple myeloma and mantle cell lymphoma cells might sustain survival signaling cascades and can antagonize bortezomib-induced apoptosis at different levels.  CK2 inhibitors could be useful in bortezomib-based combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfX_mz9rmfrLVg90H21EOLACvtfcHk0lhVVwBMp1B86g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOntLbN&md5=8360a9d311aa953f3353fe86ac54606f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0075280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0075280%26sid%3Dliteratum%253Aachs%26aulast%3DManni%26aufirst%3DS.%26aulast%3DBrancalion%26aufirst%3DA.%26aulast%3DMandato%26aufirst%3DE.%26aulast%3DTubi%26aufirst%3DL.%2BQ.%26aulast%3DColpo%26aufirst%3DA.%26aulast%3DPizzi%26aufirst%3DM.%26aulast%3DCappellesso%26aufirst%3DR.%26aulast%3DZaffino%26aufirst%3DF.%26aulast%3DDi%2BMaggio%26aufirst%3DS.%2BA.%26aulast%3DCabrelle%26aufirst%3DA.%26aulast%3DMarino%26aufirst%3DF.%26aulast%3DZambello%26aufirst%3DR.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DAdami%26aufirst%3DF.%26aulast%3DGurrieri%26aufirst%3DC.%26aulast%3DSemenzato%26aufirst%3DG.%26aulast%3DPiazza%26aufirst%3DF.%26atitle%3DProtein%2520kinase%2520CK2%2520inhibition%2520down%2520modulates%2520the%2520NF-%25CE%25BAB%2520and%2520STAT3%2520survival%2520pathways%252C%2520enhances%2520the%2520cellular%2520proteotoxic%2520stress%2520and%2520synergistically%2520boosts%2520the%2520cytotoxic%2520effect%2520of%2520bortezomib%2520on%2520multiple%2520myeloma%2520and%2520mantle%2520cell%2520lymphoma%2520cells%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0075280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonanni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioetto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrelle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span> <span> </span><span class="NLM_article-title">Multiple myeloma cell survival relies on high activity of protein kinase CK2</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1182/blood-2005-11-013672</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1182%2Fblood-2005-11-013672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=16684960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Slurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=1698-1707&author=F.+A.+Piazzaauthor=M.+Ruzzeneauthor=C.+Gurrieriauthor=B.+Montiniauthor=L.+Bonanniauthor=G.+Chioettoauthor=G.+Di+Mairaauthor=F.+Barbonauthor=A.+Cabrelleauthor=R.+Zambelloauthor=F.+Adamiauthor=L.+Trentinauthor=L.+A.+Pinnaauthor=G.+Semenzato&title=Multiple+myeloma+cell+survival+relies+on+high+activity+of+protein+kinase+CK2&doi=10.1182%2Fblood-2005-11-013672"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple myeloma cell survival relies on high activity of protein kinase CK2</span></div><div class="casAuthors">Piazza, Francesco A.; Ruzzene, Maria; Gurrieri, Carmela; Montini, Barbara; Bonanni, Luca; Chioetto, Gino; Di Maira, Giovanni; Barbon, Francesca; Cabrelle, Anna; Zambello, Renato; Adami, Fausto; Trentin, Livio; Pinna, Lorenzo A.; Semenzato, Gianpietro</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1698-1707</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Casein kinase 2 (CK2) is a ubiquitous cellular serine-threonine kinase that regulates relevant biol. processes, many of which are dysregulated in malignant plasma cells.  Here we investigated its role in multiple myeloma (MM).  Anal. of MM cell lines and highly purified malignant plasma cells in patients with MM revealed higher protein and CK2 activity levels than in controls (normal in vitro-generated polyclonal plasma cells and B lymphocytes).  The inhibition of CK2 with specific synthetic compds. or by means of RNA interference caused a cytotoxic effect on MM plasma cells that could not be overcome by IL-6 or IGF-I and that was assocd. with the activation with the activation of extrinsic and intrinsic caspase cascades.  CK2 blockage lowered the sensitivity threshold of MM plasma cells to the cytotoxic effect of melphalan.  CK2 inhibition also resulted in impaired IL-6-dependent STAT3 activation and in decreased basal and TNF-α-dependent IκBα degrdn. and NF-κB-driven transcription.  Our data show that CK2 was involved in the pathophysiol. of MM, suggesting that it might play a crucial role in controlling survival and sensitivity to chemotherapeutics of malignant plasma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKkI1sKi35X7Vg90H21EOLACvtfcHk0lhVVwBMp1B86g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Slurw%253D&md5=3b4e57e59d6479d916b5dfbf779fd6fc</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-11-013672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-11-013672%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DF.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DGurrieri%26aufirst%3DC.%26aulast%3DMontini%26aufirst%3DB.%26aulast%3DBonanni%26aufirst%3DL.%26aulast%3DChioetto%26aufirst%3DG.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DBarbon%26aufirst%3DF.%26aulast%3DCabrelle%26aufirst%3DA.%26aulast%3DZambello%26aufirst%3DR.%26aulast%3DAdami%26aufirst%3DF.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DSemenzato%26aufirst%3DG.%26atitle%3DMultiple%2520myeloma%2520cell%2520survival%2520relies%2520on%2520high%2520activity%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26spage%3D1698%26epage%3D1707%26doi%3D10.1182%2Fblood-2005-11-013672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrowolska, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, E. G.</span></span> <span> </span><span class="NLM_article-title">The physical association of casein kinase 2 with nucleolin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">15662</span>– <span class="NLM_lpage">15668</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.26.15662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1074%2Fjbc.271.26.15662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=15662-15668&author=D.+Liauthor=G.+Dobrowolskaauthor=E.+G.+Krebs&title=The+physical+association+of+casein+kinase+2+with+nucleolin&doi=10.1074%2Fjbc.271.26.15662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.26.15662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.26.15662%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DDobrowolska%26aufirst%3DG.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DThe%2520physical%2520association%2520of%2520casein%2520kinase%25202%2520with%2520nucleolin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D15662%26epage%3D15668%26doi%3D10.1074%2Fjbc.271.26.15662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderer, F. A.</span></span> <span> </span><span class="NLM_article-title">Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>969</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/0167-4889(88)90093-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2F0167-4889%2888%2990093-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=3280036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaL1cXhvValsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=969&publication_year=1988&pages=100-109&author=M.+Pfaffauthor=F.+A.+Anderer&title=Casein+kinase+II+accumulation+in+the+nucleolus+and+its+role+in+nucleolar+phosphorylation&doi=10.1016%2F0167-4889%2888%2990093-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation</span></div><div class="casAuthors">Pfaff, Martin; Anderer, F. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">969</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-9</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    </div><div class="casAbstract">A rabbit antiserum against highly purified casein kinase II from mouse tumor cells was used for immunolocalization of the enzyme in fixed, permeabilized mouse cells.  Casein kinase II was highly accumulated in nucleoli compared to the extranucleolar space of the nucleus or to the cytoplasm.  Casein kinase II samples highly purified from the cytoplasm, from the extranucleolar fraction of the nucleus, or from nucleoli exhibited no differences with respect to structure and function.  All samples originally had an α2β2 structure [α, 42 kilodaltons (kDa); β, 24 kDa], showing formation of the α'-chain (36 kDa) only in the late steps of purifn.  The pI of the α-chain of all 3 samples was 7.7 and that of the β-chain was 6.4-6.6.  With ATP or GTP, all 3 casein kinase II samples gave the same results of max. phosphorylation of purified nucleolar marker phosphoproteins pp105/C23, pp135, and B23, yielding pp135 as one of the most highly phosphorylated proteins with an incorporation of ∼75 phosphate groups/mol. pp135.  Studies on optimum conditions of phosphorylation of nucleolar phosphoproteins by casein kinase II revealed that each of the protein substrates individually responded to alterations of assay parameters such as pH and concns. of Mg2+ and NaCl, indicating that predominantly individual structural criteria were responsible for optimum phosphorylation.  The detn. of the apparent Km of casein kinase II for purified nucleolar phosphoproteins yielded values of 0.15 μM (pp105/C23), 0.1 μM (pp135), and 1.0 μM (B23), identifying them as high-affinity substrates of casein kinase II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof5BbIsQayerVg90H21EOLACvtfcHk0lh2YQudEisUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvValsb4%253D&md5=fc0dda6f7c622db7faee1d086b7ded99</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0167-4889%2888%2990093-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4889%252888%252990093-6%26sid%3Dliteratum%253Aachs%26aulast%3DPfaff%26aufirst%3DM.%26aulast%3DAnderer%26aufirst%3DF.%2BA.%26atitle%3DCasein%2520kinase%2520II%2520accumulation%2520in%2520the%2520nucleolus%2520and%2520its%2520role%2520in%2520nucleolar%2520phosphorylation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D1988%26volume%3D969%26spage%3D100%26epage%3D109%26doi%3D10.1016%2F0167-4889%2888%2990093-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreyer, C.</span></span> <span> </span><span class="NLM_article-title">Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin</span>. <i>Eur. J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=9270871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVyktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1997&pages=287-297&author=M.+S.+Schwabauthor=C.+Dreyer&title=Protein+phosphorylation+sites+regulate+the+function+of+the+bipartite+NLS+of+nucleolin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin</span></div><div class="casAuthors">Schwab, Markus S.; Dreyer, Christine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">EJCBDN</span>;
        ISSN:<span class="NLM_cas:issn">0171-9335</span>.
    
            (<span class="NLM_cas:orgname">Wissenschaftliche Verlagsgesellschaft</span>)
        </div><div class="casAbstract">Nucleolin is a major component of the nucleolus.  In Xenopus laevis, a maternal store of nucleolin is accumulated in the multiple nucleoli generated during oogenesis.  This maternal nucleolin is distributed throughout the cytoplasm of the egg during oocyte maturation and after fertilization it is gradually reaccumulated in the nuclei of the embryo.  Cytoplasmic localization of nucleolin coincides with massive phosphorylation by p34cdc2 kinase, and nuclear translocation is accompanied by net dephosphorylation.  Multiple phosphorylation consensus sites for the cell cycle-dependent p34cdc2 kinase and for protein kinase CK2 are clustered in the N-terminal domain of nucleolin.  To assess the efficiency of the bipartite nuclear localization signal, fusion proteins were constructed consisting of maltose binding protein (MBP) and the nuclear localization signal of nucleolin.  In addn., either an acidic domain of nucleolin without phosphorylation sites, or an acidic domain contg. 4 CK2 sites, or a cluster of 5 cdc2 sites was fused to the MBP-nuclear localization signal (MBP-NLS).  Nuclear translocation of these constructs was tested in an in vitro system consisting of Xenopus egg ext. and sperm nuclei.  Nuclear targetting of MBP by the bipartite nuclear localization signal of nucleolin became more efficient after addn. of either CK2 sites or cdc2 sites to the MBP-NLS construct.  Yet the cdc2 sites play a dual role.  They enhance nuclear translocation exclusively in their dephosphorylated state and promote cytoplasmic localization when phosphorylated, thereby providing a powerful cell cycle-dependent regulatory element of the nuclear localization signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoShFjXIY2oGLVg90H21EOLACvtfcHk0lh2YQudEisUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVyktbo%253D&md5=5bc8211fed444c7c061c4e1ca1c11ba2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DM.%2BS.%26aulast%3DDreyer%26aufirst%3DC.%26atitle%3DProtein%2520phosphorylation%2520sites%2520regulate%2520the%2520function%2520of%2520the%2520bipartite%2520NLS%2520of%2520nucleolin%26jtitle%3DEur.%2520J.%2520Cell%2520Biol.%26date%3D1997%26volume%3D73%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wales, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochrein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyn, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banu
Ozkan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithgall, T. E.</span></span> <span> </span><span class="NLM_article-title">Structure and dynamic regulation of Src-family kinases</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">3058</span>– <span class="NLM_lpage">3073</span>, <span class="refDoi"> DOI: 10.1007/s00018-008-8122-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2Fs00018-008-8122-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18563293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOjtrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=3058-3073&author=J.+R.+Engenauthor=T.+E.+Walesauthor=J.+M.+Hochreinauthor=M.+A.+Meynauthor=S.+Banu%0AOzkanauthor=I.+Baharauthor=T.+E.+Smithgall&title=Structure+and+dynamic+regulation+of+Src-family+kinases&doi=10.1007%2Fs00018-008-8122-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and dynamic regulation of Src-family kinases</span></div><div class="casAuthors">Engen, J. R.; Wales, T. E.; Hochrein, J. M.; Meyn, M. A., III; Banu Ozkan, S.; Bahar, I.; Smithgall, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3058-3073</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Src-family kinases are modular signaling proteins involved in a diverse array of cellular processes.  All members of the Src family share the same domain organization, with modular SH3, SH2, and kinase domains followed by a C-terminal neg. regulatory tail.  X-ray crystallog. analyses of several Src family members have revealed crit. roles for the SH3 and SH2 domains in the down-regulation of the kinase domain.  Here, the authors focus on biol., biophys., and computational studies that reveal conformationally distinct active states within this unique kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoh3f-1iz9LVg90H21EOLACvtfcHk0lh2YQudEisUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOjtrjO&md5=0f3fed01f1c5bc97d511ab5bfce7bffb</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8122-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8122-2%26sid%3Dliteratum%253Aachs%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWales%26aufirst%3DT.%2BE.%26aulast%3DHochrein%26aufirst%3DJ.%2BM.%26aulast%3DMeyn%26aufirst%3DM.%2BA.%26aulast%3DBanu%2BOzkan%26aufirst%3DS.%26aulast%3DBahar%26aufirst%3DI.%26aulast%3DSmithgall%26aufirst%3DT.%2BE.%26atitle%3DStructure%2520and%2520dynamic%2520regulation%2520of%2520Src-family%2520kinases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D3058%26epage%3D3073%26doi%3D10.1007%2Fs00018-008-8122-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeliger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastwood, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">A conserved protonation-dependent switch controls drug binding in the Abl kinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1073/pnas.0811223106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1073%2Fpnas.0811223106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=19109437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltF2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=139-144&author=Y.+Shanauthor=M.+A.+Seeligerauthor=M.+P.+Eastwoodauthor=F.+Frankauthor=H.+Xuauthor=M.+Jensenauthor=R.+O.+Drorauthor=J.+Kuriyanauthor=D.+E.+Shaw&title=A+conserved+protonation-dependent+switch+controls+drug+binding+in+the+Abl+kinase&doi=10.1073%2Fpnas.0811223106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved protonation-dependent switch controls drug binding in the Abl kinase</span></div><div class="casAuthors">Shan, Yibing; Seeliger, Markus A.; Eastwood, Michael P.; Frank, Filipp; Xu, Huafeng; Jensen, Morten O.; Dror, Ron O.; Kuriyan, John; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-144</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In many protein kinases, a characteristic conformational change (the "DFG flip") connects catalytically active and inactive conformations.  Many kinase inhibitors - including the cancer drug imatinib - selectively target a specific DFG conformation, but the function and mechanism of the flip remain unclear.  Using long mol. dynamics (MD) simulations of the Abl kinase, we visualized the DFG flip in at.-level detail and formulated an energetic model predicting that protonation of the DFG aspartate controls the flip.  Consistent with our model's predictions, we demonstrated exptl. that the kinetics of imatinib binding to Abl kinase have a pH dependence that disappears when the DFG aspartate is mutated.  Our model suggests a possible explanation for the high degree of conservation of the DFG motif: that the flip, modulated by electrostatic changes inherent to the catalytic cycle, allows the kinase to access flexible conformations facilitating nucleotide binding and release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof7hx2l1lxt7Vg90H21EOLACvtfcHk0ljOn0mzahNu1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltF2ntg%253D%253D&md5=73e6156334ecf731cb1f5e535cd7f978</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0811223106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0811223106%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DY.%26aulast%3DSeeliger%26aufirst%3DM.%2BA.%26aulast%3DEastwood%26aufirst%3DM.%2BP.%26aulast%3DFrank%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DM.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DA%2520conserved%2520protonation-dependent%2520switch%2520controls%2520drug%2520binding%2520in%2520the%2520Abl%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D139%26epage%3D144%26doi%3D10.1073%2Fpnas.0811223106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasio, F. L.</span></span> <span> </span><span class="NLM_article-title">The effect of a widespread cancer-causing mutation on the inactive to active dynamics of the B-Raf kinase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">5280</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b01421</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b01421" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=5280-5283&author=K.+A.+Marinoauthor=L.+Suttoauthor=F.+L.+Gervasio&title=The+effect+of+a+widespread+cancer-causing+mutation+on+the+inactive+to+active+dynamics+of+the+B-Raf+kinase&doi=10.1021%2Fjacs.5b01421"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b01421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b01421%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DK.%2BA.%26aulast%3DSutto%26aufirst%3DL.%26aulast%3DGervasio%26aufirst%3DF.%2BL.%26atitle%3DThe%2520effect%2520of%2520a%2520widespread%2520cancer-causing%2520mutation%2520on%2520the%2520inactive%2520to%2520active%2520dynamics%2520of%2520the%2520B-Raf%2520kinase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D5280%26epage%3D5283%26doi%3D10.1021%2Fjacs.5b01421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morando, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucheta-Martinez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Torrecuadrada, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saladino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasio, F. L.</span></span> <span> </span><span class="NLM_article-title">Towards a molecular understanding of the link between imatinib resistance and kinase conformational dynamics</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e1004578</span> <span class="refDoi"> DOI: 10.1371/journal.pcbi.1004578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1371%2Fjournal.pcbi.1004578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=26606374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlGlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&author=S.+Loveraauthor=M.+Morandoauthor=E.+Pucheta-Martinezauthor=J.+L.+Martinez-Torrecuadradaauthor=G.+Saladinoauthor=F.+L.+Gervasio&title=Towards+a+molecular+understanding+of+the+link+between+imatinib+resistance+and+kinase+conformational+dynamics&doi=10.1371%2Fjournal.pcbi.1004578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a molecular understanding of the link between imatinib resistance and kinase conformational dynamics</span></div><div class="casAuthors">Lovera, Silvia; Morando, Maria; Pucheta-Martinez, Encarna; Martinez-Torrecuadrada, Jorge L.; Saladino, Giorgio; Gervasio, Francesco L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1004578/1-e1004578/19</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Due to its inhibition of the Abl kinase domain in the BCR-ABL fusion protein, imatinib is strikingly effective in the initial stage of chronic myeloid leukemia with more than 90% of the patients showing complete remission.  However, as in the case of most targeted anticancer therapies, the emergence of drug resistance is a serious concern.  Several drugresistant mutations affecting the catalytic domain of Abl and other tyrosine kinases are now known.  But, despite their importance and the adverse effect that they have on the prognosis of the cancer patients harboring them, the mol. mechanism of these mutations is still debated.  Here by using long mol. dynamics simulations and large-scale free energy calcns. complemented by in vitro mutagenesis and microcalorimetry expts., we model the effect of several widespread drug-resistant mutations of Abl.  By comparing the conformational free energy landscape of the mutants with those of the wild-type tyrosine kinases we clarify their mode of action.  It involves significant and complex changes in the inactive-to-active dynamics and entropy/enthalpy balance of two functional elements: the activation-loop and the conserved DFG motif.What is more the T315I gatekeeper mutant has a significant impact on the binding mechanism itself and on the binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ZlGqINU3t7Vg90H21EOLACvtfcHk0ljOn0mzahNu1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlGlurc%253D&md5=43300d858e4e11207b8ac4f10dfc2450</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1004578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1004578%26sid%3Dliteratum%253Aachs%26aulast%3DLovera%26aufirst%3DS.%26aulast%3DMorando%26aufirst%3DM.%26aulast%3DPucheta-Martinez%26aufirst%3DE.%26aulast%3DMartinez-Torrecuadrada%26aufirst%3DJ.%2BL.%26aulast%3DSaladino%26aufirst%3DG.%26aulast%3DGervasio%26aufirst%3DF.%2BL.%26atitle%3DTowards%2520a%2520molecular%2520understanding%2520of%2520the%2520link%2520between%2520imatinib%2520resistance%2520and%2520kinase%2520conformational%2520dynamics%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2015%26volume%3D11%26doi%3D10.1371%2Fjournal.pcbi.1004578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmanouilidi, A.</span>; <span class="NLM_string-name">Falasca, M.</span></span> <span> </span><span class="NLM_article-title">3-Phosphoinositide-Dependent Kinase 1 (PDK1)</span>. In  <i>Encyclopedia of Signaling Molecules</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-67199-4_101748</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1007%2F978-3-319-67199-4_101748" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=1-4&author=A.+Emmanouilidi&author=M.+Falascaauthor=S.+Choi&title=Encyclopedia+of+Signaling+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-67199-4_101748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-67199-4_101748%26sid%3Dliteratum%253Aachs%26aulast%3DEmmanouilidi%26aufirst%3DA.%26atitle%3D3-Phosphoinositide-Dependent%2520Kinase%25201%2520%2528PDK1%2529%26btitle%3DEncyclopedia%2520of%2520Signaling%2520Molecules%26aulast%3DChoi%26aufirst%3DS.%26pub%3DSpringer%26date%3D2017%26spage%3D1%26epage%3D4%26doi%3D10.1007%2F978-3-319-67199-4_101748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyphers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruff, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behr, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chodera, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, N. M.</span></span> <span> </span><span class="NLM_article-title">A water-mediated allosteric network governs activation of Aurora kinase A</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1038%2Fnchembio.2296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=28166210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2hsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=402-408&author=S.+Cyphersauthor=E.+F.+Ruffauthor=J.+M.+Behrauthor=J.+D.+Choderaauthor=N.+M.+Levinson&title=A+water-mediated+allosteric+network+governs+activation+of+Aurora+kinase+A&doi=10.1038%2Fnchembio.2296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A water-mediated allosteric network governs activation of Aurora kinase A</span></div><div class="casAuthors">Cyphers, Soreen; Ruff, Emily F.; Behr, Julie M.; Chodera, John D.; Levinson, Nicholas M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-408</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The catalytic activity of many protein kinases is controlled by conformational changes of a conserved Asp-Phe-Gly (DFG) motif.  Here, the authors used an IR probe to track the DFG motif of mitotic Aurora-A kinase (AurA) and found that allosteric activation by spindle-assocd. protein Tpx2 involves an equil. shift toward the active DFG-in state.  FRET expts. showed that the activation loop underwent a nanometer-scale movement that was tightly coupled to the DFG equil.  Tpx2 further activated AurA by stabilizing a water-mediated allosteric network that links the C-helix to the active site through an unusual polar residue in the regulatory spine.  The polar spine residue and water network of AurA were essential for phosphorylation-driven activation, but an alternative form of the water network found in related kinases could support Tpx2-driven activation, suggesting that variations in the water-mediated H-bond network-mediated regulatory diversification in protein kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ1smGynvpv7Vg90H21EOLACvtfcHk0ljXV29iyOZLQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2hsLg%253D&md5=d9ccdb368be8b3c367a94990280c8a52</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2296%26sid%3Dliteratum%253Aachs%26aulast%3DCyphers%26aufirst%3DS.%26aulast%3DRuff%26aufirst%3DE.%2BF.%26aulast%3DBehr%26aufirst%3DJ.%2BM.%26aulast%3DChodera%26aufirst%3DJ.%2BD.%26aulast%3DLevinson%26aufirst%3DN.%2BM.%26atitle%3DA%2520water-mediated%2520allosteric%2520network%2520governs%2520activation%2520of%2520Aurora%2520kinase%2520A%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D402%26epage%3D408%26doi%3D10.1038%2Fnchembio.2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, E.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Aurora-A activation by TPX2 at the mitotic spindle</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(03)00392-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2FS1097-2765%2803%2900392-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=851-862&author=R.+Baylissauthor=T.+Sardonauthor=I.+Vernosauthor=E.+Conti&title=Structural+basis+of+Aurora-A+activation+by+TPX2+at+the+mitotic+spindle&doi=10.1016%2FS1097-2765%2803%2900392-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900392-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900392-7%26sid%3Dliteratum%253Aachs%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DSardon%26aufirst%3DT.%26aulast%3DVernos%26aufirst%3DI.%26aulast%3DConti%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520of%2520Aurora-A%2520activation%2520by%2520TPX2%2520at%2520the%2520mitotic%2520spindle%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26spage%3D851%26epage%3D862%26doi%3D10.1016%2FS1097-2765%2803%2900392-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truchet, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brethenou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amalric, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouche, G.</span></span> <span> </span><span class="NLM_article-title">Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">24781</span>– <span class="NLM_lpage">24787</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.40.24781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1074%2Fjbc.271.40.24781" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=24781-24787&author=H.+Bonnetauthor=O.+Filholauthor=I.+Truchetauthor=P.+Brethenouauthor=C.+Cochetauthor=F.+Amalricauthor=G.+Bouche&title=Fibroblast+growth+factor-2+binds+to+the+regulatory+beta+subunit+of+CK2+and+directly+stimulates+CK2+activity+toward+nucleolin&doi=10.1074%2Fjbc.271.40.24781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.40.24781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.40.24781%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DH.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DTruchet%26aufirst%3DI.%26aulast%3DBrethenou%26aufirst%3DP.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DAmalric%26aufirst%3DF.%26aulast%3DBouche%26aufirst%3DG.%26atitle%3DFibroblast%2520growth%2520factor-2%2520binds%2520to%2520the%2520regulatory%2520beta%2520subunit%2520of%2520CK2%2520and%2520directly%2520stimulates%2520CK2%2520activity%2520toward%2520nucleolin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D24781%26epage%3D24787%26doi%3D10.1074%2Fjbc.271.40.24781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotlyar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span> <span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7512</span>– <span class="NLM_lpage">7515</span>, <span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0ljHWdgLifzlxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pravst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavber, S.</span></span> <span> </span><span class="NLM_article-title">Halogenation of ketones with N-halosuccinimides under solvent-free reaction conditions</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">5191</span>– <span class="NLM_lpage">5199</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2008.03.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.tet.2008.03.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=5191-5199&author=I.+Pravstauthor=M.+Zupanauthor=S.+Stavber&title=Halogenation+of+ketones+with+N-halosuccinimides+under+solvent-free+reaction+conditions&doi=10.1016%2Fj.tet.2008.03.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Halogenation of ketones with N-halosuccinimides under solvent-free reaction conditions</span></div><div class="casAuthors">Pravst, Igor; Zupan, Marko; Stavber, Stojan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5191-5199</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several aryl substituted ketones, cyclic ketones, 1,3-diketones and a β-ketoamide were halogenated with N-halosuccinimides under solvent-free reaction conditions (SFRC) at various temps. (20-80 °C), whereas less enolized ketones required the presence of an acid catalyst (p-toluenesulfonic acid, PTSA).  Bromination of substituted acetophenones obeys first order kinetics v=kBr[ketone] and the following correlation with the keto-enol equil. const.: log kBr = 0.3pKE + C1, less enolized substrates being more reactive; the moderate pos. charge developed in the rate detg. step was confirmed by the Hammett correlation (ρ=-0.5).  On the other hand, in cyclic ketones an opposite relation was obsd.: log kBr = -0.6pKE + C2, indicating higher reactivity of substrates with higher enolization const. (KE).  The important role of the nature of the solvent (MeCN, MeOH) in preorganization of the ketone-NBS-PTSA mixt. prior to SFRC bromination was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo35JXYLNG53LVg90H21EOLACvtfcHk0ljHWdgLifzlxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSntLo%253D&md5=aad1479063c77f95515b962d7e89c80d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2008.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2008.03.048%26sid%3Dliteratum%253Aachs%26aulast%3DPravst%26aufirst%3DI.%26aulast%3DZupan%26aufirst%3DM.%26aulast%3DStavber%26aufirst%3DS.%26atitle%3DHalogenation%2520of%2520ketones%2520with%2520N-halosuccinimides%2520under%2520solvent-free%2520reaction%2520conditions%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D5191%26epage%3D5199%26doi%3D10.1016%2Fj.tet.2008.03.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulangiappar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulandainathan, M. A.</span></span> <span> </span><span class="NLM_article-title">Convenient electrochemical method for the synthesis of α-bromo alkyl aryl ketones</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1736</span>– <span class="NLM_lpage">1742</span>, <span class="refDoi"> DOI: 10.1080/00397910903161710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1080%2F00397910903161710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=1736-1742&author=R.+S.+Kumarauthor=K.+Kulangiapparauthor=M.+A.+Kulandainathan&title=Convenient+electrochemical+method+for+the+synthesis+of+%CE%B1-bromo+alkyl+aryl+ketones&doi=10.1080%2F00397910903161710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient electrochemical method for the synthesis of α-bromo alkyl aryl ketones</span></div><div class="casAuthors">Kumar, R. Senthil; Kulangiappar, K.; Kulandainathan, M. Anbu</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1736-1742</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">An electrochem. procedure for the effective α-bromination of alkyl aryl ketones in excellent yield was reported.  The simple exptl. procedure, catalyst-free conversion, and excellent yield of mono-brominated products are the advantages of this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRc4QUrbBO77Vg90H21EOLACvtfcHk0ljHWdgLifzlxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCntbw%253D&md5=e211ad0b8c822a1d685d265189c6319d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1080%2F00397910903161710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910903161710%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%2BS.%26aulast%3DKulangiappar%26aufirst%3DK.%26aulast%3DKulandainathan%26aufirst%3DM.%2BA.%26atitle%3DConvenient%2520electrochemical%2520method%2520for%2520the%2520synthesis%2520of%2520%25CE%25B1-bromo%2520alkyl%2520aryl%2520ketones%26jtitle%3DSynth.%2520Commun.%26date%3D2010%26volume%3D40%26spage%3D1736%26epage%3D1742%26doi%3D10.1080%2F00397910903161710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borowitz, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnes, H.</span></span> <span> </span><span class="NLM_article-title">Kinetics and mechanism of the reaction of triphenylphosphine with alpha-haloacetophenones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3560</span>– <span class="NLM_lpage">3564</span>, <span class="refDoi"> DOI: 10.1021/jo01286a060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01286a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=3560-3564&author=I.+J.+Borowitzauthor=H.+Parnes&title=Kinetics+and+mechanism+of+the+reaction+of+triphenylphosphine+with+alpha-haloacetophenones&doi=10.1021%2Fjo01286a060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjo01286a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01286a060%26sid%3Dliteratum%253Aachs%26aulast%3DBorowitz%26aufirst%3DI.%2BJ.%26aulast%3DParnes%26aufirst%3DH.%26atitle%3DKinetics%2520and%2520mechanism%2520of%2520the%2520reaction%2520of%2520triphenylphosphine%2520with%2520alpha-haloacetophenones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D3560%26epage%3D3564%26doi%3D10.1021%2Fjo01286a060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirichenko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogovoy, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kister, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of mono- and N,N-disubstituted thioureas and N-acylthioureas</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>, (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1799</span>– <span class="NLM_lpage">1805</span>, <span class="refDoi"> DOI: 10.1055/s-2004-829127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1055%2Fs-2004-829127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1799-1805&issue=11&author=A.+R.+Katritzkyauthor=N.+Kirichenkoauthor=B.+V.+Rogovoyauthor=J.+Kisterauthor=H.+Tao&title=Synthesis+of+mono-+and+N%2CN-disubstituted+thioureas+and+N-acylthioureas&doi=10.1055%2Fs-2004-829127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of mono- and N,N-disubstituted thioureas and N-acylthioureas</span></div><div class="casAuthors">Katritzky, Alan R.; Kirichenko, Nataliya; Rogovoy, Boris V.; Kister, Jeremy; Tao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1799-1805</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">1-Benzotriazole-1-carbothioamide, prepd. from 1-cyanobenzotriazole and hydrogen sulfide, reacts with amines to give thioureas R1NR2CSNH2 (R1 = MeOC6H4, Bn, pyrrolidinyl, Ph, PhNH; R2 = H, Bn).  Reactions of (benzotriazol-1-yl)carboximidamides and acyl- or arylaminocarbonyl(benzotriazol-1-yl)carboximidamides with hydrogen sulfide give the corresponding thioureas, N-acylthioureas, or N-carbamoylthioureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8squ9HXgX2rVg90H21EOLACvtfcHk0ljSmE7KN6S7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeisLk%253D&md5=fbc625fdd9d1b689ec39889d04df507b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1055%2Fs-2004-829127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2004-829127%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DKirichenko%26aufirst%3DN.%26aulast%3DRogovoy%26aufirst%3DB.%2BV.%26aulast%3DKister%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520mono-%2520and%2520N%252CN-disubstituted%2520thioureas%2520and%2520N-acylthioureas%26jtitle%3DSynthesis%26date%3D2004%26issue%3D11%26spage%3D1799%26epage%3D1805%26doi%3D10.1055%2Fs-2004-829127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha-Sircar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, K. K.</span></span> <span> </span><span class="NLM_article-title">Preparation of antibacterials from organomercurials</span>. <i>J. Indian Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADyaG3MXjtlyltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1950&pages=535-538&author=S.+Guha-Sircarauthor=K.+K.+Patnaik&title=Preparation+of+antibacterials+from+organomercurials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of antibacterials from organomercurials. II</span></div><div class="casAuthors">Guha-Sircar, S. S.; Patnaik, Khirod Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Indian Chemical Society</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">535-8</span>CODEN:
                <span class="NLM_cas:coden">JICSAH</span>;
        ISSN:<span class="NLM_cas:issn">0019-4522</span>.
    </div><div class="casAbstract">cf. C.A. 45, 3997i.  Carboxyphenylureas (I) were prepd. by adding 1 mol. KNCO to a soln. of 1 mol. H2NC6H4CO2H in hot water.  I were purified by pptg. their solns. in NaOH with AcOH and crystg. from alc.  The m.ps. of I are: ο- 294°; m- 265°; p- softens 180° then solidifies.  Hg derivs. of I were not obtained pure.  Phenyl-, tolyl-, and m-nitrophenylurea with equimol. amts. of (AcO)2Hg in dil. AcOH give the mono-Hg derivs., probably in the p-position, 2-naphthylurea (II) gives a mixt. of mono- and di-Hg compd., sepd. by crystn. from AcOH; 1-naphthylurea (III) gives only the di-Hg compd.  The following monoacetoxymercuri compds. and their decompn. temps. are given: phenylurea 125°; tolylurea, ο- 200°, m- 215°, p-238°; chlorophenylurea, ο- 158°, m- 163°, p- (IV) 172°; II, 182°; m-nitrophenylurea 202°; m-carboxyphenylurea 256°; p-carboxyphenylurea 270°; diacetoxymercuri compds.: II 284°; III 210°.  Carboxyphenylthioureas (V), m. ο-181°, m-185°, p-194°.  On mercuration one obtains the di-Hg derivs. of phenyl- and tolylthioureas and the mono-Hg derivs. of V.  The mercurated phenylthioureas are unstable to heat and light and were not tested for bactericidal action; the diacetoxymercuric compds. of III and IV have high activity against Bacillus coli, and may be useful for paper, glue, and leather industries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn14cCnsQcoLVg90H21EOLACvtfcHk0ljSmE7KN6S7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3MXjtlyltA%253D%253D&md5=78a4ae8866922b5449ab2f54cff3c72d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuha-Sircar%26aufirst%3DS.%26aulast%3DPatnaik%26aufirst%3DK.%2BK.%26atitle%3DPreparation%2520of%2520antibacterials%2520from%2520organomercurials%26jtitle%3DJ.%2520Indian%2520Chem.%2520Soc.%26date%3D1950%26volume%3D27%26spage%3D535%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcotte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">4-Pyridylanilinothiazoles that selectively target von Hippel–Lindau deficient renal cell carcinoma cells by inducing autophagic cell death</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">797</span>, <span class="refDoi"> DOI: 10.1021/jm901457w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901457w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=787-797&author=M.+P.+Hayauthor=S.+Turcotteauthor=J.+U.+Flanaganauthor=M.+Bonnetauthor=D.+A.+Chanauthor=P.+D.+Sutphinauthor=P.+Nguyenauthor=A.+J.+Giacciaauthor=W.+A.+Denny&title=4-Pyridylanilinothiazoles+that+selectively+target+von+Hippel%E2%80%93Lindau+deficient+renal+cell+carcinoma+cells+by+inducing+autophagic+cell+death&doi=10.1021%2Fjm901457w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm901457w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901457w%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DM.%2BP.%26aulast%3DTurcotte%26aufirst%3DS.%26aulast%3DFlanagan%26aufirst%3DJ.%2BU.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DSutphin%26aufirst%3DP.%2BD.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D4-Pyridylanilinothiazoles%2520that%2520selectively%2520target%2520von%2520Hippel%25E2%2580%2593Lindau%2520deficient%2520renal%2520cell%2520carcinoma%2520cells%2520by%2520inducing%2520autophagic%2520cell%2520death%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D787%26epage%3D797%26doi%3D10.1021%2Fjm901457w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seligman, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bost, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, R. L.</span></span> <span> </span><span class="NLM_article-title">Some derivatives of <i>p</i>-aminosalicylic acid</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">6334</span>– <span class="NLM_lpage">6335</span>, <span class="refDoi"> DOI: 10.1021/ja01120a533</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01120a533" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1953&pages=6334-6335&author=R.+B.+Seligmanauthor=R.+W.+Bostauthor=R.+L.+McKee&title=Some+derivatives+of+p-aminosalicylic+acid&doi=10.1021%2Fja01120a533"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fja01120a533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01120a533%26sid%3Dliteratum%253Aachs%26aulast%3DSeligman%26aufirst%3DR.%2BB.%26aulast%3DBost%26aufirst%3DR.%2BW.%26aulast%3DMcKee%26aufirst%3DR.%2BL.%26atitle%3DSome%2520derivatives%2520of%2520p-aminosalicylic%2520acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1953%26volume%3D75%26spage%3D6334%26epage%3D6335%26doi%3D10.1021%2Fja01120a533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prudent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moucadel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafanechère, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasenknopf, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bareyt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacôte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorimbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malacria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouzerh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2008.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1016%2Fj.chembiol.2008.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=18635005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=683-692&author=R.+Prudentauthor=V.+Moucadelauthor=B.+Laudetauthor=C.+Baretteauthor=L.+Lafanech%C3%A8reauthor=B.+Hasenknopfauthor=J.+Liauthor=S.+Bareytauthor=E.+Lac%C3%B4teauthor=S.+Thorimbertauthor=M.+Malacriaauthor=P.+Gouzerhauthor=C.+Cochet&title=Identification+of+polyoxometalates+as+nanomolar+noncompetitive+inhibitors+of+protein+kinase+CK2&doi=10.1016%2Fj.chembiol.2008.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Polyoxometalates as Nanomolar Noncompetitive Inhibitors of Protein Kinase CK2</span></div><div class="casAuthors">Prudent, Renaud; Moucadel, Virginie; Laudet, Beatrice; Barette, Caroline; Lafanechere, Laurence; Hasenknopf, Bernold; Li, Joaquim; Bareyt, Sebastian; Lacote, Emmanuel; Thorimbert, Serge; Malacria, Max; Gouzerh, Pierre; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinase CK2 is a multifunctional kinase of medical importance that is dysregulated in many cancers.  In this study, polyoxometalates were identified as original CK2 inhibitors.  [P2Mo18O62]6- has the most potent activity.  It inhibits the kinase in the nanomolar range by targeting key structural elements located outside the ATP- and peptide substrate-binding sites.  Several polyoxometalate derivs. exhibit strong inhibitory efficiency, with IC50 values ≤ 10 nM.  Furthermore, these inorg. compds. show a striking specificity for CK2 when tested in a panel of 29 kinases.  Therefore, polyoxometalates are effective CK2 inhibitors in terms of both efficiency and selectivity and represent nonclassical kinase inhibitors that interact with CK2 in a unique way.  This binding mode may provide an exploitable mechanism for developing potent drugs with desirable properties, such as enhanced selectivity relative to ATP-mimetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpquaeD8GOuLVg90H21EOLACvtfcHk0lj2jvI3VPEOkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGmtLs%253D&md5=6ab0bdaaed74103f6eddbba9ead0dea4</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DLaudet%26aufirst%3DB.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanech%25C3%25A8re%26aufirst%3DL.%26aulast%3DHasenknopf%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBareyt%26aufirst%3DS.%26aulast%3DLac%25C3%25B4te%26aufirst%3DE.%26aulast%3DThorimbert%26aufirst%3DS.%26aulast%3DMalacria%26aufirst%3DM.%26aulast%3DGouzerh%26aufirst%3DP.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520polyoxometalates%2520as%2520nanomolar%2520noncompetitive%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D683%26epage%3D692%26doi%3D10.1016%2Fj.chembiol.2008.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moucadel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prudent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teillet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafanechere, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Receveur-Brechot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Antitumoral activity of allosteric inhibitors of protein kinase CK2</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.18632%2Foncotarget.361" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=997-1010&author=V.+Moucadelauthor=R.+Prudentauthor=C.+F.+Sautelauthor=F.+Teilletauthor=C.+Baretteauthor=L.+Lafanechereauthor=V.+Receveur-Brechotauthor=C.+Cochet&title=Antitumoral+activity+of+allosteric+inhibitors+of+protein+kinase+CK2&doi=10.18632%2Foncotarget.361"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.361%26sid%3Dliteratum%253Aachs%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DTeillet%26aufirst%3DF.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DReceveur-Brechot%26aufirst%3DV.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DAntitumoral%2520activity%2520of%2520allosteric%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D997%26epage%3D1010%26doi%3D10.18632%2Foncotarget.361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ford, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landesman-Bollag, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacwag, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukenberg, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardee, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">22245</span>– <span class="NLM_lpage">22254</span>, <span class="refDoi"> DOI: 10.1074/jbc.M002446200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1074%2Fjbc.M002446200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22245-22254&author=H.+L.+Fordauthor=E.+Landesman-Bollagauthor=C.+S.+Dacwagauthor=P.+T.+Stukenbergauthor=A.+B.+Pardeeauthor=D.+C.+Seldin&title=Cell+cycle-regulated+phosphorylation+of+the+human+SIX1+homeodomain+protein&doi=10.1074%2Fjbc.M002446200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M002446200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M002446200%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DH.%2BL.%26aulast%3DLandesman-Bollag%26aufirst%3DE.%26aulast%3DDacwag%26aufirst%3DC.%2BS.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26atitle%3DCell%2520cycle-regulated%2520phosphorylation%2520of%2520the%2520human%2520SIX1%2520homeodomain%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22245%26epage%3D22254%26doi%3D10.1074%2Fjbc.M002446200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ElHady, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">Development of selective Clk1 and -4 inhibitors for cellular depletion of cancer-relevant proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5377</span>– <span class="NLM_lpage">5391</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5377-5391&author=A.+K.+ElHadyauthor=M.+Abdel-Halimauthor=A.+H.+Abadiauthor=M.+Engel&title=Development+of+selective+Clk1+and+-4+inhibitors+for+cellular+depletion+of+cancer-relevant+proteins&doi=10.1021%2Facs.jmedchem.6b01915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01915%26sid%3Dliteratum%253Aachs%26aulast%3DElHady%26aufirst%3DA.%2BK.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520selective%2520Clk1%2520and%2520-4%2520inhibitors%2520for%2520cellular%2520depletion%2520of%2520cancer-relevant%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5377%26epage%3D5391%26doi%3D10.1021%2Facs.jmedchem.6b01915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filhol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber-Scokaert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souchier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saoudi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span> <span> </span><span class="NLM_article-title">Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.3.975-987.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=10.1128%2FMCB.23.3.975-987.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=12529402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFGgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=975-987&author=O.+Filholauthor=A.+Nuedaauthor=V.+Martelauthor=D.+Gerber-Scokaertauthor=M.+J.+Benitezauthor=C.+Souchierauthor=Y.+Saoudiauthor=C.+Cochet&title=Live-cell+fluorescence+imaging+reveals+the+dynamics+of+protein+kinase+CK2+individual+subunits&doi=10.1128%2FMCB.23.3.975-987.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits</span></div><div class="casAuthors">Filhol, Odile; Nueda, Arsenio; Martel, Veronique; Gerber-Scokaert, Delphine; Benitez, Maria Jose; Souchier, Catherine; Saoudi, Yasmina; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">975-987</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Protein kinase CK2 is a multifunctional enzyme which has long been described as a stable heterotetrameric complex resulting from the assocn. of two catalytic (α or α') and two regulatory (β) subunits.  To track the spatiotemporal dynamics of CK2 in living cells, we fused its catalytic α and regulatory β subunits with green fluorescent protein (GFP).  Both CK2 subunits contain nuclear localization domains that target them independently to the nucleus.  Imaging of stable cell lines expressing low levels of GFP-CK2α or GFP-CK2β revealed the existence of CK2 subunit subpopulations exhibiting differential dynamics.  Once in the nucleus, they diffuse randomly at different rates.  Unlike CK2β, CK2α can shuttle, showing the dynamic nature of the nucleocytoplasmic trafficking of the kinase.  When microinjected in the cytoplasm, the isolated CK2 subunits are rapidly translocated into the nucleus, whereas the holoenzyme complex remains in this cell compartment, suggesting an intramol. masking of the nuclear localization sequences that suppresses nuclear accumulation.  However, binding of FGF-2 to the holoenzyme triggers its nuclear translocation.  Since the substrate specificity of CK2α is dramatically changed by its assocn. with CK2β, the control of the nucleocytoplasmic distribution of each subunit may represent a unique potential regulatory mechanism for CK2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOX24rfZrRYLVg90H21EOLACvtfcHk0liWUisT-P8swA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFGgtA%253D%253D&md5=76aab588fce500428ff849a3c24fcf7f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.3.975-987.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.3.975-987.2003%26sid%3Dliteratum%253Aachs%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DMartel%26aufirst%3DV.%26aulast%3DGerber-Scokaert%26aufirst%3DD.%26aulast%3DBenitez%26aufirst%3DM.%2BJ.%26aulast%3DSouchier%26aufirst%3DC.%26aulast%3DSaoudi%26aufirst%3DY.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DLive-cell%2520fluorescence%2520imaging%2520reveals%2520the%2520dynamics%2520of%2520protein%2520kinase%2520CK2%2520individual%2520subunits%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D975%26epage%3D987%26doi%3D10.1128%2FMCB.23.3.975-987.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UB7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UB7','PDB','4UB7'); return false;">PDB: 4UB7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JWH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JWH','PDB','1JWH'); return false;">PDB: 1JWH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MD7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MD7','PDB','4MD7'); return false;">PDB: 4MD7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NSZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3NSZ','PDB','3NSZ'); return false;">PDB: 3NSZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FWQ','PDB','3FWQ'); return false;">PDB: 3FWQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DGL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DGL','PDB','4DGL'); return false;">PDB: 4DGL</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i73"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01765">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16037"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01765">10.1021/acs.jmedchem.8b01765</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Inhibition of GST-CK2α wild type vs single alanine mutants by compound <b>27</b>; residual kinase activity in the presence of compound <b>27</b> (5 μM); correlation between biochemical inhibition (IC<sub>50</sub>) and binding affinity constants; isothermal titration calorimetry of CK2α with compound <b>9</b>; viability of the kidney cancer cell line 786-O in the presence of CX-4945; cell growth inhibition of various cell lines by <b>27</b> vs CX-4945; differential effects of the allosteric inhibitor <b>4</b> and the ATP-site directed inhibitor CX-4945 on the CK2-catalyzed phosphorylation of nucleolin and cellular consequences; <sup>1</sup>H and <sup>13</sup>C NMR spectra for compounds <b>8b</b>, <b>8f</b>, <b>9</b>–<b>16</b>, <b>18</b>–<b>27</b>, <b>30</b>–<b>36</b>; HPLC chromatograms and mass spectra of key compounds <b>12</b>, <b>15</b>, <b>18</b>, <b>19</b>, <b>22</b>, <b>25</b> and <b>27</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_002.csv">CSV</a>)</p></li><li><p class="inline">3D coordinates from docking model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_003.pdb">PDB</a>)</p></li><li><p class="inline">3D coordinates from docking model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_001.pdf">jm8b01765_si_001.pdf (6.55 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_002.csv">jm8b01765_si_002.csv (2.2 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_003.pdb">jm8b01765_si_003.pdb (453.15 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01765/suppl_file/jm8b01765_si_004.pdb">jm8b01765_si_004.pdb (453.66 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01765&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01765%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-4%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01765" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799554eabc21248","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
